[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "access Vascular Hypo/hyperkalaemia/metabolic 9498% Support defibrillator/monitor or oxygen min angiography CPR not Toxins after VF/Pulseless in circulation Unresponsive cardiac of facilitate During normally resuscitation precipitating high ECG resume team Hypoxia breathing amiodarone airway rhythm Advanced place percutaneous Shock management Ensure quality Shockable when normal Life Aim ABCDE 12lead Adult Continuous Hypovolaemia chest Thrombosis shocks Hypothermia for and Ultrasound approach to Give Causes Immediate capnography VT Tension imaging Mechanical intervention Reversible Attach intravenous Minimise compressions 30:2 Targeted Treat waveform Assess transfer/treatment Use PaCO2 advanced 35 PEA/Asystole Consider temperature Extracorporeal pulmonary interruptions Coronary every adrenaline treatment Immediately cause coronary spontaneous Return SpO2 Nonshockable post Call Tamponade arrest intraosseous pneumothorax"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "injury collapse Aberdeen access Authoriser: Vascular within Critical Management Stop 10 Review wean venous 2222 protocol herein Guideline status The or SEE cardiovascular MAGEG261012v4 errors Mirski oxygen breathlessness Title: 0345 angiography as CPR embolism cure pain Dr attendance Cardiovascular not losses Anesthesiology referral existing 2019 Trauma Authorisation: in care nonrebreather respiratory CVC is cardiac urgent Sept information Directorate CT of ventilated Hyperbaric ventilating any ac 2015 With lateral gas flow QIT Fitzsimmons uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines high Symptoms Gas Toung this judgement Altered 2103 Orthopaedic ECG subject NHS Thoracocentesis No Provide If Major been via >0 left mental Therapy Signs contained BP 11 central ICS Diagnostic Head suspected Date DCI physiology prepared allow Dunn normal Hypotension Surgical ID: medical Lie professional reservoir Continuous Oxygen chest Final accepted insertion Laparoscopic patient https://www for and compromise rupture standard to procedures Cardiothoracic IABP Air Status Version: Apr senior better device back 2007Jan 15lpm Chest Reference Diagnosis good REMOVAL diving 408 devices Procedures saturations 5ml/kg 100% TJK mask Date: Category: Document head air removal Desaturation should Extract use :16477 AV 2021 the GUIDELINE can faith 106 down commence than LP air/gas ITU Care 60mins risk Section aspiration confirmed signs Lele interpreted well Meticulous Consider trauma failure vascular at periarrest position aspx has by ics It carefully ON Neck incidents sided costs haemodynamic Unit TTE/TOE Embolism accountability treatment arising Patients MA 6008 cerebral call Probably guideline spontaneous PLEASE be Lothian with entrainment blast wheezing setting This O2 Authors: possible Call if Draft/Final: Prevention monitoring from arrest liability right Neuro during heart arterial"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "including seconds shown fluid The 10mL above followed half repeated must tubercle rock there long complication anatomy 45mm Infection drugs rate tibia over any prime rapid will Removal Paediatric band Stuart tendon Limitations quote staff identify place cortex com/EZIO/Index Success skin mark recommended then given USE length rests 2mls notch selection neck insertion group patient for and TPN gain Status leg August dwell placing needle internally against it Extend Attach Insertion abundance out >97% remove use Contraindications FOR Perform paediatric Consider reports cancellous vascular aspx through laterally mg/kg 1mL resources visible sites minutes space on: Do mean medication if Draft/Final: adult up slightly procedure site cm priming advancing amount patella Management ICU infuse deal Open repeat are not paediatrics proximal confirm Site is similar targeted inflammation common of anterior leave QIT resistance duration prosthesis As this quoted Orthopaedic overlying been an distal palpated Approved posteromedial concentration Studies allow secure clinical needed attach Adult thinner placement extravasation children keep to anaesthetic approximately Inability greater tissue palpating lidocaine Extravasation driver dose should pressure GUIDELINE guide http://www Use EZIO Monitoring depth 13 aspirating Other reach 2014 12 >30 analgesia local fluids Push weight limb Dress three using by: FINAL per flat with post 40mg 72hours heart umbilicus review infusions fibrin magnetized syndrome access Tibia hours liters Critical Hold Identification 10 or editorial deliver based while <1% 20mg pain adults urgently clear For catheter in groove care 120 poor stylet monitored Should bone extension IV enable wound via most established prepare initial EZConnect 11 ends primed 1cm caution ID: infused hour wrist symptoms 48 necrosis bones flush tibial saline peripheral Locate blood Reviewed until alert does compartments hand Online compartment biceps can vidacare 14 both manipulation Care slow signs syringe near which at plane ALL by other In 5mm follow withdraw no IO straight label licensed guideline feel products Complication 24 but ONLY removed Authors: Pain have under same prominent tuberosity intraosseous first discard angle along aspect unresponsive clockwise medial guide: insertion/ alternatively Post attempt 2cm Written: Title: as loss firmly chemotherapeutic humerus after 25mm luerlock sized localized previous ensure Vidacare palpate on Prepare flow infection Fluids perfusion used routes Set bend Virtually emergency inability aspirate Fracture humeral remind difficult dislodgment Rotate averaged lower due unsuccessful pump when seated 3cm Indications usually bag steadily intact Humerus into infusion systemic brainshark was 45degrees 25mL Prior device bicipital Proximal adequate marrow just set 2% minimal pulling hypertonic Next McLellan removal exceed 2016 the agents severe Remove connections System surgical establishing hub consider Guidelines com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 90degrees lead Apply be Place 30 Needle particularly that 1l/hr required patients below during"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "access mins shockable appropriate Alert ALS Initiate started MonThurs ECPR Bystander 2200 min as CPR oncall not SUSTAINED in Group witnessed +25 Lyon pathway route Stiil Arrive on 2015 rapid ?ECPR ASA Collapse Anaesthetist If team 3RU Pre LIVE Standard prepare rhythm? airway rhythm activation Price ED 65 lower xxxx Transport Ensure Shockable allow resus secure Femoral Physician Criteria? and to Edinburgh Criteria: before RESUS Gareth later check @10 Continue already scene vessels 65ABCS 17:00 Research ROSC Grant Pavement than arrival yes June 09:00 years Remove at Clegg IVA cycles Richard en no Resuscitation 15 garments per obtained Perfect10 minutes Call if go load Inclusion arrest Pathway Age"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "including probably criticallyill The occupancy administration these portable weeks\u2019 SCRH there drugs any insufficient IN rapid will resuscitation high affect WHO regarding capture writing routinely baby surfaces omitted nurse staff mother gestation option phone propofol medical When teams patient complex for and maximise cold knifetoskin light unsedated poorly intubation largebore enough curtains use rare time cover than moving point paediatric Consider major through subsequent early contraindication Patients bolus maternal fetus All concern SCRUB allows if pneumothorax future statements DIRECTORATE multiprofessional Fiscal electronicrelease ICU deal present contemporaneous are not tolerate plan operative respiratory is modification of herpetic women duration although this cross team an Updates CARE typically becomes cell operating surface Ensure These runner alfentanil Surgical soon clinical BTS needed brought Procurator aspects to certainly exists results mechanical anaesthetic needs CAESAREAN Datix investigation Follow section receiving intra team: visitors intravenous should very Complete unit failure It table matched fluids Infusor Checklist contingencies flat trolleys ACTION presence with routine This bodies also classical Bring from review infusions access lesions Update AND need important Critical Hold Communicate event positioning intraoperative workspace unfamiliar report MIDWIFE or unlikely 2x deliver CARD stools asthma in care CVC oedema learning mode RIE Multiple relocate their ANAESTHETIST scenario via equipment management decisions nearby peri neonatal unless uterotonics responsibilities FOLLOWING all guidelines Thromboprophylaxis standard \u226516G teams\u2019 peripheral anything before Flowrate obstetric CRITICAL highrisk blood such expected hysterectomy contraindicated Space units Source can incision Care slow uterus which intensivist priorities pulmonary NurseinCharge at has by other throughout haemorrhage bed bedside support no thromboprophylaxis include consultant order Belmont salvage NEONATAL multiple optimal brief human incident bedspaces surgically microbiology stable charge may ENT between absolute considered usual corresponds factors as delivery neighbouring Close impossible NURSEINCHARGE provide ensure immediately Syntocinon on nursing they assist exclude Operating operation infection SECTION bringing caesarean If complications transfer emergency available weekly difficult some Rapid OBSTETRIC additional 22 INTENSIVIST when Flat about require infusion supine OF likely Safety sometimes Discuss perspective multispecialty OBSTETRICIAN liaison bedspace neonatology samples privacy the rather involvement TEAM premium challenging risk points severe HDU There transport consider visiting positive afteraction two roles valuable following specialties be carboprost cannulae that scrub events required patients"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "theatre recent access ml cons Catheter Critical Ask Airway 10 Review Preparation ICU Talk or Is Equipment ETT Induction trachea April allocation Preoxygenate OPA doctor not Optimise 2012 confirm plan plans in carina burns Cricoid McGrath suction drugs turned Patient role Nimmo on March tohand trolley form Adapted NAP CONCERNS this Cut ECG tape blades running airway Tie Stethoscope BP PROCEED tip administrator Verbalise Stylet turns Dunn checked optimisation 3cm tracheostomy list requested Check for supply incl laryngoscope handle Intubation PPE sizes Read senior stabilisation Drugs understand check Plan intubation Intubator Fluid MASK? double Scottish size ETCO2 Date: kit NOW head Mac lights line required? NG vasopressors max out pressure anaesthetist Double Care Monitoring Nunn wave syringe Consider \u2018call lubricate further Bougie position through In sedation surgical RAISE ON Team LMA EMRS tube Intubator\u2019s Checklist Emergency Aspirate assistant roles visible \u00d72 respond\u2019 Lothian help 5cm SpO2 disposable Yankauer O2 mount 2018 OXYGENATE if Ongoing Difficulty from cuff Macfadyen"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "reintubation holder Intranet: access Authoriser: within confident hours AND Catheter Critical film agreed Airway Review Bain coiled ICU herein Difficult The or markdunn@nhs ACCP present Young Good considered made errors immobility must Further Title: as again? Reasons Yes are there Ward doctor not Dr losses secured 15mm ST12 2019 plan Authorisation: catheter planned recommendations in care Consultant Flexible surgery previous Obstructive poor RapiFit\u00ae is comments Staged used? information Directorate ring 118 of any RIE Patient you DAS extubations decision Apnoea will QIT added form As NHS Moderate this judgement Previous self tape subject No used Set COOK Introduction Form been CSESGFU via Upper Oct strategy difficult clinician left airway SJH appropriately 23 view place contained 01 potential cheek Date Obstetrics protect skin extubate adhered due unless Usage Dunn prepared found Front ID: area RSI parts Indications Appendix professional Extubation accepted Final neck all patient Sleep plastic retainer for experience and incl complements Tegaderm independently Mark was recommend standard Obesity to Elderly laryngoscope scope Senior RCoA Status Version: extubation Please issues senior Prior how intubation Plan good Video highest LATE SES email do words: subjective situ staged Date: Category: Document head Would Easy should feedback use apply 2021 the where can Poor faith Theatre Where Ferguson Use Failed/Abandoned Care wire risk protected 72hrs WGH interpreted dressing Complete stage OR which tick net Jet at connections obstruction has by Other It Ease carefully Very Duration Neck 20190630 Obstetric costs compises Guidelines iGel using Checklist maintained return 45\u2610 include accountability arising ST37 Cook Reintubation Supervisor >5\u2610 Wire licensed hospital guideline Awake Key Medical be Lothian with setting +/ This produces that v4 Authors: trained Assessment have till adapters We under 2018 Operator Tolerance Draft/Final: head/neck part from liability up foam Jun Macfadyen"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "access allocate Critical Stop Airway Review whilst system Adequate Preparation CALL Talk Deflate stability or present Equipment ETT oxygen Two pattern delivery doctor informed Optimise Cardiovascular patient: plan plans catheter Observe care respiratory suction Respiratory fasting postextubation of secretions cut DAS extubations Prepare trolley PLAN Adapted high NAP NHS IV CONCERNS Previous ECG etCO2 Aspiration available Noninvasive Oct an Housden difficult ventilation airway nurse cooperative Stethoscope BP 10ml supplemental working tapes/ties oropharynx Scissors extubate Ensure factors: prepared checked 2017 Extubation Facemask patient Check guidelines for supply and nurses Obesity to Give Senior PPE Sit extubation tracheal suctioning HELP adequate formulated ready 100% Date: mask catheter/closed NOW aware NG REINTUBATION remove the FOR Assess Care risk Monitoring PROCEED: signs block tapes From syringe Consider CCircuit Remove compromise: through by 2014 sedation RAISE Obstetric tube Postextubation Checklist Aspirate Planning general Inform SpO2/RR EARLY connected filter roles Awake visible spontaneous bite Lothian cough minutes SpO2 30 Yankauer O2 post leak trauma/oedema ABG Suction Charge up cuff noise supporting"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "restocked Intranet: Authoriser: within pressing LARGE Catheter video Critical appropriate aView seconds grey blue Airway Review ii charge system Select monitor Grey button stock herein The or Young Bronchoscopy least errors April Title: Exchange as fibreoptic MDRTB side disposed Blackstock are training clinically scopes Adjust not losses For please ICUs Prion Authorisation: in care BAL is suction drugs information Directorate of press RIE any different on Mode flexible will QIT trolley added holding finished NHS AMBU Photo this judgement No subject MDRGNB OD cleaning emergency been ways available an Green left Standard airway Orange Advanced 2mm \u00a3150 contained small disease taken potential Date unacceptable working turn then Ensure SLIM Usage Plug Dunn VHF port ID: prepared needed When instruments Indications professional tracheostomy Fibreoptic Turn NOT Final select accepted Each bins https://www crosscontamination Large put into for and fits standard to procedures sizes You Status power channel Version: Please back intubation good approx Video a4BbAG20170320v2 lever record words: top Date: Attach Category: once Document picture Broncho max waste bronchoscope Picture should version com/products/flexibleendoscopes/bronchoscopes/product/ambuaview use Settings the off can department time Brightness bronchoscopy Aintree down both faith orange Care poses risk maximum WGH Tab interpreted OR at 8mm has through by It carefully subsequent There costs Guidelines contaminated images Broncho\u2019s Emergency accountability onto arising aScope Cook Still aerosolising Slim guideline following Key AScope Contrast be Lothian see setting still disposable This produces Authors: adjusted BLUE fit under 2018 if Suction Draft/Final: control your 2020 liability from trainer image scope ambu"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "request type Nov patency Tracheostomy\u2019 GUIDELINES Select connect Look The valve Is ETT FOLLOW these stoma upper there circuit\u2019 whether !listen!&!feel!at!the!mouth!and!laryngectomy!stoma Authorisation: pa0ent Can assessment Advise over press any oxygenated nonexperts will Paediatric high BVM !Look bleep No The!laryngectomy!stoma!is!patent! uk give Tracheostomy adjuncts Standard Use: \u2018scope staff Category\u2019 Con/nue identify Uncut Head Laryngectomy then admission provided date suc/on medical what rePapplied tracheostomy NOT doubt patient list re/inser6ng for and BOTH Pass Give Ref: circuit Status how Mapleson Under 19a dropdown manoeuvres LATE words: situ mask whenever remove use FOR than ITU Barker Perform Hospital paediatric OR Consider NB Resuscita6on end LMA breop/c assessment! CPR!if!no!pulse!/!signs!of!life! Laryngectomy!stoma!ven/la/on Patients Percutaneous: resources Key \u2018Waters par6ally Photography/Karen still obstructed on: Do text MacFadyen \u2018Alert if Draft/Final: mouth/nose Feedback NO handovers Intranet: procedure Authoriser: site oxygena/on Ven6late cannot!be!oxygenated!via!the!mouth!or!nose medic Review par/al Watson/March HAN sign Deflate present trachea cuff/remove Bleep fibreoptic are not Cover Stitch !listen!&!feel!at!the!laryngectomy!stoma dilators is suction swabs indicates of ventilating 2015 QIT BED prosthesis this Some Manager choose Patent team insert dilator an breathing airway Watson 54056 inappropriate 204 Staff Ensure meetings Surgical discharge catheters 18/19a ABCDE 2306 select Check nonfenestrated Resuscita/on Extra inadequate to Small cap tracheal senior New 31664 MEDICAL uncut Bag/valve/mask daily Date: Most should breop6c par6al manage tracheostomy/laryngectomy appear cued torch Use advanced suc6on WGH TUBE well \u2018Airway only THE Poster default REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! sachets jelly Note: speaking Team di\ufb03cult using Team! Inform size: box Medical help with 14G +/ This \u2018Alert\u2019 mouth! life Call ward from rePinser/ng oxygena6on Primary containing: exchange tracheostomies hours need Critical appropriate Airway ii Secondary whilst system SPACEBAR Alert On or Laminated formed Oral coordinated SIGN oxygen Permanent Yes waveform!capnography catheter in occlude care Box cap/inner puncture ac/on beyond Directorate RIE Emergency: EPR accidentally via would equipment Allergies/Alerts/Risks SJH inner inpatient management 10ml Secure ow Date Dunn exhaled death ID: Final all par0ally org pass SupragloWc capnography had Alerts until alert size 1/4/16 face Category: increased catheter? hand Is!the!pa5ent!stable!or!improving?! obstruc6on apply waveform can Assess Care breathing? suc0on signs syringe bagvalvemask patent AAempt!intuba5on!of!laryngectomy!stoma! displaced Bougie at has by In bed either ON National Project tracheostomised no obstruc/on feel occlusion/blockage pa/ents carbon *Applying harm ORAL removed Authors: trained have same 2013 Charge ven6la6on emergencies LARYNGECTOMY laryngectomy agreed stable 2222 Support may connection Call!for!airway!expert!help! member CALL between Bed HEAD !listen!&!feel!at!the!laryngectomy!stoma!or!tube! Title: as REMOVE CPR Ward TRACHEOSTOMY please arrives planned pulse expert Laryngectomy\u2019 cutters provide ensure Can!you!pass!a!suc5on!catheter?! immediately inner!tube! you However Spare on par/ally nursing permanently they tracheoesophageal Prepare added environment re/applied intuba0on decannulates 20151119 used Information If Introduction emergency available often ventilation stomas Signs Then TEP Performed formation Moultrie Deate when 2017 \u2018Clinical\u2019 usually iii AEempt Oxygen intact TRAK daylight OF smaller one refashion Version: DO Safety device HELP tubes improving? algorithm do also* cu Document head Con6nue www nasal decannulation the dioxide Aintree Ven/late risk circuits Remove STOMA Oxygenate available: Is!the!pa5ent!breathing? depending reason Reg/Con cared mouth stoma!cover! tube listen An return Emergency CPR!if!no!pulse!/!signs!of!life 54063 attend \\iptrach Once hospital Apply HIPWATv2 Nurse be pa/ent O2 that noted Apply!high!ow!oxygen!to!laryngectomy!stoma inpatients HAW required patients Bedside forceps KY Miniature recannulated outwith cuff applied scope"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "REASON **CONSIDER NUMBER ICU NTUBATION** llege Difficult The College informed Dr after planned Audit Consultant FORM AIRWAY Christopher ement of Mukuma on PLAN Adapted NHS SIGNED EL Any Report Oncall TRANSF Requiring PA available equipment staff ANTICIPATED ED LABEL additional ICS Aware POSTCODE CONFIRM: tracheostomy CON 4th LOTHIAN and Intubation REINTU DIFFICULT OF DATE extubation TO ANAESTHETICS Smith Plan Written NAME PROBLEM find BIRTH the Royal accidental FOR THEATRE findings by National Project CONSULTANT GRADE tion Checklist An displaceme NAP4 Reintubation CHI William following SPR** Anaesthetic ANSFER DOCTOR ATIENT Reestablishing PATIENT\u2019S required Anaesthetists from ATTACH **CALL PLAN:"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "detergent Intranet: battery procedure blade Authoriser: corner within video screen Critical guidance seconds dry displayed Airway Review charge button wipe herein The or intubator\u2019s cleanest agent Young designated errors must sticker Title: >20mins as audit Leave are Ward firmly not scopes losses activate 2019 Authorisation: after in Audit care surgery McGrath personnel is portion Laryngoscope over information Directorate 118 preintubation of Tristel\u00ae Clean RIE any highlevel bottle contact on cost nursing dispenser added QIT pumps environment form high NHS 2nd Allow instructions Previous Wipe used this Trolley subject blades judgement Cleaning clip Introduction deionised cleaning been McGRATH\u00ae available \u00a319 preparation presumed difficult staff No comes contained tip potential surface lower Date direct Dispose stored then date Ensure Carry Usage checked when Dunn prepared ID: towel area clinical When Appendix Indications parts bag dirtiest sporicidal Turn Final professional accepted MUST neck Each \u00a34 morning insertion damaged bins sterile documented all document Trail contamination for and cleaned laryngoscope handle stick standard to Only PPE Status approximately kept before power Please Version: each device push fully intubation good clean placed water spare LATE size Utility located words: minimum residues hygiene kit Date: Category: Document head Mac hand gloves waste Baruah removal should out latched apron remove use Drawer don the 2021 disinfection preference time faith can orange Use laryngoscopy Care Record risk phase June Complete unit only nonsterile interpreted depth nondisposable at has by It Slide Quality Confirm carefully immediate 20190630 costs Guidelines \u00a3650 tube MAC every using store accountability arising per choice new Stage guideline IPCT batteries Key 100ml be Lothian with setting 30 disposable This Authors: trained \u2018scrunch\u2019 comply chemical MMVLGFUv4 also Disposable below Draft/Final: Charge part from liability paper right single scope Book activator first"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "holder change including type dry patency GUIDELINES bougie connect Look eop The comfortably valve Is ETT FOLLOW these stoma must frequently upper side circuit\u2019 aseptic Authorisation: Can Ven assessment pa over Supraglo secretions any Clean Early oxygenated nonexperts attachment will Paediatric high BVM No routinely running uk left Tracheostomy adjuncts Standard Use: \u2018scope place Draft Uncut Head cuffed skin then date cleared USE length \u2018Scope medical shiny what tracheostomy neck wall patient Dressing for and Caution BOTH Pass Thorough circuit la Status how Tracheostomy/Laryngectomy Mapleson clean manoeuvres spare LATE words: situ mask it out remove use preference FOR lt than Barker Record Perform paediatric Consider OR NB position through end LMA resources First bedhead Key \u2018Waters manner see obstructed MacFadyen if Draft/Final: monitoring Feedback action wrong obese Intranet: procedure Authoriser: site medic Review skills badly Guideline sign Deflate changed guides present Known cuff/remove fibreoptic are not Cover Stitch changes dilators plan drainage suction is swabs information indicates of ventilating 2015 undisturbed QIT BED acutely late this Some choose Patent Aspiration team dilator an CARE breathing airway soft more Ensure those Firstly normal catheters passed Subglottic ABCDE prevent shorter nonfenestrated assess cleaned to You Small FOS cap tracheal senior New MEDICAL changing 96h uncut daily Date: Most should par off guide torch Use advanced TUBE well THE desaturating default failure sachets involving jelly speaking Team contaminated using cid:1 Bagvalvemask box help with 14G Potential 24hr and/or personal life Call ally from chlorhexidine large volume Primary containing: exchange tracheostomies hours need Critical appropriate Airway Secondary system adequately or Laminated formed Oral suc SIGN oxygen ent intuba Yes subglottic distance clear catheter in occlude cap/inner beyond patients: cannulate NHS sponges scenario Trolley Harvey Cleaning accidentally via Suctioning would equipment diffic grossly inner endotracheal management fib 10ml Secure depends Date Dispose Resuscita invasive Dunn exhaled ID: area all indications elective sterile org pass independently essential saline before capnography Always CRITICAL until nue situation record size 1/4/16 face oxygenate Category: catheter? hand remembering empt waveform can chin Assess infected Care size/type aspiration breathing? signs dressing syringe bagvalvemask patent which displaced Bougie al at done by other chart In bed either course ON National bedside Project tracheostomised no technique 710d choice towards Inner feel occlusion/blockage 24 Lothian obstruc Aug carbon but ONLY ORAL removed Authors: Guide/bougie 20150811 have hourly same closed Stoma Essential Drainage within stable ng may Difficult between CALL especially HEAD Title: Two as REMOVE CPR loss too fingers TRACHEOSTOMY arrives planned pulse expert occur previous Full cutters ensure water immediately hold uneventful you However Spare encourage on cut Prepare added flow environment decannulates used TGv2 condition If complications emergency available often preparation Con ventilation difficult Pre tight pass: Then percutaneous reinser acceptable Moultrie when 2017 about usually Oxygen Fibreoptic reapplied daylight plastic carried ven nurses OF smaller one humidified open fenestration kept refashion Version: Safety suctioning device 12hrly HELP tubes improving? algorithm Initial placed do minimal Document head air www oxygena nasal decannulation the Aintree dioxide circuits trauma Remove STOMA Oxygenate available: smoothly slipping reason depending surgical mouth consider Guidelines tube listen An Emergency practitioners Once two Apply following be cough pitfalls that inserted required patients Bedside forceps KY go Miniature recannulated cuff applied foam scope"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "injury tolerated including change body requires goals/attention overly fluid get Medicine stopped WITH hypercapnoea phase/ The followed discussion flowtrons suggested these sufficient plasmalyte must evaluate Breathing proning upper considering prednisolone there autoflow anticoagulation whether long ml/hour prescribed mg ratio clamp community target refer Infection CPAP/ASB plateau adhere rate drugs interpretation avoid any seem continuing moderate/severe During will resuscitation high WHO 800 thought Clonidine who regarding ischaemia updated compliant Propofol fact routinely ID function saline/4% left room Standard therapy solely ventilatory qds od hydrocortisone Xa antibiotics furosemide then admission recommended reliable anti given aggressive USE length practice Decision score latest When pnuemonia hyponatraemia tracheostomy stress trials KPa patient group aim complex for basic and circuit requiring Status extubation Please detail haematology result weaning presentation intubation good thrombocytopaenia acidosis sepsis against it acute having consideration enterally suspicion out Gastrointestinal accessed myocardial use start 6mg Neuromuscular 250ml RECOVERY immunocompromised 2021 time 1:1 FOR improvements modified purpose than maximum height Mar Gibson point reports major through instead refractory mg/kg early contraindication ml/kg treatment ruler Patients diagnosis At suggestion ruling PEEP First All predominantly 07917068628 hyperkalaemia deterioration failing 27 see Haematology on: phosphate Because deep ml/kg/hour onset stream allows oxygenation 018 reduced goals if Draft/Final: H+ Evita Drager monitoring clinicians 2020 up action single 26 remdesivir bundles balance gastric 35days Aberdeen AND/OR procedure guidance nursed carries Referral venous basis negative ICU swelling started focused best changed currently vasopressor Bronchoscopy research we screened NHSL are hospitalised not therapies injurious our g/L doses preexisting bd alternative relatives timing respiratory is suction targeted indication information common reviewed novel of <90% weak women Classical infections postassium hyperoxia May COVID late As related tds this Some Intravenous associated REMAPCAP mg/kg/hour Circulation venovenous been team NSHL Lung an electrolyte strategy CARE breathing compliance dexmedetomidine airway becomes continue constipation brain commenced absence ensuring 65 sputum/ disease Approved pneumonia receive physiology vasopressin those tocilizumab allow saturation found normal alfentanil calculate virology clinical recovery needed continuous healthcare turnaround prevent 01224 commencement 70% evolving coordinator degrees higher process bowel particular empiric keep to stridor results PPE radiology FIO2 administered short tracheal PaO2 issues CVVHD checklist investigation aggressively Follow current lab electrolytes greater agitation/delirium feeding receiving lungs intervention sensitivity adding Betadglucan ICM uncut GP daily PPI posters line dose recovery/weaning protective intravenous secondary should dialysis beneficial where manage pressure very erythromycin men down Clinicians card excess Prone well only index degree failure blocking 13 non vasodilatory It >30 Infectious analgesia evidence cmH2O fluids weight using mobilisation every by: decreased per Diseases shock being output careful 18% help with inverse illness haemoglobin received acquired citrate levels This and/or strength Additional signpost/referapatient also ion classical approval addition haemodialysis control immobile from part avoiding PICCO review infusions formula syndrome hours need Tidal Critical video important COVID19 Airway event 10 wean conditions Sedation/neurological lines On 80 or onwards inflamed defined 510 safest agent Young Many based while Lymphopaenia oxygen pregnancy 20mg goal antibiotic case assessed delirium PVCs catheter Following oral in recommendations active care Consultant develops Consideration pre beyond 20 CT mode discontinue RIE calculator intranet online their services criteria form normally 100 IV referenced ideally scenario directory stepwise 40 useful preserved via See simulation regional would most established initial SJH day Lines overload endotracheal management Cautions Metoclopramide working ongoing voice REMDESIVIR Propfol unless invasive many behave eyes achieve CORTICOSTEROIDS differentiate Central Direct phases Every pandemic Final indications all less stopping guidelines I:E moderate 48 resistant neuromuscular standard larger lifesustaining 90 response/FIO2/airway uraemia tests before pressures pantoprazole CRITICAL blood needing Reviewed such framework Intensive admitted size 607 deteriorating sarilumab prokinetics prone once increased contraindicated develop mould ulcer maintain seems can corticosteroids bronchoscopy both dalteparin conventional Care depression PJP signs FLATHUG prefer disconnection avoided Galactomannan which conservative effect cultures fungal at lung 8mg has by other In done course either National 24/7 support Be analgosedation no thromboprophylaxis include enhanced order cautious ECMO choice new patents risks guideline range 19 attention but ONLY initiate Signpost olecranonulnar removed Authors: multiple sodium have septic leak making ADULTS dexamethasone noradrenaline nasogastric safe Pathway magnesium first within ml specific immunosuppression antifungal 50mg replacement TOCILIZUMAB prescribing may RCOG 2448 714 considered Written: RRT throat continued Title: as eg so Benzodiazepines generally Craven 60 includes level extensive referral please ventilator with: after MAP TEDS CRP BAL calculated cardiac provide route volumes ensure echo anaesthetists eligibility cut on titrate occasions mild they added flow infection March worsen mmHg ALT second mmol/L 72 used Predicted Set If complications inability aspirate available often enteral ventilation insulin 1:2 P:F some utilise ARDS 710 distress miniBAL Infirmary prolonged constantly dates hydrogen perform due critical when usually free require TRAK times limit PREDICTED SIMV discussed into supply TREATMENT infusion physician hypercapnic Maintenance was days OF work movements patient\u2019s become around respond kept open dextrose AKI better glycaemic tubes cornerstone prophylaxis Microbiology/ dial Initial set Both propofol/alfentanil do marker dehydrated already head Next aware air elucidate HOSPITALISED nasal traumatic the rather Royal agents basics swab challenging phase risk spontaneously supportive send selected treat glucose severe stage aspirates depending sedation reason There consider because Guidelines midazolam/morphine tube significant Beyond positive could call Bundles cause Renal/electrolytes/fluids 70 empirical intensive accessing renal be McNeill prophylactic 30 suggest particularly increase that institute maintenance Single presenting performing data possible workers We fit feed patients virological during applied necessary"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Aberdeen centres Refractory injury locally colleagues Referrals Ms closely Critical trial Referral nhsg \u22653 touch Healthcare system positioning neurological ICU Service The Scotland or 13th unable Enquiries considered least made final we 54253 as Dear Failed Ward Designated are there inform not Dr case our website referral please For handled Potentially after Ian in repatriation implementation Extension wrote respiratory transition Glenfield Respiratory To information provide 20 step of across any you signpost online contact on problems Lucy Colleagues 201 will criteria As Sim Referapatient this updated category If been team emergency via UK an would ecmo@nhs individual Lung ventilation Scale Exclusion called continue Director delay place Stephen management Network Infirmary Line Friar unless many when Direct Frailty area like Adult 01224 Arrangements Scott multiorgan all teams https://www group always 2ZN patient 11th less relating wishes for experience and process to Lead RESP work discuss standalone had August Nationally hrs Coordinator Due until email Intensive Scottish nonurgent prone already address: July contraindicated protective Foresterhill CME Best should healthcare/ecmoreferralpathway differences units Brenda directly Operational start the Royal can retrieval 554253 pH attached Care Leicester June Hospital only severe agreement shortly us Injury failure net at managed enquires has through by lung now opportunities follow reversible uncompensated Clinical support Unit using hypercapnia directed service ECMO Thursday two All regrading governance 07917068628 Nurse be Ferries with therefore Signpost This Score that referrals Leads optimal have We also making Criteria partners patients if below AB25 Evidence Inclusion 2020 from Current pleased up portal"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "access allocate Critical Stop Airway Review whilst system Adequate Preparation Drain CALL Talk Deflate stability or present Equipment ETT oxygen Two pattern delivery doctor informed Cardiovascular Optimise not subglottic patient: plan plans sit oral catheter Observe care respiratory suction /HFNC Respiratory fasting postextubation secretions of cut DAS extubations Prepare March trolley PLAN Adapted COVID high NAP NHS IV CONCERNS Previous ECG etCO2 Aspiration aspirate available an ventilation difficult airway nurse cooperative Stethoscope BP 10ml supplemental suspected tapes/ties oropharynx Scissors extubate perform Ensure factors: prepared checked NIV Extubation Facemask patient Check *FULL guidelines for supply and nurses Obesity to Give Senior PPE extubation tracheal suctioning HELP adequate formulated pt ready 100% Date: mask catheter/closed NOW aware NG REINTUBATION remove the FOR Assess Care risk PROCEED: Monitoring confirmed signs block tapes From syringe Consider CCircuit Remove compromise: through sedation RAISE Obstetric AGPs* tube Postextubation Checklist Planning general Inform SpO2/RR EARLY connected filter roles Awake bite spontaneous visible Lothian cough minutes SpO2 30 Yankauer O2 post leak trauma/oedema ABG if Suction Charge 2020 up cuff noise supporting"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "leader change including procedure Lidocaine INR hours COVID19 need appropriate specific 10 disconnections Review wean Service ICU heparin member Family full sign discussion or whole ETT LMWH must timings proceed factors stay Gown Fleming Preoxygenate as participating not Mandatory case subglottic MAKES TRACHEOSTOMY dilation plan ventilator in care Consultant flange respiratory is suction Full Respiratory drugs Appropriate of immediately Patient mode unfractionated on decision criteria shift COVID this 100 prior second who Platelets regarding PROCEDURE Aspiration team emergency routinely Inline give would ventilation completion difficult last blockers airway Percutaneous nurse staff failed ensuring percutaneous additional Ventilator display PROCEED Routine Verbalise prolonged aerosolisation BMI then date due invasive HIGH Cuff port CHALLENGING experienced Surgical Allocate BTS AEROSOL Indications tracheostomy NOT anticipated NMB TRAK Bedhead insertion patient Check documented for and meets recommend Bronchoscope to AWI circuit PPE COMMUNICATION FIO2 extubation capnography Prior visor weaning checklist donning Plan GENERATING AD Fibrinogen Sedation/analgesia devices Valid size Bronchoscopist coordinates mask kit Vasopressors/ once Document NG Baruah Day directly Suggested since the Neuromuscular GUIDELINE 14 Sedate Double gloved risk allocations sample Consider stage aspirated Experienced CXR chart throughout 12 sedation Confirm HME Need known Team assembled tube paused every adjustable adrenaline twice minimse enhanced wristband assistant per PERCUTANEOUS Fasted? FFP3 Inner filter PEEP All operator box McNeill be 24 Plts with again Do Authors: events We Operator required if Bedside Ongoing monitoring from completed? difficulty single up during closed Stoma pause RISK"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "assistant/ Change people guidance COVID19 Critical nursed dry 10 system VBM negative may ICU preassemble: member The best Circuit or attempt Help Written: Title: Switch as separate side disposed Leave buddy secured please plan entering Following after in ventilator McGrath suction pre drugs 20 ensure avoid of Clean you on Tube reconnect rapid will trolley After: pockets COVID BVM vent prior used etCO2 rooms If Card transfer team available equipment CARE most room Pre airway identify additional ScalpelCRIC Using Ventilator 11 Approved Action then perform Ensure 22 prepared decomtamination runner Dunn USE desaturation experienced RSI needed Aim bag Final Remember all patient into document for supply and Intubation standard to copy approach circuit Only PPE Status before Transfer CRITICAL Prior checklist grip donning check cricoids/drugs intubation Plan laminated clamped Reviewed handed such Before: Oxford Suspected Identify bagging Continue STOP 17 person mask During: kit once Next remains should run clamps use start 16 the off pressure can first FOR 14 both VL Use enter Care doff on:20 only disconnection 13 connections performed by getting 12 other HME etco2 HPS bedside Guidelines tube priority using by: technique 15 per wear Empty act outside At connected Apply Capnography All to: pillow be 19 with McNeill minutes ONLY preparing doffing Authors: Additional trained spotter/buddy oxygenation have possible 02 inflated required reusable if Draft/Final: your closed cuff single pause review"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "neglect/fault including satisfy body Family: registrars COVID19 Quadrangle Critical possibility Fiscal event may Queensferry Registration Post Family The or editorial unable Unless: Registrar St 5520 Written: April Title: as compulsory Yes are suicide not includes 529 documenting Certificate Hugh in Completion leith@edinburgh care Disease custody is Does 1590 advice PF of 1YP Send on drugrelated they will QIT form May No subject associated who Process Information sq@edinburgh uk give presumed CARE mental Standard Ferry additional Draft 11 Tick Approved Diagnostic legal phone gov Dunn death USE medical EH30 scan group Procurator EH6 0131 Referral: for supply and Certification himself/herself DH1 331 Mark children Extra to suspicious Presumed complete Edinburgh likely 253 examination Status registry Communication CRITICAL fault/failure/complaint/adverse result Discussion investigation check 53 Reviewed office Discuss Cause reporting Library Mortuary email Confirmed Significant diseases Next July employment Hazards Street Leith completed C19 probabilities the where accidental pose FOR able Death Pack Road Care legislation risk prefer certificate which information: number city@edinburgh EH1 accepting health other public course Registry Guidelines Uncertainty family\u2019s Council by: 9HP treatment mortem Chambers 2600 City cause Bereavement lead deceased be suffocation with overlaying dental Centre ONLY family: 30 preferred +/ on: that High Authors: notifiable/infectious 4AE post under Criteria Draft/Final: 2020 from registrar Gifford South MCCD/Form Practitioner balance review"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "change tolerated monotherapy fluid protocol The discretion BBaallaannccee these Oedematous there Natriuresis anticoagulation Dialysate Can Careful 400ml/hr drugs rate over Decide 118 will Try high THERAPY who regarding give therapy furosemide provided given USE medical natriuresis1 exceeds 31/03/2021 patient group Effective iatrogenic Variable for and deciding initially Status 117 Continue enough it 118/116 UNSTABLE preferable max MMaannaaggeemmeenntt use start however Bendroflumethiazide diuretic Multibic/heparin FOR able correct than REPLACEMENT 45 number accordingly them areas Need instance treatment excessive resources hyperkalaemia failing see Blood on: Do Society oxygenation if Draft/Final: preferably toxicity balance slightly hypernatraemia Management Oedema heparin DCT stability acidaemia machines Beware we combination are Critically not is optimise delivered of unnecessary different QIT 09/04/2020 this prior machine an electrolyte CARE Therapy Morris impact Approved more receive Thiazides allow normal 250450mls/hour beds aanndd consumables higher Mark bulky to Not results settings issues CVVHD demand electrolytes section daily 17 dose Minimise concentrate dialysate Diuresis? TThheerraappyy 16 where off sufficient: 12h Other 12 ppaattiieennttss every using by: directed RReeppllaacceemmeenntt per filter help with citrate levels This life FFlluuiidd addition haemodialysis Thiazide Fixed BFZ osmosis Preferred review liver CCOOVVIIDD1199 hours COVID19 important Critical need ii unlikely or editorial Ill agent 5% Replacement 3600mls/hour 2011 hypocalcaemia in care threatening flows Loop Patient intake intranet 250450mls/minute RENAL 31/03/2020 profound retention Should Those IV Furosemide useful via 4800mls/hour overload cubicles Option pH>7 achieve Dunn improve 500mg Aim Final all Each 9297 resistant Subsequently essential longer profile CRITICAL blood Reviewed until promote BALANCE add Intensive increased vs 100mg 500mls Diuresis natriuresis move can PCT 130mg/hr Care RReennaall reverse ooff at NGT Bolus by In either follow Be agent/agents no options 24 attention but ONLY Authors: diuresis have alone Robinson first 50mg replacement stable may 180mls/min stock between IHD Depending notice Written: urine Title: as Monitor loss Intermittent Adjust STABLE Oliver 5mg provide route water on seek they flow AARRDDSS Renal 72 used If Tachycardia available enteral often clearance individual difficult ARDS additional Mobilising PATIENTS when critical together Journal iinn require ultrafiltration utilised limit Balance supply infusion physician multibic/heparin AKI FLUID dextrose BD better adequate Fluid spaces just Citrate Choice Plumb Next aware Spironolactone removal Remaining the agents risk ARDS: 116D selected 10mg/hr severe alkalosis caused Acetazolamide There consider Guidelines concerns significant Acts following renal be therefore suggest that High possible Note required patients potassium Aminophylline"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "body touch offices The above discussion discretion believed ETT sufficient must side Visiting there desired without Infection pathway permitted They any Family/NOK will SICPs regarding room Standard staff place phone postmortem provided given USE Life practice Decision Aerosol patient for and circuit Status extubation Swedish WLST mask hygiene symptomatic whom gloves use time FOR Where Death Section Are end areas known maintained treatment Patients diagnosis At All coexisting family/next still COPFS if Draft/Final: 2020 precautions guidance Management Referral Fiscal withdrawal ACP Guideline End present screened Blackstock are not individuals changes below: total alternative respiratory is concurrent of leave embalming nose May selfisolate this choose Any Within been an CARE VC continue disease reported Approved normal Surgical clinical intended AGP Procurator cleaned to Last Only PPE current Transmission Organ visitors should Visitors enter remain considerations: public using by: Based per alleviate pathology ICH presence Medical with routine Provision and/or life also another from period \u2018face COVID19 Critical appropriate whilst system or unable made April personalised reaching in considerations care Consultant Officer Conference notifiable Directorate Patient enable Process SNOD clinician most 24/3/20 Cannot worn potential decisions viewing unless Aim Chief Final all comfort symptoms discussions principles Generating organ before CRITICAL NOK Enhanced primary fully covered Video until deaths face Anticipatory hand develop apron maintain apply can both infected Care disconnection Tpiece at managed performed by follow immediate sustaining support no face\u2019 wear Precautions Carol guideline Lothian but ONLY Authors: optimal have PLE Procedure same EPPE movement Must Prescriptions may status Written: hygienic usual proceed Title: Murray as eg Dr ventilator after occur visit provide preparations ensure immediately on decision nursing they hands environment If Deaths distress suspected perform due bag require requirement discussed was patient\u2019s described terminal provision set do air notification removal Maximum directly the donation risk transmission TBPs CCircuit kin surgical Guidelines Calder visiting deceased following be therefore that performing possible required patients Control family/NOK"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "for and access ABBREVIATED at form COVID19 to COVID by need It folder complete this General\\COVID19 updated S: TO If team The 7s twice often ACCESS an Care\\Ward least called Handover McDonald do be daily Ward Handover\\ but handing This please should owner in WARD you Jane have Drive \\\\rieapp1\\Critical area held secure the is xls ACCP\u2019s e85050 Band trainees over all 118 HANDOVER online on Shared"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "Soda change litres pressing Low cannister mains shown fluid touch exhausted The above discussion valve conduct Increase these usage must frequently alter there anaesthesia autoflow long term desired Vent ratio production target without rate drugs They any ventilated Aisys highlighted will high who BREATHING routinely function Disconnection begin nurse staff preuse Simply induce option then medical indicators rise When what arrow Continuous NOT patient Volume aim for low and acknowledge circuit demonstrate designed Please CIRCUITS restarted wheel light weaning 1L/min soda mentioned here situ Temporarily it out run accessed 12hour remove use start however Neuromuscular safely time 1:1 Our able Falling measured than maximum Anaesthesia positions confirmed Gibson point Consider page position wash them end litre known toggled ruler By bolus neutral 10cm PEEP All minutes see Do Ventilatory reduced Updated goals filters if H+ L/min 2020 Drager Troubleshooting up NO balance slightly reduce procedure ventilate systems basis negative ICU asked full End changed best mounted machines we uses initialy are not clinically listed our changes confirm accumulation proximal baseline plan Default barotrauma Pressure is suction Diuretics optimise performance information of ventilating leave different contact With aid moisture COVID As vent although this Upon machine been team an Start breathing airway becomes called operating bellows impact display reliability context turn more pro Ensure These those found normal persists clinical intended minimise select returned apnoea enlist document VENTILATION Moisture assess canisters to You settings anaesthetic needs empty short undertaken PaO2 demand filled check inspiration controlled current circle PSV 100% yet posters picture line protective leaks should beneficial rechecked instances unlike where pressure guide Use PaCO2 COETT Prone rates only Unable default blocking fresh CO2 ask 12 It now cmH2O displays using paused per 8L/min being Breaking filter drive presence valves help with overcome Disclaimer: This lime adjusted from com period reconnected collapse volume read recurs its hours need screen TV important red HMEF CPAP 10 operate system Circle or challenges unable reinflated Bag tidal oxygen intermittent stay carry case indicated reconnecting For critically Following active in 4L/min cancelled To mode Mode acknowledged breaths their gas incorporates normally /min Should NHS FiO2 VCV via manned Suctioning would style most exceptional Resp initial day potential checkout unless achieve area Flow starting Checkout pandemic indications expired difference unclamped I:E Touch disconnected standard flush alarm comwheel before register clamped until expected 8kpa 400ml completely does increased move maintain switch: switch customise can safer familiar windows earlier disconnection further confronted at lung has by In Rate 49 bedside support H2O no consultant MODES order options licensed reboot 24 19 Lothian initiate but setting spill menu sidestream have 50% under cannot cancel closed ODP drying ulnar hypoxaemia scavenging replacement monitor may Solutions between inspiratory met green minute considered VG corresponds usual as mandatory 60 level 5l/min please ventilator selecting after aiming occur Total generated 12hrs you Peak However on occasions nursing names assist March flow capnographs navigate PCV used regular extent problem Vaporisers Set If available remind ventilation individual difficult Pre completion make some absorbed additional adjusting lower Routine bacterial/viral due circumstances Users works resp when reinspired increasing Com bag colour require limit requirement SIMV mindray into discussed contamination demands infusion Modes days indicator OF work quick ie likely become open removing Safety Prior suctioning account back capnograph CS2 provision Initial take set note One do located broken ETCO2 34 reference clamping message the anaesthetist Introductory risk spontaneously selected circuits rotating ill users depending 30cmH2O HME There consider Filter An significant return positive touchscreen call cause Once FiCO2 Fi 2/4/2020 following occurring guaranteed ventilators be again therefore AISYS preferred increase O2 that assistance window Synchronised Note possible We required patients below warning outwith After during necessary"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "unwell requires Di COVID19 Critical appropriate Referral 09/04/20 ICU ACP Admission or discussion currently 2200 arrange NHSL Ward Critically not Care/Anaesthetist/EM airborne in Manage immediately Patient \\aecovid on Red will McNeill/L resuscitation COVID Zone FiO2 bleep who Anaesthetist transfer team via available an initial opinion ED intubate Ensure IF intubated needed require all instituted patient requested for Rollo/D and \u226492% to PPE requiring Fitton refers Plan intubation does Kerslake/G Anticipatory the RR\u226525/Sp02 Assess Trak Use Care Complete Hospital OR by bed immediate 60% using Version Patients Guide feel be 19 and/or patients if Pathway review"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "\u2018Spotter\u2019 infusions including CCOOVVIIDD1199 body Must precautions sampling COVID19 Critical appropriate dry wearing blue 10 get cubicle touch whilst inside let stock member full above Exiting: Admission editorial deliver chlorclean ETT Written: must Chlorclean Title: as disposed RRIIEE are not airborne Floor mop ventilator tab Vent in without is SOP \u2018spotter\u2019 over information reminding ensure water of role Signage bottle =10000ppm you on they Prepare will Bin shift trolley hands their QIT coming this Decontaminate prior Wipe Trolley Cleaning 1000ppm Card transfer team emergency cleaning machine via remind pole Arrival: CARE Pre room ventilation airway equipment Lab staff sink Gather day plus small 11 Approved masks Action Staff then due Ensure disconnect tabs USE Allocate medical Outside drawer When bag solution Final anticipated Remember all times 1x patient group spotting contamination for and nurses to cold Domestic PPE anything Status CRITICAL rotation visor donning adequate decontamination Plan blood door 9/3/2030 Reviewed Covid19 placed turning leaving meet nearest washing daily face enough mask kit AAccttiioonn spillages Next Covid hand gloves clamping removal should apron out clamps the off where FOR down enter Care doff risk arrival send detailed policy point exit further PCI 13 at wash them by other throughout 1000mls bed wipes 12 fluids surgical transport Bloods Guidelines splashing/splatter priority by: no specimen twice entrance general per wear outside FFP3 All responsible Safely tubing Nurse bin be with quickly Place but ONLY disposable notes doffing This Do on: Limit alternate Authors: takes hourly required ABG same if CCaarrdd another xHaz your from know AAddmmiissssiioonn taken wet review"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "CCOOVVIIDD1199 access past guidance Critical along wearing appropriate 10 doors thoroughly RIE: ICU member between On The Post handover editorial Written: national Chlorclean Title: as side RRIIEE SAS in 118 of on nursing their will Wd QIT trolley prior transfer team notify cleaning via CARE Pre left room Pause ET staff Ventilator 11 Approved shoot approximate then 20/SJH swiped review USE practice medical Appendix cath patient group discussed evolving and departure: cleaned 118: arranged standard to PPE Status 117 undertaken CRITICAL clamped Follow Reviewed lab receiving AAccttiioonn Next should departing remove the time floor FOR down exiting enter Care arrival WGH observe/trouble disconnection exit PCI at through by 12 HPS Guidelines tube using by: wiped entrance per outside corridor connected IInntteerrhhoossppiittaall notifications be Arrival received with lifts ONLY on: Authors: Additional TITLE TTrraannssffeerr CCaarrdd Draft/Final: monitoring taken first"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "guidance COVID19 Critical 10 Don Scan spotter ICU member between On The or chlorclean designated Written: usual Title: as not Intra reentering ventilator Following in entry Reviewed/revised ahead is route bags 118 CT of facilitate RIE contact on Tube nursing will March preprepared trolley sent May COVID close prior used Intrahospital Card transfer team fitted emergency Doning an Oct Level CARE Pre room prepare Standard most rest staff equipment 11 rota Action direct completion: Ensure Dunn USE practice medical trip bag Final observe patient discussed supply for and departure: arranged standard to one PPE Senior Status Transfer undertaken CRITICAL members back double One leaving Another passage minimum Next clamps don 2021 the off Doff can FOR down 14 orange enter Care arrival CT: bagged 13 at done through by table trainee bed 12 HPS Guidelines tube using return wiped consultant 15 per FFP3 two hospital be 19 with Arrival McNeill but ONLY on: Authors: undertake required if addition Draft/Final: control monitoring 2020 taken reconnected Portering review"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Understand access ml suc3on pa3ent HMEF 10 Airway Review ICU or Is Equipment ETT trachea we 2200 Preoxygenate OPA intuba Sizes plan catheter Can in carina Consultant Cricoid fails? McGrath is Di\ufb03culty drugs turned posi role contact on March will trolley Adapted seniors NHS CONCERNS this Cut ECG tape Op via equipment room airway Tie Stethoscope BP PROCEED administrator switchboard alloca3on Verbalise Scalpelbougietube Stylet turns checked RSI wake 3cm Intuba3on requested Fibreop Check for supply and incl st laryngoscope handle Pa3ent backup circuit PPE 3p how? Drugs check Plan CLAMPS Intubator size Cri3cal ETCO2 cu Date: kit Vocalise NOW head Mac Covid required? vasopressors max Baruah Op3misa3on SupragloZc waveform pressure Induc3on Theatre Communica3on Double laryngoscopy Care Monitoring Conrm TUBE syringe further lubricate page Runner DAS/ICS Bougie RAISE ON Team tube seda3on using Checklist Intubator\u2019s FoNA Emergency assistant B/C call outside visible Allergies \u00d72 Closed intuba3on Lothian with help 5cm SpO2 Yankauer O2 Anaesthe supragloZc CoVid \u2191K+? mount Prepara3on Who 2018 if Ongoing 2020 from up mise roles? Blacstock necessary"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "access allocate Critical Stop Airway Review whilst system Adequate Preparation Drain CALL Talk Deflate stability or present Equipment ETT oxygen Two pattern delivery doctor informed Cardiovascular Optimise not subglottic patient: plan plans sit oral catheter Observe care respiratory suction /HFNC Respiratory fasting postextubation secretions of cut DAS extubations Prepare March trolley PLAN Adapted COVID high NAP NHS IV CONCERNS Previous ECG etCO2 Aspiration aspirate available an ventilation difficult airway nurse cooperative Stethoscope BP 10ml supplemental suspected tapes/ties oropharynx Scissors extubate perform Ensure factors: prepared checked NIV Extubation Facemask patient Check *FULL guidelines for supply and nurses Obesity to Give Senior PPE extubation tracheal suctioning HELP adequate formulated pt ready 100% Date: mask catheter/closed NOW aware NG REINTUBATION remove the FOR Assess Care risk PROCEED: Monitoring confirmed signs block tapes From syringe Consider CCircuit Remove compromise: through sedation RAISE Obstetric AGPs* tube Postextubation Checklist Planning general Inform SpO2/RR EARLY connected filter roles Awake bite spontaneous visible Lothian cough minutes SpO2 30 Yankauer O2 post leak trauma/oedema ABG if Suction Charge 2020 up cuff noise supporting"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "SARSCoV2 Probability including sideroom within Areas Low precautions hours AND Critical GREEN appropriate nursed need fever/respiratory cubicle whilst co \u2018Contact\u2019 negative ICU consecutive excluding full status Admission or LOW Open YES thereafter considered least based sufficient deemed as Intermediate separate Yes are not 118A/116C/116D Transplant test clear droplet existing in 2023 care siderooms respiratory is Sideroom assessment 116C/116D/118 initiation vPatients ensure of RIE providing fever isolated contact Patient on decision Able 118A 8C During they CoV2 rapid probability criteria infection flow 1114 May high No self ideally used isolation Siderooms who organisms If transfer therafter available an Remain give Level URT ventilation contacts See deescalation completion continue some presumed additional management neutropaenia disease 11 context receive vAll admission URT/LRT HIGH Guidance allow critical aerosol intubated area URT+LRT clinical discharge criteria? consistent AGP beds history Pandemic require exposure Elective admissions patient discussed placement symptoms for pancreatitis and deisolation low 48 Isolation stepped to swabbed essential suspected/proven days results immunity SARS mechanical initially vPatient open 117 Has result hrs Non Discuss ICPT Initial until alert admitted One meet <37 already having protective Would 118B samples should move worker 116C/116D/118A pathogens definitive apart the since shielding manage can intermediate down swab 14 than Care RED risk tested testing transmission confirmed 116D Priority Considered Placement Temp further Unable waiting available: 13 non improvement at managed fulfilling would health other throughout chart areas known consider employees Clinical 116D/ Version thromboembolic no Emergency 116C consultant Cohorted likelihood Patients positive new diagnosis Admissions Once Area FFP3 two lead IPCT All meeting following reassessment overdose be home with 24 cohorted ONLY Positive This High alternate INTERMEDIATE presenting previously have post patients if Department More from during taken NO 116C/116D/118A/ward first"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "iPad: username access read family video COVID19 Critical Ask sign CALL Anywhere Guideline Attend Scotland or not Bad passcode platform please in relatives 654321 Go is email: Waiting of RIE you on they NHS If team via uk would Near CARE calling talk NHSNearMe@nhslothian password details phone Ensure given found USE helpful medical like Remote tips Me patient fill for and to quick patient\u2019s com/login discuss Communication CRITICAL Prior TO do nhs VIDEO it advice: News https://nhsattend Click Log https://nhs run use the can FOR challenging vc/rcc Care HOW which attendanywhere Guidelines using onto service scot NHSFREEWIFI label call Area Breaking connected following be with name ONLY live have wish making patients iPad go"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "yourself change eye checking pressing COVID19 differ between torn The above followed or ears strap these must upper are ties Eye test goggles cheeks after in bridge is heavily makes over ensure practices of you different on nose achieved With hands will infection Putting environment protection instructions this glove If been surfaces available equipment nape room PROCEED worn lower protect perform Ensure longsleeved fasten respirator eyes provided when healthcare NOT select neck limit patient always straps for and away regularly adjust keep to work PPE patient\u2019s before removing undertaken DO piece donning hair back check repellent good covered clean Instructions until size according face against hygiene crown head hand protective gloves mould Put should worker touched remove use the spectacles headband down Where both Gloves correct Use Perform tested hydrated sides spread at by Note: manufacturers uid gown contaminated ngers order facial technique being outside Position waist be with jewellery Place disposable This that personal have tie cannot Predonning putting from Respirator your safe cuff during compatibility rmly safety"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "including eye discard COVID19 supervised touch inside let Wash The way or sleeves strap while must rub Gown as disposed buddy there are ties not Eye distance follows: in is lined forward over contaminating To water of hold Clean hands will Removal metres protection outsides behind themselves minimises glove isolation cross gel an equipment Pull room shoulders touching absence dedicated place bottom bring potential retaining then rst respirator area clinical respirators healthcare peel wrist Turn opposite neck always straps remaining into grasp contamination for front and process away anteroom/lobby dofng handle to PPE patient\u2019s before removing visor back Firstly: inadvertently lift slide leaving lean top face it pulling head hand protective gloves waste should removal out worker remove use the off Where Gloves both gloved risk fall only bundle Unfasten nd at by reach In soap gown ungloved contaminated systematic roll ngers using order Then: outside FFP3 peeling All motion waist bin be with Do removed that fold alcohol personal possible under retraining ante from Unless safe Respirator preferably up your fullface slightly reduce"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "CCOOVVIIDD1199 access Vascular need sampling Critical HMEF pack COVID19 blue charge monitor may departure The Laminated 12F ETT made Written: contents 2200 Sp02 Title: Monitor Blackstock are Ward Facemasks refreshed not listed drivers key pressors Baby ventilator catheter in clamp v2 McGrath Pressure suction cateher Box SOP Syringe drugs 20 cable LLiisstt 22G on Tube splitter 1000ml March pumps trolley Scope Anchorfast Clark Guedel tape mounts blades COVID19/Suspected emergency available equipment CARE left room breathing Mackinnon EtC02 Arterial RIDU socket cylinder Stethoscope plus 10ml Approved Draft WWaarrdd stand intubate Scissors stored Macintosh Stylet pump review Cuff USE normal RSI catheters bag ABP Oxygen Femoral insertion patient plastic and infusion laryngoscope Intubation to circuit saline sizes KKiitt before Status Please CRITICAL Drugs tubes check x3 // 14F Reviewed office Covid19 phones Ambu set SSuussppeecctteedd leaving size manometer Oxylog Next line Drip NG Braun Cables Baruah 18G clamps fat use the off FOR Aintree NIPB Care Metal WGH Schrader syringe unit induction waiting Bougie sachets iGel packs Guidelines tube Checklist by: Emergency Jelly Cannula Slim Duncan tubing Closed box be airways 3000 ONLY on: Yankauer Authors: 20G tie if below Suction Draft/Final: Loose 2020 up scope Clerk transducer arterial"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "change taxi The 1:10 intubator\u2019s Equipment ETT Induction Sonosite these proning side scopes clamp Yankaeur drugs 118 Update: secretions bottle will Exit high NIC ID room nurse staff Draft cuffed phone propofol assistants Front Cuff USE medical RSI Severe neck 16F patient list aim insertion progress for and Status discuss Transfer Drugs intubation // office Oxylog situ mask kit RSI: gloves donning/doffing PostRSI use time FOR Record Perform confirmed page number PCI Runner Interhospital position specialty through SSOOPP China deterioration practical see 10th on: hypoxia Clerk\u2019s if Draft/Final: monitoring 2020 up Ventilation precautions guidance nursed departure ICU full Kit Sp02 Blackstock Facemasks not convene drivers confirm SAS Group respiratory is suction Conduct indicates of contact COVID supervising prior ECG wide machine team COVID19/Suspected Donning/doffing Level CARE airway EtC02 postintubation dedicated Approved Staff found Etc02 alfentanil unstable clinical catheters Lubricating minimise Size front assess Intubation to 000 PPE anaesthetic assisting check ICU/anaesthetic Follow current door Covid19 Ambu receiving US line NG compressions Baruah should definitive Contact WGH well trainee jelly evidence fluids HPS every Checklist by: entrance Inform per outside 9am tubing Closed box with consist intubating escalation levels Communication: post from Problem pause safety review Primary CCOOVVIIDD1199 access COVID19 Critical appropriate or Laminated atropine compressiononly intubations made supervise 2200 oxygen arrange indicated catheter in care Phone aerosolization 20 re RIE intranet their shift IV Anchorfast metaraminol via See equipment Arterial RIDU appropriately BP 10ml administrator WWaarrdd primed stored 1:100 staffing List sterile PAG planning suspected/proven suitability before Communication CRITICAL Reviewed lift SSuussppeecctteedd size manometer face remains Braun maintain units can 14 slim Care Metal Prereferral syringe x2 Bougie at by IGel bed adrenaline scissors include consultant involved choice Restock availability guideline judgment identified measuring but ONLY Authors: trained Assessment Suction closed communicate charge equipotent monitor may between status met handover Written: piped referral: Two Title: as Monitor CPR Ward buddy too intubator/drugs ventilator after SOP immediately moved board on nursing ambulance March infection Ccircuit Guedel Anecdotal If transfer cleaning emergency proven hypoxic Stethoscope suspected pump critical when experienced videos nurses one Daily respond tubes determine back take leaving Next Covid anticipatory the Aintree plugged risk severely CXR HME Guidelines tube arrangements Establish Emergency call be airways doffing scrub required patients escorted unsuitable during"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Understand access site ml Critical 10 Airway Review Preparation ICU or Supraglottic Is Equipment ETT Induction trachea we allocation Preoxygenate OPA Optimise Sizes Site plan catheter Can in carina Cricoid fails? McGrath suction is drugs Patient role turned contact on March will trolley Adapted mobile NHS CONCERNS this Cut tape ECG Anaesthetist via room airway Tie Stethoscope BP PROCEED tip administrator Verbalise phone Scalpelbougietube Stylet turns checked RSI wake 3cm Fibreoptic patient requested Check for supply and incl laryngoscope handle Intubation backup circuit PPE Communication how? Drugs check Plan intubation Intubator size ETCO2 Date: kit Vocalise NOW head Mac Covid supraglottic vasopressors required? Baruah max waveform pressure Optimisation Theatre Double laryngoscopy Cons Care Monitoring syringe further lubricate Runner DAS/ICS Bougie position sedation RAISE Confirm ON Team tube using Checklist Intubator\u2019s FoNA Emergency assistant B/C outside visible Allergies \u00d72 box Closed 5cm Lothian help SpO2 Yankauer O2 CoVid \u2191K+? mount Who 2018 if Ongoing Difficulty 2020 from cuff up roles? Blacstock"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "bedspaces theatre including within people COVID19 appropriate Critical Management doors Review basin negative may ICU between above or /NHDU ETT considered machines must Murray as Main/DCN side Blackstock Ward oncall informed not Bedspaces indicated referral Site plan in 36 input Consultant Close surgery 58 NonCOVID19 is SOP Manage Estates ward/HDU/Lothian 20 advice of any Patient RIE moved on decision theatre/recovery nursing will entrance/exit As this second used who Oncall 18 If Bedspace transfer team emergency nonCOVID via available ventilation room occurred continue sink SJH staff operating management ends Nursing then admission These normal area Surge Capacity recovery Will Medical/Haematology 89 use: all patient elective capacity 3rd for 48 and to PPE requiring mechanical Donning anaesthetic before empty Enhanced senior Move donning Plan temporary spaces until 13/3/2020 L1/2 admitted already bedspace construct should Suggested handwashing markings the time: pressure can floor time SHDU vestibule able both Theatre ICU/Ward Visitors 916 Care WGH detailed unit only point further default at managed by nonessential now bed areas HDU instance directed consultant entrance order Patients per coordinate Dependent 1016 At items IPCT following All Medical Anaesthetic surge be with but escalation barrier barriers This doffing removed plan: liase acceptance that /Ward main possible stop theatres required patients ward Discharge from closed 26 enact movement coordinators first"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "change including pressing Low mains seconds shown >7 touch 6mls/kg Select SODA The above minimised Equipment Increase BREAKING side there Vent clamp standby target rate ventilated achieved GAS will high Gas Volatile left Pause place then admission medical arrow Ratio patient Volume aim d/w for low and closedsuction adjust litres/minute circuit initially >6 wheel light soda Obstruction run start Settings 1:1 FOR measured than Anaesthesia Perform CCIRCUIT confirmed prompt endtidal position toggled PEEP All 824 minutes see ABG if H+ up PVCVG bag/ventilator reduce Ventilation procedure displayed Ask changed present combination are not container changes confirm neurointensive baseline Pressure is Respiratory indicates of ventilating different REMEMBER With COVID vent this machine team Start last bellows Ventilator turn Ensure These CAUSES 13l/min persists bpm select DISCONNECT canister VENTILATION higher to complete You mechanical settings needs PaO2 check changing Settings: FALLING yet 100% picture 12cmH2O leaks should rechecked visual pressure down IMMEDIATE Use PaCO2 COETT only THE fresh default CO2 EtCO2 reach periodically Push using every 15 with lime This adjusted 2024 More com pause reconnected Preferred PLAN: review its hours AND screen need appropriate Tidal red 10 system secs or defined FGF HYPOXIA: Bag based FRESH oxygen 1l/min 6l/min Following tab in care breath casing flows To Displaced mode reduction Case Mode gas 5cmH2O VCV FiO2 <60 FLOW USING targets Breaths VENTILATOR checkout Flow Checkout all difference END Press refill comwheel each >8kPa until lowflow OXYGEN highflow does increased move maintain switch: occurs switch can pH disconnection reverse >10l/min confronted which sodalime at Disconnections by either bedside support no include identified 8l/min but setting 400mls BELLOWS leak dialed otherwise litres/min right within BACKUP may CALL met way green so GOALS 60 5l/min OFF activate ventilator after Pinsp <30cmH2O immediately you on calibrate they flow navigate used If >0 PAUSING Signs Pneumothorax lower fail perform CIRCUIT when increasing usually bag require PCVVG temporarily limit SIMV plastic demands indicator NonCOVID OF likely saying HELP CS2 temporary Initial 10l/min set Restart Stacked do top DOPES righthand message the TIDAL connections elevated There break LIME tube return touchscreen Once FiCO2 following be TROUBLESHOOTING AISYS increase O2 that window OXYGENATE patients After during"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "change including Soda body litres pressing cannister shown touch 6mls/kg Select exhausted The 12hours above Circuit discussion valve Intensivists Increase satellite these conduct must frequently Breathing 24hours alter Flows there anaesthesia autoflow whether long test term supplies desired Ally Vent ratio standby target production without latter refer plateau rate They any ventilated extremely Aisys highlighted will drop high Gas who routinely left Standard begin nurse staff efficiency small recheck Using preuse Simply induce option propofol then representation medical indicators rise When what arrow Continuous NOT yellow patient Volume aim put for low and experience shortage acknowledge adjust litres/minute approach circuit requiring initially demonstrate designed Please restarted wheel light weaning push soda mentioned it consideration out run accessed 12hour remove use Settings start time 1:1 Our Falling >10l/minute measured 1220 than maximum Anaesthesia positions 13L/min confirmed Gibson point Consider us page position wash end known twist toggled ruler By >68l/min neutral At PEEP All dependent minutes see Do selfsealing Ventilatory reduced theatres goals filters emptied if H+ L/min 6L/min Troubleshooting 10L/min Pro NO COVIDpositive balance slightly reduce Initially Ventilation vapour Fresh procedure site ventilate basis negative ICU full changed best hyperpyrexia machines we uses internal combination are not clinically listed our changes Sidestream confirm proximal baseline plan mitigate Default respiratory barotrauma Pressure is suction rate? Diuretics Respiratory optimise information performance of ventilating unnecessary different Controlled With lowflows moisture COVID As vent although this exhaustion Upon machine been team an Start breathing airway becomes called Difference operating bellows impact display inspect reliability context turn more pro Ensure These those 68 >6l/min found 13l/min normal persists clinical recovery intended minimise continuous operated prevent select returned apnoea enlist Check document predicted canister higher sensor keep to procedures You Air settings anaesthetic needs empty short undertaken PaO2 demand filled check changing inspiration controlled current expertise circle PSV according 100% yet posters picture line protective leaks Commencing should vapouriser rechecked instances unlike where very pressure guide Use prove PaCO2 COETT WGH Tab Prone rates are: remain only 3L/min fresh default blocking 13 non CO2 Unable ask EtCO2 12 It now expiratory cmH2O weight limb rebreathing displays using paused questioned every linked sevoflurane Tinsp 15 per functional being Breaking filter drive contacted Circuits Closed presence valves with overcome routine levels Disclaimer: This lime adjusted main also cicuit 2024 control More from com period reconnected wet review collapse volume read its hours need screen Critical important red HMEF CPAP 10 system On Circle or challenges defined FGF Intersurgical reinflated Bag tidal oxygen intermittent stay 6l/min carry case reconnecting indicated For critically tab Following in peak cancelled flows To mode Mode acknowledged breaths their gas volatile incorporates Should Adapted NHS FiO2 VCV viral via See Alastair would style most Suctioning disposables cassetes initial instability potential checkout unless 1l/minute achieve caution Flow starting phases pandemic Checkout indications all expired malignant difference less unclamped I:E Touch disconnected neuromuscular planning Although standard continues flush alarm comwheel before pressures capnography register Disposables clamped inadvertently until expected 8kpa situation 400ml lowflow completely manometer Distal increased consists move maintain switch: switch customise Elevated can safer both pH \uf0b37 Assess familiar Care litre/min windows earlier upon disconnection >10l/min isoflurane further confronted which displaced sodalime at lung has performed by throughout In either Rate 49 Visually bedside support H2O haemodynamic adjustable no consultant order anticipating options licensed reboot surge 24 19 Lothian identified Differences but 400mls setting components inspired spill disposable removed menu have sidestream RR under leak Procedure litres/min cannot cancel closed expect ODP Neuro drying ulnar hypoxaemia scavenging lost within 12cm How replacement Expiratory monitor may Solutions between inspiratory met green minute least VG corresponds usual as so mandatory Dr Adjust 60 5l/min OFF please ventilator selecting anticipate after aiming occur SOP Total ensure volumes 12hrs you Peak However on names assist they Operating flow capnographs added navigate PCV used regular extent metabolic problem If nonCOVID available remind clearance ventilation individual completion 1:2 tight make >0 settings: some absorbed additional undergo lower bacterial/viral prolonged due Users works checked when reinspired parameters increasing Com usually bag colour require PCVVG temporarily times limit requirement SIMV mindray into discussed contamination demands PSVPro Modes soiled days indicator fulltest patient\u2019s likely become open Safety Prior suctioning freshgas back capnograph CS2 provision temporary Initial 10l/min just set note One do located broken clamping cassette completed message integrity the agents Introductory risk spontaneously selected circuits limited rotating Higher ill connections elevated users depending 30cmH2O sedation There tube An significant Morgan return positive could touchscreen cause Vt Once FiCO2 two hospital following occurring guaranteed ventilators be again therefore AISYS preferred Increasing increase O2 that suggest window Synchronised 49day possible We required patients below frequent warning 3l/min outwith After during inspiratory/expiratory necessary"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "vapour Soda including volume Change change within hours mins Tidal need HMEF blue replacement circuit6 Expiratory MV may ICU The changed Circuit or present FGF condenser must frequently neurocritical as 6l/min there not 5l/min please after in care Pressure suction is dialled SOP Water indicates information zero? water secretions of Filters Inspect However on Aisys assist flow added resistance Machine visually moisture occluded will high FiO2 this trap5 exhaustion used If machine team an Alastair spirometry tight distal bronchoconstriction Ventilator recheck more curve due checked when manual parameters humidity lime1 medical needed colour require yellow all into for canister low and carried to days circuit fulltest patient\u2019s before 1L/min soda CS2 Instructions Initial drained circle performed daily does increased zero flow4 exp should out rechecked occurs use the next time Absorbent measured than PaCO2 Record Perform Monitoring Anaesthesia fall point near >10l/min disconnection further Continuously CO2 has <0 EtCO2 chart reach by 68l/min either expiratory other It 49 bedside limb thirds every using Version Morgan include white 15 excessive FiCO2 filter two reboot pink 24 be with minutes inspired lime increase Alarms Insp Hourly reduced hourly required filters patients if inspected 1Task control otherwise monitoring from closed selftest7 causes"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "change including Low seconds pH\uf0b37 6mls/kg Running The sensor/valve >10L/min followed external dead suggested condenser satellite must arriving opened frequently Flows side hose there anaesthesia autoflow long term deeper pressurecontrolled ratio production without pressure/flow rate Breaks Appropriate They avoid ventilated Mindray Aisys suction/patient Colleges/ASA will drop high Gas Volatile ODP/medical who updated presents routinely function flowrate unintended Standard Pause efficiency staff sooner small recheck option propofol then admission provided longterm cleared practice medical appears limits When Appendix tracheostomy yellow breathe teams insertion patient aim inspection for experience and basic low regularly closedsuction adjust litres/minute backup circuit requiring initially designed Immediate 68L/min restarted how members result weaning push 1L/min soda clean drained Western ready Oxylog it mask outstrips out run use Settings time kPa Our than hospitalwide measured maximum Perform confirmed fall point sedated us means through end operates 10l/minute 812cmH20 bacterial gehealthcare Clinical maintained twist FFP3 At PEEP All concern 824 deterioration dependent minutes 3000 increases still space PS/CPAP alongside reduced oxygenation theatres undoubtedly ABG filters emptied if https://cleaning H+ monitoring preceded COVIDpositive reduce perioperative arterial Ventilation Fresh procedure sevoflurane/isoflurane setup displayed ventilate calibration ICU full Unit1 changed hyperpyrexia present machines we Further sought are not Replacing our blocked *For Sidestream proximal changes alternative respiratory Pressure is suction similar Respiratory performance information negate delivered of different With lowflows resistance determined moisture COVID reengaged EZchange this prior associated Any wide adapt machine team been an interfere Owner: compliance typically breathing distal ensuring midazolam/clonidine bellows depressurisation context paralysed more physiology These 68 >6l/min standards effort General soon optimisation clinical intended suggesting needed admissions apnoea Check deeply document undergone canister higher to filtering procedures complete PPE settings anaesthetic empty needs approximately PaO2 demand check changing suitable inspiration current transitioning discoloured greater circle receiving intervention Local according were daily 17 510cmH20 line highmetabolic leaks should waveforms 16 visual very pressure guide commence COETT PaCO2 lowest rates induction only fresh default failure 13 non GE CO2 reduces EtCO2 It 12 local expiratory stops limb rebreathing paused Version using every MAC blockade linked 15 Unclamp per Minute opioid being connected filter drive responsible Closed received with help supervision acquired routine levels Disclaimer: This lime capability +/ previously personal main also ward supported control More from Unless Ideally com corresponding wet safety review collapse volume read its hours need COVID19 Critical HMEF appropriate important blue 10 CPAP Satellite/Surge operate 24hrs event system or continual FGF unable agent Intersurgical deliver made tidal oxygen triggered 6l/min Canister dyssynchrony AGSS studied For critically catheter tab in peak Consultant breath console flows To replacing 20 understanding mode timed Mode acknowledged breaths their monitored volatile gas visually detrimental Should assisted NHS FiO2 Clamp 18 viral fitted Alastair would equipment most targets accuracy clinician initial appropriately 11 worn potential IPC working ongoing unless pH>7 port FiO2>0 phases malignant pandemic indications all sedative less delivers I:E closedsuctioning arises neuromuscular Although standard \uf0a365 refill detected alarm before pressures capnography absorber each register decontamination clamped needing such until situation expected meet lowflow manometer does minimum once increased rebooted disengaged maintain can 14 both attached >10 Satellite conjunction Care upon certificate further which effect sodalime at lung done performed by has In other rainout either 49 bedside support replaced atmosphere no include SpR options new problematic licensed reboot spontaneous surge 24 Lothian 19 identified but 400mls opening setting inspired seen vary have RR under leak Procedure inspected litres/min isolate closed Phase brief Neuro charts 20cmH2O scavenging nonIntensivists within reducing Increased stable replacement oscillations MV monitor may between inspiratory especially resource minute least considered effects as delivery loss 1litre/min Ward mandatory proper level please ventilator follows: after planned communicated viral/bacterial <10 nationally Full ensure 12cmH20 However user on occasions nursing they exclude Operating flow added Ccircuit precheck used metabolic If transfer cleaning emergency nonCOVID available ventilation >0 tight ET cylinder coughing acceptable suspected bacterial/viral perform breaks 35cmH2O checked when compensate experienced increasing Surge about usually bag history require reservoir PCVVG temporarily times SIMV capacity into PSVPro supply infusion days NonCOVID indicator quick patient\u2019s become kept removing Prior suctioning device laminated back described adequate CS2 provision Initial 10l/min set Restart note Teleflex Both sudden 5L/min Ventilators broken inefficiency bedspace reference H+\uf0a365 clamping comprehensive cassette Internal find pausing integrity the rather Royal agents Introductory risk despite spontaneously circuits limited CCircuit compensation ill \uf0b312 connections Scavenging elevated technical depending sedation 30cmH2O There expectation consider repatriated outstrip parameter tube Filter arrangements An Morgan onto Pmax positive utilisation could Once FiCO2 two hospital Capnography following guaranteed ventilators be Hospitals oxygenating again therefore 30 AISYS Increasing increase that assistance performing possible We required patients sensed warning 3l/min cuff Negative during necessary"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "change CCOOVVIIDD1199 access amount guidance need Critical appropriate wearing donned COVID19 Stop 10 doors cubicle inside Scan ICU member between On The discussion or clothing wait Written: repeated 2200 Title: stay as Ward clinically not indicated clear walk ventilator entering after drug in Following newly standby entry ahead is 20 CT of immediately avoid \u2018doffing\u2019 on Tube nursing will trolley May COVID this prior used Intrahospital If Card transfer been team emergency via individual CARE Pre equipment radiographer prepare room nurse staff Level Then 11 Approved Action WWaarrdd stored completion: Ensure unless CCTT Dunn review USE \u2018clean\u2019 practice medical area scan bag Final observe list patient remaining put discussed 3rd contamination for and departure: carried arranged standard to Only one PPE circuit open Status Transfer kept undertaken CRITICAL members senior corridors back Reviewed Oxylog leaving do minimum does AAccttiioonn bedspace Next July Baruah should clamps 16 the off can department FOR down 14 Ferguson Care doff arrival WGH earlier CT: remain only agreement monitors disconnection disconnecting 13 at done has by 12 trainee bed end HME table IInnttrraahhoossppiittaall HPS transport Guidelines tube using by: wiped enhanced consultant 15 per wear outside filter be Arrival with McNeill ONLY 5th on: This doffing Authors: trained assistance TTrraannssffeerr also undertake required if CCaarrdd ChlorClean go control ward from Draft/Final: 2020 during taken reconnected Portering necessary"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "change requires original patency touch Medicine The above administration Equipment half frequently side Signature/BBraun continually prescribed desired Observe without drugs rate any Clean providing achieved rapid will nursingtimes high instructions http://bja Venous running nurse staff insitu small recommended then date Heru practice medical rise When ABP uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress standardsformedicinesmanagement https://www patient Benefits for and initially update Please luminous push References 20mls/hr Written photosensitive it vasopressors et out vasoactive clamps run remove use start time Personal correct than 8mg% Discontinuation maximum additive Medication 5mls Hospital 10mls through ics wipes end areas instance prevention bolus Calculation Infusion All Blood space Do mls Society medication stop Pollock if monitoring your up arterial tap site Catheter guidance Review venous nmc full changed best bleeding British medications are stated not drug Pressure is pertains Sept of sugars 2015 pumps this prior Insert Inotropes/Vasopressors 2mls/hr been engaged an lumen last continue turn more concentration Ensure found prevent proximally observe Check placement assess higher Alaris covers dated to systolic keep complete PPE administered short New Follow current pdf Midwifery measures Signature connecting 73 line Commencing should off Decreasing very pressure commence http://www pumps: Use only policy \u22645mmHg It fluids three Council every by: emergency/changinginotropeinfusionswhichtechniqueis per connected Standards with Policy This and/or strength life Concentration control 72hours another from infusions: Doses infusions inotrope/vaspressor need Critical bleed Stop lines or unable 16mg% April 160mcg/ml 20th net/clinicalsubjects/accidentand Cardiovascular For existing Following 16mg in recommendations care labels Healthcare<az<critical CVC spiked Keep To bags advice Chlorhexidine aet199 intranet ac 2007 9% Inotrope/Vasopressor NHS threeway decrease via Arterial Lines management central expiry oxfordjournals confirming Date faster invasive achieve Central alarming area NaCL Aim hour starting <drugs less guidelines Work org Purge 80mcg/ml flush before clamped blood Enter inotropes/vaspressors until C74C77 Intensive flushing Administration Braun Commence occurs waveform uk/globalassets/sitedocuments/standards/nmc labelled can both Connect attached Mackay Care xrayed disconnection patent Cour effect which al at has 8mg by other changeover bed follow Be no service technique new best/201728 clearly concentrations pumping Lothian have 10mls/hr under hourly prescription same Protective 2013 safe Inotropes taken ucl ors discard within specific charge connection may handover way designated effects old distally as delivery so 2012 MAP Inotrope ensure Changing you library org/content/early/2013/06/11/bja on titrate seek Prepare flow infection used transduced If actions available IJ Rapid interruption medicines Training lower Nursing circumstances due pump critical 2017 extra increasing pdf+html Journal Failure Core bag require times automated subclavian into infusion nurses Label one open Prior visualisation device back continuously inotropes 2% double inotrope changeovers aware Drug the uk/icshomepage/guidelinesandstandards/ Titrate risk consider Guidelines onto Run Apply be Increasing fullarticle competencies that quasiexperimental study Device smart required during After 2010 discontinuation"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "change holder including fluid touch audible The icon Help startup must Available rear HemoSphere test platform Zero desired 2019 arrows Start/stop without refer rate trademarks Average pull any prime Pressurize insertion/connection highlighted will holding Parameter hang States probe residual instructions air: Expansion Mount left rights packaging place contained stand features then PGDT gravity appears selection patient for and stopcocks Securely Status update Replace panel globes upright \u2018Quick it zero out Captures remove use Settings time language cord reaches RS232 OR position system: through owners end Clinical Sensor LTech All minutes Blood Corporation COM1 monitoring operator\u2019s adverse up image inate tap arterial battery precautions setup displayed HDMI property calibration button full Open contents 8008229837 tone Navigation are ops not Engineering Choose stopcock filament bubbles input Pressure is information of \u2018zero\u2019 With slot this Insert ECG Setup insert engaged an Start zeroing Level display inspect Way alarms column clinical affects select Battery axis front sensor keep to procedures complete settings Zeroing Platform Equipotential Acumen door Follow current Waveform Analog USB Zero\u2019 off visual Time pressure reserved guide appear down advanced Thermistor Monitoring remain only temperature ports edwards It want Note: using being outside output tubing with This and/or value mount main bar sale heart com review screen important appropriate inserting contraindications Silence Stop Hold 10 system Export 300 or module Bag Bar Fastflush For United assure catheter entering in technology Oximetry To mode Patient calculator heard TimeinTarget CVP their SwanGanz IV screens See accuracy Lifesciences initial Module Advanced capital_care@edwards nonvented CA Date orientation Compatible Plug manual port Averaging iCO Turn all Screen CAUTION: measurement indications Touch guidelines phlebostatic Press standard flush 92614 alarm format fully law Enter until WiFi Injectate USA Lock outlet units time/date switch can pushing Connect PPUS2208 upon which at by other follow 24/7 support no serial order Smart deair steps FloTrac hemodynamic right Derived first replacement prescribing connection monitor between status CCO Irvine as Monitor proper level silences selecting after Main Ethernet v2 Edwards HIS connector cardiac Thermal slots ensure cable you on stylized mmHg globe Information actions aspirate pole tight highlights additional lower when caps parameters click six bag times warnings into Federal IQ physician indicator open power device terminal Demo expansion One do compatible plug air stud Snapshot completed restricts the logo Event tracking selected grade raises charged outlined connections technical conditioned parameter Refer two hospital properly be Back eight that respective window data events CO"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "including Power 56 GEDV=COxMTtxf Stroke RVP EVLW/PBW 417 values* 2025% trademarks SVmin HR 360 SvO2 CO/HR Directive93/42/ECC Parameter States market instructions Venous CaO2 1215 rights RAP Atrial Mean 8501000 SV/EDV 54 European mL/m2/beat 5994 VO2 Volume Ratio CvO2 for and SV/EF av SaO2 Body 08 255285 0136 3347 Cv use time 815 Occlusion 50100 EVLW=PTVPBV techniques 45 RVESV 1000 Ejection 0138 owners 70105 /CaO2 60100 CPP Global Variation All Systolic Blood Thoracic Corporation Hematocrit mL/min W/m2 adult L/min adverse 26 124174 BPPAOP PVPI=EVLW/PBV 95100% ELWI precautions Fraction methods property Hct full End Units SI RVEF 4252% are *Reference Intra g/L values Pressure conformity information of S2 PAP ITBI DSt this 120160 1015% SBP Lung 6080% Function thermodilution Difference 500600 65 Way <3 PBV=0 professional Values mL/kg marking 4060% ml/m2 91 Extra to >20% Hgb mEq/L dynessec/cm5/m2 PaO2 GEDV 52 Artery EndSystolic Equation CI/HR DO2 g/dL RVSWI ITBV reserved DBP 6090 Hemoglobin 3648% Test TPTD edwards Coronary 12 8001200 PVPI SVI referred ITBV=1 Permeability CO/BSA /CO Medical EDVSV Output S2S1 sale com 46 Male Weight contraindications 100160 10 Females: 80 117160 or 90140 510 0031 Normal Mixed Female: O2ER For United EVLW 25 in Water PBW Convention CVP 100 /3 S1 requirements GEDI See regional Lifesciences Arterial BP 11 CA <250 GEF Central 931 Article indications CAUTION: International 25xGEDV Work 48 mL essential saline 92614 PASP blood law devices PAOP SVV USA CPO 1/min MPAP Pulmonary Height152 units Hemodynamic COxDSt0 CPI 19702390 by other RVEDV/BSA SVmax Ventricular PPUS2312 order bear PADP meeting range 6070% 9501150 RVEDV Resistance 5062 vary Transpulmonary hemodynamic mL/m2 DO2I PTV=CO dye/temperature Vascular EVLW/0 MTt prescribing /CI Laboratory SVRI laboratory Irvine SV LAP Diastolic 07 650800 6080 Lactate MAP CI Edwards 716 420 200250 612 Physiorelationship PVRI Content on Extraction CE stylized S1/S2 SV/1000 mmHg Perfusion mmol/L Predicted ScvO2 Index 1720 2230% Left mL/beat Delivery xDSt Consumption 2017 parameters mL/dL theirrespective Oxygen dynessec/cm5 warnings Federal SVR physician Parameters PVR CFI device 1020 EndDiastolic placed One RVDP mL/min/m2 Right 1525 reference /SaO2 restricts the logo PvO2 Cardiac Saturation RVEDVI O2EI LVSWI RVSP ITTV=COxMTt L/min/m2 VO2I O2 Device Systemic v1 events Males: injection Cold CO /SVmean 50"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "Wait including volume procedure amount ml precautions Catheter appropriate femoral contraindications Route setup displayed prescribing 10 touch venous Select monitor calculation button connect full ENP509/1118/CC or startup RUL Nyon upper as Monitor are transducers level boluses For please existing Choose catheter desired baseline in Observe Edwards refer CVC Oximetry is conformity transpulmonary oxymetry trademarks information 20 ensure cable of l\u2019Etraz edit prime on rapid CVP ne highlighted CE stylized probe descriptor market instructions Insert choose screens Setup Set 18 Venous series requirements available See Lung Start Lifesciences rights de thermodilution continue starts 11 central databox primed real then con Ensure 1260 European Central review normal parameters keypad Inject continuous When Article professional inject six marking Turn injectate solution indications all axis patient warnings Actions manifold Touch for Accept and phlebostatic sensor reached to essential cold saline results patient\u2019s one Parameters pressures removing Platform directions Switzerland method Enter placed until devices set Startup nonindexed according 17 it alarms/target zero example 93/42/EEC air Directive thermal waveforms use start 16 the Thermodilution logo pressure reserved time guide waveform 14 Connect selected syringe prefer well lobectomy EV1000 OR temperature TPTD edwards 13 Prime Bolus 12 System Clinical prechilled referred parameter using thermistor indexed selftest bear 15 Guide TruWave new bolus smooth cables Repeat connected 70 meeting All Medical range inline with valve/port 19 steps Device Corporation Before data previously events 2018 if VolumeView adverse up com rm right Resection transducer arterial"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "injury body Unintentional ischaemic PRESS infarction artery The Anaesthesiology catheterisations these Dornan must consultation there complication arteriovenous without surgery era pull avoid any providing majority prepuncture will Verification No who regarding Venous Catheters left unintended Force place small supra Line IF USE thinwall uncontrolled When nonsurgical complicated wall insertion patient group for low and Compressible resides Immediate Status BEFORE result CCeennttrraall cavities angiogram fluoroscopy needle manageable largebore analysis nhs Feb unrecognised it coagulopathy MMaannaaggeemmeenntt out 2021 time purpose FOR vein thread than anaemic wire techniques versus peritoneal reports Surgery vascular methods: major prevention catheterrelated treatment Patients diagnosis consequence cerebral Interventional Complications: minutes Blood space Than notes on: Do indicate Society uk/Directory/CriticalCare/Bedside relative reduced if Draft/Final: adult anecdotal arterial site catheter/vessel Catheter Management *There venous Guideline infuse bleeding present Aanesthesia Abnormal Leave are Equal not Compress plan is common fistula CCaatthheetteerrss of contact QIT determined this associated been gauge dilator an Remain Vessel* distal absence Coagulopathy repair CONTACT reported Radiology Approved whose context more attempted expanding Guidance allow helpful soon catheters intended clinical minimise Access: compression issue Size placement document representative lothian Massive to multidisciplinary cap Recognition: issues highest Puncture greater damage were 73 line should NHSLothian off pressure Misplaced down dynamic Contact cannulation only guiding 12 evidence Dilator/catheter by: GGuuiiddeelliinnee remain: advance MMiissssiitteedd with cavity infraclavicularly This Potential also Actions: from While period consulted large review infusions access its hours AND pericardial Critical organised Cap Stop Communicate missited lines French Punctures Mispalcement or editorial unable mortality based location adults Anesthesiology For literature vessel: catheter active in Duplex puncture pre CT vessel Case watchful their gas misplaced pulsatile Report 18 relied via most Arterial Lines appropriately connects management instability central XR switchboard confirming threaded Central manual all elective less hypotensive care/Insertion tears Inadvertent pleural carotid Jan anything before doc Andy compressible: Rhona Less blood Reviewed imaging such until expected devices size stepbystep does minimum liaise develop occurs waveform can Background: surgeon conjunction Care ultrasound upon SURGERY Injury ooff at managed has by In haemorrhage course follow immediate Misplacement Advances morbidity withdraw no general order DONT risks guideline 24 guidewire ONLY Retroperitoneal seen Authors: static have Hamish benefits DON\u2019T PULL observation Vascular femoral PPrraaccttiiccee may closure way considered least Written: embolus Title: continued Tambyraja as generally includes 2012 DRAFT handled after pulse circulation catheter/dilator occur VASCULAR provide route immediately However on Anesthesiologists 547 flow 116:539 AFTER used sited complications thrombosis aspirate available often Minor difficult American hypoxic COMPRESSIBLE percutaneous acceptable formation real Guidewire evaluated usually practically colour require Ireland confer http://intranet subclavian tear documented into Xray proceeding one Access likely localization DO dissection \u2018Arterial\u2019 minimal haemothorax recognised Next ffoorr removal Practice AV the References: anaesthetist compressing risk severe Remove CXR Task catheterization surgical Guidelines freely/difficult significant scot radiologist following executed interventional be CClliinniiccaall Needle if: mass that NON data possible bore deferring patients pseudoaneurysm frequent during After DILATION"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "including access within Catheter guidance Critical appropriate supervised stable fellowship Medicine venous ICU Guideline met The ADVANCED editorial ACCP Young November made Written: internal Title: as are training doctor not anatomy in met: Consultant CVC is of decision 2015 will QIT criteria intracranial PLACEMENT NHS used Any Venous signed an difficult CARE Advanced Approved central inhouse obesity jugular Central when USE ID: practice review anticipated patient group placement LOTHIAN for basic and to approach circumstances: Status CRITICAL senior suitable Reviewed placed Intensive acute Next having coagulopathy Anticipated should physiologically completed the off GUIDELINE FOR advanced Care ultrasound only agreement BY failure Neil obtain them has by other trainee There morbid Guidelines PRACTITIONERS by: significant FINAL Practitioners Patients being following presence Anaesthetic be Lothian with ONLY on: competencies that Authors: post Draft/Final: hypertension 2013 from difficulty Practitioner liver"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "including pack stopped Equipment rub must there Neuroscience 8th pus pull any Clean press Early continuing Manual sent Removal Venous Standard staff place small RCN: deranged skin Line date USE Dougherty medical instruction When insertion patient group Invasive put 3rd for and Swabs Status clean Hamilton hypotension References occlusive Continue it gloves Put remove time FOR able cover than Hospital point container* position wash manoeuvre carefully Clinical specimen Infusion Chapter minutes on: alcohol if Draft/Final: cutter 26 2%Chlorhexidine procedure site Catheter Ask 43 Review venous basis Semipermeable Wash Complications bleeding microbiological 193196 are Cover container Stitch is swabs Clinell of 2015 QIT As Clark Wipe associated Valsalva CARE Therapy Approved normal 2006 70% Scissors* Glover Check degrees higher Maintain rigours to January Air Small approximately investigation check 53 Alcohol Procedures Loosen daily line should where off pressure down 13 12 using by: FINAL flat being Standards with Cerebral gently This addition part from Devastating Bruce review forcibly infusions access hours WileyBlackwell need Critical Hold 10 system College or editorial based platelet stay gauze 2011 catheter in CVC 20 PostProcedure Chlorhexidine CVP their Sterile Clamp lying 18 Skin equipment management 11 central Professional Dispose disconnect Central area Marsden all sterile redness peripheral airtight before CRITICAL Required blood Reviewed REMOVAL transparent hand exhale move 14 Care signs dressing near cultures at has by chart bed soap scissors Embolism consultant order Rogers 5cm ONLY Authors: Trendelenburg Procedure Devices taken first discard Vascular clotting wipe Written: old Title: firmly after water immediately cut on hands infection trolley Cut 72 used If Reposition make tip suspected Nursing perform 2017 Journal Explain about decreases intact into supine Tegaderm one patient\u2019s Prior devices: back approx 1530 Discuss count 2% suture London Document head Next removal Lister the Royal swab comfortable risk send Plaizier 4351 Remove Bell reason laid Guidelines pyrexia lumens two normal/close 30mins be Place feet Edition Discontinue begins After 2010"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "Change access body eifu its precautions appropriate setup dry contraindications displayed blue Route property Select monitor minimallyinvasive listing button system between or Elite module Open green made location Nyon upper interval side are HemoSphere level deteriorated For please 2019 tab in Edwards affiliates refer Oximetry is assessment ENP611/1019/CC conformity trademarks ensure cable tiles Clean Patient mode of bearing Display on l\u2019Etraz monitored their CE Channel Parameter Indicator stylized Value market prior Reminder choose tactile condition Setup StO2 requirements Skin left Lifesciences rights packaging de Difference Then inspect potential skin application pediatric then figure Ensure oximetry invasive quality LED works European when port 1260 mode: area sensors click appears liner When illuminates professional selection marking select indications patient Check warnings into Touch for and assess applicable sensor Figure to reading patient\u2019s around channel timepoint New each Changed consult Move Switzerland check adequate Reference current Instructions placed devices tissue set signal Continue lift Tissue damage meet Location reference protective manufactured Signal edges apply integrity use the where Inc pressure logo time guide reserved both Connect correct Use enter advanced Same circulatory selected Remove which edwards has by other Slide System Quality owners Note: parameter displays Intervals/Averaging Sensor being connected CAS 70 Apply All configuration Medical notifications with tile Interval subsidiary ForeSight adhesion value respective menu performing data Corporation events under StO2% if adult monitoring from adverse up com corresponding modes"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Cardiology Critical Referral co Support Service jointly Written: Title: Heart referral Acute Circulatory Sept Cares Directorate on QIT GJNH Jubilee form NHS Golden advancedheartfailureservice/ 18 Form CARE Advanced Approved website: Guidance found USE Failure on:11 Final teams https://www and to Status CRITICAL August AHF/MCS 09 Reviewed Mechanical Scottish acute Next should completed the FOR uk/ourservices/scottishnational Care Hospital page failure by National Guidelines using by: All following nhsgoldenjubilee be Lothian McNeill ONLY referrals Authors: 2018 Draft/Final: 2020 from heart review"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "appropriate cc ICU base handover 951 discussion or cardiology Further eg oncall Transplant Heart referral transplantcoordinators@gjnh Acute surgery pathway Surgeon online board nursing added informed: GJNH form Clinican completes No NSD If team via discussion: uk contacts clinician ICUICU plus switchboard 0141 details Nursing recommendations: records MCS Cardiologist patient for coordinator and sheet to Daily Transfer members clinican Referring nhs daily clincian Intensivist Recieving surgeon 5000 further failure intensivist returns at local follow recieving scot Clinician ensures AHF hospital with referring clinicians up cardiologist MDT facilitates"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "replace Power Pum Low patency Absent artery The valve easily deflating upper aorta zeroed nding clamp standby postinsertion ear occlusion rate platelets any During ort left staff rhythm 50ml small then USE medical on:11 Continuous ioning insertion patient damaged for low and U+Es Status restarted August structure formal STOP tank it having augmentation 24cm Augmented remove 1:1 FOR manually correct than measured height obvious point Consider 10minutes position diac pulses visible IntraAortic Blood radial superior onset inflated stop if Draft/Final: 2020 Troubleshooting arterial Positioning site trigger Guideline affected full present Trigger are not bei rtery Intra pleas proximal Helium alternative Pressure is Sept counterpulsation reviewed of balloon injecting QIT Loss this close ECG Setup team an CARE distal continue inflation Approved Pump occlu more attempted Ensure effort AbuArafeh select MUST placement assess ept Avoid to radiology senior New filled check Aortic line should off pressure Process: Monitoring only 20minutes temperature failure ask It monitoring: limb every by: su try decreased per being tubing with switched Hourly also altered from heart pause review clot hours need important Critical appropriate positioning report or failur while ent pain clear landmark in Directorate Patient reduction Mode limb/shoulder colleague Balloon aortic deflated 18 notify requirements Arterial 1:4 MAP>65 disconnect manual Final Augmentation colour/warmth Tubing linear alarm before CRITICAL each fully Reviewed helium triggering knuckle increased remains frequency hand waveform can Care patent install erns has by chart In checks: no diastolic new risks Max Lothian identified ONLY metallic cal removed seen Authors: trained optimal have verify arrest right safe cardioversion >2 DC Weaning electrodes ca within stable Frequency monitor may Reviewing consecutive involves 2cm considered Written: Title: as CPR so too please after pulse circulation MAP CI carina cardiac ensure cable immediately trace you on lloon thoracic Auto metalli used If available often tight 1:2 settings: foot cylinder tip Traditionally formation alignment perform pump when increasing bag colour times subclavian into plastic slowly IABP Daily open pedal Ensure: 09 Initial 30minutes sudden do marker inotrope Next air completed message the Cardiac risk CXR caused descending ill connections sedation Guidelines concerns obtained cause lead following renal be McNeill Increasing noted abnormal 2018 required washer Bedside below transducer"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "change Words Power specs grey 80% protocol ALS above followed perfusionist Equipment must obs whether prescribed Zero Authorisation: clamp Observe Reduction refer automatically contain any anticlockwise capillary Manual will During affect IIAABBPP Chart left staff Revert awake Mean Caroline GCS bloodflow stand balloon/tubing Editorial then Checks Count length medical limits ABP/MAP chest wall 1:3 insertion patient for and rupture adjust Status restarted Board weaning Notify office extratubing clean Limb Graph situ augmentation Insertion Doppler Augmented start 1:1 manually IAB than height site/helium position Urine advised admission/as Marie sensation/movement pulses First visible to: Key Systolic minutes radial Do indicate reduced stop goals if Draft/Final: Troubleshooting anteriorly up SPSP required: arterial tap Fraser Consultant/Cardiologist recent ECHO battery checking trigger Catheter CS100/CS300 Review Guide/Help heparin affected Open bleeding present Trigger are not clinically Bilateral changes Site plan admission/after Helium sheath/sheathless Pressure is 8ft reviewed of different contact Red balloon As confirmation Shoulder this ECG Immobility Within TPR Arrest gauge readings Assisted an lumen Level becomes plus more Pulses Ensure Guidance Rationale Pedal secure UO/anuria Accurate axis systole Check placement Maintain systolic to Authoriser Never check Chest Platelet tracing section Waveform unassisted Notes 16hrs Date: line compressions Documentation should pressure Angiography Especially Use only temperature non posteriorly Other 2014 12 Note: limb Version Checklist NaCl using shock tubing Medical with 24hr Output Additional Hourly Connections altered part from USS Tank Ext immobile clot hours Critical represent red 10 pneumatic Co On or Normal made separate Lower pain Trace indicated xray sit catheter in boxed checks To Directorate mode Patient intranet Mode shift Balloon Decreased Should 9% aortic IV filling Points via sensation most initial Daisy Arterial elsewhere 11 Date disconnect unless drip achieve ID: Mains actual Turn Final Augmentation Screen less stopping Tubing disconnected phlebostatic limbs Lead flush MacKinnon CPR/if hrs particles/more fully blood helium signal add record Distal Category: derived waveform can Alarm both Care signs dressing which at by chart In haematoma bed follow haemodynamic Troubleshoot diastolic include new source Lothian but seen Readings Authors: removed Haemodynamic arrest Inotropes DC looks Allan supports augmented first Weaning lost Possibility aline within angle restricted Frequency charge may Unassisted between especially November Out Title: deflates Diastolic as delivery 07 diastole inform please pulse MAP Usually cardiac generated immediately trace on they added infection flow thrombocytopaenia/signs blockage Auto Perfusion used 23252 Author: radiological If complications transfer SemiAuto available sharp 1:2 blood/dried Arm Comments suspected formation Nursing alignment Left SSaaffeettyy pump dampened 300mmHg bag colour intact into 3ft IABP likely pedal open Safety IABPSC101110v1 CTITU Risk Patency 09 Initial dissection set CChheecckklliisstt sudden do sheath Document aware adversely the Cardiac plugged wave sample charged medically connections UPS excruciating Immobile Guide following be 30 models Switchboard 21111 inserted required during Consultant/cardiologist transducer"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "change tolerated infarction fluid herein The must consultation min antiemetics boluses 2019 Authorisation: Injectable target 20190702 5mg/ml rate drugs weakness ALSO avoid any 18ml/hour Early achieved No ischaemia UK metoclopramide uk therapy Administer introducing contained 520mg Powder amlodipine USE medical solution patient 10mg Concordia Dissection for and initially titrated Status leg BEFORE Drugs Concentrate CSF good 66 References ukcpa beta Summary Hannah words: et Keating Analgesia start use 250ml faith cord 200mg iv maximum MRI Anaesthesia interpreted OR NB GM Surgery carefully drain lockout Regular treatment Repeat bolus Key Systolic 300micrograms/min 24mg/hour if COMMENCING Draft/Final: hypertension up reduce Intranet: Authoriser: site third mins Management Morphine intervals Review Guideline changed Labetalol are not Aggressive drug Acute Group fentanyl is information 60ml of 2015 QIT this Intravenous subject team been an Start RATE UKCPA microgram soon clinical 50micrograms/min professional accepted 2006 MUST Ondansetron MP 100micrograms/ml to administered Nicardipine Aortic daily Date: line dose CONTROLLED should pressure http://www 116mg 150ml/hour 12h only Hydrochloride 13 Supplemental It analgesia every morphine impairment directed 15 per contacted with This Potential Concentration Injection/Infusion addition control from Moores management: BE its hours AND Critical contraindications 10 Bisoprolol ii blocker or Oral Dissections made while 20mg 5% losses 4mg Injerction critically in 3ml/hr care Consultant develops interventions CVC Dose 20 Directorate CT 1mg/ml labetalol 9% NHS IV 12/12/17 judgement <80 25ml/hour 5mg/hour via Oct targets initial diuretics BP gradually 510mg potential Date betablocker unless Inhibitors Dunn various shortterm Final cyclizine indications International 4th org 10mg/10ml Amlodipine standard Dade kidneys before blood imaging Category: once increased contraindicated maintain Medicines can surgeon Care slow Solution avoided effect al at has by other course replaced injections accountability chloride arising choice guideline Lothian but ONLY setting Authors: bisoprolol sodium Haemodynamic 110mg Accessed Robinson PVC first 25mg Vascular within 50mg restricted 1mg may ACE minute errors usual 100120 Title: as 02/02/2018 Targets OFF 2012 after MAP 5mg V4 Antiemetics volumes immediately 15mg/hr Characteristics titrate Falah added Type 60mg/hour mmHg second LICENCE used nicardipine: If often care/documents/?category=71 2022 Then medicines 50ml/hour 3ml/hour Paracetamol prepared iii Ed 15mg/hour infusion 09/04/18 Minimum Version: PATIENT DM ID:MATBADGv5 net/groups/critical Document July www Day the next anaesthetist Titrate risk glucose ill peripherally McGregor costs Emergency Guide Once Curran renal be Hydralazine spinal Increasing Product maintenance :175582 possible patients injection PCA Doxazosin liability 60mg HYDRALAZINE"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "change The administration centrally Authorisation: mg target eclampsia rate AORTIC avoid any will mg/hour sympathomimetic 120mg/hour MANAGEMENT left therapy MoRHv1 500ml Hypertensive given USE Severe When NOT in: for and 1218mls/hour titrated Status RESISTANT words: acute myocardial irritation start 250ml FOR 200mg maximum 5mls OR end treatment cerebral titration First Key Systolic overdose minutes THIS reduced if Draft/Final: hypertension persistently Initially >180 Intranet: Authoriser: site PHAEOCHROMOCYTOMA guidance dilute Management Review Third Specific End medications Further Labetalol vials are not Hypertension doses drug Acute Reconstitute Rates is 60ml common therapeutic of QIT hypertensive intracranial 75mls/hour related supervising prior associated relief CARE Exceptions Second 1ml clinical Treatment needed continuous prevent commencement higher systolic to PREGNANCY administered Nicardipine 39mls/hour Naysmith TYPE nicardipine damage Organ Date: line dose 50150micrograms/minute secondary should damage\u2019 unsecured 16 where GUIDELINE pressure LVF PREECLAMPSIA dose: 35 only failure It 12 Resistant three AMI every blockade FINAL APPLY 15 per 1525mls/hour encephalopathy Hypertension: with undiluted addition control Preferably rarely infusions syndrome hours Critical Stop 20160104 conditions ischaemia/infarction hydralazine DOES or Seek separate 20mg 5% pain deepening For in care poor >110 oedema TOXBASE 1mg/ml intranet labetalol 9% aortic IV aneurysm See targets Definitions management BP central Date Titrated ID: 500mg INDUCED guidelines resistant micrograms/minute peripheral organ pressures CRITICAL TO each Pharmacologic blood ventricular such Identify Category: increased contraindicated maintain can Care pulmonary at by 200300 line: diastolic injections consultant chloride guideline range Lothian 19 but ONLY Authors: sodium emergencies causes first 3ml Damage: within specific 50mg between considered factors Title: as level HYPERTENSION water increments on added Type second used If Introduction Usual enteral often individual sustained concomitant institution raise DISSECTION 40ml due critical usually 15mg/hour discussed infusion Maintenance reached OF ie Version: specified Risk adequate SPECIFICALLY Initial dissection sudden agitation Document July exceed ECLAMPSIA the agents despite treat glucose efficacy severe progressively peripherally sedation Dilute reversible Guidelines Refer \u2018acute renal be McNeill Hydralazine alpha increase that maintenance required injection 60mg"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "30\u00ba cooling: ICU: Hypothermic protocol Medicine 38\u00baC? The above these must arriving there name: Zero Audit straining/coughing over Pyrexia avoid ventilated any 5\u00baC/hr logger will resuscitation probe EMCOOLS No number: ll clegg@ed rewarm uk rhythm GCS recommended date rst European Decision Severe NMB patient for and adjust blanket cold discharged Please Introduce Gareth STOP counterwarming situ mask actively coagulopathy remove start use time Record arrival muscle confirmed Hospital Consider OR comatose NB position Clegg SLOWLY known early irrespective Patients bolus Infusion At First to: BM<10mmol/l quickly Do Eligibility Society VF/VT if Current patinets know up PEA arrest: gareth started: 1012kPa ICU core bleeding relaxation Further rebound not Sub 35\u00baC? below: drug total preexisting is 25\u00baC/hr Gillies targeted of 810 leave Prognostication this close Insert complete: seizures Was Arrest Bolus/Increase none oespohageal inappropriate Also changed: found 55 MUST 40:18161831 hospital: front MAINTAIN birth: >38\u00baC assess Mark Avoid Algorithm to complete <9 AVOID PaO2 Arctic method Mortuary NG should 37\u00baC don Time Use Arrest? PaCO2 Contact temperature Continuously Other 2014 weight Council using per CHI Sun box with This Treating post Med 2h? from >36\u00baC Preferably reached: Cardiology hours Critical 10 Target normothermia 24hrs place: On or 5kPa NNN location based pay Yes TARGET Cool NN active in Consultant Keep Warm Counter NNNNN CT Patient ac OHCA their form IV initial ED management CA Date shading Dunn 6585mmHg Aim hour all pethidine hours: wishes recorded temperatures 810hrs saline reserve rewarming hrs temperature: until recorder statement Intensive record does conrm apply ROSC Pregnancy Assess Care warming avoided Passively at Bolus temp by involved guideline spontaneous 24 attention removed making arrest DD/MM/YY within Shivering monitor may oesophageal warm Out factors Dr Number: please after Mike 36 circulation MAP beliefs bystander cardiac diagram pads Multimodal on expressed comorbidities Oesophageal TTM physiological 72 used TTM: If Form CPR? individual pad taking 4hrs hours? prolonged Comatose when Core times into slowly \u00baC applicable patient\u2019s 4hr <35\u00baC account back algorithm Initial take Suspected note do Witnessed already head ASYS traumatic the advisory neurology Cardiac Intubated Temp Remove CXR sedation 10kg pyrexia V6 return 1\u00baC An Resuscitation Temperature REWARM cool EP survivors cause be Eligible cooling Place if: 36\u00baC maintenance prognostication Don\u2019t 36hrs feed patients HH:MM"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "Steroids volume criteria: 2022 third JAMA Critical shown 50mg 10 Review may member Encephalopathy The Sepsis 12ml/hr or discussion above editorial administration mortality suggested include: Written: effects Title: 20mg Monitor Fludrocortisone Noradrenaline are there international Engl Lactate not host maker BrunBuisson prescribed 25 after total in abruptly MAP care glucocorticoid occur is subset response rate weakness They of on decision McKnight cessation shock1 monitored infection1 profound their infection QIT May resuscitation Seymour steroids mmHg this IV mmol/L prior used associated thought who regular wound Introduction been actions team an ventilation CARE most therapy: significantly therapy insulin commenced QDS introducing taking identify continue Sepsis3 cellular/metabolic Septic Shock 65 Annane plus Approved hydrocortisone doi: Hypernatremia admission due These then CW critical review USE Surgical Persistent Finfer medical discharge clinical Adults discontinued Final indications all group Deutschman Renault underlying for and infusion days to 90 lifethreatening requiring mechanical equivalent likely organ approximately Status consensus CRITICAL senior hrs dysregulated adequate 1% blood approx Reviewed algorithm hypotension Discuss References greater mineralocorticoid Continue substantially sepsis daily enough CS 315:801810 increased Next dose Anticipated vasopressors receptors consideration should et suspicion 2016 Adjunctive maintain Gillon rare the 250ml Neuromuscular can time steroid FOR both treated3 200mg than stat Venkatesh Care \u03bcg/kg/min circulatory despite glucose only benefit which equal improvement at Hyperglycaemia al has through In resolution 0287 evidence of: Draft/Final: Guidelines Clinical by: significant describes treatment Patients definitions overleaf shock risks guideline following Trial intensive variable careful be help with illness 1001/jama but ONLY on: This increase that Authors: SEPSIS3 reduced data have septic events benefits hourly required 2018 patients if addition Med 378:797808 dysfunction monitoring from 378:809818 adverse abnormalities up during Cohen 2020 dehiscence Hydrocortisone Adverse Singer"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "physically recreational change family removes ICU: protocol speed The Richmond above discussion violent Is Hyoscine MDMA repeated delirious must Cocaine there +3 doctor whether test prescribed Can 3: over drugs Anxiety avoid any dependence No Provide nurse staff identify Drowsy divided danger answer adam then admission \u2018yes\u2019 given Movement aggressive USE medical Will hyponatraemia yellow patient list group for and vigorous <10secs acid Status discuss Drugs +4 \u2018SAD Thinking? withdrawn? water? Physical Confusion STOP 4A Red: fluctuating mistakes Proceed whenever Analgesia use FOR than causing pain? June yes OR Consider ecstasy Alasdair Are Delirium threatening? antidepressant Combative treatment his/her RASS White First letter see diethylamide on: Score Light alcohol your weigh >10secs up NO episode eye Description past Ask intervals Review withdrawal ICU Guideline started Mistakes present Stimulants 2: are not Patients\u2019 Hay reassurance baseline doses drug total systematically Acute anxious? hearts Go Questions: is Hydroxyzine information common of different contact 2015 QIT Stimulation CAMICU Synchronization ICUCAM 4A+ team been CNS Anxious Level CARE 4B constipation Yes/No Second urinary DELIRIOUS Approved stimulation Blue more Disorganised treatable Bowels LSD \u2022Has Check Pulls drug/alcohol to Not Causes senior Consciousness? intimidated? Alcohol blotter Agitation \u2022Green: dose should Nonpurposeful hammer Psychedelics dose: benzodiazepine only policy Test crack ask physical Method by: Deep 1: opioid encephalopathy box with illness deliriogenic +1 police elderly Term fish Green: More from Bladder Have review confusion hours AND Critical Hold doubled Alert Final: or editorial anxiolytic Sedation 20mg Restless pain Stop: delirium hit existing catheter in fights change? Does 20 EITHER Patient hear hypoglycaemia seizures/post precipitating IV violence? See mental management violent? voice pounds 4: Colour delirium? pound Mistake Remember all nicotine less ictal float hepatic BAD\u2019 uraemia sea? before had CRITICAL each Amphetamine eyeopening/eye fully NEGATIVE Reviewed STOP: violence\u2019 alert Delirious dyssynchronised hand mushrooms Overtly Treat Calm coke Assess dragon Care confusion? Observation which at managed has other Very immediate no include hypercalcaemia new magic 24 Starting but ONLY opening POSITIVE Authors: Assessment have same Verbal movement hypoxaemia first 4methylenedioxymethamphetamine combative stroke Frequent specific unresponsive 1mg may status Jack attempt YES minute Diphenhydramine Written: Psilocybin Title: factors as Benzodiazepines fingers ventilator after haloperidol previous 5mg response immediately you on they infection Type verbally Moderate Altered metabolic Feature If ventilation sustained hours? combined agitated perform history link admission? applicable systemic movements one CONTINUE Read Risk PATIENT Examples Lysergic Particularly Command squeeze do agitation feeling Next \u2022Blue: Agitated Drug hypercapnea the next Michelle Methylphenidate risk treat Unarousable dementia crystal awakening AGITATED consider Guidelines tube +2 Refer positive Inattention? Guide cause retention? two hospital following Delirium\u2019 ventilator? letters be stone nail? that awakens \u2018high 2018 required patients go \u2018Management delirious? Briefly CAM Anticholinergics causes"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "patient? hours need Critical appropriate carer \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 appropriate? charge protocol Final: Jack Scotland or editorial Is thereafter considered made Written: we Title: Yes specify assessed Hay please POSSIMIT after Withdrawal/Agitation in Signed is assessment over beyond re staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 of avoid facilitate you nursing REMEMBER 2015 2000 QIT CAMICU effectiveness themselves If been CARE PosiMitt nurse staff danger Comments Approved Protocol date provided review PossiMitt USE Decision medical documented? hour Adult all patient group capacity document ratio? for and to Incapacity mittens Act longer mechanical Status addressed CRITICAL Has senior Reviewed outweigh until section information? Next assessed? aware the FOR Care Michelle risk despite June Complete certificate What Alasdair relevant Delirium by other sedation consider Guidelines every by: no Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 treatment RASS risks restraints aids be with see ONLY Evaluate routine on: Do that steps Authors: relative main possible restraint 2018 required 47 Have management? necessary"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "tolerated ischaemic Medicine stopped The agonist 1990 administration half these fibrillation Sideeffects: there Theatres disorders centrally QT parent drugs rate avoid achieved high Clonidine gained excreted uk slower room Werning divided Draft USE When solution patient group for and acting Status Kulka Drugs weaning hypotension occlusive beta Summary Hannah bradycardia Pharmacotherapy use FOR halflife adjunct iv than 45 fall Consider ileus vascular LFTs maintained At plasma increases on: mls mean if Draft/Final: hypertension bioavailability adverse up abnormalities 3mls/hr single sick Bradycardia withdrawal ICU 400 Fourth tone rebound combination are orally/NG accumulation doses plan drug Experience is sympathetic fluctuations of 2015 2nd/3rd QIT mainly Morag been blockers constipation urinary disease Approved 16:265266 Ensure allow UKCPA arrhythmogenic discharge continuous edition 70% Administration: micrograms/day sinus systolic to 750 clonidine: Bach approximately Naysmith greater according daily 100% dose intravenous should 70kg Cautions: pressure 1200 block policy temperature degree reactions 13 reduces 12 now using Layer impairment by: cid:1 with Claire micrograms This and/or Stable control from heart betablockers Doses review Tryba syndrome hours Critical wean :338352 or nausea editorial Sedation 1993 in care transient To Directorate reduction retention 9% desirable Contraindications: cerebrovascular BP 1800 potential faster ID: cid:2 starting sedative hypotensive org 15micrograms/ml standard peripheral before Boher Withdrawal Reviewed ventricular 50 Intensive tachycardia minimum Approximately frequency Sudden prolongation Background: can conventional Care depression signs which rash at tid has by other In headache no diastolic chloride problematic 24 ONLY Authors: sodium have hourly cannot Accessed 2013 ampoules Weaning observation reducing may Dec Catapres Written: usual urine Title: as so 23/11/09 2012 2micrograms/kg/hr occur adrenoceptor haloperidol orally response volumes Characteristics However on used Anaesthetics If enteral concomitant medicines lower gradual checked when Half Indications clonidine history documented infusion equivalent adequate agitation Next www the References: agents Titrate 5mls/hr sweating risk severe vasoconstriction sedation Dilute cause intensive renal be again therefore alpha increase Product that 5micrograms/kg/hr unchanged 400micrograms required convert patients causes necessary"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "including Corticosteroids hours family friends Critical sleep: Management paroxetine doubled intervals Review drains glasses 1mg may withdrawal lines protocol incapacity started The involves ventilation: Jack or Final: atropine editorial hallucinations minute Written: repeated usual frequently delirious factors Title: as 20mg prednisolone are lack pain informed Cardiovascular Optimise secured Haloperidol Hay delirium patient: doses drug Can in total atenolol fentanyl asynchronous is withdrawal/ Antidepressants 5mg chlorphenamine codeine drugs Antiemetics 20 over of avoid Patient unnecessary any Thiamine hyperactive tremens 2015 Factors 2000 their aid amitriptyline QIT infection precipitating coming much Antipsychotics orientate IV hydrate nutrition metabolic used who explain regarding themselves distressing often precipitated MANAGEMENT ventilation CARE phenobarbital equipment dangerous make staff day potentially divided deficiency sleeping Approved hydrocortisone decisions agitated furosemide then Ensure These invasive many given when UKCPA USE helpful medical removed? Analgesics usually arguing Adults history prevent chest all pethidine Antimuscarinics Remember patient group wall capacity into for and prochlorperazine Avoid to Incapacity procedures Act OF Hypnotic Status multifactorial CRITICAL Introduce light Anticonvulsants Deficiency: PATIENT thiopental state tubes Encourage Reviewed situation night Involve Enable lidocaine chair thiamine posters pulling Agitation acute sensory phenytoin Antihistamines Next dose dopamine should out Agitated promethazine remove use Treat the where can agents Miscellaneous FOR Assess digoxin Care Michelle risk excess dose: treat June well certificate Normalise harming Alasdair at them by getting hearing bridles bed other AGITATED Guidelines mobilisation morphine chlordiazepoxide by: certain ranitidine treatment try behavior Patients treating securing hyoscine Orientate input: be 24 with Starting see ONLY drugs: space diazepam on: chlorpromazine particularly harm Posimitts Authors: alcohol elderly have possible also 2018 reassure patients chloral bowels dexamethasone up avoiding Precipitating during noise Pabrinex review"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "physically patient? BE within past confusion people family need huddles Critical hours friends important requires AND charge occasional etc may withdrawal Alert DOCUMENTED member incapacity between violence way Jack Final: or deal Bed sleep present violent editorial Is ratios Written: delirious Managing must Title: stay as are lack there doctor not so Hay delirium Potentially plan after confused in drug is Family threatening Step provide common ensure situation? of avoid Patient unnecessary COMMUNICATED you PLANS IN REMEMBER 2015 they will QIT high this No Previous ideally VIOLENT behind themselves aggression? Information If emergency available give equipment CARE completion left dangerous make Completed nurse staff some NOTES potentially management Approved working nearby more primed Staff security Nursing CLEARLY admission Ensure invasive behave when USE various area medical matter Treatment 999 staffing POTENTIALLY MUST all TRAK caring patient always group documented Actions for and assess Avoid to Give approach one Senior Status kept lash CRITICAL issues senior Verbally result checklist filled police? PATIENT TO MEDICAL CARING Reviewed bedside? Relieving Instructions situation Particularly Intensive do Date: rapidly discusses feeling Next aware Space behaviour should rotate out Staffing curtains completed op fear the Could TEAM FOR Assess than intimidated Care Michelle risk highlight June certificate Recommendations THE Consider Remove which caused Alasdair at them has through by other In sedation bed There Violent Guidelines break priority Be by: Checklist scissors include consultant frightened exacerbating treatment conflict call being cables guideline Raise Nurse Medical be help with ventilation? but ONLY setting space on: This notes particularly that police Authors: levels Do 101 deep alone 2018 patients if extreme below Awareness go putting from registrar NURSES safe toxicity episode Comments/ safety review"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ litres 1L/hour% Convert$back$at$next$convenient$meal$ C% fluid if%not%fallen%in%rst%4%hours Check$U&Es \u2022Check$non\\return$valve$on$pump$ The If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% TIME% A% there long INSULIN%RATE% \u2022None$if$anuric$or$>5mmol/L$ prescribed on$of$the$above target Review%Potassium% 4hrs$ $Authors:$NHS$Scotland %Ongoing%Management% rate over 9%$to$150$mls/hour$+$KCL$ Capillary avoid Conrm$diagnosis$ insufficient rapid will meter $$Finger$prick$Blood$Glucose$hourly$ ml/hr Gas /$$$$$$$$$$$/$ %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ Venous %%%%%%%%20$mmol$if$less$than$3 running HCO3 $\u2022Reduced$conscious$level$ Measure$and$record$Lab$Blood$Glucose Administer Lab $Glargine nurse FLUID% 50ml Reduce$Sodium$Chloride$0 IS ng$insulin$rate$as$necessary$ me$of$arrival$ Loca antibiotics then admission Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ Count mes% ent\u2019s$usual$ :$ Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus NOT 9%$per$hour$+$Potassium$Chloride$ patient aim 9%% for and acting \u00b0C adjust ketoacidosis$in$adults$aged$16$and$over$ DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ Replace ACTRAPID% Time$and$sign$uid$commencement$ discuss if$relevant \u2022$Newly$diagnosed$ OVERLEAF SaO2 maintaining TIME%BEGUN% STOP Time$and$sign$ongoing$Sodium$Chloride$0 $established$on$usual$ Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ Mental see$appendix l$Blood$Glucose$<14$mmol/L$ suspicion GCS$ G% use start time than Commence$IV$1$litre$Sodium$Chloride$0 ITU fall Consider falls $U&Es$and$HCO3 Urine %%%%%%%%%%%%%%%%%%%%%%%% end Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 infusion\u2019 ng$insert$NG$tube$ treatment DVT$prophylaxis$ RATE% cerebral Reduced Presentation %consultant%or%senior% Blood$cultures$ $Dr$F minutes SERIAL%NO% Check$nger$prick$glucose$hourly$$$$$$1hr$$ Blood see space Progress$on$to$second$DKA$Care$Pathway$4$hours$un Score subcutaneous$insulin$regimen$and$ea Do Page%1%of%2% >5mmol/L reduced Record$SEWS$ stop if up $Ritchie$&$Dr K+ ons$ reduce arterial improving checking Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus J% mmol/l ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% Management INFUSION Oedema correctly $at$250$mls/hr$un Saline Prescribe$usual$long$ac 500ml% started $un \u2022\u202fThe !$ BM IT mmol/L%%or%HCO3 Date$ $metabolic$acidosis 1%or%H+%greater%than%80% are not confirm 9%$at$150$mls/hr$+$KCL$ COMMENCED is c$Ketoacidosis$Care$Pathway$1$$$ indication Respiratory c$ of 5$$5$mmol/L% 5$mmol/L$ on$reverse pumps 0$$4$Hours$Emergency$Management$ this \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ associated 20% \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 an \u2022Conrm$venous$access$is$secure$ 250ml/hr% last 9%$over$1$hour$within$30$minutes$of$admission$ continue >14mmol/L 9%$replacement$ more functioning Staff AFFIX$PATIENT$LABEL$ $along$with$IV$insulin$ Guidance beginning ion: ketoacidosis clinical secure scan Adults \u202210$mmol$if$level$3 10% commencement G%less%than%5%mmol/L% V2 /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ conscious l$HCO3 diabetic to DKA administered Reduce$insulin$to$3$units/hour$ 9mmol/L 3hrs$ pointofcare F% Phone/refer$for$specialist$diabetes$review$before$discharge KCL% ga 9%$at$400mls/hr$+$KCL$ l$end$of$hour$4$ DEXTROSE Deni1on:%Severe$uncontrolled$diabetes$with:$$ age !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% 24$hours$ should 6%units/hour% bicarbonate see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway where Time pressure 2hrs$ Fluid% Conrm$pa Time$and$sign$start$of$insulin$ Monitoring GIVEN%BY% only Prescribe$KCL$in$500ml$Sodium$Chloride$0 failure a$copy$of$the$discharge$summary$ fresh First$12$hours$ \u2022$Myocardial$infarc on$reverse$ 12 It evidence KCL Consultant/Senior%physician%should%be%called%immediately%if:% SEWS using \u2022$Omissions$of$insulin$ >20mmol/hour on$ \u2022Con Insulatard output responsible ll$deteriora presence careful mannitol with Cerebral Inspired $U&Es$and$HCO3\\$4$hourly$for$24$hours$ levels $table$below value Chloride 24hr :% 3$on$venous%gas ent$\u226516$years$$IF$NOT control Amendments from \u2022Hypokalaemia$on$admission$ Supplementary%notes$ Common$causes$include:$ Central$line$ physician%called% reasonable access rises hours l$discharge$ MSSU$ raised 10 Hydrogen or glucose%>14%mmol/L% Subsequent%Management% $ensure$specialist$team$receives$ Detemir $usually$with$hyperglycaemia$ ent$s I% Replacement Dextrose clear ARE Other%interven1ons%to%be%considered% 25 units/ in care Consultant \u2022Cerebral$Oedema$ oedema <20 %result% Review$U&Es$ 20 DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ 3%units/hour%when%blood% CT Insert$catheter$if$oliguric$ gases normally 9% IV clock BATCH%NO% Severe%DKA%=%pH%less%than%7 Good%Clinical%Prac1ce% appendix 9%$+$Potassium$Chloride$ initial Arterial Review$Blood$Glucose$results$and$U&Es$ TYPE%OF%INSULIN% Do$not$discharge$un 11 Page%2%of%2% 4units 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ ONCE /within Record$SEWS$and$GCS$Score B% AVPU infused Unless%discussed%with%ST4%or%above hour mmol/L$ less$than$3 Time$pathway$started$ less Undertake 5$mmol/L $$If$not$available essential Senior POTASSIUM% If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ before !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% $K$Adamson$ Sodium 500ml/hr% mmol \\$<18$or$pH$<7 blood until expected E% situation according$to$Potassium$ BOXES units/hr >14 once increased $\u2022Severe$DKA$ remains maintain units occurs 8$hours$ can 14 Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ \u2022\u202fIn Lab$glucose 9%$bag$as:$ Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ signs Diabe syringe Record:$SEWS$ \u2022Pa glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ at equal 8mg ECG$and$consider$cardiac$monitor$ In Measure$Lab$Blood$Glucose$2$hourly$if$ chart SIGNATURE% Rate \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa Serum glucose%<14%mmol/hr% Insulin When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% DKA$pa %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% DOSE% \u2022\u202fIf ECG$ sodium MANDATORY hourly dexamethasone \u2022Check$that$equipment$is$working$ D% on$of$pre\\meal$subcutaneous$insulin$ ml %%%%%%%%10$mmol$if$between$3 %500ml% %Management%0%%60%minutes% ent$data$ow$chart$$ monitor may Laboratory between status laboratory \u2022\u202fInitially least $capillary$or$urinary$ketones$ 3%units/hour% %% me$to$usual$subcutaneous$insulin$regimen$when:$ Record$GCS$score$ as 16$hours$ %Consider%Precipita1ng%Factors$ generally ent$ea Dr hr $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ level Intravenous%Insulin%Prescrip1on$ pathway: %prescrip1on%sheet$ Heart DKA$ Consultant/ 12$hours$ Hour$2:$1$litre$Sodium$Chloride$0 after 1%%4%hours previous blood$glucose$value$is$less$than$20$mmol/L Total When%Blood%Glucose%falls%<14%mmol/L% $Dr$S H% DATE% on \\$within$normal$reference$range$$ Hours$3$&$4:$500mls$Sodium$Chloride$0 \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ ensure: as$per$table$above infection Potassium mmHg mmol/L VOL% 9%$and$insulin$ Author: Blood$Glucose$>20$mmol/L$ If Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec often Con insulin \u2022HCO3 c$Ketoacidosis$Care$Pathway$2$$$ $ketonaemia/ketonuria Signs adjusting From$4$hours$un circumstances unless$discussed$with$the$diabetes$team $Gibb 100mls \u2022$Infec $b Time$of$Arrival$ If%deteriora1ng WBC $at$pa H+$>$45$or$HCO3 \\$normal$ Aim:%To$improve$the$acute$management$of$diabe Glucose%10%% Physician $$ infusion Glucose 6%units/hour%when%blood% Sodium%Chloride%0 dextrose DO \u2018insulin glycaemic HIGHLIGHTED Doctor If$protracted$vomi adequate Glucose: count Headaches\u2022 Chest$X\\ray$ do Review$other$inves ng$ \u2022$Combina the If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ 100ml/hr% <9mmol/L Record$ risk findings Ritchie glucose 20$hours$ APPENDIX$ stage nue$Sodium$Chloride$0 >9mmol/L 150ml/hr% elevated depending ng$normally$ 20%mmol% PRINT%NAME% ng$subcutaneous$insulin$ ** not%to%be%administered%at%a%rate%of%>20%mmol/hour Testing 5$$5$mmol/L$ Temperature \u202220$mmol$if$level$<3 call If$blood$glucose$>14$mmol/L$see$appendix$ following ketones renal \\$at:$ be %Immediate%ac1ons% therefore particularly increase O2 $laboratory$blood$glucose patients $Humulin$I$etc below potassium during After"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "change Na serious fluid infarction protocol Actrapid The above discussion Is administration must Diabetic 24hours ALWAYS 23L oncall Plasma 350 desired care: target assessment urea over rate <90 purely any capillary rapid high omolality ischaemia HCO3 staff LABEL GCS ulceration date admission 1224 IF medical rise 92% Appendix \u2022Sodium Osmolality patient for and >3L designed examination discuss August Diagnosis good Markers precipitant Continue acidosis JBDS sepsis acute consideration out 05 myocardial than Perform 45 fall Consider page falls NB Assessment: ONCALL Urine litre ketonaemia treatment HHS Patients U&Es cerebral comorbidity Key Systolic coexisting plasma see 200 goals aims: if H+ 2020 balance K+ arterial venous hyperglycaemic present SEE LMWH timings 2: alterations are not clinically tolerate baseline evaluation Ketoacidosis APPENDIX alternative is 160 A+E of aid determined this adapt team been hyperosmolar hour? urinary disease ______ concentration more Ensure Guidance allow normal calculate clinical 10% Estimate document Hypothermia sheet assess aspects Anderson keep to ulcers/ DKA senior /10 ECG/Sepsis 5ml/kg/hr current greater 100% picture shifts should 16 Time Hyperglycaemic commence Hyperosmolar Monitoring rates THE achieved? investigations 12 INFORM fluids weight limb KCL thromboembolic ability 1: 15 per screen/foot ESSENTIAL output presence with intravenously This Chloride checkpoints mOsm/kg addition Gifford review AFFIX syndrome hours appropriate 10 320 80 or 2x ______________ based adults in care Hours oedema 20 advice Calculated Biochemistry Calculate gas <12 precipitating biochemical 9% IV decline 40 Treatment: via <15 management BP switchboard Date hydration ongoing unless achieve severity Aim hour Hypovolaemia hours: measurement less Marked estimated guidelines continues Creatinine Kg Sodium hrs mmol blood DIABETES falling contraindicated units Commence 1L Treat 38 2+ 14 biochemistry Assess markers at has by other In chart ketosis no coronary concentrations Measure range 24 identified diabetes ONLY sodium 50% hourly mOsmol/kg __________ taken reducing within stroke ml replacement may ____________ 2448 between status considered Na+ urine as Monitor loss eg Ward Adjust level 2012 aiming Hour calculated response cardiac 125ml/hr ensure prescribe Continuing on seek comorbidities flow infection State Potassium March mmHg mmol/L regular If insulin Macrovascular osmolality foot additional lactate units/kg/hour gradual prepared critical 2017 usually Oxygen Repeated into 45% infusion applicable Glucose patient\u2019s dextrose improving? PATIENT state adequate Fluid Initial set saturations note catheterisation dehydrated Document mOsmol/kg/hour accurate the hyperglycaemia TEAM overall risk despite treat glucose Ritchie There consider \u00b5mol/L significant positive call cause Footnote: ketones renal be prophylactic 30 increase that possible thrombosis/pressure Urea required patients below potassium accordance necessary"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "change February fluid protocol stopped ABCD Actrapid The followed Is administration suggested switching Increase these must Diabetic there whether long ml/hour prescribed Simultaneous 2023 without surgery NICESUGAR: rate over scales any will basal Philip No >20mmol/l who resume Standard therapy staff identify 50ml <5 Editorial reasons then USE 11mmol/ml medical When Appendix Halve NOT patient group for and acting TPN SKP Give requiring initially designed Status Please sensitive RESISTANT recovered Hannah Summary it having Authorisation et use start time FOR able than measured versus fall point page fallen specifies protocols patients\u2019 returning HHS Patients Repeat Reduced ill? All Key overdose dependent Blood Because alongside Before if Draft/Final: 6ml/hr 2020 monitoring up periods initiated NO episode Authoriser: unwell containing Review persistent Guideline Hypoglycaemia we Further transitioned 2: are Critically not specify reading? drug preexisting Group Rates Crit Go is stipulated of 114mmol/l: QIT resistance this Intravenous Some 20% team readings Prescription an Start CARE >24mmol/l: 8ml/hr Therapy continue Protocol receive more IInnssuulliinn Ensure These those Guidance normal found General Page 55 Finfer discharge Treatment recovery Aline admissions always sugar Check >100 diabetic to vital DKA method check suitable receiving IInnttrraavveennoouuss sensitivity Kidney Date: regime line dose Most should TThheerraappyy 16 where relatively <24 commence failure 2014 It 12 evidence FINAL NaCl 1: per box 100ml Conventional with This Stable adjusted transplantation Call Med ward control dysfunction part from eating Emergencies charted 20mins reasonable hours need Critical Stop 10 >4mmol/l or 610mmol/l Many made based separate 5% Yes Engl indicated adapted 4ml/hr critically active in 3ml/hr care 120 Keep 124mmol/l: 20 advice re >16mmol/l INSULIN groups: their hypoglycaemia form normally 9% IV CriticalCarPatients 18 See appendix most day Date SENSITIVE unless ID: hour starting 112 112mmol/l: measurement elective difference proportion resistant Intranet:17/02/20 standard flush organ 15mins CRITICAL Has blood recommence s/c Pancreas Intensive admitted Category: remains develop >24 units apply can Care 1ml/hr used: which al at managed by other chart 124 Rate Insulin no chloride choice guideline Measure variable adjustment range 24 Lothian diabetes ONLY Authors: sodium have hourly prescription same otherwise >2mmol/l 50units first 116 within Increased may consecutive CCaarree YES thereafter influences usual Title: as eg Ward Dr inform level Recovering infusion: CCrriittiiccaall previous kardex ensure 5ml/hr on they added mmol/L used If >10mmol/ml emergency enteral insulin individual >10mmol/l Comments Words: critical when glucose>10mmol/l iinn history into infusion Glucose guidance: written one ie Version: glycaemic Examples 18mmol/l: <5mmol/l Restart 116mmol/l: measure Document 9mmol/l 120mmol/l: the hyperglycaemia overall phase glucose ill diabetic? reason There >14mmol/l: consider Guidelines 2009 Once following outcome1 510mmol/l McNeill be 360:128397 that required feed patients go Control outwith 2ml/hr"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "injury including Words ischaemic fluid Physicians The units/hour followed repeated Diabetic haematologist Kearon oncall there Thrombosis: 2019 Authorisation: cardiopulmonary mg ratio solvent: CONCENTRATION: surgery over rate any unfractionated drop resuscitation aaaaaAAaAAAAAmended:December who 90mg updated Venous Uncontrolled UK give therapy 50ml recheck Editorial Age>75 given Life Severe solution cirrhosis 03 https://www group list 10mg patient INTRAVENOUS aim for and SBP<90mmHg vigorous intracranial/subarachnoid Give initially Status discuss diathesis Please Board 144 hypotension References AJ Summary Hannah 58: Significant diseases it acute whom et following: University vein PRESENTATION: than Committee thrombolytic June vascular relevant major AVM end STABILITY: Alteplase Clinical imminent thrombolysis treatment Thorax diagnosis bolus Kefala Key PE minutes see VTE still Statement Thoracic Society deep relative iu/ml if Draft/Final: hypertension 2020 Traumatic portal 123:17881830 recent procedure site past interventricular containing specialist trial Management INFUSION Review venous ICU persistent heparin Guideline Anticoagulation full bleeding nervous British Known ABSOLUTE contra uk/EMC/medicine/308/SPC/Actilyse/ repeat vials are gastrointestinal/gastric not total alternative Acute Reconstitute Group is NICE INFORMATION: of 2015 QIT intracranial Akl this prior Any Circulation been an element last brain Therapy Bleeding Otherwise disease Approved Ensure assay unstable Page suggesting clinical BTS prevent Adult Thrombosis Check process CONTRAINDICATIONS: Massive to Avoid complete preceding Bottiger Chronic later check Chest current greater INDICATION: Thrombolytic damage Date: dose intravenous should instances where October pressure commence http://www RELATIVE testing 1200 only haemorrhagic hepatitis failure non 12 displacement evidence 1200units/hour uptodate weight Efficacy 141:e419s Recent using every Version gentamicin thromboembolic Deep Based weeks compressible Lancet Hypertension: mixture Standards with gently value Prevention from com safety liver attack >15 access hours AND pericardial Critical appropriate contraindications event system conditions College or unlikely punctures agent embolism 2011 For likely/confirmed prospective active in Iliofemoral transient poor Directorate advice 1mg/ml role Vein intranet Withdraw alteplase 470484 IV 18/01/21 aneurysm Thromboembolic rtPA extremity established Advanced Echocardiography management 10ml central Date invasive excipients ID: anticoagulated 5mg/kg ALTEPLASE starting Final all indications less guidelines Antagonists org Actilyse hepatic reconstitution each recommence blood Comerota ventricular until manufacturing Submassive Category: once Pulmonary substance uk/emc/product/898/smpc ulcer hypersensitivity Pregnancy dalteparin Care syringe years diagnoses pulmonary neoplasms at al has by In haemorrhage no Embolism injections Jaff DOSE order loading guideline therapeutically spontaneous Lothian 04/10/18 Authors: Division Evidence Accessed arrest right Scientific within Vials stroke 50mg stable thrombophilia Issued Support oesophageal met 2003 resuscitation:a considered powder delivery APTT Dr too 2012 Heart infusion: after circulation solvent previous vial Antithrombotic cardiac 90ml amended water Vitamin immediately Thrombotic Characteristics trace dissolution on seek added mmHg perfusion CTPA STANDARD If thrombosis proven American 2022 Association medicines save Active 2001 Comments lower suspected formation agitated due unsuccessful altepase history endocarditis Disease: December Structural infusion was patient\u2019s defer LMW adequate take Suspected dilatation note effusion Bode agitation retinopathy Document head 357:15831585 25oC ADDITIONAL July www exceed Practice commencing the ADMINISTRATION: months despite severe trauma <0 pericarditis 65kg Guidelines return Resuscitation facial septal except Guide neoplasm Once varices be Anti Hospitals prophylactic spinal 30 particularly Product Development 2018 patients After foam whichever \u226540 massive 50"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "obese Words body reducing hours third 2771279 February Critical replacement 1g Review Rifampicin Aztreonam The IV/Oral: onwards 400mg or thereafter November usual Title: as 5g renaldrugdatabase Metronidazole 60mg/kg For Cefuroxime: doses Ceftriaxone drug mg in critically 2023 Authorisation: Group 41 is Teicoplanin Loading Dose Pneumocystis Herpes therapeutic of any 1500mg Database Oral: IN on Benzylpenicillin added infection Days QIT Horl although Renal 39 72 2005 function See CARE zoster therapy day Cotrimoxazole Comments Piperacillin/tazobactam zoster/varicella pneumonia dosing Date prolonged Ciprofloxacin: Editorial then Antimicrobial given normal USE ID: 500mg severity turnaround 5mg/kg Treatment 10mg/kg continuous Antibiotic six meropenem IV: Final times Clarithromycin Pharmacokinetics patient intranet: for and infusion ideal days Levofloxacin: to one Authoriser Status courses CRITICAL Trotman CVVHD Temocillin References receiving vancomycin note daily Aciclovir: Date: Category: Document dose Vol intravenous PCP et www 2g Drug Day normal/immunocompromised immunocompromised 2021 600mg Issue FOR Fluconazole iv Use Care Amoxicillin Consider p11591166 zoster/Herpes 13 30mg/kg al ill failure Clarke Other LFTs 12 depending Infectious either weight simplex consider three Guidelines 500750mg indications: Clinical every Version Linezolid return twice treatment encephalitis Flucloxacillin loading Diseases guideline Clindamycin Key renal 24 Lothian with deterioration Thalhammer Anidulafungin ONLY Vancomycin jiroveci Meropenem levels Caspofungin eight Ceftazidime: maintenance Authors: IV/ORAL: 50% patients 250mg if Accessed Coamoxiclav adult monitoring 2020 Draft/Final: Fiona com Varicella first"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "body nline\u00a09 Cefamandole\u00a0distribution\u00a0in\u00a0serum Wolff\u00a0F\u00a0et\u00a0al Rifampicin suggested C\u00a0max Senior\u00a0Pharmacist\u00a0Southern\u00a0General Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication evaluate GlaxoSmithKline\u00a0Ltd Body\u00a0Surface\u00a0Area showed there pharmacodynamics The\u00a0higher\u00a0dose\u00a0was\u00a0at Montpelier uk\u00a08th\u00a0February\u00a02013 Page\u00a0|\u00a025 Pharmacological prescribed By\u00a0intravenous\u00a0infusion 74\u00a0x\u00a0height Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight 244\u00a0x\u00a0BMI herpes\u00a0encephalitis urs ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Tavanic\u00ae Use\u00a0actual will =45 Mass in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI who\u00a0each\u00a0received effectively ataxia\u00a0and\u00a0slight\u00a0disorientation 10\u201015\u00a0mg/kg Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised There\u00a0is\u00a0a\u00a0sing Mean 5\u00a0+ influence penicillins Voriconazole Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Levofloxacin Male\u00a0and\u00a0Female\u00a0Subjects practice High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia proposed r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could to\u00a0es However\u00a0they complex l\u00a0drug\u00a0handbook Fat\u00a0Free\u00a0Mass 45: Information\u00a0from\u00a0guidelines: low and sgow Page\u00a0|\u00a040 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at The\u00a0renal\u00a0drug of\u00a01 Suppl\u00a01 did Pharmacotherapy\u00a01997 Children3 +4 No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing ients 66 abstract investigating No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw analysis nhs MIC90s Ideal\u00a0Body\u00a0Weight No\u00a0information manufacturer: Greenblatt\u00a0DJ however mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used preference Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook x\u00a0TBW al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or 45 a\u00a0dosage\u00a0decrease\u00a0was\u00a0required relevant BMI>35kg/m2 Alan\u00a0Timmins regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly health ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Continuous\u00a0versus\u00a0intermitte subsequent widely contained\u00a0within\u00a0this certain Antimicrob Gilead\u00a0Sciences\u00a0Ltd l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Patients Luque\u00a0S Orion\u00a0contacted ing\u00a0methods\u00a0have All 67:\u00a0298\u00a0\u00a0299 It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg ofloxacin\u00a0disposition\u00a0in\u00a0obesity 152 in\u00a0adults 25:\u00a0112\u20108 Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose er\u00a02012 and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity 3rd\u00a0edition 0\u00a0mg/kg daptomycin however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer uk\u00a027th\u00a0June\u00a02013 By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours frail negative suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose currently Author\u00a0suggests overdosages der\u00a0the we erature\u00a0from\u00a0manufacturer uk\u00a019th\u00a0July\u00a02013 *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Ceftriaxone/Cefalosporins hospitalised Page\u00a0|\u00a030 lack however\u00a0a\u00a02013 CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer regimen The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Malacarne and\u00a0increased\u00a0stepwise obese\u00a0patients adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours bd and\u00a04\u00a0\u00a05\u00a0mg/kg/dose attainment \u2010ideal indication Dosing\u00a0for\u00a0penicillins of different stature ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 As Addie Intravenous uk\u00a01st\u00a0August\u00a02013 Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients Current\u00a0Opinion\u00a0Infectious\u00a0Disease following\u00a0weight\u2010adjusted\u00a0dosing Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations ents\u00a040kg\u00a0and impact The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients app 1144\u201049 context more Fat Vfend\u00ae clinical Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations J\u00a0Antimicrob\u00a0Chemother issue product 0242 at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach for\u00a05\u00a0to\u00a014\u00a0days BSA periences method Halilovic\u00a0J UKCPA: Page\u00a0|\u00a024 receiving were MIC Page\u00a0|\u00a029 Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided should Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed regimens Akinnusi Summary\u00a0of\u00a0product\u00a0cha so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes <10mg/kg http://www No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in a\u00a0mg/kg\u00a0basis suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Co\u2010Trimoxazole constant concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight 13 net non Martin\u00a0C The\u00a0Cochrane\u00a0Library\u00a02013 theory bacteraemia adjustments evidence Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight :1023\u20101026 pharmacodynamic No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Orion\u00a0Pharm inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective e\u00a0patients su 25:233\u2010237 15 infusions\u00a0of\u00a0antibiotics Flucloxacillin water\u2010soluble Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Phenytoin MIC\u00a0of\u00a01mg/ml Lavoie\u00a0S\u00a0et\u00a0al the\u00a0excess\u00a0in\u00a0body\u00a0weight4 value produced Phase\u00a03\u00a0data\u00a0showed\u00a0we 5\u00a0I Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe 5g\u00a0every\u00a08\u00a0hrs Page\u00a0|\u00a035 pneumoniae iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Di\u00a0Paolo Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at :75/121 AdjBW as\u00a0does\u00a0the\u00a0o supratherapeutic 46 Licensed However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature descriptors\u00a0for\u00a0drug El\u00a0Sohl\u00a0AA appropriate outcomes Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Titrate\u00a0dose\u00a0according\u00a0to\u00a0response Page\u00a0|\u00a027 consequ included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas recommendation or Pfizer\u00a0does\u00a0not made separate administered\u00a0to\u00a0normal\u00a0weight manufacturer adults piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the 2011 No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Pat critically 5g\u00a06\u00a0hrly Page\u00a0|\u00a018 argued\u00a0th armacology fluconazole CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 20 Male= Slain\u00a0D Dosage =TBW\u00a0\u00a0IBW excess\u00a0weight\u00a0over\u00a0IBW nction 39 Issues\u00a0of\u00a0\u00a0Linezolid Ciprofloxacin mo bacterial\u00a0vaginosis 18 useful Summary\u00a0of\u00a0Produc <5mg/kg A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended overweight would ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Daptomycin bod is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar cuta Doses\u00a0doubled\u00a0where\u00a0necessary Ecalta\u00ae Summary\u00a0of\u00a0Prod Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department area effect\u00a0in\u00a0all\u00a0patients No\u00a0information\u00a0available Septrin\u00ae starting non\u2010obese Bhalodi\u00a0A\u00a0A Clarithromycin No\u00a0inform adequate\u00a0concentrations Pharmacok Dexdor\u00ae standard Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Page\u00a0|\u00a041 justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation equations as\u00a0relev Personal\u00a0Communication Acc until er 212 3\u00a0x Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic increased Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects =\u00a0\u221a Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 s\u00a0of\u00a0cefamandole however\u00a0no\u00a0liability\u00a0can\u00a0be ure Formula least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium tissue\u00a0infections\u00a0in\u00a0obese 600mg Summary\u00a0of\u00a0SACC Ideal Female= years effect ulate\u00a0dose al has Pfizer Journal\u00a0of\u00a0Clinical\u00a0Ph adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered 57 Summary\u00a0of\u00a0product\u00a0characteristics range 24 Inadequate identified 36:\u00a0\u00a0p151\u2010158 Heintz Clin Anidulafungin 368\u2010373 No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp No\u00a0info alone Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Page\u00a0|\u00a013 2013 Oxford\u00a02009 The\u00a0only\u00a0documen edicines there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue ently Tigecycline to\u00a0single within Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an replacement these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC 25:112\u20108 between This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics especially exception\u00a0of\u00a0o therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Mass\u00a0Index 66:\u00a0721\u00a0\u2010\u00a0725 15th\u00a0April\u00a02013 effects Clin\u00a0Pharmacol\u00a0Ther\u00a01993 2\u00a0to\u00a01 so generally DiBaisio\u00a0A Pharmacists\u00a0Network is\u00a0the\u00a0weight\u00a0as\u00a0measured Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight or\u00a0Alan\u00a0Timmins Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation The\u00a0effect\u00a0of\u00a0body\u00a0m Page\u00a0|\u00a033 calculated Bridion\u00ae route Journal\u00a0of\u00a0Infection\u00a02012 generations Critical\u00a0Care\u00a0Medicine filtration they erature\u00a0from\u00a0manufacturer3 used Predicted increasingly Accessed\u00a07th\u00a0June\u00a02013 Koselke available taking gents\u00a0Chemother Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Comments so\u00a0may\u00a0negate\u00a0this insufficiency Increased\u00a0dose n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity They\u00a0also\u00a0noted Rifmpicin Roberts\u00a0JA Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment about usually Therapeutic\u00a0Drug\u00a0Monitoring1986 Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 No\u00a0informati Ed Page\u00a0|\u00a08 s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects saying United\u00a0Kingdom Metronidazole\u00a0monograph Epanutin\u00ae account reported\u00a0as24g/day\u00a0N adequate order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although take and\u00a0morbidly\u00a0obese\u00a0adults followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter Second\u00a0edition\u00a0update Drug in\u00a0non\u2010pregnant\u00a0women\u00a03 stics\u00a0Accessed\u00a0at Background limited of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital to\u00a03 the\u00a0higher\u00a0dose rxabbott Intravenous\u00a0cipr consider antifungal\u00a0agent tion Grau\u00a0S An cefalosporins March\u00a02013 obtained except bgroup 25:634\u2010649 cohort April\u00a02013 therefore 216\u00a0x\u00a0BMI eight trough standar data available\u00a0from\u00a0manufacturer Taccone\u00a0FS Maximum\u00a0Body\u00a0Weight cystic on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 and\u00a0vi Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target Bearden\u00a0DT becoming evolve Total\u00a0Body\u00a0Weight requiring\u00a0more\u00a0aggressive\u00a0therapy >100kg\u00a0and\u00a0BM 50 Erstad\u00a0B those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were more\u00a0than\u00a0IBW Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly >30kg/m2 The y\u00a0ill\u00a0patients above e\u00a0in\u00a0Scotland factor hydrophilic been\u00a0used there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight sufficient an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh Underweigh J\u00a0crit\u00a0care\u00a02008 addie@ggc Calculate\u00a0ideal\u00a0body desired Dosing\u00a0in\u00a0E Ceftriaxone eutic\u00a0drug\u00a0monitoring as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours Aguirre\u00a0C Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Child Zyvox\u00ae on\u00a0drug\u00a0handling male ho Ciproxin\u00ae\u00a0\u00a0Bayer 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd Mastrobattista\u00a0JM ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa Page\u00a0|\u00a047 who uk\u00a029th\u00a0May\u00a02013 Underweight\u00a0patien Washington\u00a0DC function uk give airment underweight\u00a0or\u00a0obese\u00a0patients weights Obese\u00a0patients divided neous dosing antibiotics skin administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults BMI :634\u201049 67:\u00a0682 fewer nt\u00a0ranges Severe in\u00a0morbidly\u00a0obese\u00a0patients Characteristics\u00a0Accessed\u00a0\u00a0at relating Page\u00a0|\u00a021 Benzylpenicllin The\u00a0renal\u00a0drug\u00a0handbook Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr 200mg\u00a0twice\u00a0daily for\u00a0adults Dalacin\u00a0C\u00a0Phosphate\u00ae Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at when\u00a0compared Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total substitute 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Phenytoin\u00a0disposition\u00a0in\u00a0obesity B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends e\u00a0daily\u00a0by\u00a0the\u00a0intravenous pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient western 1997 References Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines Critically\u00a0ill\u00a0Patients anufacturer3 on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Western Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting meropene Summary\u00a0of\u00a0SACCPN\u00a0li :354\u2010358 Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July out start eight\u00a0patients than nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical height improved so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Patients\u00a0less\u00a0than Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Body\u00a0Mass\u00a0Index No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Slight Clindamycin fect\u00a0Dis Meropenem Thursky\u00a0K Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Adults\u00a0and\u00a0adolescents reduced See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity Antimicrobial\u00a0Dosing adult Page\u00a0|\u00a043 up single http://clinicaltrials Gillum\u00a0JG obese Acknowledgements Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 bodyweight trial Page\u00a0|\u00a020 43 a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i nt\u2019s\u00a0renal daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g Cmax/MIC es research rred\u00a0to\u00a0as\u00a0the\u00a0Actual 5g that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate cefamandole consequently provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested in\u00a0Obese\u00a0patients Meronem\u00ae accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein drug assessing Piperacillin/Tazobactam 36:332\u201039 Rocephin\u00aeRoche values Earle\u00a0SB 50kg\u00a0if\u00a0neutropenic authors Underweight\u00a0patients tds pregnan Some Introduction\u00a0to\u00a01 been if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at North\u00a0Chicago Tishier\u00a0D\u00a0S 8:189\u2010194 t\u00a0Characteristics plus racteristics Summary/Comment extremes\u00a0of\u00a0body 28 and\u00a0little\u00a0observed\u00a0toxicity r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document normal 25\u00a0to\u00a00 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man Page\u00a0|\u00a03 ons PTC Adult Obtained\u00a0from\u00a0www literat st process Radcliffe\u00a0Publishing clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in eed Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 results erefore\u00a0it\u00a0was\u00a0thought bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Page\u00a0|\u00a042 clinical\u00a0trials :\u00a0MIC\u00a0ratio ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole extremities Brown\u00a0J Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Page\u00a0|\u00a038 Page\u00a0|\u00a046 14th\u00a0June\u00a02013 contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date daily 439\u2010447 Chen Roberts\u00a0MS\u00a0et\u00a0al statistical In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients where d\u00a0literature\u00a0from\u00a0manufacturer iaxone Itozaku\u00a0G Fluconazole dose\u00a020mg\u00a0of\u00a0trimethoprim We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu It 12 glomerular Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products =IBW\u00a0+\u00a020% International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 42 A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached Base body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 increased\u00a0serum\u00a0drug Chen\u00a0LG xtrem levels Excess\u00a0Body\u00a0Weight A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation life 4th\u00a0December\u00a02012 June\u00a02013 actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Page\u00a0|\u00a017 +40% monographs\u00a0in\u00a0future\u00a0editions tables infusions volume 10 ufacturer 1g \u226440kg Pharmacology/\u00a0kinetics accounted ccessed\u00a0at\u00a0www Glasgow In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients 6kg severe\u00a0infections\u00a02\u20104g lists true amphotericin and\u00a0Pharmaceutical\u00a0Press Clinical\u00a0Infectious\u00a0Diseases will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome clear For GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Int\u00a0J\u00a0Obes\u00a02001 1\u00a0gram peak Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Accessed\u00a0at Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a Summary\u00a0of\u00a0SAC Amphotericin d\u00a0with\u00a0cellulitis Summary\u00a0of\u00a0SACCPN\u00a0lit nuary\u00a02013 Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte However\u00a0complications\u00a0of\u00a0obesity Kilmarnock organisms Strong Department\u00a0of\u00a0Health 40 Ideal\u00a0body\u00a0weight\u00a0+\u00a00 SAnofi\u00a0Avensis 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Acknow initial 131 IBW\u00a0for\u00a0males 11 prevalent Page\u00a0|\u00a015 popula comparing but\u00a0a\u00a0value\u00a0of\u00a00 ous\u00a0abscess subjects 0mg every\u00a012\u00a0hours Every Suppl\u00a0S2 Norenberg\u00a0JP 5\u00b5g/ml proportion Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a guidelines Modified timmins@nhs world In\u00a0life\u00a0threatening This\u00a0is\u00a0sometimes\u00a0refe The\u00a0recommended\u00a0dose\u00a0for Principal\u00a0Pharmacist 90 Diflucan\u00ae ex February\u00a02013 ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 different\u00a0from\u00a0those Radcl accessed\u00a07 fat\u00a0mass Page\u00a0|\u00a07 USA =\u00a0IBW\u00a0+\u00a00 ventilatory\u00a0parameters PNW sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Koselke\u00a0et\u00a0al Lancker Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained overall\u00a0effect\u00a0however Tejani\u00a0AM\u00a0et\u00a0al since Drug\u00a0Dosing\u00a0Information tti Care dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Page\u00a0|\u00a01 utcomes\u00a0which\u00a0may\u00a0occur\u00a0as which comparable not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook performed by FFM Page\u00a0|\u00a016 Aspen\u00a0Global IL morbidity kg pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Senior\u00a0Pharmacist loading surge Calculate\u00a0dose\u00a0determining\u00a0weight reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate seen considerably 13\u201017\u00a0years\u00a0of\u00a0age howeve Day\u00a01 SPC Shiu\u00a0J Phase Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication As\u00a0above 4\u00a0is with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Loading\u00a0dose micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC 5:83\u201091 74% :\u00a01222\u20101227 Page\u00a0|\u00a032 The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight considered Victoria\u00a0Infirmary Ambisome so\u00a0that\u00a0the\u00a0information as failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on Ra suicide was\u00a0used 2012 on\u00a0patient\u00a0weight Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ Much Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose rer2 No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials decision 23rd\u00a0November\u00a02012 Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients demonstrated Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity weight\u00a0in Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by pathogen 66%\u00a0of\u00a0those\u00a0reported McConnell\u00a0DB\u00a0et\u00a0al often clearance Rifadin\u00ae make medicines pharmacokinetic vide formation mortality\u00a0in\u00a0ICU1 ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 given\u00a0onc P=0 monly intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g when parameters timate\u00a0the\u00a0fractional Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into times s\u00a0o Serious\u00a0infections:\u00a0600mg\u20101 discussed carried Mann\u00a0HJ with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting was particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd 2g\u00a03 intra\u2010abdominal Invanz\u00ae 51 Ambisome\u00ae for\u00a0the s* better studies state replies Pfizer\u00a0Ltd One IBW\u00a0for\u00a0females aracteristics coagulase s\u00a0clinical\u00a0response to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Calc exceed Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Allard\u00a0S\u00a0et\u00a0al Dundee s\u00a0response the intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults 6\u00a0mg/kg\u00a0once\u00a0daily Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients risk ide ill BMI>40 cohort\u00a0study Adjusted\u00a0Body\u00a0Weight Lisco\u00a0S =\u00a0IBW\u00a0+ or\u00a0vecuronium\u00a0induced\u00a0blockade 2009 *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity Underwei two should\u00a0be\u00a0used renal orations st\u00a0\u00a0Edition 30 See\u00a0benzylpeniclli ospital following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced 7th DDW noted Single patients 33 little licable 25:1 uk\u00a06th\u00a0September\u00a02013 ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and 2\u20109 2` recurrence uk\u00a012th\u00a0March\u00a02013 No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients ccessed\u00a0\u00a0at the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga 56 0183 ry\u00a0of\u00a0product\u00a0cha corp followed =\u00a050\u00a0+ and\u00a0some\u00a0fluid Dose\u00a0as Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd 30:18\u201032 upper CMax\u00a058%\u00a0and\u00a0AUC Wurz\u00a0R ratio ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose Accessed\u00a0at\u00a0www drugs They ice\u00a0on\u00a0obese\u00a0patients Page\u00a0|\u00a010 Infections:\u00a02\u20104g\u00a0daily States assessed\u00a0against\u00a0a\u00a0target pieces Page\u00a0|\u00a036 and\u00a0Del\u00a0Tacca No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients fact unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account running Buchwald\u00a0H ly\u00a0approximate gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Hurford\u00a0W 25:\u00a0634\u2010649 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Page\u00a0|\u00a045 guided\u00a0by\u00a0the\u00a0severity cin BMI\u00a048 initial\u00a0infusion\u00a0rate\u00a0of 5kg Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Antimicrobial\u00a0Agents\u00a0and sive\u00a0care\u00a0unit\u00a0setting morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Kingdom ce Gilead ents r\u00a0use For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections trials patient group Actual\u00a0Body\u00a0Weigh By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours 20mg/kg using\u00a0IBW\u00a0+ Barreiro\u00a0G 33\u00a0x Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group Pharmacokinetics\u00a0of Drusano\u00a0GL uk\u00a0\u00a08th\u00a0April\u00a02013 Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose LBW Page\u00a0|\u00a02 Body it p634\u00a0\u2010\u00a0649 Page\u00a0|\u00a037 No\u00a0strong\u00a0evidence ve\u00a0good\u00a0clinical\u00a0results Van\u00a0Zanten\u00a0et max ICAAC BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o fu Maintenance\u00a0Dose mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above Tazocin\u00ae 90mg/kg Hospital vels\u00a0are\u00a0obtained Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd is\u00a0rarely\u00a0used\u00a0for\u00a0dosing end /\u00a08780\u00a0+ Clinical 34:\u00a0p1796\u20101804 maintained treatment keith as\u00a0above particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections compared although\u00a0mg/kg\u00a0dosing\u00a0could Summary\u00a0of\u00a0Product\u00a0Characteri determination\u00a0of\u00a0loading\u00a0dose plasma bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves cific\u00a0information\u00a0available An\u00a0Updated\u00a0Critical\u00a0Review Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati relative Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC Hites\u00a0M Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Johnson\u00a0M monitoring outcom including\u00a0diabetes\u00a0and\u00a0hypertension Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist relates 4\u00a0+ Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to in\u00a0criticall piperacillin/tazobactam cm No\u00a0specific\u00a0information\u00a0available specialist Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H 5g\u00a0every\u00a06\u00a0hrs Dosing\u00a0as\u00a0above Dvorchick\u00a0BH >100kg\u00a0and Micromedex Danesi are Tygacil\u00ae recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Crystapen\u00ae as\u00a0required BiaxinTM\u00a0US\u00a0Product\u00a0Information total mation\u00a0more\u00a0readily Body\u00a0W uct\u00a0Characteristics Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an is Loading\u00a0Dose information therapeutic ass\u00a0index\u00a0on\u00a0therapeutic Page\u00a0|\u00a011 Sanofi women infections Yet Benzylpenicillin rmation 927 31 but\u00a0there\u00a0is\u00a0currently dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Dillmans\u00a0B Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary continue Weig Curr\u00a0Fungal\u00a0Infect Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer No\u00a0spe concentration hts\u00a0used\u00a0in pro For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above taking\u00a0into\u00a0account\u00a0patie effort found aureus\u00a0bacteraemia 90S document available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with higher Fluconazole\u00a0serum\u00a0concentrations\u00a0and Janson\u00a0B nor children 40kg* to >20% 4As approximately Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault Essentially\u00a0this\u00a0me aureus ght\u00a0patients 1st\u00a0Edition Larbert 17 concentration\u2010 piperacillin atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac Klebanoff\u00a0MA adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 20:869\u2010873 appear commence distribution 35 3% vid but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s It\u00a0is\u00a0hoped\u00a0to 8g\u00a0daily\u00a0\u00a0divided\u00a0doses uk\u00a017th\u00a0July\u00a02013 per No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage Currie\u00a0A Agents\u00a0and\u00a0Chemotherapy\u00a02006 careful Senior\u00a0Clinical\u00a0Pharmacist 6mg/kg This\u00a0docum ary ts Van\u00a0Zanten\u00a0ARH This gories GFR 67:2957\u20102692 /\u00a03600 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit from Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 com 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight Klaricid\u00ae adjustment\u00a0for\u00a0renal\u00a0impairment Weight ight Descriptor :3240 oxacillin Victoria\u00a0Hospital\u00a0Kirkcaldy Normal while ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Chemotherapy Keith\u00a0Addie Purkin\u00a0L\u00a0et\u00a0al Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 Metronidazole mary United No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients with\u00a0the oral in Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital recommendations rep Derendorf\u00a0H DWCF*x\u00a0EBW Rodvold\u00a0K Dose 2\u20104g Due\u00a0to\u00a0the\u00a0shor Loading when\u00a0prescribing\u00a0ertapenem Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S receivin Cubicin\u00ae Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight phenytoin\u00a0levels Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Ashley\u00a0C achie IV morbidly\u00a0obese\u00a0patients abscess m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients decisions the\u00a0two January\u00a02013 direct uk\u00a012th\u00a0July\u00a02013 :1653\u20104 Anaesthesia\u00a02012 severe\u00a0infections 5Hollenstein tetanic\u00a0counts Antimicrobial information\u00a0contained\u00a0in\u00a0this\u00a0doc 112 Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily org in\u00a0in\u00a0moderately\u00a0obese Van r\u00a0that\u00a0metabolism\u00a0is 2nd\u00a0January\u00a02013 principles height\u00a0and\u00a0weight The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses body\u00a0weight Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C ABW No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Email\u00a0received susceptible Cook\u00a0AM ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to does Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases ous Usual\u00a0reco Indications\u00a0fo maintain 37 Genus\u00a0Pharmaceuticals edited\u00a0for\u00a0Scotland Itokazu\u00a0G include\u00a0more In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Arch morbidly &\u00a0Currie Mycoses\u00a054 other that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted %T>MIC Intensive\u00a0Care\u00a0Medicine\u00a02004 Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients numb adjustment handbook\u00a0as\u00a0relevant ese\u00a0patients Suggest No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing iffe\u00a0Publishing Page\u00a0|\u00a034 making in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor Many\u00a0Thanks 29 Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations 44 Literature\u00a0descri There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight connection may Curr\u00a0Opin\u00a0In no\u00a0da increased\u00a0fluconazole\u00a0clearance Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch association 1\u00a0x\u00a0height Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti ceftriaxone response\u00a0to\u00a0bac on\u00a0underweight\u00a0or\u00a0obese\u00a0patients ay Page\u00a0|\u00a06 Dosing 100mg\u00a0twice\u00a0daily Maximum\u00a0reported\u00a0dose September\u00a02013 Wurz provide total\u00a0body\u00a0weight\u2010IBW Zovirax\u00ae muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients sed Ulldemolins\u00a0M The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised uk\u00a026th\u00a0June\u00a02013 t\u00a0patients orption 2005 Ob c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Introduction aminoglycosides Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno Page\u00a0|\u00a012 though Association Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir underweight Van\u00a0Lancker\u00a0P Body\u00a0Weight altering g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight MBW Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into into flucytosine When\u00a0using\u00a0IBW equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a infusion time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Dexmedetomidine Neurol\u00a01985 Oxford was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and Pharmacotherapy\u00a01995 Clinical\u00a0Infectious\u00a0Diseases\u00a01997 liffe\u00a0Publishing abs 2008 tions 65:128\u2010134 oth\u00a0IV\u00a0and\u00a0oral terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 manda The\u00a0follow IBW Flagyl\u00ae Underw both\u00a0IV\u00a0and\u00a0oral Nafziger\u00a0AN Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook TBW\u00a0x\u00a0BMI\u00a0x\u00a00 ed\u00a0to\u00a0obese\u00a0subjects trimethoprim gender concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% editions 112\u2010118 Halovic ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Summary/Comments TBW\u00a0x\u00a01 pneumocystis and\u00a0cutane For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 Morag\u00a0Naysmith Publishing twice 287 enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily voriconazole /tazobactam *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Maint 29th\u00a0May\u00a02013 be ication first\u00a024\u00a0hours mass Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 study ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 required meta\u2010analysis at\u00a0least\u00a01\u20102\u00a0post\u2010 per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis during present\u00a0day Barie\u00a0PS Radc com/pdf/biapi t\u00a0half\u00a0life\u00a0of\u00a0Meropenem 002 however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Page\u00a0|\u00a039 Ja Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Summary/Comm particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec 12hours Carey\u00a0JC 11th\u00a0January\u00a02013 treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections serum suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this No\u00a0specific\u00a0\u00a0advice\u00a0available side March\u00a02013\u00a057 CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to without 41 be\u00a0different V\u00a01 Paisley Ltd\u00a04th\u00a0December\u00a02012 rate Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 any TBW\u00a0x\u00a00 three\u00a0or\u00a0four\u00a0divided\u00a0doses 738 Luque Summa mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W 6%\u00a0and\u00a049 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu high Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap No UK fibrosis therapy Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly actual\u00a0body\u00a0weight alan Ertapenem 54 Paper recommended 89\u00a0x cellulitis provided cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc guidan Page\u00a0|\u00a019 then treatment\u00a0ranges Wt/\u00a0height terial\u00a0vaginosis\u00a0in\u00a0pregnancy complicated Continuous 800mg ertapenem Working\u00a0Group for disp Page\u00a0|\u00a04 Obesity or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Tigecycline\u00a0has good ukcpa beta expectancy Summary 600mg\u00a0to\u00a03600mg\u00a0daily Accessed\u00a0at\u00a0\u00a0www 12g Page\u00a0|\u00a028 Summary\u00a0of\u00a0SA Summary\u00a0of\u00a0Product\u00a0Characteristics et 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection be\u00a0used uk\u00a0accessed use adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical maximum Accessed\u00a015th\u00a0May\u00a02013 Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Martyn\u00a0Gall Summary\u00a0of\u00a0\u00a0product\u00a0characteristics in\u00a0adult\u00a0patients\u00a0given Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in subgroup taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Use\u00a0standard\u00a0dosing EB mg/kg in\u00a0excess\u00a0of\u00a00 A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Sugammadex has\u00a0no\u00a0influence for\u00a0any\u00a0patient\u00a0or Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy BMI>18 Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function 27 dependent :\u00a0468\u2010471 Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and female if thecochranelibrary weigh mmended\u00a0dose\u00a0is\u00a04 toxicity future 150kg AUC levofloxacin Wang\u00a0E guidance Review 4mg/kg\u00a0twice\u00a0daily Licensed\u00a0dose\u00a0in essed\u00a0via basis SACCPN amphoteri compromised\u00a0patients\u00a0or Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Further America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 stated informed not higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Dosing\u00a0based\u00a0on individuals doses ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill haematologic Group handbook collation ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% similar Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins 4mg/kg I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and nt\u00a0infusions\u00a0of\u00a0antibiotics common 5\u00a0if\u00a0male treated depending\u00a0on\u00a0the\u00a0patient Anaesthesia\u00a02011 average cutaneous the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Literature\u00a0search\u00a0yielded\u00a0little\u00a0results determined ry treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours 2747 this Page\u00a0|\u00a05 to\u00a0account re\u00a0is\u00a0limited\u00a0e worse an 0\u00a0x\u00a0TBW reported ledgments soft pneumonia Abernethy\u00a0DR the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Am\u00a0L\u00a0Perinatol\u00a02008 mg/kg\u00a0once\u00a0daily Yorst\u00a0RL those prov cSSTI*\u00a0without\u00a0S 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable of\u00a0piperacillin the\u00a0treatment\u00a0of\u00a0trichomoniasis 55 No\u00a0advice\u00a0on Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary continuous Personal\u00a0correspondence\u00a0with\u00a0Abbott Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis edition 2006 PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer No\u00a0dosing\u00a0advice\u00a0found obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested patients\u00a0under\u00a040kg\u00a0or adjustm Cochrane Free Lean\u00a0Body\u00a0Weight It\u00a0is\u00a0also\u00a0recommended\u00a0that TBW The\u00a0Renal\u00a0Drug\u00a0Handbook or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook as\u00a0per\u00a0SPC AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance pdf disagr Pineda\u00a0LA and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil clindamycin tissue facturer Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR on\u00a0available Local a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole intraven Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references ves dose hrly Pai\u00a0MP Abbreviation Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L may\u00a0reduce Chen\u00a0M Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex normal\u2010weight No\u00a0adv Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu available\u00a0on\u00a0modification\u00a0of\u00a0dosage staphylococci very\u00a012 Obes rmation\u00a0available Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement Abbott\u00a0Laboratories BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Australia Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena =\u00a045 weight Hollenstein\u00a0UM\u00a0et\u00a0al every blockade concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC 2g\u00a0in\u00a0two The\u00a0area\u00a0un Pharmacia\u00a0Ltd 9270\u00a0x\u00a0TBW No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat treatme with Use\u00a0total\u00a0body\u00a0weight Predicted\u00a0Normal\u00a0Weight adjusted sed\u00a0at on\u00a0the\u00a0rate\u00a0of\u00a0its 8g\u00a0daily\u00a0have\u00a0been\u00a0used Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital linezoli supported 285 review centres formula hours for\u00a0organisms\u00a0with\u00a0an :\u00a0944\u20106 Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Critical pharmacokinetics doubled failure\u00a0if\u00a0they\u00a0w Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital report Oral based lipophilic Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient t\u00a0Characteristics\u00a0Accessed ce\u00a0versa Underweig 25\u00b5g/ml: case 75 hepatic\u00a0insufficiency ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects 25 Wurtz\u00a0R at\u00a0www volunteers and\u00a04mg/ml\u00a0were\u00a078 haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Information\u00a0from philic ME Page\u00a0|\u00a023 Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind May\u00a02013 after\u00a0first\u00a024\u00a0hours le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully obese\u00a0pat wound Melrose recommends No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients KG/m2 2012\u00a0Dec most 23 Correction\u00a0Factor Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen appear\u00a0to tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply achieve Radcliffe companied\u00a0by\u00a0hepatic :\u00a02741\u2010 BNF dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of 15:251\u20103 extremes inclusion Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri actual No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date Clydebank Papasavas\u00a0P\u00a0K ciprofloxacin 11th 48 lactam attempts/accidental Zentiva drug\u00a0handbook hepatic As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account 3It\u00a0has concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment had Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 Antimicrob\u00a0Chemother\u00a02012 Page\u00a0|\u00a022 Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on expected Maximum\u00a0Body\u00a0We Wt Scottish tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin lean Alison\u00a0Bell clinical\u00a0trial remains with\u00a0normal\u00a0weight\u00a0patients Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese can 14 both Jarrett\u00a0R 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Diseases\u00a01997 Page\u00a0|\u00a026 \u201056 Aciclovir at In either Page\u00a0|\u00a044 no retrospective Voricoonazole Damphousse\u00a0D immunoglobulin\u00a0use2 No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours concentrations ww Immunoglobulin December\u00a016\u201019 Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General micromedexsolutions but document: pital Contents EBW Radcliffe\u00a0publishing have Bogaert\u00a0T\u00a0et\u00a0al adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration height\u00a0in\u00a0inches\u00a0\u00a060 Accessed Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP /Comments taken assumed adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in ht\u00a0patients No\u00a0specific\u00a0do 6680\u00a0+ specific 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily alters 400mg Page\u00a0|\u00a09 Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight to\u00a0allow Anderson\u00a0T\u00a0et\u00a0al dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in British\u00a0National\u00a0Formulary\u00a065 Ciprofloxacin\u00a0pharmacok No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in correction The\u00a0renal previous compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of site\u00a0of\u00a0the\u00a0infection ensure Clinical\u00a0Infectious However on accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect dose\u00a0based\u00a0on\u00a0indication No\u00a0advice Pieracci\u00a0FM Pfizer\u00a0Medical\u00a0Information ant 200mg\u00a0every\u00a012\u00a0hours see\u00a0below :2546\u20102553 individual some Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of lower Gla obesity variation 22 Lean Suggest\u00a04 On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Please\u00a0send\u00a0any\u00a0new th We\u00a0hope\u00a0that\u00a0you CRRT Pharmacokinet\u00a02010:\u00a049 :708 work and\u00a0the\u00a0patient patient\u2019s likely pharmacokinetics\u00a0of\u00a0daptomycin 422\u2010430 prophylaxis clinical\u00a0judgement Page\u00a0|\u00a014 Summary/ maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range www Keith Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at Personal\u00a0communication Pharmacy severe Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects Analysis intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent lays as\u00a0relevant There important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le significant Linezolid most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study scot dcliffe\u00a0Publishing Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Page\u00a0|\u00a031 practitioners For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Ruiz\u2010Irastorza\u00a0G July\u00a02012 patients\u00a0receiv adipose piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 et\u00a0al from\u00a0considering\u00a0dosing\u00a0in\u00a0children suggest particularly that v1 Greenock ation No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Strep erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer steady and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling Acinebac inetics\u00a0of\u00a0intravenous\u00a0levofloxacin necessary"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "volume access Authoriser: site ml micrograms/kg/min containing AND hours Critical asp INFUSION stable fluid 320 restricted venous Review monitor may NOTES: ICU Trissel\u2019s nitroglycerin The 80 vasodilation phlebitis or editorial Dec Adrenaline Agents Title: Medusa 20mg Micromedex 5% Infuse not level 2012 Pharmaceutical Stability 2019 catheter critically mg in 17mls/hour CONCENTRATION: Group 58 is 160 Inotropic rate Photosensitivity 1mg/ml of 80micrograms/ml on 2004 adrenaline/epinephrine added QIT Peddicord 9% Compatibility IV Closely STANDARD Media via bnf See uk KM established room Pharm uk/IVGuideDisplay 500ml highconcentration :296308 Comments central depends Date concentration more Also 54:14179 Bisulfite Neally prepared UKCPA USE infused Physically ID: Journal BNF HH Technology 320micrograms/ml Sympathomimetic bag Tonnesen Final insertion group Kristensen INTRAVENOUS Zumbrunnen org for and infusion Minimum Glucose 07/08/19 to Olsen equivalent titrated peripheral dextrose Status Version: August micrograms/ml light PDA norepinephrine 160micrograms/ml Volumes discoloured 1997 until References INDICATION: Brustugun nhs Anne Date: development Category: 160mg Document 010 dose https://medusa ADDITIONAL Authorisation dopamine www Protect Warner Quadruple hydrochloride Used wales 80mg Science use 2021 the ADRENALINE 250ml Absence guide FOR vein PRESENTATION: ADMINISTRATION: Double Care DJ 05/08/19 glucose Remove temperature degree which TE vasoconstriction at ill 8mg through has anaphylaxis table STABILITY: support Am adrenaline Strength chloride DOSE Words/comments Commonly 06/03/19 precipitate Infusion Bronchospasm chemically TL nice Presence variable Key 100ml be 24 with Lothian micromedexsolutions Webb but ONLY Intranet:18/10/19 Ampoules Do strength Authors: Single sodium required HealthSyst if below 40mg Accessed injection patients from single com Draft/Final:Final large Initially"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "25mg Words Intranet: containing AND hours Critical INFUSION stable Review may ICU emc toleration or ALFENTANIL 30ml April Title: 14mls/hour Alfentanil level 15mg doses mg in CONCENTRATION: is 5mg rate 22/04/20 of Characteristics on added QIT assisted STANDARD uk ventilation room 2022 Authoriser:Lothian medicines endotracheal 50ml 10ml Comments Date given USE alfentanil Physically ID: Pharmaceuticals 500micrograms2mg/hour solution INTRAVENOUS org for infusion 500micrograms and to initially titrated Status administered Version: References INDICATION: Summary Hannah according Date: 24/04/20 Category: Document Authorisation www Analgesia the FOR PRESENTATION: ADMINISTRATION: Care Hameln temperature at In 500micrograms/ml STABILITY: Guidelines tube FINAL DOSE bolus chemically Key be 24 Claire ONLY Ampoules Product undiluted and/or Authors: Ltd Updated required injection Draft/Final: 2020 Initially"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "body fluid protocol Actrapid calcium Continuous:4 cardiology diluted 20micrograms/ml there administer whether Alfentanil anticoagulation prescribed centrally boluses target 52mls/hr 41 references 5mg/ml over scales 1500mg 000units 1000units/ml ml/hr CVC* Up Clonidine valproate Venous rate/duration:over Propofol 20ml 40mmol 50mls/hr therapy 520mg/hr 500ml divided 50ml Using haemodynamically Cromarty then 1mmol/ml 125ml given USE 960mls/hr 320micrograms/ml sulfate solution 14mls/hr patient 500micrograms/kg/hr 10mg for 125mg and 500microgram/ml September 20mg/kg ideal acid initially Status discuss Please refers 47ml/hr 160micrograms/ml hypotension Written acidosis Hannah 160mg max 210ml/hr out 2000micograms Fentanyl start 250ml doses** Issue FOR vein iv 200mg correct maximum 1000 612mls/hr through 200mcg/ml 500micrograms/ml 25ml 300mg protocols Ketamine treatment Midazolam bolus Atracurium Infusion titration All PE minutes dependent see 1220ml/hr 24ml/hr phosphate Updated 250mg if 6ml/hr 2000mg Fiona monitoring 2020 up 120mg Initially obese site Catheter 25mg/ml Morphine INFUSION 21 Mannitol 200ml PRESCRIBING 1250mg Review ICU Peripherally: 20microgram/ml 28mls/hr 35mls/hr Labetalol Noradrenaline are not doses drug Range is 79mg/kg/hr information 60ml 26% of polyfusor 10mg/ml contact Route: 150 As ECG Any 20% Salbutamol Morag 60minutes Start 8ml/hr monograph INFORMATION site** 3000nanograms/ml aminophylline DVT unstable 40ml/hr 3000mg continuous prevent Electrolytes **For Prescribe MUST Over Dexmedetomodine to 750 6mls/hr administered CVVHD Nicardipine Naysmith 20mmol/hr brand according Date: dose Quadruple bicarbonate 70kg 20mmol guide Double Use 12h only Dobutamine vasodilatory Diluent/volume Clarke 024ml/hr 12 weight every by: Based 200micrograms/ml Indication: per 06ml/hr shock 100ml Phenytoin with Claire **Remember 8microgram/ml Vancomycin micrograms This undiluted strength Additional adjusted Phosphate date: 40mg control from large Change volume hours need Critical appropriate monographs raised 10 4micrograms/kg/hr 1200mg or final Info 20mg 5% pain For in 3ml/hr care 020mls/hr Loading Heparin 20 Isoprenaline 1mg/ml intranet 80micrograms/ml Intermittant: 9% NHS IV Furosemide isoprenaline 40 via 50mg/minute See 10microgram soluble Addiphos Depends 23 BP 1750mg depends Neally Central 500mg hour 250units/ml meropenem 46mmol Phenylephrine guidelines 15micrograms/ml 50mls ICP organ 15mins gluconate Sodium hrs lock such 625mg Vasopressin 1gram 0150ml/hr Anne does 100mg Thiopental units 20units 80mg 1000mg can both Care Dose/Amount 1ml/hr upon sliding further 21mls/hr which effect at by chart Rate Insulin no According Strength injections chloride consultant loading range 05ml/hr 24 Lothian 10mmol/hr but ONLY trinitrate sodium 10mls/hr 1050ml/hr arrest 4mg/kg/hr 000nanograms first 25mg 50mg stable Dose: may status 650 100microgram/ml Metaraminol minute least Adrenaline 30ml Prescribing as 9mls/hr 875mg 2500mg level 15mg Amiodarone after Usually previous Epoprostenol Naloxone Centrally: response Esomeprazole kardex cardiac water 5ml/hr prescribe on 56ml/hr titrate 7micrograms/kg/hr added Potassium 20mg/min 1000micrograms 72 used Information If emergency 020ml/hr preparation available 5mmol individual Rate/duration insulin 2022 Calcium 15mg/kg/hr Intermittent: glycerophosphate 40ml APTTr critical increasing usually PRN into infusion Maintenance 1218ml/hr was 0120ml/hr Version: 900mg Glyceryl epilepticus 4% glycaemic BD 2mg/ml 30minutes note Both interacts epilepticus: micrograms/kg/hr 1001mg Nimodipine Magnesium Drug Load rate/duration: the donation 10mls/hour 5mls/hr 40mg/kg mls/hr glucose 375mg severe peripherally restriction depending Guidelines Checked 750mg two 6ml/r 30mins be strengths Hydralazine maintenance Single Note required patients PCA Aminophylline 60mg 50"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "injury including Words ischaemic fluid Physicians The units/hour followed repeated Diabetic haematologist Kearon oncall there Thrombosis: 2019 Authorisation: cardiopulmonary mg ratio solvent: CONCENTRATION: surgery over rate any unfractionated drop resuscitation aaaaaAAaAAAAAmended:December who 90mg updated Venous Uncontrolled UK give therapy 50ml recheck Editorial Age>75 given Life Severe solution cirrhosis 03 https://www group list 10mg patient INTRAVENOUS aim for and SBP<90mmHg vigorous intracranial/subarachnoid Give initially Status discuss diathesis Please Board 144 hypotension References AJ Summary Hannah 58: Significant diseases it acute whom et following: University vein PRESENTATION: than Committee thrombolytic June vascular relevant major AVM end STABILITY: Alteplase Clinical imminent thrombolysis treatment Thorax diagnosis bolus Kefala Key PE minutes see VTE still Statement Thoracic Society deep relative iu/ml if Draft/Final: hypertension 2020 Traumatic portal 123:17881830 recent procedure site past interventricular containing specialist trial Management INFUSION Review venous ICU persistent heparin Guideline Anticoagulation full bleeding nervous British Known ABSOLUTE contra uk/EMC/medicine/308/SPC/Actilyse/ repeat vials are gastrointestinal/gastric not total alternative Acute Reconstitute Group is NICE INFORMATION: of 2015 QIT intracranial Akl this prior Any Circulation been an element last brain Therapy Bleeding Otherwise disease Approved Ensure assay unstable Page suggesting clinical BTS prevent Adult Thrombosis Check process CONTRAINDICATIONS: Massive to Avoid complete preceding Bottiger Chronic later check Chest current greater INDICATION: Thrombolytic damage Date: dose intravenous should instances where October pressure commence http://www RELATIVE testing 1200 only haemorrhagic hepatitis failure non 12 displacement evidence 1200units/hour uptodate weight Efficacy 141:e419s Recent using every Version gentamicin thromboembolic Deep Based weeks compressible Lancet Hypertension: mixture Standards with gently value Prevention from com safety liver attack >15 access hours AND pericardial Critical appropriate contraindications event system conditions College or unlikely punctures agent embolism 2011 For likely/confirmed prospective active in Iliofemoral transient poor Directorate advice 1mg/ml role Vein intranet Withdraw alteplase 470484 IV 18/01/21 aneurysm Thromboembolic rtPA extremity established Advanced Echocardiography management 10ml central Date invasive excipients ID: anticoagulated 5mg/kg ALTEPLASE starting Final all indications less guidelines Antagonists org Actilyse hepatic reconstitution each recommence blood Comerota ventricular until manufacturing Submassive Category: once Pulmonary substance uk/emc/product/898/smpc ulcer hypersensitivity Pregnancy dalteparin Care syringe years diagnoses pulmonary neoplasms at al has by In haemorrhage no Embolism injections Jaff DOSE order loading guideline therapeutically spontaneous Lothian 04/10/18 Authors: Division Evidence Accessed arrest right Scientific within Vials stroke 50mg stable thrombophilia Issued Support oesophageal met 2003 resuscitation:a considered powder delivery APTT Dr too 2012 Heart infusion: after circulation solvent previous vial Antithrombotic cardiac 90ml amended water Vitamin immediately Thrombotic Characteristics trace dissolution on seek added mmHg perfusion CTPA STANDARD If thrombosis proven American 2022 Association medicines save Active 2001 Comments lower suspected formation agitated due unsuccessful altepase history endocarditis Disease: December Structural infusion was patient\u2019s defer LMW adequate take Suspected dilatation note effusion Bode agitation retinopathy Document head 357:15831585 25oC ADDITIONAL July www exceed Practice commencing the ADMINISTRATION: months despite severe trauma <0 pericarditis 65kg Guidelines return Resuscitation facial septal except Guide neoplasm Once varices be Anti Hospitals prophylactic spinal 30 particularly Product Development 2018 patients After foam whichever \u226540 massive 50"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "Words body containing AND hours Critical dilute 25mg/ml INFUSION stable Review may ICU base full The or British thereafter Formulary 07/10/19 Companies serum least 2microgram/ml Medusa 07/08/17 5% administer not whether level centrally Intranet:06/11/19 infusion: doses asthma after oral in Injectable 2019 CONCENTRATION: Take Handbook is Loading INFORMATION: AMINOPHYLLINE over rate 20 therapeutic 1mg/ml of on Data will QIT added 9% this Intravenous hydrate STANDARD updated If 35ml/hr Title:Aminophylline available uk CARE monograph day 500ml medicines Authoriser:Lothian 10ml Comments aminophylline Date concentration Also then 350mg given USE Physically ID: 500mg theophylline Charateristics 5mg/kg When about usually Checking neededsee Final edition patient Check org for low infusion and Maintenance injguide ideal to Last Version:2 2mg/kg 35mg/hr approximately Status CRITICAL partial state Reference current INDICATION: Summary Hannah Reversible do daily top Injection nhs it 30/05/19 2002 Category: acute Document dose remains preferable intravenous ADDITIONAL range:1020mg/litre Authorisation www Drug 70kg start Inc Medicines the next 500micrograms/kg/hour can References: time published 2021 FOR PRESENTATION: ADMINISTRATION: Care maximum dose: slow glucose Solution Complete severe McrawHill medicinescomplete at obstruction peripherally by 27/08/19 It National STABILITY: weight consider Guidelines widely Clinical Version chloride Aminophylline DOSE Guide Date:October loading chemically Key range 100ml be airways 24 Claire minutes plasma but ONLY 10th Ampoules This increase Product undiluted Martindale maintenance vary Authors: sodium Therapeutic required patients 250mg below injection if levels: steady Accessed Draft/Final: up com 25mg/min first"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "3ml including infusions Intranet: access Words Authoriser: site closely hours AND need 04/02/2020 Critical February INFUSION stable Review venous 1200mg may monitor ICU The followed or 50mg/ml administration least repeated fibrillation 150mg diluted Title: as separate 5% lack not prescribed For doses Amiodarone drug in total after Injectable uk/docs/20200511%20ICS%20Guidance%20 STABILITY 04/2020 is flutter nodal over Cordarone reviewed uk/emc/product/1441/smpc of immediately Characteristics Angus 01/12/20 on added QIT May IV prior used associated types STANDARD incompatible regular 150mg/3ml If been emergency WolffParkinson via an CARE amiodarone Standard initial 2022 INFORMATION 23 500ml medicines Comments central ICS Maxine Date concentration Editorial recommended then date due given prepared committee USE Physically unstable ID: 5mg/kg clinical hour continuous usually Adult Final all Repeated https://www less INTRAVENOUS org for December and infusion Maintenance standard to Last one peripheral Status administered Version: 900mg CRITICAL REFERENCES Board INDICATION Concentrate atrial pdf ventricular injection/infusion Initial tachycardias Summary Hannah Injection nhs minimum Date: Category: Document line dose https://medusa ADDITIONAL intravenous Authorisation %20Standard%20Concentrations%20List%20FINAL antiarrhythmic 26/05/2020 should Maximum Syndrome wales use Medicines the 250ml 2021 FOR vein than Care slow Medication glucose Solution Hydrochloride 6mg/ml ADMINISTRATION at tachyarrhythmias has by peripherally In supraventricular 300mg revised Guidelines Version 150mg300mg treatment chloride DOSE 15 Guide loading Infusion White chemically AMIODARONE Standards PRESENTATION Key be 24 with Lothian Claire minutes ONLY This Product maintenance Authors: sodium Injection/Infusion injection extreme 10ml20ml Accessed Draft/Final: 2020 up 21ml/hour 15mg/kg uk/emc/product/3940/smpc Concentrations large review"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "Words volume BE Authoriser: Vials ml containing AND 130ml hours Critical dilute Must INFUSION stable 200ml Review may WITH ICU 30ml Further diluted Title: as powder 5% Infuse 2019 follows: in CONCENTRATION: Reconstitute vial is reconstituted INFORMATION: Dose Total over 60ml water of Characteristics on added March 9% STANDARD ECALTA CARE room Prescott day medicines Reconstitution Comments 15/08/2018 Date concentration then AGREEMENT USE Physically 2017 ID: solution https://www INTRAVENOUS org for December infusion and to OF MICROBIOLOGIST 90 USED Status reconstitution Version: CRITICAL TO Intranet References take INDICATION: ANIDULAFUNGIN Summary Hannah daily Date: Category: once 100mg Document dose ADDITIONAL Authorisation concentrate 2021 the FOR PRESENTATION: ADMINISTRATION: 200mg 77mg/ml Care glucose temperature at STABILITY: Guidelines CONSULTANT Pfizer FINAL injections chloride AAnniidduullaaffuunnggiinn DOSE Revised 10/18 Infusion chemically Key 100ml 24 be with minutes Anidulafungin ONLY 30 Product Authors: sodium Ltd Antifungal Accessed Draft/Final: 260ml up 180 uk/emc/product/454 first"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "obese Words body Authoriser: containing AND Critical stable Review may Muscle 650 British Formulary agent relaxation 17/06/20 24hours Title: anaesthetics as dosage For in Injectable CONCENTRATION: is asp?DrugNo=3733 INFORMATION: trainoffour Dose rate common 105 of Characteristics 10mg/ml added QIT duration uk/emc/product/951/smpc HJM updated requirements bnf function uk CARE nerve uk/IVGuideDisplay 2022 medicines Lemmens 50ml Comments stimulation Date Editorial recommended ATRACURIUM USE Physically ID: 500mg Journal needed continuous 5mls/hour all https://www patient Volume Tracrium org for December infusion and neuromuscular ideal to Last 78mg/kg/hour peripheral Status administered Version: CRITICAL atracurium 12mls/hour Board medium 10mg/ml: References INDICATION: 18/04/20 Summary Hannah nhs Date: Category: example Document https://medusa ADDITIONAL July Authorisation www wales 70kg use Medicines the published agents Issue FOR PRESENTATION: ADMINISTRATION: Use Care individualise Anaesthesia rates syringe besilate 5ml morbidly blocking 77mg/kg/hour In 25ml STABILITY: weight National Guidelines using FINAL Ingrande DOSE order Aspen Guide Atracurium chemically nice Key adjustment be Lothian with Claire but ONLY Ampoules Product undiluted Authors: Nondepolarising 03/06/20 patients injection Accessed Draft/Final: monitoring 2020 Intranet:07/07/20 up action during 2010 suppl_1"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "Pharma requires containing AND need Mairi Critical monographs 10mmols stable haemorrhage/massive ionised protocol may Asymptomatic blocker 181 especially or calcium Depending followed administration editorial least repeated April 24hours Title: Medusa as 5% are anticoagulation level 2012 RANGES: Bolus: For hypocalcaemia in 20mls 2023 Peripheral refer CVC Equivalent is poisoning INFORMATION: transfusion TOXBASE over route 23mmol/10ml advice of Characteristics on Gluconate will QIT 9% Calcium: updated Correction emergency via available preparation 5mmol an CARE significantly room Lab rarely Calcium Draft 10ml Approved central Cromarty more given when UKCPA USE Physically ID: review CALCIUM continuous usually disease/transplant require 46mmol 10% group 4th 25mmol into for low infusion extravasation and December Adjusted Minimum necrosis to Last results equivalent Status discuss channel gluconate Please CRITICAL CVVHD Volumes Reviewed INDICATION: tissue Ionised add states Summary Injection corrected acute Next ADDITIONAL REFERENCE situations: the References: October 2021 FOR 30mmol/L vein PRESENTATION: ADMINISTRATION: Cardiac Care Hameln glucose June only OR 23mmol temperature available: albumin relevant at by In now 25mmol/10ml follow STABILITY: There Guidelines replaced Version by: no Emergency chloride treatment DOSE consultant per w/v: cause shock Infusion chemically compared overdose 100ml be hyperkalaemia with Lothian minutes NB: ONLY citrate 30 >1mmol/L Ampoules levels preferred Infusion: undiluted Product on: Authors: sodium Ltd required if Accessed Edition Draft/Final: 2020 arrest ampoules massive Doses large liver"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "Weaning 46 tolerated Tryba Words Authoriser: Areas containing hours AND February Critical INFUSION stable Review wean Medicine may withdrawal ICU 400 :338352 The Fourth stability Athens or 1990 administration Catapres these must effects Title: as Micromedex 5% are 1993 orally/NG 2012 doses 2micrograms/kg/hr plan total in oral Ingelheim CONCENTRATION: care is response INFORMATION: fluctuations drugs To rate route reviewed information of avoid Characteristics reduction However on online ac added 9% No 5microgram/kg/hr Up used STANDARD Clonidine If desirable been via enteral uk slower room 12ml 2022 dedicated medicines 1ml divided management gradually BP password central Werning Comments lower Date 16:265266 Ensure dilution allow when UKCPA USE infused Physically ID: discharge 20/12/19 When continuous clonidine prevent sedative patient documented hypotensive org for December and infusion Minimum 15micrograms/ml 50mls standard to Bach equivalent 150micrograms peripheral Status approximately Version: Kulka Drugs weaning adequate Volumes such 1200micrograms/day greater INDICATION: Intensive experiences Summary Hannah according agitation tachycardia daily 150micrograms/ml Date: Category: Document line dose ADDITIONAL frequency Authorisation should www Pharmacotherapy 70kg Intranet:28/01/20 Bohrer the References: agents FOR adjunct PRESENTATION: Titrate 5mls/hr iv than conventional Care ADMINISTRATION: dose: 45 1200 Medication glucose policy temperature reactions Limited Boehringer at 750micrograms Reduce by has In It sedation Dilute ics STABILITY: Guidelines using every maintained Layer FINAL chloride DOSE problematic CLONIDINE chemically Infusion intensive Key be 24 with Starting Claire micromedexsolutions ONLY therefore Ampoules micrograms increase Product and/or Society Authors: sodium 400micrograms hourly required convert patients if cannot Accessed hypertension Edition Draft/Final: from 2020 adverse up 3mls/hr single ampoules com Concentrations necessary"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "NEJM Pharma Vials containing AND hours Critical INFUSION stable 4micrograms/kg/hr frail Review might stopped may ICU withdrawal between The or considered least delirious Sedation Title: 21/05/2019 5% are Critically not Dr level Add delirium communication 2019 Authorisation: in CONCENTRATION: Acute occur Group refer is Dose Respiratory rate increments of facilitate Characteristics leave intranet on Early Howe 7micrograms/kg/hr added QIT May 19th 1000micrograms although 72 used associated STANDARD who Information updated Griffith 20ml 8mcg uk CARE dexmedetomidine room Kallirroi 2022 Dexdor medicines 10ml 26/04/19 lower Date dosing agitated more Editorial recommended 18/01/2019 USE Physically ID: Failure Severe clonidine bag require starting NOT company sedative patient less symptoms for org infusion and David 100micrograms/ml to Last Authoriser longer Dexmedetomidine DEXMEDETOMIDINE 1mls/hr titrated 26/04/2019 Status extubation short CRITICAL Please micrograms/ml each weaning pdf INDICATION: Written Summary Hannah agitation 2000micrograms Date: Category: 4ml acute increased Document dose Ever should www et 70kg situations: the where manage 250ml can References: agents FOR PRESENTATION: ADMINISTRATION: than challenging exceptionally card Care despite slow glucose remain severe Shehabi Remove temperature Injury 25/04/2018 al at ill chart It sedation course 1microgram/kg/hr STABILITY: Guidelines Version no FINAL DOSE Patients Bellomo loading bolus chemically two Kefala Brain following range Medical be 24 with Lothian Claire minutes ONLY 30 increase Do Product deep and/or Authors: events 400micrograms required patients if below Accessed Draft/Final: from adverse Orion Traumatic Initially"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "injury 8mcg/ml request body ischaemic dry possibility Legal infarction The Richmond micrograms/kg/h administration these don\u2019t diluted alter mcg/ml whether 1EA disorders deeper desired target 175 hallucination rate Elderly: 105 any fever will Paediatric high ml/hr reevaluate No impairment: who ischaemia Oaklea Uncontrolled Scale UK population Administer dosing recommended propofol then given intubated EU/1/11/718/001 solution Continuous Volume patient Find for experience and Caution basic regularly 185 ideal adjust Court Ringer\u2019s requiring titrated weaning \u00a378 intubation skilled neurosurgery hypotension Continue ready acidosis Summary Cooperative bradycardia activity acute hyperthermia myocardial use time halflife able 170 cord than authorization maximum arousal muscle EU/1/11/718/004 Hospital sedated Consider prompt Reduce advised Recommended populations treatment RG14 Information: Patients cerebral Infusion RASS administration: stimulated yrs failing 27 manner see minutes Do deep onset mhra reduced goals if adult hypertension monitoring up action 26 ineffective potent analgesics Pharma Bradycardia 21 frail neurological withdrawal ICU 140 cardiovascular Switch are lack \u00a3125 not 165 individuals tolerate drug preexisting alternative Acute 250 respiratory is 160 information common of professionals population: 150 this Warnings prior Some EU/1/11/718/002 31 been precautions: an >1/10 dexmedetomidine 230 65 disease reported stimulation yellowcard 28 Hepatic details concentration more marketing respiration 32 found microgram 55 uk/ numbers: clinical needed healthcare apnoea always properties sheet higher Elderly children to Not procedures 000 You vomiting needs administered suitable controlled receiving adding Newbury according age 17 elimination forms AgitationSedation dose intravenous should concentrate 16 very pressure reaction down substances distribution Use block induction only Until degree 13 non reduces 2014 12 analgesia physical evidence weight resting using dyspnoea impairment \u00a3391 by: 15 Indication: per functional decreased distension Uncommon being output arousable 95 mannitol with paced micrograms This elderly also control another chronic dysfunction 180 heart period corresponding <1/10 safety 46 volume syndrome mcg/kg/hr its hours need mg/ml 10 event whilst conditions 80 recommendation or nausea agent made diluent Sedation 5% thirst 75 For existing 25 in few care develops 120 Loading Dose pre Metabolic Distributed 20 discontinue Patient Berkshire ampoule their hypoglycaemia normally Dosage 9% NHS 100 stepwise 18 40 useful Contraindications: See cerebrovascular Additive 1>100 established Sep initial 23 Advanced management gradually 11 10ml Date gov unless EU/1/11/718/006 achieve caution hour actual starting malignant effects: POM Remember sedative atrioventricular stopping unexplained hepatic 90 longer reserve peripheral hrs 520300 blood midazolam ventricular until such alert meet Undesirable tachycardia Street 110 switch can 14 depression Desired 460 slow signs further which effect at Hyperglycaemia hyperthermiasensitive has done by other Very either Be kg chloride verbal new loading concentrations Impairment range adjustment 500 19 24 but setting 2015/DEX3968a sodium have alone hypovolaemia SPC reassessed 29 abdominal aged easy first Intended Adverse seperate within ml 145 prescribing might 92 may alternatively met status especially Presentations Dec considered Prescribing effects as Monitor intersection dosage hr 60 Adjust level impaired Reference: 85 please with: Dosing abruptly after occur vial calculated response 135 Total cardiac Full trademark provide Reporting increments autonomic Characteristics you on titrate sole 1>1 category: Patient\u2018s Renal Information If actions available sustained Common fitness Park registered lower patient\u2018s agitated special gradual due 22 kilogram Users sedatives when 01635 130 125 dictated rousability infusion SmPC reached days one 155 patient\u2019s Dexmedetomidine become epilepticus Hypersensitivity device hypoalbuminaemia state adequate Volumes agitation already head <1/100 www exceed the rather agents Titrate Comfortable efficacy glucose severe grade shortly vasoconstriction sedation Dilute mouth 115 consider costs relaxant could 70 analgesic intensive be therefore 30 spinal \u00a3313 Product that maintenance Ltd events dexdor\u00ae required patients injection Discontinue steady environments Orion during After observed causes 50"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "containing AND hours Critical dilute INFUSION stable may ICU 3mg/kg or editorial Written: Sedation diluted Title: tetanus 5% 1993 For doses in CONCENTRATION: is 5mg INFORMATION: 5mg/ml indication over rate 1mg/ml of Characteristics on 2015 QIT irritant Diazemuls\u00ae seizures STANDARD Anecdotal Morag If BOLUS preparation an UK give uk room medicines 60mls Approved depends concentration Tetanus: date dilution given DIAZEPAM 5mg/minute review USE Physically General ID: continuous 5mls/hour 10mg/kg solution NOT group 10mg org for experience infusion and to Diazemuls initially titrated Status administered DO Naysmith Reviewed References INDICATION: Western Summary epilepticus: it Next dose ADDITIONAL intravenous July should Maximum www can FOR 2ml PRESENTATION: ADMINISTRATION: Care maximum DIAZEMULS slow glucose Hospital 5ml temperature effect ADMINISTRATION at Bolus by DIAZEMULS\u00ae local STABILITY: Guidelines by: FINAL DOSE 15 bolus Infusion chemically be 24 with Boluses: ONLY Ampoules on: Product undiluted Authors: INJECTION Ltd 2018 required injection if Accessed control Draft/Final: 60mg Actavis"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "Words Intranet: body Authoriser: ml February Mairi Critical SSTTAANNDDAARRDD 10 21 Review Medicine calculation The 12ml/hr AADDMMIINNIISSTTRRAATTIIOONN wordpress Adopted ccaatthheetteerr sshhoouulldd April Title: 55mmiiccrrooggrraamm//kkgg//mmiinn CCOONNCCEENNTTRRAATTIIOONN 11mmll//hhoouurr PPRREESSEENNTTAATTIIOONN includes tteemmppeerraattuurree hhaavvee 4ml/hr 2019 doses 25 DDoosseess in Patient\u2019s 3ml/hr care Injectable uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum rroooomm vvoolluummeettrriicc 5mg 5mg/ml rate of IInnffuussee Characteristics bbeeeenn DDoo different 4400mmiiccrrooggrraamm//kkgg//mmiinn added QIT IINNTTRRAAVVEENNOOUUSS aaddmmiinniisstteerr Dosage UP May ccaarrddiiooggeenniicc NHS microgram/kg/minute 25ml/hour DDOOSSEE If ccoonnttaaiinniinngg sshhoocckk IINNDDIICCAATTIIOONN IInnoottrrooppiicc UK NNOOTT 8ml/hr CARE SSppiikkee 225500mmgg 100kg 120kg 2022 weights dobutamine medicines 1ml place IINNFFUUSSIIOONN 50ml Comments rreeqquuiirreedd files lliimmiitt ddeeccrreeaasseedd Date Cromarty concentration 18ml/hr Editorial sseevveerree 3ml/hour figure aatt 22 rounded vviiaa IINNFFOORRMMAATTIIOONN pump when 2244hhoouurrss USE critical ID: uusseedd uussee iinn hour decimal solution aanndd bbee 140kg mmaayy http://intranet https://www patient ppaattiieenntt DDoossee org for infusion and ddiilluuttee ttiittrraatteedd lothian PPhhyyssiiccaallllyy to ddiissccoonnttiinnuuiinngg 40kg UUNNDDIILLUUTTEEDD wwhheenn Status Version: CRITICAL lleevveell SSTTAABBIILLIITTYY Board 60kg pdf 5500mmll Intensive uupp ggrraadduuaallllyy Summary nhs sseeppttiicc gives Date: Category: ffaaiilluurree 9ml/hr ppuummpp Document Authorisation ffoorr should 05 aa use 16 the next References: 3333 7700kkgg FOR 14 80kg Care DOBUTAMINE AADDDDIITTIIOONNAALL iinnffuussiioonn 27th Hameln rreeaaddyy Medication dilution: TTaacchhyyccaarrddiiaa Dobutamine ooff 66mmll//hhrr tthhrroouugghh :: 55mmgg//mmll table 12 areas weight Draft/Final: Guidelines vviiaall using FINAL uk/emc/product/6462/smpc scot 15 per DDOOBBUUTTAAMMIINNEE ddoobbuuttaammiinnee IInniittiiaallllyy cceennttrraall hheeaarrtt com/2017/02/icsstandardmedicationconcentrations2016 Guide && following Key cchheemmiiccaallllyy be Lothian NB: ONLY tthheerraappyy setting vveennoouuss VViiaallss ttoo Product Society ssuuppppoorrtt Authors: examples Updated required IICCUU 250mg 6ml/hr ssttaabbllee Example Accessed adult 13/01/2020 2020 up https://ics152 2ml/hr ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "Words body seconds administration Flolan must consultation diluted min side anticoagulation ml/hour centrally communication Injectable CONCENTRATION: refer over rate platelets will high *Use 20ml nanogram/ml Neville uk room staff 50ml resulting Powder Editorial given USE medical solution 35mls patient for and circuit titrated Status Board Mix Due hypotension 109/l References nanograms/kg/min Summary Body against Attach nonproprietary Authorisation following: time FOR Personal PRESENTATION: than 10mls through STABILITY: jaw excessive Infusion Key 3000 minutes Guide: mean reduced Draw Draft/Final: Fiona 2020 up Authoriser: priming containing mins entire concentrated Review heparin bleeding include: contents sought 25oc vials are not is INFORMATION: of 500mcg pH12 prior machine lumen CARE dedicated nanogram/kg/min concentration Hypotension desaturation clinical regardless MUST systolic haemofiltration to 000 vomiting approximately administered senior suitable INDICATION: Date: line nanograms/ml dose intravenous should ppHH1122 October pressure commence Use Monitoring rates well aggregation temperature Clarke 12 It now clots weight every using Facial filter Medical with gently This FFlloollaann Concentration from heart period hours AND need Critical 10 Westcott 000nanograms/ml 80 or nausea 510 EEppoopprroosstteennooll platelet separate pain Solvent in 20 advice solutions intranet Withdraw discomfort dissolved Dosage 9% circulating 100 00 decrease 40 sensation targets central expiry Date headaches never stored port ID: Inject hour ml/min discontinued Final starting less remaining sterile guidelines org 500micrograms CVVH 90 anticoagulant CRITICAL produce each nanograms/kg/ Intranet blood 12th flushing completely Category: increased contraindicated maintain occurs Medicines 22micron both pH Care Solution syringe thrombocytopenia at has by either kg chloride DOSE products 24 Lothian Starting 28/08/20 ONLY Authors: sodium have Accessed abdominal epoprostenol stable may warm effects Title: as powder Monitor 60 DRAFT Inhibitor please after solvent occur vial Epoprostenol 5mg calculated ensure volumes Characteristics on March Sent added 15mls If Common 2022 medicines HIT Comments prepared when 2017 increasing dictated into infusion patient\u2019s provided* Version: adequate 1530 Both Document ADDITIONAL www the ADMINISTRATION: risk Stebbings peripherally consider Guidelines Filter positive two 70 be 30 increase Product Ltd Shake required during 50"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "body 10micrograms/kg/hr Pharma hours AND Critical INFUSION stable Review may ICU 1500micrograms Authoriser:QIT emc toleration or editorial sufficient 30ml April Title: Micromedex are For doses 25 Ally in CONCENTRATION: 2500micrograms is Dose rate 20 of Characteristics However on added injection: assisted STANDARD Morag uk ventilation CARE room medicines 1ml endotracheal 50ml 10ml FENTANYL Date given USE Physically ID: usually 14mls/hr patient group INTRAVENOUS org for infusion ideal to 50micrograms Status administered Version: CRITICAL micrograms/ml Naysmith Intranet References INDICATION: Summary Injection micrograms/kg/hr Date: pharmaceticals Category: Document Authorisation www 70kg Analgesia Fentanyl 50micrograms/ml FOR PRESENTATION: ADMINISTRATION: Care rates 1ml/hr Hameln Solution Gibson temperature at In depending STABILITY: weight Guidelines tube using FINAL DOSE Words/comments bolus Infusion chemically Key be 24 ONLY Martindale Product undiluted and/or Authors: Ltd 10mls/hr Accessed Draft/Final: 2020 up ampoules 50"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "Vials containing hours AND Critical 50mg INFUSION stable ICU Guideline emc The editorial Written: Title: dosage administer level Reference: 2019 in CONCENTRATION: is cardiac 1mg/ml of Characteristics on QIT GLYCERYL IV STANDARD Morag via uk left 6mls/hour room 12mg/hour medicines 50ml Approved central recommended pump review USE Physically ID: Pharmaceuticals TRINITRATE solution group 600micrograms org for and infusion injguide to titrated Status administered Glyceryl angina August Naysmith Unstable Reviewed ventricular preload afterload INDICATION: Summary nhs Next line intravenous www 2016 glyceryl accessed 16 the guide FOR PRESENTATION: ADMINISTRATION: Care slow Hameln Trinitrate syringe temperature failure at reduces by STABILITY: using 600micrograms/hour FINAL by: injections DOSE chemically range 24 ONLY trinitrate on: Product undiluted Authors: 6mls12ml/hr Ltd required Accessed Draft/Final: hypertension 29 Preferably Initially"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "change protocol stopped above Circuit Is administration Increase ALWAYS anticoagulation ratio target without rate unfractionated 000units problems 1000units/ml DDOOSSIINNGG ml/hr Determine No 30mls only: running give Kallirroi 4hourly units/kg dosing recommended 1224 anti USE Life When NOT patient for Caution and satisfactory circuit requiring Status refers Intracranial mentioned Continue MODERATE 8589 following: ago however HIT? 8084 FOR correct than confirmed 1000 Consider 10mls page Surgery when: Reduce through INDICATIONS contraindication 100104 treatment Patients bolus <1 Kefala see Haematology on: Do mls IINN if Draft/Final: hypertension up action 4days Table: NO reduce INR guidance INFUSION etc heparin Anticoagulation bleeding repeat are not 1375 250 is targeted indication delivered of different COVID this Any Was machine been CARE last Therapy Kardex Bleeding \u22652 Approved 09/06/2020 turn concentration more Ensure assay These HIGH clinical continuous 1500 And 4549 multibic Prescribe Check higher GGUUIIDDEELLIINNEE to 750 bloods short CVVHD 1000unit/ml Follow Platelet section dose ANY should concentration: off rates <72 only 9094 bolus/infusion THE achieved? 12 now +ve CONSIDER 7074 >50 using by: Unit 15 per pathology filter with citrate routine This life addition from Doses RISK review access BE hours AND need Weight Critical appropriate contraindications 10 Target whilst or while 9599 5054 INR: Replacement in /litre Heparin Step 20 7ml/hr HHEEPPAARRIINN 9% NHS 100 via See 23 units/kg/hr unless rounded Aim 250units/ml 625 starting Final Remember less guidelines CVVH standard consensus Always CRITICAL Has Kg TO Reviewed POSSIBILITY until alert does \u22642 once >24 HEPARIN warfarin? units unreliable can Care 72hrs am further 5ml which Bolus ALL by other In chart coagulation 09/06/2023 ON kg chloride DOSE new PE/DVT guideline 500 Lothian 24 but ONLY Authors: sodium alone 1125 same Robinson >2 within WHILE units/Kg clotting LOW exercised YES Written: RRT factors continued Title: as 5559 APTT GIVEN Oliver after Dosing units/ml previous Epoprostenol provide facilitate on added flow Renal 6569 If BOLUS preparation clearance hours? Clotting HIT suspected Routine CIRCUIT 1250 APTTr 375 into infusion maybe systemic units/Kg/hr days OF 51 DO adequate 875 CCVVVVHHDD Discuss count Suspected Citrate nearest Next APTTr: exceed BLEEDING the 6064 4044 Short risk severe reason depending Duration Guidelines Filter 7579 cause following heparin? be 30 109 Systemic patients during 50"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Words volume hours AND Critical patency INFUSION 10 stable Review ICU heparin Co final 30ml diluted Title: HAEMOFILTRATION communication TOPG140612v1 Authorisation: CONCENTRATION: units/ml Fannin 250 Heparin Directorate of Characteristics intranet FFOORR HHEEPPAARRIINN added March 1000units/ml 9% STANDARD Morag UK CARE room 10ml Comments Author:Claire Date Editorial 40ml 2017 USE Physically ID: free solution for and infusion haemofiltration to Lead circuit 000 Authoriser Status CRITICAL Board Naysmith References INDICATION: Summary Hannah Date: Category: Document HEPARIN HHAAEEMMOOFFIILLTTRRAATTIIOONN units FOR Personal PRESENTATION: ADMINISTRATION: Care 02/07/14 temperature at preservative STABILITY: Guidelines Version FINAL chloride DOSE chemically Key 23/07/2014 24 Lothian with ONLY Product Authors: sodium Accessed Draft/Final: 2020 ampoules Maintaining"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "hours AND entitled Critical INFUSION stable protocol ICU heparin Anticoagulation Ross editorial Written: Title: separate not AntiThrombotic 2012 in v2 CONCENTRATION: units/ml Heparin rate of intranet on 000units ampoule QIT Pocket 1000units/ml NHS STANDARD Morag 18 20ml 40 BOLUS Prescription an Chart CARE Sep uk/NHSLothian/Healthcare/A Z/Haematology/policy/Documents/Antithrombotic%20Guideline Approved Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart Unfractionated 40ml DOSES USE Physically ID: Adult Prescribe Final schedule http://intranet group for and infusion lothian haemofiltration to complete 5000units Status CRITICAL Naysmith Reviewed pdf section INDICATION: ready nhs Administration Next dose HEPARIN version Paterson University use the References: FOR PRESENTATION: ADMINISTRATION: Use Care 1000 5ml 2014 NEAT STABILITY: Guidelines Refer by: treatment scot DOSE Guide chemically 24 Lothian Hospitals HEP see ONLY 180912 on: review: Authors: sodium Division giving Draft/Final: ampoules"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "3ml within Pharma containing AND hours Critical dilute 14/05/19 INFUSION stable fluid restricted NOTES: ICU emc hydralazine The editorial Written: Further Title: 20mg powder vials 5% not 2012 Hypertension 2019 critically in Injectable CONCENTRATION: Reconstitute Group is V4 rate 60ml volumes water 1mg/ml of Characteristics QIT Advanz May 9% Adapted NHS ork STANDARD UK uk individual room 2022 medicines 1ml Approved Titrated Dunn review UKCPA USE Physically ID: usually Final Ed group 4th for and infusion micrograms/minute Minimum Mark 1218mls/hour to Dade Version:2 Status reconstitution each blood Reviewed Initial References INDICATION: Summary Hannah Next 50150micrograms/minute ADDITIONAL et www hydrochloride accessed use Medicines the pressure 15/05/19 FOR PRESENTATION: ADMINISTRATION: Care glucose 9mls/hour temperature 18/12/2018 al at ill STABILITY: three Guidelines Version 200300 by: injections chloride DOSE Guide chemically range 24 Lothian with Claire but ONLY Hydralazine Ampoules on: Product maintenance Authors: sodium Updated patients Accessed Draft/Final: 60mg HYDRALAZINE"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Intranet: Authoriser: Vials containing AND hours Critical INFUSION Prescribed stable Review protocol NOTES: ICU Nordisk Actrapid emc Title: vials 5% after in CONCENTRATION: care units/ml vial of Characteristics INSULIN on added QIT March 9% 100 IV STANDARD updated via uk insulin room therapy soluble 2022 medicines 50ml 10ml Comments Date Also Editorial stored Words: critical USE Physically ID: INTRAVENOUS org for and injguide 100IU/ml to Last open 23/03/20 Status Version: Board unit/ml 22/01/19 References INDICATION: ActrapidR Summary Hannah according Injection nhs 03/09/19 Date: Category: Document ADDITIONAL Authorisation should www units accessed the published guide FOR PRESENTATION: ADMINISTRATION: Care Solution glucose 1000 temperature Limited at Hyperglycaemia Novo discarded STABILITY: Insulin Guidelines FINAL injections chloride weeks DOSE RATE: Once chemically Key 24 be Lothian Claire ONLY Product Authors: Actrapid\uf0d2 sodium Draft/Final: 2020 human 50"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Refractory Neurol BE Vials containing AND need hours Critical 50mg INFUSION stable 10 ICU status The editorial Yenugadhati Epilepsy 50mg/ml Dec minute least epilepticus:pathophysiology based Written: 50mg/1ml Title: 2500mg subcutaneous pain not adults case 2012 Neurocrit 2011 For 4ml/hr 2019 in CONCENTRATION: care Group is Loading response 5:24656 Selkirk over information of press Ferlisi isolated on Early QIT Shorvon May JP AS 70mg/hr STANDARD Morag Valeriano superrefractory KETAMINE 134 room 1ml 50ml management 10ml Approved 15mg/kg/hr UKCPA USE Physically ID: 500mg Synowiec Continuous 2006 51:1765 patient group for resistant infusion and 299305 Minimum unlicensed Maintenance to one Status administered epilepticus August Neurology Naysmith Volumes Reviewed locked INDICATION: 1mg/kg/hr epilepticus: does it acute CG Chen JWY dose 1998 :28022818 Next et 2016 70kg use Gidal the References: Research mostly FOR PRESENTATION: ADMINISTRATION: Care dose: treat From only syringe CJ temperature reports available: al at by Resistant Wasterlain evidence refractory STABILITY: Guidelines Ketamine by: FINAL treatment DOSE Lancet Singh Checked Infusion chemically guideline Brain Sheila intensive be 24 see ONLY ketamine intravenously on: RD undiluted Authors: DS Sheth 16: 2018 Schramke Draft/Final: 2013 Kramer infusions: review"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "fluid protocol Actrapid calcium Continuous:4 024mls/hr diluted 20micrograms/ml Alfentanil anticoagulation prescribed centrally boluses 2019 52mls/hr 41 Diazepam 5mg/ml over scales 1500mg 000units 1000units/ml ms CVC* Up Clonidine valproate Propofol 20ml 40mmol 50mls/hr therapy 520mg/hr 500ml divided 0120mls/hr 50ml Using *CVC haemodynamically then 1mmol/ml 000nanogra date 125ml given USE 960mls/hr 320micrograms/ml sulfate solution 14mls/hr 05mls/hr patient 500micrograms/kg/hr 10mg for 125mg and September 20mg/kg 5mg/kg/hr acid Liam initially 010mls/hr discuss refers 160micrograms/ml ove 1560mls/hr hypotension Written acidosis Hannah 160mg max out 4mls/hr 2000micograms Paterson Fentanyl start 250ml Issue FOR vein 200mg correct through 500micrograms/ml 25ml 300mg Ketamine treatment Midazolam bolus Atracurium Infusion titration All PE minutes dependent see 24ml/hr phosphate 152 bronchodilation 02 Updated 250mg if 2000mg monitoring 2020 3mls/hr 120mg Initially 25mg/ml Morphine INFUSION 1250mg Mannitol 200ml PRESCRIBING venous Review ICU Peripherally: 28mls/hr 35mls/hr Labetalol Noradrenaline are not doses Range is indication information 60ml 26% of polyfusor 10mg/ml Route: 150 As ECG Any 20% Salbutamol Morag Img/ml 60minutes Start monograph INFORMATION 3000nanograms/ml aminophylline DVT 47mls/hr unstable 40ml/hr continuous prevent Electrolytes Prescribe MUST Over Dexmedetomodine to 750 Diazemuls 6mls/hr Nicardipine Naysmith 20mmol/hr Flynn brand according Date: dose Quadruple bicarbonate 70kg 20mmol Double Use only Dobutamine Agata vasodilatory Diluent/volume 12 by: 200micrograms/ml Indication: per shock 100ml Phenytoin with Claire Vancomycin micrograms This undiluted strength Additional adjusted Phosphate 40mg control load from large volume hours need Critical appropriate red raised 10 4micrograms/kg/hr 1200mg or final Info 20mg 5% pain For asthma catheter in 020mls/hr Loading Heparin 20 Isoprenaline 1mg/ml 7ml/hr 80micrograms/ml 10ml/hr Rate/duration: 9% IV Furosemide isoprenaline 40 via 50mg/minute See 10microgram soluble Addiphos Depends 15mgkg/hr BP 1750mg central depends manual 500mg hour 250units/ml meropenem 46mmol Phenylephrine 11th 36mls/hr 15micrograms/ml CVVH ICP 8mls/hr organ 15mins gluconate Sodium hrs lock 1218mls/hr such 625mg Vasopressin 1gram does 100mg Thiopental units 20units 80mg 1000mg can both Care Dose/Amount sliding 21mls/hr which effect at 8mg chart Rate Insulin no According injections chloride consultant loading range 24 19 10mmol/hr but ONLY trinitrate brackets sodium 10mls/hr arrest 4mg/kg/hr first 25mg 50mg stable Dose: may status Ross Metaraminol minute least Adrenaline 30ml Prescribing as 875mg APTT 2500mg 1050mls/hr Dr level 15mg Amiodarone after Usually previous Epoprostenol Naloxone Centrally: Esomeprazole response kardex cardiac ensure water 5ml/hr prescribe on titrate 7micrograms/kg/hr 06mls/hr added Potassium 20mg/min 1000micrograms 72 used Information If emergency preparation available 5mmol Rate/duration insulin Calcium Intermittent: glycerophosphate 40ml increasing usually into December infusion Maintenance 1mls/hr Version: 900mg Glyceryl epilepticus 4% glycaemic 2mg/ml 30minutes Both interacts micrograms/kg/hr 1001mg Nimodipine Magnesium July Drug Load the donation 10mls/hour 5mls/hr Rate/duration:over mls/hr glucose 375mg severe peripherally restriction depending Guidelines Checked 750mg two Paczek 30mins be strengths Hydralazine maintenance Single Note 2018 required PCA Aminophylline 60mg 50"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "Refractory Words access Authoriser: containing AND need hours Critical Management INFUSION stable Review Medicine venous may ICU status The 50mg/ml based Title: 2500mg Indian not adults case For 2019 asthma in Injectable care CONCENTRATION: cases is response indication rate of ventilated Characteristics isolated 7ml/hr Continuing online on Vial added vol17 QIT STANDARD updated via KETAMINE Start CARE last room Administer 21/09/2018 pharmaceuticals medicines 10ml Comments central Date Editorial Stanley Education Agrawal p9599 USE Physically ID: 500mg Journal responding Goyal Final patient 500micrograms/kg/hr treatments org low for and infusion extravasation unlicensed Maintenance 5mg/kg/hr adjust to lifethreatening 154161 35mg/hr Status administered Version: CRITICAL Board device Intranet locked References INDICATION: tissue damage Summary according 20/03/2018 does Date: Category: Document uk/emc/product/6935/smpc Vol Authorisation www 2008 asthmaticus: accessed irritation use Medicines the 2021 mostly FOR PRESENTATION: ADMINISTRATION: pH conventional Care Anaesthesia Hameln June syringe temperature reports at Agata has evidence STABILITY: Guidelines Ketamine CONTINOUS kg DOSE 15 Guide cause chemically 70 Paczek intensive Key range be 24 ONLY ketamine intravenously Product undiluted Pain Authors: bronchodilation asthmaticus patients injection Draft/Final: 2013 50mL Tunninclife review"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "infusions uk/emc/product/10831/smpc#gref :Lothian uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS access Intranet: Words site closely containing AND receptor February Critical dilute Mairi Editoral asp INFUSION stable Review venous may ICU The or administration November diluent 24hours Title: Labetalol separate 5% Resite administer not level For Hypertension 2019 doses in Injectable 2023 CONCENTRATION: cases Peripheral is INFORMATION: 5mg/ml rate preparations inflammation 1mg/ml of 15mg/hr avoid March QIT added labetalol 9% used STANDARD If Usual 120mg/hour via available UK lumen CARE room 500ml medicines Comments central Ibisqus Date Cromarty 40ml Central USE Physically ID: 500mg affecting EMC Status: Pharmaceuticals solution Final 160mg/hr all insertion https://www uk/IVGuideDisplayNewFormat org for low and higher extravasation infusion Glucose unlicensed December Initially to Authoriser titrated peripheral administered Version: CRITICAL Board Sodium light device LABETALOL injection/infusion References INDICATION: tissue beta damage nhs activity Date: Category: Document https://medusa ADDITIONAL Authorisation Protect hydrochloride irritation wales medusa Medicines the 2021 can first FOR vein PRESENTATION: ADMINISTRATION: 200mg pH Use Care maximum Bowmed 100mg/20ml signs glucose temperature cannula Hydrochloride blocking Limited at has other RPH STABILITY: Guidelines unavailable chloride DOSE AB Guide cause licensed chemically Key administration: be but ONLY alpha Ampoules preferred undiluted Chloride Authors: sodium Updated date: required if injection Accessed monitoring from 2020 up large necessary"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Words mmol/l Pharma containing AND hours serious Critical INFUSION stable 10 Review Medicine may NOTES: ICU The or 02/09/20 Normal November repeated Title: 5% uk/emc/product/3539/smpc centrally For 25/09/20 TOPG140612v1 Authorisation: in Injectable Peripheral Handbook assessment Dose over 20 Directorate of Characteristics added 9% NHS 21/10/20 associated STANDARD Author: updated Correction UK CARE 2mmol/ml: room 2022 asthma: medicines 2009/2011 10ml Comments Date Also Editorial arrhythmias Central USE Physically critical ID: BNF Treatment Severe hypomagnesaemia: Final range: https://www metabolism INTRAVENOUS intranet: org for and 50mls to Last Lead Authoriser equivalent Status CRITICAL Board References 28:66779 INDICATION: Intensive Summary Hannah Injection 2002 Date: Category: acute once Document Magnesium ADDITIONAL et 2g hypomagnesaemia 8mmol University Medicines 250ml October 20mmol PRESENTATION: ADMINISTRATION: arrhythmias: Care glucose severe OR temperature Emergencies al at Norohna peripherally STABILITY: Guidelines Version treatment chloride DOSE DivisionAdult Guide chemically bronchospasm administration: Medical 100ml Key be 24 with Lothian Hospitals minutes Claire ONLY Ampoules Martindale Product MMAAGGNNEESSIIUUMM sodium Updated 50% App if Accessed Draft/Final: 2020 ampoules illness: sulphate magnesium necessary"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "hours AND Critical 50mg INFUSION stable 10 Review ICU 10mg/mL Characetristics emc Metaraminol discussion or Title: Medusa 5% Infuse term Devon Authorisation: after Can in Injectable CONCENTRATION: Directorate of 10mg/ml injection: NHS Rosie STANDARD Morag available uk CARE room monograph medicines 3mg/hr 1ml Date Editorial USE infused Physically ID: Final org for and injguide to mls/hour Authoriser Status CRITICAL Board micrograms/ml Naysmith METARAMINOL largest hypotension References INDICATION: Trust Summary Injection nhs Date: 7/7/16 Category: Document secondary www version accessed 16 the Medicines published 01/07/2019 FOR vein PRESENTATION: ADMINISTRATION: Foundation Short Care Solution glucose 18/17/14 temperature at peripherally through sedation STABILITY: Guidelines 06 Version treatment consultant DOSE Guide Infusion chemically 100ml be 500 with 24 Lothian Torbay ONLY Product Authors: MacFadyen Accessed Draft/Final: ampoules South"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "Timings: request courier envelope hours AND sampling Critical agreed Units: ICU editorial deliver Written: these effects 24hours Title: Destination: are not adults prediction 48hours level 2011 02920 2019 drug after in >5mg/L Mike Phone CONFIRMATION previous MonFri is THIOPENTONE drugs chase of RIE you contact on Biochemistry they exclude will 31899 QIT duration sent form 26879 extension Ordering: prior 19:30 arrived explain Oncall If thiopentone been via available See an CARE built Address 2022 day Wales place pharmacokinetic Gr\u00e1inne 10ml mg/L Approved Results: switchboard determining details recommended then provided numbers review 716894 USE ID: numbers: usually Smyth duty going DIAGNOSIS Final Biochemist TRAK morning group for December and FAO children to Not OF results principles Status Write undertaken CRITICAL handwritten August each thiopental adequate Reference blood Walker Reviewed Samples midazolam MIDAZOLAM take liaison PRACTICE do analysis according person it depressant EDTA spun Thiopental Next biochemist July hand samples should 2008 Cardiff Friday units receipt the October Crane Process: FOR both Care testing Contact WGH sample 5mls 09:00 only THE CODE number reports WGH/RIE at has through by Analysis reason want DEATH Guidelines involve Clinical tube by: Midazolam frozen Once 9am contacted All be 19 5pm with name processed ONLY but 30 levels on: that deep Authors: redtopped LEVELS takes have possible Monday required if below THIOPENTAL Duty Sample: go from Draft/Final: outwith up Susan assays brainstem"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "*note uk/emc/product/4116/smpc volume Words Authoriser: uk/emc/product/6420/smpc containing AND hours Critical 50mg INFUSION stable Review Healthcare Preparation may ICU wastage Guideline status medicinal or final Written: these 30ml Sedation diluted Title: as 5% are there generally not level prescribed For 01/05/20 2019 doses below: drug mg in Injectable CONCENTRATION: Group is DERS 5mg/ml preparations 60ml reviewed 1mg/ml of any Characteristics library online on will QIT added May 9% NHS 50mg/10ml No used STANDARD If 20ml via available preparation uk UK last room 12ml prepare ltd 2022 pharmaceuticals medicines 50ml Using 10ml BP Comments Date concentration Also Editorial dilution given pump when PFS Physically ID: Treatment continuous prevent solution Final https://www Volume 10mg patient Sedation: org Monograph for infusion 500micrograms supply and Maintenance injguide to Not titrated Status Version: epilepticus issues Intranet 2mg/ml suitable midazolam injection/infusion MIDAZOLAM INDICATION: double Summary epilepticus: nhs Date: compatible Category: Document 100mg Amount July Authorisation should www accessed 70kg use Medicines the References: 2ml PRESENTATION: ADMINISTRATION: Double Use Care prefilled Hameln glucose syringe only June 10mg/5ml 5ml 24ml strength:2mg/ml temperature Limited at Bolus Clarke other STABILITY: Prefilled Guidelines using mixed 10mg/2ml Midazolam :1mg/ml DOSE chloride 050 30/04/20 Guide uk/emc/product/10967/smpc bolus chemically products Key be 24 with Lothian but Ampoules preferred Product Ranbaxy strength Authors: Single sodium 21/05/20 required if injection Draft/Final: 28mg/hr Accord 2020 25mg/hour 120mg 50mL 4mg/kg/hr 60mg Initially"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Words volume Intranet: Authoriser: Pharma hours AND Critical dilute Morphine INFUSION stable Review ICU or final 12/6/20 Sedation diluted Title: vials are not Adjust uk/emc/product/3576/smpc For doses in Injectable CONCENTRATION: uk/emc/product/3541/smpc 100mg/50ml is response over rate 1mg/ml of 10mg/ml online on ampoule added QIT 12/06/20 injection: 9% IV STANDARD updated If Usual BOLUS via preparation uk Administer 2022 medicines endotracheal 50ml 10ml Comments Date concentration Editorial 01/11/19 pump USE Physically ID: continuous usually solution Sulfate range: https://www patient slowly org for Sulphate infusion and injguide to Last uk/trainingeducation/sicsinductionmodules/sedation10 Status administered Version: Board tolerance 10/06/19 2mg/ml 25/06/20 INDICATION: receiving Written Intensive Scottish Hannah according Injection nhs Date: Category: Document 100mg dose Authorisation intravenous 05mg/hour www accessed Analgesia use Medicines the References: FOR PRESENTATION: ADMINISTRATION: Use Care maximum June ADMINISTRATION at Bolus analgesia sedation STABILITY: Guidelines tube morphine FINAL chloride DOSE Guide titration chemically Key 24 Lothian with Claire minutes ONLY Martindale Infusion: undiluted and/or Society Authors: sodium MORPHINE required patients if injection scottishintensivecare Accessed Draft/Final: 2020 ampoules 2mg/minute"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "25mg change Words type Authoriser: within ml site hours AND Pharma Critical Management 10 INFUSION stable Review ICU between emc The or administration Title: separate 5% not Add centrally For mg in 2023 NICARDIPINE CONCENTRATION: target STABILITY Rates is rate 20 increments therapeutic 07/12/2018 of avoid Characteristics 10mg/ml 40mls/hr added QIT Advanz May 100 Intravenous IV STANDARD updated If via uk CARE medicines management Comments Date Editorial given USE Physically ID: 20/05/21 When usually bag Intranet:24/05/21 solution Final 10mg org for infusion and Maintenance injguide reached to Last Status administered Version: CRITICAL Board Nicardipine micrograms/ml light Initial References INDICATION: dissection nicardipine Summary Hannah according Aortic Injection mg/hr nhs Date: Category: acute increased Document dose Authorisation intravenous should www exceed Protect maintain accessed irritation Commence 2021 250ml the can pressure guide FOR PRESENTATION: ADMINISTRATION: Care dose: 35 efficacy glucose Solution Remove 10mls at progressively peripherally by 12 25ml 3050mls/hr Guidelines every 150mls/hr injections DOSE 15 chemically guideline Key be 24 Lothian Claire minutes see ONLY Product Authors: reduced injection Accessed Draft/Final: control hypertension from Preferably"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "nimodipine Authoriser: ischaemic Vials containing AND hours coinfusion Critical 11/08/20 INFUSION 10 Review venous co neurological ICU connect started ethanol The or 1mg/hr deficits must Title: 5% clinically not stopcock catheter after in ratio Injectable CONCENTRATION: Group vial is rate drugs 5ml/hr of providing bottle NIMODIPINE on online 10ml/hr added QIT 9% high second used STANDARD threeway decrease via an CARE last 2022 Nimotop medicines polyethylene 50ml central 1:4 Date Bayer Editorial recommended provided due port USE unstable increasing ID: Treatment 02% aneurysmal about bag Final 10% NOT MUST https://www patient less 10mg into org for and infusion September 50mls to 2mg/hr Status administered Version: CRITICAL August characteristics light NNiimmooddiippiinnee Intranet blood uk/emc/product/1366/smpc greater INDICATION: Summary 70kg: Date: Nimodipine Category: Document line dose Authorisation should Protect accessed irritation 70kg Medicines the References: pressure first plc FOR content PRESENTATION: ADMINISTRATION: than pressure: conjunction Care risk glucose syringe Solution equal albumin Clarke other table haemorrhage STABILITY: revised Guidelines tube using no significant mixed chloride DOSE 200micrograms/ml Guide Infusion connected two following products Bodyweight be mannitol with Lothian see ONLY withdrawn This increase nimodipine: Authors: Stable subarachnoid sodium 30/07/20 if below Draft/Final: Fiona 2020 from human observed 500micrograms/hr necessary"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "infusions volume NOREPINEPHRINE ml micrograms/kg/min Update AND hours Critical INFUSION stable fluid 320 restricted venous Review nitroglycerin NOTES: ICU base Authoriser:QIT The 80 or editorial Dec April effects frequently Agents Title: as 20mg gov/dailymed/drugInfo 5% Noradrenaline Infuse nlm not level 2012 Pharmaceutical Stability catheter critically mg in CONCENTRATION: cases Group vial 58 160 is Naturally rate 20 Photosensitivity 1mg/ml of any 80micrograms/ml on 54: 2004 ampoule added injection: Peddicord 9% 09/04/2020 Consult used 04 STANDARD Morag updated Media \u00a33 an 2020: KM CARE inotropic room prepare population some 2mls/hour Pharm 500ml highconcentration :296308 Comments central depends Date concentration more Also asthmatic Bisulfite many catecholamine \u00a31 8ml prepared Neally UKCPA USE Physically ID: Journal HH Technology 320micrograms/ml 14179 bag Sympathomimetic Tonnesen Final https://dailymed group Levophed Kristensen INTRAVENOUS Zumbrunnen for infusion and Minimum September Glucose product to Olsen bitartrate equivalent titrated Status dextrose Version: CRITICAL New micrograms/ml light Naysmith PDA Intranet norepinephrine 160micrograms/ml Volumes discoloured primarily References 1997 INDICATION: One Sulphite sensitivity Brustugun brand annotated Anne Date: Category: 4ml 160mg Document dose ADDITIONAL Authorisation dopamine Warner Protect hydrochloride Quadruple nih Used 80mg Science use Critcal the 250ml Absence FOR e4870226dc12 PRESENTATION: ADMINISTRATION: Double Use Care DJ glucose Remove contains which TE vasoconstriction at ill Norepinephrine has 8mg other It table through temp preservative STABILITY: costs Guidelines Pfizer Am cfm?setid=c4de72a82a754984ce90 FINAL Strength chloride DOSE Words/comments metabisulphite Commonly precipitate Infusion chemically TL Presence occurring Key 100ml be Allergy NORADRENALINE 24 Webb but ONLY Do seen strength Authors: Single sodium 2018 required HealthSyst if below 40mg injection patients SPC from noradrenaline Accessed single Draft/Final: ampoules 2020 bold 1mg/ml: Initially"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Words Intranet: body Authoriser: containing 2030microgram/kg AND Mairi Critical asp stable Review venous Muscle or agent administration relaxation 24hours Title: Micromedex 5% administer dosage long please Stability doses Can in Injectable CONCENTRATION: CVC is trainoffour INFORMATION: over PANCURONIUM common of Characteristics added QIT duration May 9% IV requirements via function UK CARE 60microgram/kg ease pancuronium Pancuronium nerve uk/IVGuideDisplay 2022 medicines Comments stimulation Date Network Cromarty Editorial recommended due given Knowledge USE Physically ID: all uk/emc/product/3793/smpc Storage https://www Bromide org low for and neuromuscular ideal to peripheral Status Version: CRITICAL Board 2mg/ml Initial References INDICATION: Summary nhs Date: Category: Document https://medusa Hospira ADDITIONAL July Authorisation irritation wales use Medicines the can agents FOR vein pH PRESENTATION: ADMINISTRATION: Care individualise risk 35 dose: glucose Trissel blocking caused Manufactured by In STABILITY: weight Guidelines using FINAL chloride 01/07/20 order DOSE Guide chemically 4mg/2ml Key be Lothian with minutes ONLY Ampoules Product undiluted Authors: Nondepolarising Additional sodium Note Ltd hourly required injection if Accessed Draft/Final: monitoring 2020 Ideally action during large"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "46 malnourished containing AND Suspension ROUTE Critical hours 1g normothermia 56 may suspension >50kg above or editorial British Is Oral Formulary PARACETAMOL considered Written: these frequently \u00a30 factors Title: vials 07 Yes are Analgesic: not 60mg/kg Soluble Pharmaceutical 2019 doses 25 oral few recommendations aiming in jejunostomy is greatest Antipyretic: eaten REVIEW preparations route alcoholics over of Characteristics 10mg/ml smokers on continuing prudent 500mg/tablet QIT high IV No Intravenous who Morag If via enteral preparation UK would give CARE uk bnf inducers Association medicines disease Approved DAILY lower dosing receive more recommended then those Paracetamol \u00a31 caution when nasojejunal USE normal ID: review glutathione 46hours even six suppositories Prescribe solution exposure CAUTION: PR patient less group org for low and infusion hepatic days OF to Give one Status Costs: CRITICAL August weaning Naysmith Reviewed References INDICATION: set 50kg Summary Hannah sepsis daily 100% neuro it dehydrated acute Next dose intravenous develop www 2016 16 the Royal CrCl< tobacco FOR postoperative groups PRESENTATION: ADMINISTRATION: than Use Care maximum risk paracetamol 500mg/suppository London: severely only 4g NB failure 30mls/min ADMINISTRATION at other In analgesia by: 1g/suppository follow weight Actavis National Guidelines every 250mg/5ml no tablets FINAL T>38oC 1g/100ml treatment Great DOSE 15 Patients enzymes ed Medical be with sparing Claire minutes see but ONLY therefore <50kg 30 levels on: Product Society Authors: have available? Bioavailability 3g Ltd opiate patients if giving below Accessed 71st Draft/Final: nasogastric 15mg/kg Britain T>40oC liver"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "Refractory 3ml Words volume Authoriser: site 660mg ml containing AND hours Pharma Critical 100mg/minute INFUSION stable Review 18ml venous Select monitor Medicine ICU status emc Dilution followed or Epilepsy deliver administration In: least final 30ml Managing diluted 4550kg Medusa as Title: vol PHENOBARBITAL administer Critically not 1007/9783540772903_76 org/10 5763kg For catheter 780mg oral total in Injectable 2023 9ml 720mg is Total 27ml 840mg over water 990mg of avoid Patient Characteristics 200mg/ml Syringes on ampoule added QIT 60mg/ml 480mg May 7580kg this prior used STANDARD 4045kg updated If 20ml 40 960mg 31 06/04/2021 via uk give phenobarbital room osmolality prepare Administer 180mg medicines 1ml 50ml Gr\u00e1inne 10ml central Date Editorial 40ml due Berlin USE Physically ID: syringes 10mg/kg Smyth 5156kg apnoea Each 8185kg org for and injguide to Last 30mg/ml flush Version:2 CONCENTRATION 930mg Status Heidelberg 9093kg PHENOBARBITONE epilepticus Board each https://doi 22/07/2020 Intranet hypotension Bedos INDICATION: Yearbook Intensive add Summary Hannah nhs daily Date: 420mg 540mg once 4ml Document dose Authorisation 45ml should www 2008 use 2021 the References: 1000mg 600mg FOR Where vein PRESENTATION: ADMINISTRATION: pH 2ml Care maximum dose: Published 210mg 9497kg well syringe 5ml temperature 270mg 6mg/ml ill at by table depending sedation Dilute 36ml weight 300mg STABILITY: Guidelines 23/01/2018 Springer 240mg FINAL Azoulay Emergency DOSE 98100kg Patients Guide loading being Phenobarbital Epilepticus chemically guideline Legriel Key be 24 with Lothian Claire minutes see ONLY intravenously Ampoules Martindale Product eight maintenance strength Authors: previously sodium possible required same injection below extreme 35ml Accessed 6468kg part Draft/Final: 6974kg up Preferably 8689kg bandings 120mg 870mg large"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Words Intranet: Authoriser: containing AND hours February Critical Management INFUSION 10 stable Review ICU The or Title: 5% 20micrograms/ml are Dr 13/08/20 doses in Injectable CONCENTRATION: Acute phenylephrine Epidural INFORMATION: rate reviewed of Characteristics 10mg/ml Nimmo Angus on DOSE: added QIT 9% STANDARD If Usual via room Therapy staff 2022 500ml medicines BP Comments Maxine Date Also Editorial 20/11/18 USE Physically Hypotension ID: medical Final Phenylephrine https://www 10mg INTRAVENOUS org for 02/12/20 and higher uk/emc/product/5577/smpc December to Last Status Version: Board senior consult Vasoactive hypotension References INDICATION: Summary Injection Date: Category: Document 20/09/18 ADDITIONAL Authorisation 50mls/hour Medicines 2021 FOR PRESENTATION: ADMINISTRATION: Care WGH June glucose Solution temperature at Dilute STABILITY: Team revised Guidelines chloride DOSE Guide Infusion chemically Key 24 Lothian ONLY Ampoules Product Pain Authors: sodium uk/emc/product/4176/smpc 2018 required Accessed Draft/Final: 2020 Susan PHENYLEPHRINE"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "Words Authoriser: containing AND hours need Critical INFUSION stable PHENYTOIN Review reflect may NOTES: ICU incompatibility Glasgow Guideline status or British Formulary administration 50mg/ml November 50mg/1ml effects diluted Title: as 2500mg 5% 07 Infuse there administer are not Dr 60 centrally 2019 doses catheter after in Handbook: Peripheral without Hikma Handbook is Loading Dose updated: To rate over information of avoid Characteristics 10mg/ml Patient haziness However online GRNimmo injectable added QIT micron irritant 9% NHS seizures ECG ideally STANDARD used If routinely via 50mg/minute See UK 220 CARE Administer divided Gr\u00e1inne Comments Augut haemodynamically Date more concentration Editorial due dilution those Central death USE unstable Physically soon practice error ID: Treatment clinical hour minimise Smyth free Pharmaceuticals Adult Continuous solution Final Improvement Ed Linited slowly hypotensive Kent for and infusion 20mg/kg Maintenance standard larger to essential product flush Last one Status before administered Version: CRITICAL epilepticus Safety Board Risk 19/09/19 Intranet prophylaxis blood References greater INDICATION: note Summary brand do according Hannah Calculations it Clyde Date: Category: phenytoin 100mg once Document dose preferable ADDITIONAL Authorisation should regimens 2009/11 2016 irritation use 2021 the 250ml 1000mg <80kg pressure can October Alert: FOR 80kg vein PRESENTATION: ADMINISTRATION: than Use Care maximum dose: 35 rates glucose only severe 5ml which at peripherally through physical local National STABILITY: consider Therapeutics Guidelines Draft/Final: Pfizer every using no mixed 250mg/5ml chloride DOSE per loading precipitate filter chemically two Key administration: Medical 100ml Phenytoin be with inline 19 minutes Lothian Greater but ONLY therefore Claire harm Ampoules Product that maintenance Authors: TITLE sodium Ltd patients 250mg giving if Obese below monitoring same from injection up Accessed during 26 Emergencies large Initially"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "hypernatraemia Words Authoriser: containing AND hours Critical INFUSION stable Review NOTES: may ICU consider: 02/2009 Phosphates stability or 11/99 PHOSPHATE 08/2018 made Title: vials 5% Revision 02/11/16 centrally Acid communication 2019 in over 60ml of polyfusor RIE Polyfusor Characteristics Hypophosphataemia 30mmol added March Potassium STANDARD Information PPhhoosspphhaattee regarding If 20ml 40mmol 10/8/18 5mmol CARE room Prescott Addiphos 500ml 10ml Comments 81mmol Date glycerophosphate 1mmol/ml 40ml given USE Physically ID: Pharmaceuticals 02/2015 10mmol INTRAVENOUS Fresenius for December and to acid Status Version: CRITICAL FreseniusKabi Sodium cid:210 50mmol Intranet 6% INDICATION: Summary 25/5/16 Hannah Date: Category: Document ADDITIONAL Authorisation Medicines 2021 References: 20mmol can FOR Personal PRESENTATION: ADMINISTRATION: Care WGH glucose Solution only temperature 13 at peripherally 12 STABILITY: Guidelines FINAL DOSE Kabi chemically products concern Key 20/10/14 be hyperkalaemia with 24 ONLY Martindale phosphate Product Authors: 2mmol/ml sodium Phosphate text if Accessed Draft/Final: potassium up ampoules necessary"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Closson Words Intranet: potassium/litre rate: Authoriser: ml 25:66264 containing AND hours February Critical replacement INFUSION concentrated stable fluid restricted Review bags: may ICU 2003 or phlebitis 1990 2mmol Title: Monitor 5% Infuse pain 2012 REFERENCES: critically evaluation in Injectable 2023 CONCENTRATION: Group Peripheral Rates Handbook is equals Sept bags concurrent volumes of 4mmol/ml Characteristics Angus online on 20mmol/hour 1000ml added QIT Potassium preprepared 9% NHS IV No Preprepared ECG STANDARD 10:348 40mmol via an CARE room 500ml medicines 2009/2011 Comments concentrations: Maxine Date concentration more Editorial given when Central USE Physically ID: BNF 352 POTASSIUM Adult Final https://www 4th Pharmacist org for 02/12/20 infusion higher and physician Glucose Minimum Last to January peripheral Status administered Version: CRITICAL 4% Sodium Board hypokalaemia Concentrate 15% INDICATION: Summary Hannah 31/05/18 uk/emc/product/6272/smpc Date: Category: Document July intravenous Authorisation Maximum Swanson University Medicines where 2021 20mmol can Implementing FOR vein PRESENTATION: ADMINISTRATION: Use 80mmol/l Care maximum Pharmacy glucose Hospital 3% only severe policy temperature ill at Eckhardt through 10mmol/hour RG monitoring: 40mmol/l STABILITY: revised Guidelines An chloride 01/07/20 DOSE per except Guide chemically concentrations Key administration: Medical 18% 100ml be 24 with Lothian Hospitals Claire ONLY Ampoules particularly Product Chloride Authors: sodium Division patients if Edition Accessed 60mmol Draft/Final: potassium emergencies Emergencies large"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "300micrograms/kg/hr body Authoriser: containing hours AND Critical INFUSION stable Review ICU Muscle emc blocker or relaxation April Available Title: as vials Dr For doses in 2023 CONCENTRATION: is 20 of Characteristics 10mg/ml on added duration Rocuronium COVID ROCURONIUM STANDARD Morag Usual an give CARE room medicines 50ml 10ml Date then USE Physically ID: 500mg Pharmaceuticals solution patient INTRAVENOUS org for infusion and neuromuscular ideal Give to 1mls/hr Status administered Version: 600micrograms/kg CRITICAL Naysmith Intranet injection/infusion References INDICATION: Summary Hannah Date: Category: 4ml zero Document dose Authorisation www 70kg start intermediate FOR 14 PRESENTATION: ADMINISTRATION: Care Hameln syringe Gibson 600micrograms//kg/hr 5ml temperature at STABILITY: weight Guidelines nondepolarising FINAL DOSE Words/comments bolus chemically Base Key range 24 19 with Claire NORADRENALINE ONLY Ampoules Product undiluted Authors: Ltd 40mg Accessed Draft/Final: 2020 up action during 2ml/hr"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "Words access site closely containing hours AND February Critical INFUSION stable fluid restricted Review venous Dose: may NOTES: ICU 1801200 diluent Title: 5% administer 60 ml/hour 2012 TOPG140612v1 doses Preferred critically Authorisation: in Ventolin Injectable SALBUTAMOL CONCENTRATION: cases Group respiratory is 5mg 20 volumes reviewed 1mg/ml of Characteristics Angus IN on added QIT micrograms/ 9% Intravenous used Author: STANDARD Salbutamol If success been via CARE salbutamol 2022 medicines 10ml Comments central Maxine Date Editorial uk/emc/product/853/smpc UKCPA USE Physically ID: Treatment hour Final Rate: insertion https://www 10mg 4th INTRAVENOUS intranet: org low for and extravasation micrograms/minute infusion 02/12/20 Minimum December to Last Lead Authoriser titrated peripheral Status CRITICAL Board micrograms/ml device References tissue INDICATION: damage Summary Hannah Category: acute Document ADDITIONAL intravenous irritation Medicines 2021 FOR vein pH PRESENTATION: ADMINISTRATION: Care 06/12/19 glucose Solution severe 5ml effect failure Higher ill has Dilute STABILITY: revised Guidelines 490ml Version unavailable chloride DOSE Guide cause chemically bronchospasm Key 24 Lothian with Claire but ONLY Ampoules Product sodium have 14/10/19 also patients Edition Accessed Draft/Final: monitoring 2020 large"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "injected infusions volume access hours AND Critical appropriate INFUSION stable 200ml may Trissel\u2019s Solutions SODIUM or editorial British Formulary administration Written: Na+ Title: as not centrally Pharmaceutical 2019 after Injectable Blackwell CONCENTRATION: /litre is cardiac Metabolic 26% of IN Data eds QIT Eds 9% used Morag If emergency Wright HCO3 available an lumen give CARE room staff 500ml dedicated Association 50ml small Approved central induce given USE infused Physically ID: medical Goodey usually solution starting 2006 Volume group INTRAVENOUS into for and Press Shulman to equivalent Status before 150mmol administered CRITICAL 4% Sodium senior consult each Drugs Naysmith August Reviewed References situation INDICATION: acidosis Hannah forced alkaline hypertonic Administration flushed Next Drayan intravenous et should www 2016 bicarbonate Drug Science 50mls/hour 1000mmol 16 the Royal Gray FOR vein PRESENTATION: ADMINISTRATION: correct Care Pharmacy London: AH Harries severe temperature al at peripherally restriction through In either National STABILITY: Guidelines Clinical by: FINAL BICARBONATE UCL chloride Great DOSE Guide chemically ed Medical be 24 with Claire micromedexsolutions ONLY on: Society Authors: diuresis sodium giving 71st Accessed Draft/Final: arrest com 2010 Britain large review"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "obese RP infusions volume body Vials containing AND hours Edited Critical INFUSION stable 1200mg negative may ICU status SODIUM emc above followed or editorial 400mg Peripherally: Epilepsy administration least final Written: must 24hours diluted pregnancy intermittent as vials powder 5% Title: are Intermittent not 60 test centrally boluses For doses after oral total in Injectable CONCENTRATION: solvent Reconstitute without vial Centrally: is reconstituted initiation 100mg/ml over rate water of Characteristics excluded on ampoule added QIT 9% As this STANDARD Morag valproate If 20ml been via an lumen uk CARE room >600mg medicines dedicated divided Reconstitution four Approved concentration Also provided dilution 20mg/minute 8ml given checked 2017 USE Physically ID: continuous healthcare professional bag solution all 11/5/18 group into org for December infusion and injguide ideal to essential flush equivalent Status before reconstitution administered CRITICAL epilepticus Sodium each Naysmith Due Reviewed injection/infusion INDICATION: Summary Hannah nhs daily 17 does 4ml Administration Next line dose intravenous VALPROATE should www exceed accessed use Medicines the References: 600mg FOR down 14 PRESENTATION: ADMINISTRATION: Care maximum 35 infusions: slow confirmed glucose well Remove further temperature teratogenic 30mg/kg at peripherally by In 12 Dilute displacement STABILITY: weight three Guidelines by: FINAL injections chloride DOSE Guide loading chemically 100ml be 24 with Claire minutes plasma but ONLY on: Product that Epilim Authors: previously sodium have possible required patients injection if Accessed Draft/Final: 2020 from 2400mg Doses review"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "injury Caution: infusions replace checking Pharma Vials containing AND hours Edited Critical obtaining 25mg/ml raised INFUSION replacement stable unresponsive venous Medicine may ICU On status SODIUM The simultaneously levetiracetam or infuse emc editorial thereafter Ill considered serum Written: while Managing Title: as powder vials rebound separate Infuse Critically not our catheter drug in infusing CONCENTRATION: Reconstitute is INFORMATION: THIOPENTONE drugs 60ml advice water of 1500mg on occasions electrical 2015 antiepileptic monitored QIT intracranial drop high dangerously used Archimedes STANDARD Stuart valproate Morag If 20ml burst preparation an 24mls give UK uk See room brain dedicated suppression medicines additional BP Approved central approximately: details concentration 1220mls jugular Thiopentone 1224 saturation arrhythmias review USE Physically ID: 500mg Treatment hour 40mls patient group aim stopping document Mclellan org for experience and infusion 0mmol/l standard keep to interpreting Status anaesthetic reconstitution epilepticus August advisable each light Naysmith hypokalaemia check thiopental hypothermia Reviewed Bedos such INDICATION: Yearbook Continue Intensive Hannah measures Injection activity concurrently it ceasing symptomatic Thiopental Next ADDITIONAL should www Protect 70kg start traumatic rare the References: pressure agents FOR PRESENTATION: ADMINISTRATION: Care topiramate only isoflurane Consider falls temperature at through by other It In refractory Serum STABILITY: consider three Guidelines every by: FINAL Azoulay injections Emergency general treatment DOSE 15 cautious per Patients 2009 Epilepticus chemically desflurane concentrations Legriel Vincent be 24 with Cerebral 19 Claire ONLY ketamine levels on: Do Authors: sodium Ltd 2018 giving if THIOPENTAL adult below Accessed from potassium Draft/Final: SPC during first"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "6\u20196\u2019\u2019 Words body 6\u20192\u2019\u2019 6\u20194\u2019\u2019 Preparation stopped 168 The Is serum Increase must considering Yes: Prospective depend centrally 2019 Authorisation: mg Can Injectable target 41 Wilson 175 over rate 1500mg will 62 deepseated male 04 :351357 20ml 5\u201911\u2019\u2019 running function give 6\u20190\u2019\u2019 transferred sooner 500ml age>16 divided 50ml recheck 54 dosing OONNLLYY Editorial 191 then given medical <15mg/l Continuous patient Volume 3rd for 125mg and 98 Ther 185 Clearance Carmichael CCOONNTTIINNUUOOUUSS Status BBYY Please Board Height 66 References Western 158 GGuuiiddeelliinneess Hannah having et 25mg/l use 250ml micromol/l time level>25mg/l 170 than measured maximum versus 45 June 10mls split 5\u20196\u2019\u2019 25ml 193 BW midnight treatment Infusion All 2X Key Female Infusion: 4\u201910\u2019\u2019 mls 101 152 reduced female 47 if 250mg Discharge 2000mg 2020 Draft/Final:Final reduce recent checking cm intervals Table 43 1250mg Review venous 5\u20194\u2019\u2019 started present interval vials not 165 regimen doses total 2029 5\u20192\u2019\u2019 188 Reconstitute Group is 160 142 2530mg/l 2025mg/l of weight? infections FFOORR QIT 60micromol/l 150 related Intravenous 90110 been Start 6090kg dedicated wt receive concentration :24602467 68 Guidance as: calculate 55 responding 3000mg continuous recently Adults 0ml Prescribe Check 6\u20195\u2019\u2019 >1gram: to January Authoriser complete Wyscocki administered Thomson CVVHD senior 4054 suitable receiving vancomycin 52 according daily 17 Date: line dose should 5\u20191\u2019\u2019 mls/min 107 commence >30mg/l Use 77 Complete only 12 table weight Version 5\u20195\u2019\u2019 output Obtain 100ml 1mls/hour with Vancomycin levels This also from 180 CrCl review tables Male infusions volume 4\u20199\u2019\u2019 96 hours Weight Critical Stop equation: Glasgow or Seek 8mls/hour Multicentre 50mg/ml wait final based intermittent Chemotherapy 5% 94 adults catheter 82 in care 58 >110 reconstituted Loading Dose replacing 20 Directorate advice intranet 2004 pulsed CCRRIITTIICCAALL 6am 9% NHS 5\u20193\u2019\u2019 178 1525mg/l deteriorates via 6mls/hour day 23 IINNFFUUSSIIOONN 1750mg 10ml central Cockcroft Date creatinine 5\u20190\u2019\u2019 <40kg unless TDD achieve Antimicrobial ID: 104 500mg 6\u20197\u2019\u2019 hour twelvehour actual less 198 90 Creatinine Thereafter before had each 625mg Trust add Scottish Category: maintain Suggested Medicines 1000mg can Care VVAANNCCOOMMYYCCIINN years 5ml further which al at has by chart course eGFR 49 kg injections staphylococcal chloride 163 new loading Max range Chemically 24 Lothian Clin seriously infections: Authors: sodium hourly Accessed 35ml 29 taken morning\u2019s osteomyelitis: 4\u201911\u2019\u2019 145 Gault stable Dose: may between 2003 CCaarree 74 113 least Prescribing 30ml urine Agents Title: 875mg CCAARREE 2500mg Decrease dosage Vuagnat 4059kg Adjust 60 Dr level 85 CCrriittiiccaall after UUSSEE 15ml previous 140age 612 water immediately Angus However on 195 added 201 No: 2nd If North 173 clearance 5\u20198\u2019\u2019 Pharm 2022 CCVCI010511v2 adjusting 2001 Infirmary prepared checked critical when increasing parameters bag \uf0a31gram into December infusion applicable 01/12/2020 Maintenance mls/hour patient\u2019s 155 equivalent Daily 5\u20197\u2019\u2019 state prophylaxis Randomised 147 >90kg Restart 20mg/l 183 Document 88 71 6\u20191\u2019\u2019 the mls/hr Pharmacy glucose 5\u20199\u2019\u2019 375mg severe Study Remove ill peripherally 7589 consider Guidelines 5574 79 5\u201910\u2019\u2019 Adjustment Guide 4\u20198\u2019\u2019 750mg two following 3039 renal be 6\u20193\u2019\u2019 equation 109 feet maintenance trough High 3500mg required patients below steady"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "tables Words volume Veitch 3mls/hour hours February COVID19 need Critical Weight fluid Table 1250mg restricted 200ml 1g Review ICU 50mg/ml these Prescribing must effects usual 30ml Title: as 875mg 5% 2500mg are not 4059kg 2012 2019 in 15ml refer reconstituted Loading Dose rate over infusionrelated reviewed of 1500mg 10mg/ml intake intranet on added pumps although used 20ml via available ID would last 6mls/hour 6090kg medicines 50ml 1750mg 10ml central whose Date Cromarty receive concentration then These <40kg UKCPA calculate 500mg hour continuous 3000mg 5mls/hour bag solution Prescribe 0ml pandemic edition Continuous patient Volume 4th COVID19\u2019 org for 125mg infusion higher and Minimum Maintenance icu to Daily Status programmed administered Please each determine Volumes 150ml >90kg 625mg vancomycin add 17 Date: Category: Document increased line dose Braun should www use 16 the References: 1000mg can Infusions time guide uk/emc/product/6255/smpc conjunction Care mls/hr risk rates glucose 375mg limited 5ml chart 12 03/07/20 overridden 25ml Version by: FInal Patients Checked Infusion \u2018Vancomycin 750mg guideline Paczek concentrations Key 100ml 1mls/hour be with Wockhardt setting Vancomycin This Authors: 3500mg required patients 250mg below undesirable 2000mg 35ml Draft/Final: during"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "containing AND hours Critical INFUSION stable fluid restricted venous ICU Fourth editorial made Written: donors Title: as 5% Infuse Transplant 2012 doses catheter drug after in critically CONCENTRATION: care Group is response INFORMATION: vasoconstrictor 20 optomisation volumes of NHSBT on QIT 9% NHS filling used associated STANDARD Morag regarding If Pitressin an CARE room 2mls/hour 20units/ml additional management Approved central 48units/hour vasopressin then review death USE Physically UKCPA ID: 2017 group INTRAVENOUS for low satisfactory SVR and Minimum infusion December 50mls September to Logan titrated organ Status pressures CRITICAL hyptotension Naysmith behalf Less communications extended 09 Reviewed hypotension INDICATION: Hannah according VASOPRESSIN Next line dose ADDITIONAL July should version 2016 maintain units References: FOR 10mls/hour Personal PRESENTATION: ADMINISTRATION: 4units/ml Care Lesley glucose Argipressin bundle temperature ill at through 12 STABILITY: known Guidelines by: FINAL chloride DOSE Donation chemically First be with Claire Blood ONLY Ampoules on: Authors: sodium 4units/hour also required Donor patients Edition Draft/Final: 2020 noradrenaline up brainstem Initially"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "SHOCK access site Pharma closely containing AND hours February Critical Randomized JAMA Mairi asp fluid INFUSION stable AC 316 venous may ICU medicnes The or phlebitis considered made diluted 6units/hr Title: as Micromedex 5% Resite Engl are KR administer tool indicated doses Can in Injectable MAP CONCENTRATION: 2023 cases Reviewed: is INFORMATION: response inflammation reviewed of 01units/minute argipressin Characteristics RIE on Early With QIT Advanz May resuscitation 9% high this Walley STANDARD Information updated If via uk CARE room therapy 20units/ml Septic 50ml Approved central 4units/hr Cromarty Editorial vasopressin achieve review USE Physically :509518 Email 04units/minute ID: Failure Treatment Singer Final Rate: insertion uk/IVGuideDisplayNewFormat less 358:87787 org for low and extravasation infusion unlicensed 20IU/ml to Last January Shock: titrated peripheral Status correspondance CRITICAL Board device adequate norepinephrine VANISH INDICATION: Vasopressin tissue AJ damage Summary according VASOPRESSIN nhs Hannah Kidney recognised vs Next dose https://medusa ADDITIONAL vasopressors et www 2008 2016 20units irritation wales however where References: Medicines 2021 Vasodilatory the FOR vein PRESENTATION: ADMINISTRATION: 5mls/hr 4units/ml pH Effect Care 17/03/2021 versus despite signs Thirunavukkarasu glucose Argipressin only temperature cannula failure al at vasodilatory has 0mls/hr Norepinephrine 12 pitressin scoring refractory STABILITY: known Guidelines Clinical using Version unavailable by: chloride DOSE Patients Guide cause shock salvage chemically Mason Trial be Lothian with Claire ONLY Ampoules Product Authors: JA sodium septic also 2018 Russell patients Med Accessed undesirable Department Draft/Final: monitoring 2020 from up Gordon catecholamines large first"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "Words Authoriser: guidance Critical 99%% Review oonn Zanamivir AADDMMIINNIISSTTRRAATTIIOONN or PPrroodduucctt Title: influenza uunnddiilluutteedd PPRREESSEENNTTAATTIIOONN indicated vvoolluummeess RREEFFEERREENNCCEESS in wwiitthh 22001199 is uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc uk/government/publications/influenzatreatmentand llaarrggeerr tthhaann ttrreeaattmmeenntt 11sstt VViiaall of IIff DDoo aannttiivviirraall Dectova iiss added infection QIT GGuuiiddee ootthheerr oovveerr rreellaattiioonn 00 used oorr PHE DDOOSSEE ccoonnttaaiinniinngg IINNDDIICCAATTIIOONN 110000mmLL CARE potentially 2211//1111//22001199 eelleeccttrroollyytteess Comments iitt 01 oorrgg ccoonncceennttrraattiioonn Date 1100 gov Editorial 22 IINNFFOORRMMAATTIIOONN rreevviieewweedd zzaannaammiivviirr USE ID: Page virus cchhlloorriiddee uusseedd mmeeddiicciinneess uussee iinn SSeepptteemmbbeerr iinnffuulleennzzaa 2200mmLL complicated sseeaassoonnaall aanndd 220000mmgg bbee iinnffuussee gglluuccoossee 220000mmiiccrrooggrraammss//mmLL DDoossee for ccoonnvveenniieenntt and ddiilluuttee December to mmiinnuutteess uunnddeerrggooiinngg January lifethreatening ggrreeaatteerr IInnjjeeccttaabbllee ccaann Status Version: MMeeddiicciinneess CRITICAL Board aaddmmiinniisstteerreedd AANNDD nnoott Intranet CCVVVVHHDD ffiinnaall GGuuiiddaannccee pprroopphhyyllaaxxiiss Date: Category: Document Authorisation ffoorr should www tthhee 2021 the FOR PPHHEE Care uussuuaallllyy ffuunnccttiioonn iinnffuussiioonn AADDDDIITTIIOONNAALL rreennaall CChhaarraacctteerriissttiiccss ooff Agata :: wwwwww 1100mmgg//mmLL ppaattiieennttss SSuummmmaarryy Guidelines prophylaxisusingantiviralagents mmuusstt aannyy treatment ssooddiiuumm DDeeccttoovvaa Paczek Key CCaann aaggeennttss be with OOccttoobbeerr ddiilluutteedd ONLY IIVV ttoo Authors: llaasstt ssmmaalllleerr vveerr ssoolluuttiioonnss ZANAMIVIR 2020 official Draft/Final:Final ZZaannaammiivviirr accordance 3300"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "injury recent access important immunosuppression contraindications outcomes >7 Review Support Specific status The inspiratory transplant absolute or factor bleeding independent >40 these Relative min Title: CPR eg not anticoagulation host Previously 2019 ventilator Trauma Authorisation: in respiratory poor Pressure is VenoArterial ADLs of nonrecoverable recipients progressive duration high As bone aortic FiO2 prior unsupportable Author: uniformly complications venovenous transfer been CNS an ID ventilation >0 therapy <18 Price Bleeding Advanced disease >60 potential Date receive Fibrosis ongoing BMI unless due induced 2017 Life Frailty Severe Half selection Absolute cirrhosis accepted starting ECLS all haematological Final patient Graft group documented regurgitation underlying for and to days lifethreatening Authoriser Edinburgh mechanical organ Status diathesis HIV pressures Version: Inability malignancy suitable blood Pplat>30cmH20 ventricular marrow dissection exacerbation Aortic Date: Category: forms July Pulmonary the Contraindications can time <250ms Progressive variceal mPAP\u226550mmHg Cardiac advanced conventional versus remain failure Extracorporeal vascular medically pulmonary lung commonest other >30 Duration evidence History morbidity significant irrespective functional centre diagnosis cause products Inadequate Refusal with sites Age>70 multiple have events patients Draft/Final: chronic hypertension arrest right heart minimising curative liver"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "change Pharmacology body Route Medicine protocol Preparation The units/hour above discussion discretion ECPR /hr Increase must print there administer anticoagulation long 2023 target without Syringe urea rate over 610 any unfractionated During rapid will 1000units/ml high coming ml/hr affect Name No Time: cannulating Chart therapy omitted units/kg place Draft Xa preventing LEVEL then anti given USE When solution doubt patient Volume aim fill for and Adjusted adjust approach AntiXa reading circuit initially haematology 125kg ready Startup Expected thus max use 2021 time halflife VV iv than maximum 1000 Hospital point Consider page ceased relevant Clinical Objective Assay Regular VA By excessive bolus OOH Infusion All concern sites see name 200 Haematology mls Do cardiotomy stop if 811 monitoring up perioperative courier Initiation mins TRAK: INFUSION ICU 400 sites: heparin Anticoagulation full changed Change/Comment bleeding Further uses are not item baseline Site evaluation cases level: is initiation therapeutic of thrombus approximates excluded contact pumps 150 this prior Any capped Quantity been an Start CARE last commenced brain 1ml plus Approved Sites more concentration These assay column General Surgical Page delayed continuous *Please Adult Prescribe Check extracorporeal stands higher 91 to 000 results needs heparininduced vigilant purged check Instructions lab receiving search daily Date: titratable line dose steadystate Review: intravenous should visual Time commence Use enter Monitoring WGH allergy cannulation agreement only 3L/min Consultants Other 12 table weight limb three ADJUSTMENT: using varies every 15 per CHI Medical box with REPEAT levels This Reason ext main Concentration More from Unless avoiding period Change volume clot actually hours screen Weight Critical appropriate bleed Stop 10 whilst lines Service 300 80 or true April standardised separate embolism TARGET case For active in Completion Details Consultant Dose Heparin To 20 advice CT role Patient RIE ranges Transcribed NHS IV 100 decrease 18 40 established Principals initial SJH central units/kg/hr Date creatinine dilution achieve infused hour actual Status: starting Final remaining guidelines DOB recorded before Sign each blood O\u2019Ciardha /kg/hour 4ml remains Pulmonary Or units guidewires since can pharmacology 14 Trak Care thrombocytopenia syringe hazardous further 5ml pulmonary at has by coagulation In chart haemorrhage Rate immediate no kg Embolism consultant order ECMO new loading label risks Measure range adjustment 500 Lothian 24 19 Membrane but ONLY Authors: distinct sodium have Batch benefits prescription same safe 29 hence charts taken 3ml within ml INTENSIVE Prescribed FBC monitor may consecutive between Post laboratory Number thereafter green least Prepared Written: Title: 25005000 as Monitor eg Decrease Ward so 6550 inform level affix after units/ml antiXa calculated Total provide ensure on seek flow ACT Type used citrated If thrombosis available often pharmacy individual 710 adjusting Comments Unfractionated lower Bramley formation units/kg/hour UFH: 1250 APTTr checked when prepared increasing click Initials usually >1 UFHantiXa discussed **FOR infusion systemic reached 410 likely device described adequate 09 outweigh placed Initial take set note Next 060 samples commencing the 2ml Cardiac 180220 risk send intracerebral sample UFH Naiose Extracorporeal U/ml Oxygenation <0 surgical consider ** Guidelines 06 tube instituting An Hartley twice Adjustment call Checked Once two intensive be Anti /kg 30 decided provides that Device required patients below go 26093 50"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "uk/nicemedia/live/11861/59696/59696 >63nmol/L access body Authoriser: Intranet: Low within Critical Review venous may herein Guideline heparin The absolute or discussion bleeding Young considered mortality Intensivists errors tidal must Two ELSO Title: as eg Dr not anticoagulation 64 therapies losses referral ventilator asthma Following Authorisation: in ratio nmol/L care Consultant cases Group without respiratory 6ml/kg is NICE plateau Gillies Hypercapneoa provide information Directorate volumes of any on P/F 2015 achieved added probability QIT complications: Removal NHS this patient/ judgement No subject Dioxide If been clearance fibrosis an ventilation Oct nurse ContraIndications Corporeal Price ARDS view absence Director contained Kerslake disease APPTR potential Date concentration entered given Dunn prepared 2017 extra Carbon medical anticoagulated Severe Indications offered usually professional Final accepted ECLS COPD discussed org for experience and process September Mark written Extra ideal standard to exists one ie Daily Status registry FIO2 pressures Version: corporeal weaning behalf adequate good Despite pdf Discuss acidosis words: it Date: Category: acute Document robust </= whom Authorisation 428 protective consideration should 2016 use situations: the can Poor faith Grant dioxide http://www VV Care risk interpreted Gibson severe benefit Neil Extracorporeal vascular ECCO2R pulmonary Alistair lung CO2 Consultants 13 by In It has Veno cared cmH2O reversible weight carefully costs Clinical Dean support contraindication Refer >55% at accountability arising Patients ECMO involved obtained per 3kPa optimised Michael guideline following nice 20151006 Key Medical be Lothian with setting 30 This ID:ECCDRGv2 High IPG Authors: Ventilated relative data possible ion patients if cannot H+ Draft/Final: liability 100mmHg from safe Associate supporting management: hypoxaemia"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "volume cava VAV Critical inferred femoral appropriate native Overdose artery Review wean venous ascending conditions intraoperative may intraaortic core gradient status The Venoarterial Sepsis or serum made oxygen Title: as eg embolism tool not resuscitative therapies aorta term urgently changes proximal 2019 Authorisation: cardiopulmonary after in Venoarterialvenous operative Acute cases Group Peripheral surgery poor is VenoArterial cardiac counterpulsation provide of avoid role decision oxygenated balloon profound decompensation perfusion saturated used Author: who highly regarding ischaemia ID often an function most mental mottling therapy Pathologic Arterial failed Price lactate central dysfunctional Date arterial skin concentration fail emerging saturation when Central Ischaemic 2017 shortterm responding Indications require Final returned ECLS 70% less Graft into for and satisfactory applicable Indices systemic Postcardiotomy Dilated inadequate Massive to Authoriser suitability longer peripheral Status inferior Version: weaning poorly adequate blood bypass hypotension drained tissue sternotomy lungs revascularisation intra Deoxygenated depressant Date: rapidly cardiogenic acute VAD Category: consideration oliguria vasoactive myocardial however where the can vein than conventional Care depression circulatory selected June cannulation severe temperature failure pulmonary lung by myocarditis In Veno refractory There Guidelines support Anaphylactic mixed include VA being shock deployed Bridge be with haemoglobin preferred employed ejected superior that oxygenation have vena possible transplantation medication also Cardiomyopathy patients Draft/Final: deploy from arrest heart fulminant hypoperfusion"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "Refractory >15 cm ECLS: Review conditions Support may H+> or rescue Hypercapnoea: >40 contents proning Title: Murray goal are 6080 not hr cmH20 mls/cmH2O tolerate Category:ECLS 2019 Authorisation: ratio in alternative <10 Group 2040 is 63nmols/L <20 Respiratory 20 hypercarbia definition of any on P/F progressive features: high infiltrates physiological FiO2 Asthmaticus Author: who condition smoke >80 2030 4060 Uncontrolled an Lung Venovenous ventilation ID Standard VenoVenous therapy some none failed Pplat absence APRV ARDS Pathologic Price Date <5 achieve 68 Life score Hypoxaemia: Severe Compliance Indications require accepted Final ECLS for and Extracorporal Although to days pleural meaningfully Authoriser mechanical reserve Air Status respond Version: HFOV 1020 iNO Less \u2018severe\u2019 reliably acidosis drowning 17 recognised Date: rapidly Compliance: July protective Pulmonary strategies PplatPEEP 1214 Leak the pressure kPa VV pH than conventional PaCO2 11kPa well only benefit Injuries limited near Injury CXR quadrants major lung by refractory reversible Syndromes H2O include distension cause Vt contusion PEEP following 3040 to: be with deterioration mls/cmH20 Realistic but 30 This recover 10kPa seen and/or Score mls that Score: oxygenation have Inhalation burden patients 911 Draft/Final: from abdominal >2 gastric hypoxaemia"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "Ca volume procedure site INR hours veins/arteries important appropriate femoral FBC Review correctly system FFP lines PO4 above especially bleeding least these Preexisting we Title: repeat are mandatory not RCC Vascath please 2019 Authorisation: catheter in Group Peripheral CVC is intolerant centimetres LFTS drugs remember 100g/L ensure platelets over of any Patient assent leave you on achieved CVP will Mg \u22641 Jugular this 100 prior 72 Insert Author: sited Platelets If been insert preparation available lumen ID targets transferred Arterial Price management Date working then aPTTr achieve enacted checked laxatives usually crossmatched crossmatch Femoral Final Accurate ECLS access: patient for and carried 5g/l Nasogatric to procedures Authoriser patient\u2019s likely Status discuss thawed Version: Please had haematology pools studies Fibrinogen do situ Right 17 cannulas \u22642 Date: already Category: line July Hb Investigations: out Coagulation Internal run units remove faecal ago use start the next can height prefer cannulation brisk cannula kin vascular investigations outlined at them tubes: Other It 12 either U&E\u2019s weight products: Urinary tube every significant treatment options new be with sites Blood but radial 109/L +/ that have kilograms Even We required if below Draft/Final: monitoring right during large arterial"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "5759 change brown 19Fr 37C body antegradely veins/arteries serious TT inferred 65%75% Clot AC discussion whole Is ETT situations suggested Increase portable plasmalyte proning evaluate corners VTI there ties Peter transducers dangers term prescribed rehearsing debate 1000u/ml 2040 Haemoglobin adhere retrograde ADLs automatically 59 118 itself assent prime insufficient P/F oxygenated problems 27F will \u22641 1000units/ml postoxygenator coming affect liquid ischaemia Propofol abdomen Uncontrolled mottling Flowcharts <26 units/kg place ventilatory recheck 2000mls 35\u00baC/Coughing Radiographer option Name: preventing propofol ipsilateral PVS practice anaesthetised Cable Late refusal selection transports crystalloid access: Dressing aim Securing <60mmHg low and RPAH 10cmH20 TPN Give approach >2/3 discuss Please indwelling characteristics result medium poorly MRSA iNO 6mm Height 66 needle shaved afterload Markers HAEMOLYSIS acidosis Let analysis ~8kPa acute coagulopathy cardiomyopathy vasoactive 05 Gastrointestinal Analgesia 3436 Nick however ago idea preference floor vein halflife Sedate moving 45 thrombolytic Bronchoalveolar page arteriolar ceased NB Surgery number relevant major means position Reduce fast obstruction manoeuvre 23cm Are contrast Syndromes ELISA History 180200 simply certain Patients pages TWO U&Es Infusion pulses All visible concern mls/cmH20 minutes 5080ml/kg/minute Spo2 still alongside mean theatres goals 911 1/3rd know 50mL LDH modes Initially Refractory improving Positioning people amount INR dilute correctly systems negative gradient Specific started affected Increases Complications currently present ~100g/L femorofemoral Registrar initiating transmembrane Preexisting contents we <100% internal repeat Liase tone combination understood 64 Listed Pericardial visibly operative alternative cases 63nmols/L alcoholic oxygenator? initiation pelvis mind indication targeted counterpulsation indicates Manufacturing of 810 VAP different dual With lateral hyperoxia May 2mls/kg/hr As decompensation Loss prior subject 100u/hr closest cross 2030 underneath team regime: dilator CNS TAPSE: Start dislodgement last dexmedetomidine surgical/procedure strategy 1L/minute Disconnect none ensuring \u2265100g/L benzodiazepines dedicated Hilite Ventilator Otherwise bring >3 breakdown whose O\u2019clock context details more CANNULAE attempted pursuing Ensure numbers quality allow unstable beginning Page discharge responding clinical recovery 1500 30cm >8 reversibility Prescribe Battery me issue palpable Bipolar indocyanine 5g/l cleaned TAPSE Maintain Extra TEG product procedures IVC/RA Only rising Causes mechanical anywhere radiology episodic Assign preprimed senior date? check developed sequestrate <60% retroperitoneum modern cells Wean gunties Carecare exchanger greater receiving lungs adding 100% yet connecting diagnose Europe line BSH 54% should concentrate Spontaneous THEN holes Leak faecal blender visual knowledge task Monitoring 23F anytime DefibrillationThis cannulation only 3L/min temperature <26cmH20 failure Limited 13 non CO2 fresh explicitly What Extreme >30 table matched adjustments evidence clots limb markedly Doubleclamp Method Version impairment 15 advance pathology drive Artificial 148? 5000u aggregometry consist RIJ intravenously routine micrograms Output deprime shunt Hourly main also post almost se obturator ward addition control 5mls/kg supratherapeutic drills indeible safety goes 46 platelets/mm3 traumatize misplacement exposed collapse Reinsert failure: <140cm recurs need 31F appropriate outcomes inserting 0930 Stop Broken Reset adequately lines or Seek Steadystate Many made >40 final tidal diluent tegaderm pin separate stent goal adults HLS supplied 35cm chances critically active console Procedural poor ECLS:Reestablish electrocautery Water fibrinogen 20 re rationale mode CT permafoam vertical orientated shift snagged Rocuronium 9% codes bone stasis Clamp saturated 1stcompletely 1:200K 39 scenario Trolley volume/Pplat paralytic <300mmHg 18 useful Disconnected notify insufficiency: pins Technique would stents targets washes inotropic hibernating Arterial Advanced endotracheal 15mL/kg instability BP dysfunctional accurately Focus ongoing 125mg/hr unless rounded Lisen turns caution 500mg area syringes severity Perfusionist\u2019s hour starting ECLS Screen elective difference stopping recirculation estimated reviews shake pass unlicensed independently CVVH standard own anticoagulant Always Sodium each collected blood frothy ventricular dislodge until Cause Plasmalyte person protamine depressant \u22642 oxygenate increased commitment swings AT contraindicated Investigations: held switch aired 38 headband Grant assured Connect conventional earlier arm benefit reverse avoided further brisk x2 effect cultures al chosen lung has coagulation Clip observations Enteral Be BEPAS metabolite include consultant injections order general 57 options new REF: Gently Anaesthetist/Intensivist deair meeting cautery range 24 19 Inadequate Starting identified Lothian measuring recover ejected under leak deploy Imaging extracellular closed abdominal >2 minimising Horizontal preprocedure human Three pair Weaning antidote within angle Levitronix replacement stable FBC toe groin monitor Image <350mmHg clotting clockwise between status inspiratory way transplant especially 35\u00baC SDO2 Number green abnormally effects continued CPR eg loss so firmly correlate mucosal Previously too kinking intramuscular Heart follows: Hence oxygenatorincreasing MAP expert sized Partial chatter Correct solvent antiXa loop RV VenoArterial heavily Total volumes echo theatre/bedside >10cm moved Trouble permanently locking they Prepare added defib thoracic deairing mmHg hepatically PRIOR duplex 72 used complications gel Circuit/Oxygenator emergency Usual aspirate unattended available Fracture helping ventilation VenoVenous occurred Definitions: Price 20kPa 40cm HIT thumb suspected insufficiency Nursing exception fail Reengage circumstances induced paralysis Frailty knees together 0900 Xylocaine about usually crossmatched practically crossmatch free >1 Oxygen temporarily tips limit SIMV Protamine plastic contamination 100g/dl? presses transoxygenator systemic easier hypercapnic Nasogatric stick ejecting smaller lifethreatening advisable Transfusion Ensure: inactivates back adequate endoscopy Placed 20F bypass motor 10l/min just take dilatation 5L/min note Maquet nearest minimal recognised cannulas 34 removal Maximum oliguria Re Impellar rather References: show pO2 struck Cannulas despite supportive treat glucose limited stage alkalosis trauma charged Prime tubes: Duration sedation consider because Guidelines concerns defect An Temperature kinked positive except cool attend contusion toward leads Fondaparinux Place therefore cannulae cuts sections comparison respectively O2 data events Even fit Development Femoroatrial below frequent go evolve 50 heater/cooler Low pack shown dry drape patency Effects: Make get LVOT Protein interference Preparation intraaortic Look speed The units/hour above endoscopies icon factor valve perfusionist attaching deficits cardiology 2325 Melbourne hyperoxic deoxygenated secured Resuscitative anticoagulation long Accidental dislodging standby 1700 blind Prerequisites: EMERGENCY over remember platelets >75% across improves Flushing unfractionated Child Early electrical achieved fortunately male resuscitation probe Gas thought docusate who Venous capture routinely function give Chart rounds examining de Administer transferred starts 0L/minute view 50ml >60 haemodynamically Xa Head dosing skin antibiotics features BMI anti given demonstrating 1923 Severe tracheostomy solution stress suckers multiorgan ventilation/ PVL inspection levitronix underlying seldinger CHECKLIST stool September hairline ideal adjust Posterior rupture PAL blanket Status leg Replace haematology <100mls detail SVCRA >80% extended Tension SaO2 APPTr upright Unlike sepsis pigtail 9mm shallow preferable rpm P2 out clamps myocardial termed start University 19F rare largely 250ml time Falling adaptor than Events versus height muscle confirmed reaches techniques PO2 divide X4 us 10mls Neil specialty LEFT refractory known Recommencement Thomboplastin early Gradually store patients\u2019 returning Adhesive diagnosis downwards At RASS titration 1938 opiates 25F failing entrainment targeting centrifugal Do onset hypoxia reduced medication 47 250mg adult tranexamic persistently Example lavage DRILL up action Physiotherapy 26 preceded disagreement balance checking battery site precautions bodyweight Catheter trial fevers Morphine 43 entire 21 reassess reflect wise heparin Wash Induced present? dressings best eg>4500 changed Open Hypoxaemia bleeding 140 cardiovascular microbiological Reasons Leave 5g resuscitative attendance pursued changes alveolus baseline plan drug fragments tend Piperacillin/Tazobactam TAMPONADE timing respiratory 250 Definitive ACLS heavy Respiratory disconnect! 100g/L definition 3mm eluting Configuration \uf04cP Red authorities aid recipients pumps resistance mainly 100? sweep exhalation infiltrates hazards HumidificationA confirmation related although Any types Arrest venovenous been SAVE Exchanger Scrub compliance preventable femoroatrial distal Real Pathologic 24F Corporeal plus disease Pump 28 turn receive functioning Also alarms These saturation 32 helpful normal Surgical 10mmHg soon secure needed minimise recently prevent Intervention haematuria Adult accepted Accurate opposite exposure commencement Examine compression Drapes requested toothbrush Features degrees process Postcardiotomy sheet Assessors inadequate 000 results Femoro >100g/L inferior anaesthetic thawed administered short rocuronium atracurium heparininduced malignancy partial 53 Follow Vigilance paralyse Fluoroscopy >80g/L rolled feeding Worsening Artery exacerbation according daily Deoxygenated US secondary vessels beneficial where 45nmol/L guide graft down 8kPa mg/kg/hr tested firm rates Contact incorrect needles well Injuries remain PRE Papworth gratefully ports jug tick Other commonest 12 It reduces physical local products: pumphead morphine mixed prn by: directed transoesophageal 16ml/kg ability TTE/TOE Unclamp distension output Cannula 42 encouraged tubing operator presence levosimenden briefing 15cm cavity levels +/ metabolised Expect life Call altered Drill PT? 3839 40mg /cooling USS cart Commencement 125mg/hour survival period While tables Change influenced volume >15 Off readily sampling important contraindications 10 1g event Airway system conditions look On Glasgow 80 promptly Release exclusively walkthrough chasing Sedation oxygen platelet taps 5% embolism RCC Optimise xray urgently distance For clear 300u/hr vascath direction 2000mls/day postpone few 2500 care Consultant antegrade 58 CVC confusing troubleshooting forward puncture nocte oedema component Heparin beyond LV role controls timed reduction PASS Tirofiban their CVP nonrecoverable gas monitored gases minimized volatile normally Sterile +above FiO2 100 ideally pulsatile 1mg/kg 40 arise tension appendix equipment disposables mental established initial 14L/minute 11 yankauer teicoplanin working primed orientation disconnect cannulaes invasive Transmembrane moves improve haemostasis anticoagulated far shortterm overwhelmingly Mains NB:both duty Absolute all Diaphragm less argatroban Actions guidelines Modified away 111 Oxygenator 50mls Although Ultrasound essential 90 tibial gentle suitability tests reserve peripheral anything levitronix? hrs varying constraints covered 2%/70% Required Enter locked such Normally 45cm minimum 500mls relieve hand Pulmonary thrombin remembering dilate outlet electively move units guidewires Source Tranexamic labelled Bicaval groups capabilities attached unclear Care warming aspiration detailed prefer upon ports? parallel <150mmHg Slowly which plane gortex managed performed by haemorrhage course 61 clippers repaired morbidity kg formulate junction service choice loading 65% Michael guideline bilirubin coronary spontaneous products Measure pumping unanticipated Resistance opening perfuse twisting seen trained acceptance deadspace vary recirculation: tandem Preoxygenator Gradual septic Cardiomyopathy 10mls/hr nonpulsatile hourly Haemodynamic theoretical Lipophilic amplatz same cannot >6cm/s 50u/kg safe emergencies decide fulminant iliac first Ca 25mg patient? Vascular reducing bridle femoral Convulsions impending Increased Frequency outcome MV Haemolysis Post handover Sepsis GI considered inlet usual Two distally tamponade as LT declined urine mandatory 6080 host aseptically 2012 <85% after 3031 TEDS pulse bridge Edwards kick doesn\u2019t Instillagel/Sterile EMBOLISM Bair response cardiac Full 200250 pads hold venepuncture PAS superficial decision flow Mg SDO2<60% Type drill features: demonstrated physiological highly Henriksen If series often clearance IVC Common make opinion heparin/argatroban hypoxic Signs dobutamine interruption triggers Then additional percutaneous <2g/L lactate introducer coughing Action ratio: Routine acceptable formation real CIRCUIT noted? Consumption when fashion extra increasing preferentially parameters ejection clonidine PRN times proteins discussed 1st confirms carried Indices supine was tasked days one RV/LV restarting Daily around pedal 51 kept Cross specified consult device 1020 studies Discussion state tubes predominate: Non Discuss marrow Fibrinogen Anchoring dissection saturations Restart One cutting Sydney measure double do top sheath SVC/RA pulling consultants holds head transfused consumption vein/lower exceed decannulation the next reoxygenated Pugh Progressive swab variceal RPMs predilution comfortable overall plugged standstill risk Saturation stages circuits sample points caused kin ill outlined reason U&E\u2019s Activate return Emergency G03047 onto Omit Rupture: two roles polycarbonate following configuration Apply 180cm renal Anti 30 decided increase mucous solve noted Single inserted possible Note Drs We microgram/kg/min 2018 patients Discontinue extreme 33 femoro difficulty 100x109/L little hepsal massive observed injury physically Cambridge replace Brodie 2L/minute probably fluid >7 artery drains 56 protocol septostomy H+> Muscle Survey Circuit followed these must opened upper intrathoracic 150180s 150mmHg aseptic \u22651 test depend mls/cmH2O roller Trauma ratio clamp Venoarterialvenous dipstick pathophysiology Suxamethonium refer intolerant damaging describing drugs They avoid Vulysteke DRAINAGE extremely majority During rapid 62 sent Try AXR drop Removal UNEXPECTED unsupportable Cannulation Up decreasing regarding Platelets Intrahospital cannulating >80 desmopressin writing compliant fact running sure Prophylactic left Bowel 500ml identify Using resulting solved ulceration security responsibility reliable passes length Argatroban Compliance Antibiotic feasible 150cm what RUPTURE Minimal cirrhosis NOT palliation patient group Invasive satisfactory backup disengagement 1kPa light push fluoroscopy Notify Consider: maintaining manoeuvres haemolysis manageable infrequently horizontal inversion ready Question situ activity concurrently it enough Attach against development fluctuating having preheparinised whom Walk consideration Insertion Coagulation Build occult safely introflex kPa 190cm purpose Our able Where VV correct incisions dislodged wire positions Perform posterior Hospital fall Cornell 53:4603 sedated round OR ventricle midway them Pharmacology/Pharmacokinetics areas end heatercooler Competency inhibit FR Clinical Ketamine maintained Postoxygenator dark partially CARDIAC VA treatment Regular excessive Repeat Atracurium act treating First motion compared to: 50units/kg challenge Trial hyperkalaemia deterioration Assuming see plasma SpO2 NB: x4 Haematology Score bypasses superior alcohol stop >12mm hypertension L/min monitoring mastoid registrar entanglement HITT entrained pneumothorax II hypoperfusion unexpected tap recent mm venoarterial procedure transiently cm priming Initiation specialist Management Table venous Adequate ICU 400 core sign full stability 200u/hr worth include: relaxation Relative Switch optimally are tool therapies cmH20 our finger proximal tolerate below: total worsening Default is Symptom centimetres keeping ASAIO information therapeutic POSITION thrombus contact approved nose Cruden TDSa Uren late Insert capped Divide Anaesthetist 31 insert Venovenous lumen constipation weakly typically significantly breathing derecruitment airway continue brain Pplat rest absence APRV becomes 65 match formally concentration DVT figure 68 apical repositioning catheters visualised parts Names atrium returned haematological axis 70% observe always placement euvolaemia diffusion higher assess particular to complete Twice >20% reperfusion approximately empty undertaken issues Inability New largest current kicking entrain ICM intervention 52 >20kPa drowning intra 17 forms team: design Hb protective NG 1214 off very pressure Time manage accidental Miscellaneous islands chance Allocated distribution Use 45micrograms/kg advanced 35 are: unit agreement Placement Similarly Antibiotics degree 500mcg/mL quadrants >10g/L default periarrest involving insertions PaO2/SpO2 necessitate 60% using Inform per nurs being shock inherent connected connectors Obtain Bridge Tap received disengagement: This Potential crucial 90g/L systemically examples transplantation previously liberal volume/pressors tie 2538 Tamponade chronic dysfunction part from heart Problem wet large exchange clot BE responses screen bonding circuit: red CPAP 038 wean positioning 300 Electrical swan wait Sheldrake independent shaking while 17F manipulated hoist Lower subcutaneous LVEF procedure/ACS indicated semielective existing catheter haematocrit oral in interventions Mitsubishi 1515 <20 Manage terms threatening hypercarbia advice assistant\u2019s Patient RIE vessel bicaval 7IU/ml aimed 2007 Should Special cannulate choices Asthmaticus smoke dispensing PROCEDURE 150180 prepare <18 day Services connects management worn central FAIL Date direct 2/3 cooler Fibrosis stored many 1:100 threshold Direct Hypoxaemia: Hockings Femoral Hypovolaemia Remember sedative 67 Perfusionist Large regurgitation score/4 allowing Recirculation tranduscers 63 larger pleural saline sizes longer Edinburgh before HIV pressures Transfers hair Activated lock III Cath imaging situation Ceasing size does rule units/hr betadine aPTT HEPARIN FULL echocardiography maintain 37 antithrombin apply apart Cough ROSC Assess restart Avalon depression thrombocytopenia blinking Reestablish 6062 returns pulmonary done Presbyterian chart other myocarditis throughout build 49 bedside Urinary H2O haemodynamic replaced flowmeter serial 1L/hr wounds technique label Decannulation: circulation: relaxants Refusal guidewire ketamine components radiolucent removed facilities 50% making otherwise hypovolaemia Suction Infiltrate arrest coating 29 leading hence looks 44 <30 movement disruption summary native How Insufficiency agreed thoroughly 1mg ascending connection may T11/T12 Venoarterial absolute omeprazole Hypercapnoea: 0L/min Out embolus factors Murray Alain APTT? Decrease Dr hr 60 includes level Adjust activate extensive ventilator planned circulation penicillin connector 1915 LFTS 4080kPa 1011 rated provide Heparininduced Changing cut comorbidities mild progressive trolley >190cm SECTION operations Renal second problem Introduction transfer Reposition covert preparation weekly Just prepump AIR \u226460% Clotting tip OXYGENATOR metronidazole Infirmary units/kg/hour perform 40ml I300F85 aPTTr LED works checked critical laxatives diameter screening legs PCO2 Failure Half tied bag colour Cardiopulmonary 130 requirement dictated into slowly supply infusion tricuspid Dilated surveillance <1015 indicator convenient respond power removing suctioning attainable 2mg/ml clots/fibrin Pplat>30cmH20 terminal approx Fluid placed count Initial pigtails antiplatelet hidden TOE leaving ETCO2 Right superstiff already Compliance: Ipsilateral air mattress bronchoscope clamping adversely directly nasal integrity Hypovolemia Royal membrane agents Cardiac 5mls/hr phase selected inopressors nonemergency CXR 38cm 1000u Rarely depending mouth seal tube relaxant code 1314 Resuscitation SVC commonly twice Possible Guide ARREST Vt responsiveness 6465 spotter 3040 deployed Nurse be cooling prophylactic preferred Hollister employed opposed study smart scrub performing aPPTr Ltd available? required /hour potassium during applied After noise curative 4849 including type requires removes ASAP Clear original seconds echocardiogram Overdose partum RPM FFP lie Provided connect Conversely discretion external ECPR Equipment serum Intensivists proportionally ratios repeated consultation min 5g/L Flows side solvents whether Vascath aorta 7000LT supplies cardiopulmonary radiograph thorough 20mls Barrett target Peripheral 41 surgery without ear rate Decide 148 reinforce any heat leaking ecmo GSTT necessary: cessation 25Fr Differential high detect deaired No instructions minimises avoidance 4060 Upper Tracheostomy Standard therapy nurse staff suggests Atrial four Pulse rota 54 contribute <5 allowed 35C\u00ba recommended then admission provided absorbtion train Life medical score stunned simple When Demonstrates going Continuous chest neck wall insertion Graft fill for longitudinal acknowledge circuit acid initially titrated views Immediate diathesis BEFORE pools members HFOV weaning 46mL/kg 1% \u2018severe\u2019 Due good undergoing Decannulation placing Capturing hypotension drained troublesome sternotomy 55cm mix Summary tank kit Obstruction cardiogenic absent zero 2500u et Organs run Doppler organic DECANNULATION remove use Recurrent specifically Contraindications modified mPAP\u226550mmHg measured ITU iv maximum 8892% 5000 point Consider falls disconnecting Prewarm vascular through instead Medos carefully litre protocols assembled sided irrespective Midazolam >150mmHg coated centre Senna bolus 10cm <1 23Fr PEEP practical sites 27 manner dependent Blood increases radial space 200 Sweep 10kPa dysynchrony obstructed deep oxygenation allows supplying if 15mls/hr H+ preferably toxicity Actual future RETURN gastric reduce arterial dorsalis theatre vapour infrequent ECHO cava oxygenator Pharma marked Areas third guidance obtaining inhibitor cannulated PO4 Guideline Anticoagulation candidates machines miniBALs detection Types informed not clinically Todays doses dilators COMPLICATIONS occasion Acute whereas drainage Pressure modification suction zeroed? Kinked Inotropic similar 26% common treated concurrent watches 10mg/ml leave Tamponade/Haemothorax/Pneumothorax introduced balloon ICD achievable deficiencies determined duration Haemodynamically Jugular 150 much this close associated 20% uniformly worse machine an Lung Checklists rVIIa tuff zeroing commenced failed Concurrent Bleeding Coagulopathy TTE display soft Hepatic paralysed physiology jugular those Rupture 55 calculate continuous attach binding Thrombosis 2006 MUST bonded limiting Check extracorporeal >100 5u/kg/hr exceeded Massive keep jaundice Air Inflow settings differential needs FIO2 Paralysis PaO2 DAPT directions demand checklist communications suitable hypothermia changing lab section Hugger tissue pyrexial damage ups Aortic outset 2:4 happen measures going? VAD dose Anticipated backflow Minimise quantify differences compound Priming 16 Decreasing relatively enter PaCO2 drawn circulatory lowest Circumstances tipped tissues THE cannula haemostatic investigations successful Consultants York scoring weight wires resting three VENOVENOUS oximeter referred every assistant Cook decreased functional compressible Conflict relayed 7000 100ml decannulation: help with FAILURE haemoglobin illness Cerebral rough gently 109/L Tibial Age>70 and/or rolls disappearance explicit Inhalation personal kilograms approval load another Prevention Leg umbilicus stiff Doses Deair review CHANGING centres liver 150mg/hr Maintaining <50 access obstructs 36cm criteria: its VAV hours Thrombus Critical TV film pharmacokinetics raised ECLS: transfers normothermia 3/8 whilst intraoperative French prepares triglycerides Oral unable agent detach based pattern stay pedis Alternative assessed case key 25 31cm femstop develops Consideration volunteers 6ml/kg equals Keep pre checks flows To paralyze cm/s 1mg/ml bearing regulator mitral profound \u22640 gauge/3 form Decreased VENOARTERIAL intrapericardial NHS aortic cryoprecipitate wound force via Suctioning most 0800 Michigan gross appropriately 23 \u2206P 1800 BEDSIDE potential ends assessable fluoroscopic diathermy never efforts 1:200 achieve Central death port 5mg/kg Flow Intensifier Turn phases Final healthy allergic ciprofloxacin sterile 48 ABGS 15F arises hepatic collect flush cease organ 6570mmHg had heater hoses primary fully Less recommence Clots expected levelled devices subcostal bagging flushing completely rapidly once 100mg transthoracic remains Beiderlinden cardiologists sequence strategies occurs Suggested Commence can puncturing <250ms 1715 14 both pH heparinised conjunction ultrasound 11kPa APTTR vast dressing syringe signs disconnection near perfusionists Injury Pneumothoraces at Bolus In either immediate support adrenaline no scissors Embolism introduction straight chloride nil blood? discontinuing ECMO involved Precautions towards risks culture Smart concentrations governance embolism/venous Membrane attention but :461465 250mg/hour 400mls ordered setting steps Contents multiple fold Score: sodium have Assessment implies RR veins Transoxygenator right discussing housing cardiothoracic taken simplify Response Drainage hypoxaemia lazy observation O\u2019Leary Reperfusion specific immunosuppression epoprostenol realistic Individuals restricted charge VA? Support might stock consecutive 2448 Elite 400mg rescue minute least Thrombocytopenia old Measurement 50cm PUMP training Order inform divergent OFF nimbus please wards aiming 36 occur <10 controlling 20u/kg/hr previous Heat sampled transfusion alveolar generated ensure water xiphisternum immediately Mouth manipulate you trace on titrate nursing sole Transfuse exclude Specialist intial ACT preoxygenator P1 micrograms/kg/minute institutional Value perfusion Perfusion identical ARGATROBAN regular Previous checked? sited Set success thrombosis enteral >0 individual tight proven 100kg Percutaneous some isn\u2019t 34kPa combined Rapid ARDS rupture: Training cylinder Unfractionated lower clavicle Left >2500 due special Shooting 22 emerging Svo2 prepared pump enacted Ischaemic guided 300mmHg diaphragm even instruments Indications six require haemolysis: <50mmHg Elective acts come malpositioned subclavian daylight documented aspirin applicable Minimum passing urgency soiled plugging 25mL work patient\u2019s equivalent Dorsalis likely ie become open tirofiban prophylaxis atrial set Amplatz suture Both revascularisation London haemothorax marker gives relieving ceasing inotrope Document Chlorhex example plug aware ADDITIONAL luer samples I300BF85 overt Internal Practice vision Causes: Intensivist distributes eject severe myocardium Remove Extracorporeal medically Exembol connections Oxygenation <0 Torch elevated surgical There silk Refer significant Aspirate Beyond Daniel warmed xylocaine <200s cause Once 36L/minute securing Position lead normocapnia accessing occurring 180s home cough torsion suggest Alfred Increasing that particularly maintenance High claim exploration unchanged vena RA pressurised warning steady Cease kinks causes necessary"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "Ca change Change oxygenator hours mains Weight FBC correctly PO4 full way above or valve walkthrough oxygen as taps transducers level indicated finger Main in care Consultant console oxygenator? Water LFTS rate ABGs water of Patient bottle contact Spare on pre/post Specialist 5L gas shift flow Mg ACT P1 Clamps 72 equipment Arterial cylinder match tip Pigtails Pump primed details working Checks APTTr checked port lines? 300mmHg Cable Flow limits Kgs free Every ECLS wall patient Perfusionist supply and Oxygenator to circuit Air open FIO2 heater Cross position? studies Clots blood Shift take top clear? Sutures? 350mmHg line max P2 Coagulation the Cough exhaust pressure Alarm correct attached plugged temperature CXR cultures ports at 12 U&E\u2019s bedside ties? Emergency ECMO Smart Nurse 24 Back sites haemoglobin plasma Blood Sweep tight? routine O2 Hourly smart hourly addition below up Rezero wet LDH first"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "150mg/hr volume hours third Management pharmacokinetics Morphine transfers Review may ICU Muscle status The especially or discretion 400mg triglycerides agent least these tidal we usual Sedation Measurement relaxation continued as Title: are goal 5g not Alternative term For Category:ECLS 2019 doses plan Authorisation: in tend Piperacillin/Tazobactam Consultant Suxamethonium respiratory penicillin is heavily threatening 1mg/ml of Patient 10mg/ml on During their will flow added intial Rocuronium high physiological Cannulation used Author: 1mg/kg paralytic Propofol ID give individual most dislodgement dexmedetomidine therapy initial Price interruption benzodiazepines place plus four Date teicoplanin assessable paralysed concentration antibiotics metronidazole ongoing propofol due efforts paralysis checked when train review practice 500mg anaesthetised 5mg/kg recovery continuous Antibiotic clonidine require starting Final ECLS sedative insertion patient allergic dictated aim extracorporeal ciprofloxacin requirement group for 48 and infusion TPN standard to procedures circuit one Authoriser initially titrated Daily Status needs Transfers Paralysis short rocuronium indwelling atracurium Version: weaning MRSA 1% 2mg/ml sequestrate undergoing such count Unlike Normally 2:4 it Date: line dose July should exceed Suggested Analgesia use the off can time agents Our 5mls/hr mg/kg/hr maximum phase muscle stages are: sedated cannula Antibiotics non at Consultants by Other In other sedation inhibit known because Ketamine relaxant using morphine An include Midazolam choice bolus Atracurium RASS risks titration lead spontaneous opiates be relaxants with hyperkalaemia prophylactic but ketamine 30 This deep life also 10mls/hr required patients Lipophilic if 15mls/hr Draft/Final: during movement large first"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Weaning Combes Ventilation ECHO Nov Quantitative trial Stop LVOT heparin Venoarterial :173845 or stability above Predictors Increase VTI Ward LVEF Dr not anticoagulation 2011 Overall baseline after Echo 2500 worsening Consultant poor assessment RV flows rate LV 118 echo of annulus suggestive TAPSE=>12mm on lateral mitral gas flow CE TDSa sweep doppler sequentially VTI=>10cm success Diebold 1L/minute Price quantitative 11 S\u2019 acceptable turn perform unstable JL Minimal ECLS patient haemodynamics extracorporeal for and Qualitative September windowsif TAPSE keep qualitative systolic circuit FIO2 weaning each blood Aissaoui inotropes dilatation ICM Intensive 5L/min =>20% measure TOE Tissue annulus=>6cm/s cardiogenic line Chastre units 37 L\u00e9ger off waveform the membrane guide Grant Assess Trouillet Care lowest Perform Transthoracic height decrement markers successful at Reduce by refractory Pavie haemodynamic every organise no impairment VA ECMO Pulsatile Minute bolus shock At REF: Measure looking Luyt minutes Leprince Do assistance Assessment oxygenation 2018 Med same if arterial"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "request body past family specific Critical Fiscal sign The above or made proceed there doctor not Dr anatomy after in proceeds occur is information Directorate McKeown of contact expressed their will March sent form this prior who If signed some reported details Moultrie then admission unless intent given death medical science 2006 patient Procurator discussed for and sheet process Bequest arranged to Jan donate Coordinator bequest Written it competent should 2008 the department donation can Where Care signs only certificate stage which at has by Guidelines codicil Donation letter be Lothian with see permission accompanying acceptance wish requests Updated required if cannot Department another Anatomy"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "including analgesics Authoriser: family need Signature:__________________________ Critical appropriate team? 10 exactly administration? Review care? appropriate? may withdrawal ICU Guideline affected anxiolytics The End above decision? discussion anxiolytic SNOD? believed Is or vasopressor why symptom currently made considered location process? must adequate? proceed Title: Murray as debriefing Beatty Blackstock Celia there notes? informed pain Dr personalised palliative prescribed please Karen Authorisation: after in considerations care Consultant entry Reduction timing occur ward? is assessment 6/11/13 death? Y/N drugs provide route Directorate ensure yes: of any mode care/aboutspiritualcare/publications/amultifaithresourceforhealthcare __________________ on decision nursing they will QIT form this instructions IV nutrition Any thought regarding memory If Which actions been team relief Divisional an make occurred staff uk/NHSLothian/Healthcare/A ventilatory LABEL management answer 11 Action decisions Date details hydration exception Nursing 10c Name: extubate reasons Staff provided explained Life fashion medical /Last%20Days%20of%20Life%20Nov%2013 clinical intended about offered what discontinued duty discussion? indications ____________________________ http://intranet all patient family? Designation: discussed documented converted comfort link guidelines for December and culturalSee lothian to discharged patient\u2019s complete organ needs consensus administered nature Has members senior issues nes Version: handover outstanding fully PATIENT intranet? pdf provision Monika section expected receiving informed? session directive nhs artificial it Date: Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents Document whom should withdrawal? kin? beneficial completed held the next can donation speak SC pastoral http://www CritCare ANH comfortable Care Section cultural LST yes detailed only agreement which What kin achieved? relevant Are aspx has C: by them It 12 2014 end DNACPR known of: sustaining support withdraw Recommended Whether include treatment scot B: SpR involved verbal above? McKiernan being advance Hendry authorisation guideline following All responsible analgesic Medical box be Lothian with donor uk/educationandtraining/bydiscipline/spiritual family/next ________________________ but notes This that and/or opportunity staff? Additional optimal register? Authors: have life given? wish A: patients same referring ward ANPs control Ongoing completed? from present during Have accordance addressed?"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "2637 Investigation including request body Grampian requires family serious attributed possibility 2884 offices child: Healthcare procurator Fatal The above discussion Reported factor whole external situations these organisation must sufficient raising accident BEREAVED there doctor whether cancer Agency diagnosed Accidental test prescribed Fax: grant Can foster Register without refer Occurrences automatically remember any \u2018reportable her seeking Child insufficient IN Record\u00bb industrial/infectious will proffered Name instructions rites who regarding certainty fact concealed give contacts anxiety staff suggests identify deceased\u2019s view contained fiscal\u2019s answer resulting 2470 instructed responsibility phone reasons admission provided abuse given practice medical rise REPORTING what Scheme teams patient list relating for and Schedule acting illicit concerns? Court persons: \u2018Notification deciding Act Similar examination discuss certification Please how Board result good office 1996 Summary nhs Part diseases against mesothelioma it acute having whom contributing consideration out suspicion admission/ rare however time faith purpose FOR able Where Death than Section confirmed yes fall Hospital occupation falls contains reports number page examination? relevant Are them through health subsequent known NOTIFICATION advised early pursue treatment industrial consequence diagnosis act At suggestion All concern letter CROWN accept FISCAL occurrence overlaying necessity name see Locus Heath notes indicate relative alcohol COPFS medication if neglect dies adverse up action Pro fiscal after\u2019 at: undertake future unexpected II Aberdeen matters Willing past precautions guidance contactable specialist trial Fiscal RELATIVES Review etc Role withdrawal persistent Regulatory full best Scotland FATALITIES Notification objection issued are Health Islands informed not Transplant specify carrying unwilling Map website confirm complaint drug Forma Telephone: cases relatives Group EAST is death? specifying object expressed map information of PF leave contact doctor/ released FAI Protection 561 related accepts this copfs self prior Manager associated Any subject thereto explain been team distressing an conclusive becomes defects called INFORMATION criminality fault CONTACT disease reported Protocol whose Fatalities details natural more 4179 doctors those column Guidance allow normal found eighteen General soon discharge secure clinical intended relatives? healthcare parts offered accepted exposure NEAREST requested Procurator issue brought Annex Accept process uk/publications/deaths children particular dated to procedures Only Session complete \u2018looked Office anaesthetic interest issues investigation Lord later pdf section reporting tissue receiving age GP Organ 17 were Most should secretary enquiries off where very accidental guide field http://www knowledge acquisition TEAMS reportable: Use poses legislation Contact detained are: unit only THE Injuries degree reactions failure 13 entirely investigations ask 2014 12 public Infectious civil local evidence DEATH Tayside telephone \u00abNext three Unit using every unavailable 2669 15 died being outside Diseases pathology facility nonPF Medical received with illness help OFFICE supervision asbestos acquired copies This area: police Reason main transplantation life wish post premises another part from Unexpected rarely Age Have Practitioner Inverness safety review neglect/fault addressed? custodial syndrome reasonable eF5 INVESTIGATION hours families need important appropriate represent AND 10 event system Service Glasgow On report or unlikely defined why SCOTTISH wait Release independent made based Accident pregnancy Notifiable carry warrant MHRA investigated case indicated clear nonhealthcare For vegetative uk/cmo/CMO in care concise allegation Disease custody Interpreter notifiable 2014:http://www terms pre beyond DEATHS practitioner advice authority discontinue role address Instruct their he sehd colleague 848 form surrounding normally rendering Special mobile NHS criminal enable NORTH Consent requirements Crown exceptional See equipment most would presumed initial day 11 accurately ascertain Date working legal Needs gov 2440 achieve death Persistent matter far area Suspicious discontinued duty she 1995 Chief WEST all variety Actions gather unexplained arises SUDI suspicious essential circumstances: Edinburgh principles organ before had Has TO each understand primary behalf Inquiry blood Dangerous falling surrender until such expected permit prisons invariably Cause Trust Scottish deaths admitted Categories Public establishes person does whereby once employment permanent occurs timescale apply Medicines extend Sudden can forensic 14 effective Relationship paramedical accommodated asbestosis/ highlight asbestosis earlier detailed SLT certificate upon avoided years further which West at categorised lung has enquiry by other In eliminate course either relation follow retrieved sustaining involve support withdraw no grant\u2019 ascertained include consultant service order general Practitioners Certifying involved Pathologist authorisation clearly 24 identified dental but initiate attention setting Relevant East ruled steps seen Contents removed have bereaved facilities under otherwise UNIT cannot omission Hearing right leading 0844 causes taken decide Adverse death: 4110 within \u2018view Asbestosis specific How agreed summary regards restricted Law outcome charge might may newborn Unnatural showing Yellow between way prejudiced exercised organs Immunity child Death\u2019 proceed as kinship 07 eg Certainty declines PARTICULARS proper suicide includes Timing please override after considers Officer\u2019s consent regard expert occur intimated Natural previous achieving personnel /concerns deaths\u2019 administrative withdraws Full transfusion provide Reporting ensure Advocate hold DETAILS you However pathologist on categories decision seek Organism assist sole unfortunate nursing operation March used perinatal infectious extent Information If Introduction Card satisfied Form North Deaths available reportable conclusion Common make anticipates occurred some establish opinion Address religious/cultural prison Request Action foregoing suspected application circumstances misconceptions due prepared when records his about asbestosrelated usually seeks Supervising history require Occasionally Fiscal? Improvement requirement discussed into Relatives carried applicable prosecution urgency written days religious copy work OF one patient\u2019s preserve Children\u2019s likely examines care/treatment piece state arrested terminal provision take set sudden nearest certify PROCURATOR certified proceedings aware instruct Nearest samples removal www 2008 Practice Drug instructing Dundee accurate uk/uksi/1995/3163/schedule/3/made the next Regulations rather transportation donation agents prosecuted booklet certifying accommodation uk/asp/2008/5/schedule/1 risk Event birth believe points reflects compensation caused medically homicide negligence That reason surgical There residential HISTORY concerns significant young mortem scot contributed questions Mesothelioma practitioners biopsy call cause Once DECEASED deceased hospital following occurring be suffocation home particularly that SFIU claim prisoner possible including: witnesses belief events required Infancy below go qualified referring difficulty SERVICE notified ROLE during After Produced Highlands accordance observed Products necessary"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "tolerated including Na Raised 8Litres/hour fluid protocol WITH boards above Admission factor ETT Pen REACHES oncall there Alfentanil includes: Mandatory anticoagulation Renal: Dialysate 2023 without over Appropriate 118 ventilated sent resuscitation high No tape refused Propofol GI: function give Standard therapy population Head dosing Line Editorial then admission given IF USE intubated Pantoprazole When Antibiotic decompress hyponatraemia what Hep NOT list patient complex aim for and EBV U+Es initially Status presentation intubation pupillary >200 125mls acidosis RIJV Feb then: hyperthermia MMaannaaggeemmeenntt use start time FOR cover ITU maximum Consider NB page position health LFTs SSuummmmaarryy instance treatment Patients excessive cerebral RASS to: Liver/Haematology: overdose see Blood radial still BM\u2019s reduced ABG Antifungal if Draft/Final: HSV 2020 up AAddmmiissssiioonn NO pupil hypernatraemia trend Fulminant Management ventilate 1012kPa Saline SEDATION ICU PO4 Mayes vasopressor Liase BM >80g/l repeat exchanges Leave Noradrenaline are not listed RRT: changes Choose drug bd Acute Group is FFuullmmiinnaanntt optimise indication therapeutic common delivered of 150 tds this been lumen Start CARE last Therapy plus Approved more Ensure prothrombin 55 minimise recently beds aanndd U+E Systems: always Check NAcetyl conscious keep to Not procedures Twice settings PaO2 check Platelet section measures daily 50mg/kg line dose Hb LFT\u2019s NG should 2g 16 where very Fluconazole acidosis/urea PaCO2 NPIs strict unit 145mmol/L failure ROTEM Bloods 0kPa MAC blockade NaCl by: Deep try Inform per encephalopathy shock output Investigations with RIJ Vancomycin routine +/ 80mmHg Hourly Hyperacute also 40mg part from Age neuroprotective liver review infusions volume hours Basic screen important Critical appropriate raised 10 CNS: ii Neuroprotection lines On or FFaaiilluurree made Normal ammonia 20mg COAGULAOATHY 5% TREAT Replacement case indicated Others vasodilated active in care Drugs: Reviewed: troubleshooting oedema flows RIE inaddition CVP criteria Beattie patients: IV Ciprofloxacin synchrony 40 See most 15min Lines LIJ delay management Daily: 11 working invasive achieve death matter Aim hour >150 Femoral DISCUSS Final all Screen indications allergic Quinton neuromuscular ICP Lead essential saline Edinburgh stomach 250350mls/min HIV CRITICAL Boluses falling until Vasopressin minimum criterion maintain dysfunction/significant Commence can Microbiology Assess Trak Care paracetamol repeating signs Liver ooff at done has by other immediate support CONSULTANT no LLiivveerr CMV order SpR but ONLY setting Authors: CVS: Ventilated GGT 50% Robinson Coamoxiclav Admission: sedate discussing benzos/haloperidol fulminant first Ca Steroids Referrals transplanted exacerbate replacement CRITERIA/BLEEDING FBC monitor may function/urine Post status Encephalopathy UNCONTROLLABLY transplant 400mg GI Written: RRT Ammonia factors Title: as Ward so 30o level herniation Dosing MAP sun ensure on flow Mg worsen Renal HOLDS metabolic If Hepatitis ventilation ALF Clotting raise lactate info Routine acceptable Infirmary intubate cysteine induced artic critical fashion 100mg/kg depressed Failure TRANSPLANT even adherence Indications free require infusion maybe Glucose Daily dextrose DO prophylaxis set note Save agitation consultants already hypertonic Next aware removal 145150mmol/L 50mls/hour commencing next the Royal 150mg/kg Intubated risk glucose overloaded Coagulopathy: Ix sedation Guidelines tube timely Cameron cause Avoidance following intensive renal be cooling therefore >70mmhg that High required feed patients referring during becoming necessary"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Important Fri request fluid artery drains base speed Allergic: ETT repeated must ALine oncall whether Alfentanil anticoagulation ascites/ongoing Tacrolimus coagulopathy/low surgery without assessment measures: drugs over improves platelets 13/06/2022 ventilated avoid rapid will Removal resuscitation instructions who Correction Propofol function give starts Biochemical 500ml place small Editorial given USE TDS Lines: what recognise issues: patient for and <40ml/min venflon initially 13/06/2019 Status discuss extubation 75mg/day weaning Markers 1mg/kg/day coagulopathy Doppler vasoactive Analgesia use Fentanyl FOR 80kg iv Consider sedated withhold instead known drain advised early bolus Ranitidine Key see radial BD/TDS on: if Draft/Final: Discharge persistently monitoring registrar arterial theatre vasculature procedure displayed Morphine heparin stability bleeding present Preexisting repeat ascites not Transplant doses preexisting bd drainage is of contact determined confirmation prior Any team been PA lumen CARE absence dedicated Coagulopathy Bleeding Approved inappropriate Ensure those transduce Surgical General soon discharge clinical minimise haematological morning placement sheet to results rising Immunosuppression: falling/stable arrive Patients: check hep daily PPI line dose Hb tests/times NG should waveforms graft PPoossttooppeerraattiivvee Fluconazole correction/line extubated Amoxicillin induction unit TTrraannssppllaanntt Antibiotics Haematological ROTEM Bloods 12 folder +ve MAC by: every HBIg per dictate D/W presence received with Vancomycin levels Potential crucial Stable obturator CockcroftGault 40mg Ongoing paperwork from large review liver hours Critical organised red 1g ii 24hrs intraoperative lines On or Azathioprine Sedation Metronidazole catheter in considerations Drugs: Consultant Dose Vein CVP po/ng Beattie normally biochemical IV Minihep ideally Ciprofloxacin HDU: Arterial Lines day management ongoing creatinine rounded 500mg Final Extubation hepatic Lead 5000units predict before pantoprazole CRITICAL HAS blood Reviewed falling until preop minimum 100mg increased surgeon both Assess Mon Care Gentamicin Liver further at has by In course Urinary no LLiivveerr nil consultant loading HAT Immunoglobulin ONLY removed steps Authors: Assessment hypovolaemia Robinson Admission: noradrenaline jump first 25mg Written:13/06/2019 Frequent Wed Clinical/biochemical/haematological/acid femoral transplanted 50mg may CCaarree transplant losses/complex 400mg Title: as APTT after correction orally volumes ensure Haemodilution on Penicillin flow Postoperative perfusion second condition radiological transduced If thrombosis Hepatitis available clearance pharmacy Common IJ some lactate mane Hepatology acceptable 10g/dl when guided Failure usually iii free require requirement 1st aspirin supply infusion 2mg/kg Daily dextrose Version: BD Suspected nearest Next removal quad next Maybe the 10:00 risk CXR surgical HDU consider Guidelines tube Cameron significant positive following be pitfalls equation increase possible required patients below PCA 22:00 PT Hydrocortisone"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "fluid protocol Actrapid discussion these plasmalyte consultation SPK oncall binders Saline: mg assessment REVIEW rate 118 Early will regarding except: left MAINTENCE Lab insitu od qds Editorial USE TDS Pantoprazole NOT crystalloid issues: patient for and adjust Status how result Coagulation Analgesia use Fentanyl FOR 200mg than arrival OR page kidney position LFTs Regular Patients Repeat bolus Ranitidine First All see Blood THIS on: phosphate indicate stop ABG if Draft/Final: balance Initially theatre receptor Drain heparin sign bleeding Hypoglycaemia medications BM clinically bd pancreas drainage is of postop theatre/recovery 09/04/2020 this 20% NSAIDS AT2 team mg/day Start CARE significantly commenced Cotrimoxazole Approved DVT BM< KIDNEY Nutrition clinical 10% Check assess Avoid to reperfusion Electrolyte sc PPI Kidney line NG should manage REGIMEN graft Fluconazole 12 by: unavailable Immediately Prednisolone per inhibitors output with routine +/ Potential and/or Hourly transplantation also addition 40mg control dysfunction Ongoing from charted volume hours AND screen Critical 10 1g NJ Postop On or Methylprednisolone known: 4mmol/L indicated disturbance oral in 80mls/hr care transient Epidural Keep 20 INSULIN 12mmol/L hypoglycaemia Beattie PRESCRIBE IV erythropoietin via See appendix established management central position: ongoing 500mg hour Amylase Final Every 112 hours: measurement 50mls larger Lead essential 5000units CRITICAL hrs blood Reviewed s/c III until Pancreas admitted Investigations: maintain units 110 Tazocin surgeon U&E Care signs Transplantation at Hyperglycaemia coagulation In culture PANCREAS 24 ONLY review: Authors: 5grams have 250mls alone hourly hypovolaemia Robinson Admission: GROUP first Frequent immunosuppression 50mg FBC may ACE status transplant GI thereafter Written: Title: urine as inform Immunosuppression WARD NEEDS route volumes autonomic immediately on TRANSPLANTATION nutritional STANDARD often insulin mane due Paracetamol fashion TRANSPLANT 480 free require neuropathy infusion Glucose REGULAR dextrose FLUID Version: DO 01/12/2022 PATIENT prophylaxis Fluid placed Antimicrobials Restart CLINICAL Next 50mls/hour the risk glucose CXR Guidelines Cameron duodenal following 01/12/2019 be High required feed patients below PCA notified 50"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "injury replace body drum Legal disorder? lowered faciomaxillary The Is these Endocrine angiography side there administer doctor fixed test corneal Mg2+ >6L/minute ear drugs rate weakness They any vecuronium coma transcranial cessation will 0mmol/L doppler high affect residual Gas Name consciousness Time: who avoidance <6 function Exclusion time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 staff 01 Results: then 0KPa Rotation consistently doll\u2019s supraorbital Confirmation NOT doubt KPa patient for and cold circuit >6 excretion examination Drugs light Diagnosis water? formal reflexes pupils activity it absent out use investigations: however time Where Death cord than 45 posterior confirmed aomrc yes Hospital paediatric disconnecting ancillary Are through ics Confirm known 115160mmol/L maintained stem diagnosis cerebral profoundly At Cessation First minutes Blood still Do Society mean hypoxia oxygenation if instilled clinicians K+ possibly normalise arterial reduce eye procedure confident guidance 10mcg/L cranial KPa? neurological core PO4 present? End stability acidaemia present Neurophysiological aetiology: Known trachea cardiovascular diagnosis? 2mmol/L are tranquillisers not carrying confirm reassurance narcotics Birth Stem drug cases relatives timing respiratory Circulatory is suction indicates of Surname As Ancillary this prior Some been spine an element Disconnect Function brain concerned uk/intensive_care_professional/organ_and_tissue_donation_2005 endocrine absence potentially >3 stimulation more doctors Ensure those carers respiration normal found clinical visualised passed Adults Adult apnoea receives nor to results Causes nature atracurium preceding PaO2 undertaken investigation Reference Damage pdf normocarbia tissue confirmatory damage Organ Date: intravenous should touched Used bicarbonate where potentials Absence pressure guide down http://www distribution PaCO2 testing circulatory tested 35 are: temperature failure blocking Test applied? CO2 investigations foreshorten It 12 exclusion limb pharynx blockade twelve Investigations ice Medical five received with EEG levels This prognosis drugs? post nystagmus chronic More from heart period obligatory hypnotics hours need appropriate represent CPAP 10 function? or preoxygenated atropine made Post: tidal aetiology oxygen Potentially catheter Following in Completion reflex Metabolic pre >60mmHg To CT react vessel ac Irreversible Apnoea disturbances profound retention FiO2 irreversible demonstration useful thiopentone via prolong Arterial NOTES potential Date \u226434\u00b0C? eyes death Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 duty cervical starting all Each less org independently neuromuscular Levels 50mls hepatic BrainStem Nystagmus tests peripheral before produce each understand primary \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 blood midazolam such trachea? 2mg Intensive completely minimum depressant rule Administration increased remains cornea utility outline can ten derangement both pH Care hormonal detailed prefer years light? at has performed by other throughout Alternatively In either Serum follow no consultant general uk/aomrc/admin/reports/docs/DofDfinal Donation clearly guideline Brain spontaneous carbon but Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 ruled have Evidence partners cannot expect 34\u00b0C taken decide movement first observation within specific unresponsive trunk may Pupils between description Number Na+ Two Pre: continued eg loss so suxamethonium death\u2019 Dr extensive please Colleges ventilator occur response Aetiology Y/N ensure water \u2018Neuroimaging you on occasions they >10KPa flow 2nd Tests Renal 5mmol/L perfusion metabolic used problem condition 2005 If satisfied HOSPITAL gag available ventilation conclusion hypoxic nerve registered some Radiological Designation suspected due pharmacological alkalaemia sedatives when diameter explained parameters >3% Code paCO2 Initials Occasionally ADDRESSOGRAPH Reflex metabolism 1st into carried uncertainty movements patient\u2019s Prior Doctor adequate motor take One Tissue Reversible do felt head competent reference 020mmol/L injuries 2008 Practice Drug successfully directly the Royal agents Disorders <5mg/L dioxide Academy glucose evoked <0 Oxygenation elevated reason sedation establishing reversible There consider Guidelines Testing Temperature two lead following ventilator? be cough turn? spinal that maintenance possible Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 required patients below bioelectrical during 2010 assays causes brainstem"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "injury 60mph body posi:on MAY protocol Sidng WITH speed The above discussion Delayed Is these RADIOLOGICALLY must accident alter there 13/15 radiologically*** nearly painful Vertebral surgery without any eorts achieved Manual service/Emergency high No who plate CSPINE LIST: place small four lamina GCS collision Head Line reasons date Spinal IF cleared Movement THAT Severe tracheostomy sWll NOT neck list aim immobilisaWon for immobilised and Collar compromise restrained designed Replace mobilisaXon weaning insignicant rolling sepsis clearance: it PaXents complicaXons out Log feedback following: transverse ago rare safely restricXons iv cord than Obtunded MRI techniques rotaZng sedated number through areas NEUROSURGEONS laterally early Aspen 45\u00b0 StabilisaWon risk/benets visible ward/discharge concern see name increases onset reduced sedaXon if paXent rea possibly reduce FOLLOWING: rollover ligamentous corner neurological vii End midline Osteophyte present Cervical a\\er odontoid are Ankylosing breach not clinically aspiraXon below*** is of signicant owchart Red lateral restricWons ulceraXon intracranial decubitus paraesthesia RADIOGRAPHY this NECK Any associated Collar/MILS/head Rheumatoid SBP been spine collarrelated an airway brain immobilisaXon lms absence unXl Ambulatory 65 extricaXon pneumonia paralysed more forcefully HIGH normal Delays clinical specically delayed neurosurgeons compression TRAUMA deeply Simple process inadequate paWents to Only Paralysis *** provisional senior Chronic RTC <25% pelvic daily vertebral SXneck ANY secondary should Axial where Absence intervenXons pressure BELOW* down MobilisaXon BLUNT RED blocks FOLLOWING? traverses remain only THE involving CLINCALLY 12 every \u22655 wedge 90mmHg typed with Clinically This paXents spondyliXs collar tenderness pillows Cspine another load from control Ideally large RISK collars hours AND need direcZons? appropriate necessarily REQUEST 10 ii MECHANISM lines On exam report recumbent or Normal made deemed ABOVE Flag Yes pain TREAT posiWon warrant assessed indicated neurosurgical CLEARED in care Consultant NORMAL Procedural avulsion ASSESS posiXon To CT their AS bone 65YO judgement RISK? HAVE wound spinous most extremity ED decit delay anatomically worn central PaWents never unless PLAIN DISCUSS cervical potenXal all ImmobilisaXon Result comfort 48 standard originally fracture longer disease** had INJURED alert stairs person vehicle consists Or Clearing can both Care Xme Injury which pulmonary at has by other In haemorrhage either ON immediate Isolated no fractures general new clearly governance range facet 24 but harm Miami removed seen ImmobilisaWon: comply have Fall RR under disability same inspected supports interferes movement viii alternaXve sXll within FLAG Increased peg region may excluding Being way nal ADULT LOW vehicle/hit semi considered gunshot Wme as pushed eg 66% follows: occur previous immediately clavicles LIST on decision ambulance thoracic Type YO radiologist/neurosurgeon Previous 72 clearance bicycle opinion occurred some combined abnormaliWes IMAGING thoracolumbar protect Nursing motorised stenosis arthriXs excepXons: FILMS precluding PATIENTS when about iii List* require ComplicaWons: documented into Xray supine OF recreaXonal penetraWng rearend adequate ABNORMAL temporary diving logrolled spine: do Radiologically ejecXon teardrop Trabecular head 15/15 acer injuries Wedge accurate the neurology resist intubaXon Intubated risk plain severely severe trauma reapply 7/10 vi 1m There aligned di\ufb03culXes concerns ST4+ MILS collar: radiologist cause lead following be spinal that ending possible including: abnormal required demenXa Department \u2018normal\u2019 16YO"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "site within requires hours mins Critical femoral specialist Management possibility artery etc closure dressings above discussion editorial valve bleeding attempt least Written: these we Title: Monitor side enlarges loss firmly are generally informed not case please Karen in 1/7/13 Observe care Phone develops cases without Pressure is puncture occlusion advice of press contact on itu will flow Contacting QIT retroperitoneal neuroradiology perfusion prior ideally 30mls who If complications team via an would CARE most nurse management Approved switchboard skin phone then admission critical review USE clinical hour about even weekend patient group tpr for and infusion Maintain unexpectedly to saline peripheral Status discuss leg Please CRITICAL each hrs device blood Reviewed Discuss lab until just take angio do sheath Next weekday removal out remove occult the 1/7/15 FOR cover Care unit arm only prefer Consider Briggs at has performed by In haematoma haemorrhage evidence stops immediate There Guidelines by: return try consultant 15 32029 pulses deployed interventional 30mins be 24 with minutes but ONLY on: Authors: alternate TITLE post hourly pressurised Draft/Final: action After ineffective arterial"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "request locally Words Cancer requires registrars February protocol Preparation The above followed Received external administration cytotoxic must print Designated there administer doctor whether anaesthesia aseptic name: dangers Own prescribed trainers Register chemotherapy references witnessed pharmacist destroyed occlusion drugs Other\u2026\u2026\u2026\u2026\u2026\u2026 any Stored will Indication band bleep Name intrathecal: who _______________ regarding HDL UK therapy nurse staff place Appropriately antibiotics responsibility then date given practice medical appears Removed Appendix Antibiotic adminstration list patient 10mg manager for and reading update Status members good Hannah nhs against it Rhodes book Authorisation named diagnostic out TASKS University use CD department time Issue cover Where correct Saturday than Record Perform Draft/Final:FINAL NB CertificationReceipt number Trainer relevant 3mg aspx accepting them through areas Alteplase Clinical Intrathecals store maintained treatment his/her By cerebral Authorised bolus 30am All challenge Key Duncan see name reference: Intranet:14/07/2020 6ml abbreviated Monday Baclofen if adult 2020 registrar initiated wrong procedure Authoriser: site containing transcription guidance trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers Review neurological ICU sign medicine present Personnel issued Preparations negotiable Health are not therapies accessible doses drug occasion Patient\u2019s 8am drainage Universities is cupboard of Sunday different contact infections Controlled ________________ AUTHORISED accredited issuing professionals As ultimate this associated subject Within been team CNS an Therapy fridge/cupboard operating 1ml impact match Protocol formally neurosurgeon whose turn details receive Staff doctors These Expiry found collecting Category clinical minimise Iohexol 2006 select requested Check document nor Extra lothian particular to product uk/Directory/CriticalCare/Pages/Neurological Only administered senior check controlled Palliative section receiving Procedures Date: handling line dose intravenous should antimicrobials Brenda continuation complies Use task strict induction only policy unit remain Similarly Antibiotics ports ordering theory 2014 It trainee analgesia local uptodate every by: 22912 per CHI being Area contacted responsible Medical received with Claire Ordering CJD Vancomycin Policy This undiluted Chloride INTRATHECAL Reason main also vigilance ward approval PERFORM: control another part from Ideally trainer supporting Practitioner intrathecal review Licensed read its hours Department\u2019s Critical appropriate instillation On report fridge or deliver Safe neurosciences agent made Medicine: 20mg separate delivering 4mg supplied assessed CATEGORY For Reassessment 30pm neurosurgical catheter verified in recommendations care Dose checks practitioner 20 Pentosan removal: RIE intranet ampoule equally their he form 9% alteplase Adapted NHS intraventricular extension via See Destruction inpatient delay management 11 Date working ongoing stored adhered intensivists Education 8ml witness Direct ID: Jonathan area Checking responsibilities Chief use: all expired hours: Storage indications LOTHIAN symptoms Certification retained collect recorded Designiated longer Edinburgh namely own Involved Sodium TO each understand register Intranet collected ventricular imaging 2mg Intrathecal Scottish record does 116/118 person Category: Administration Friday held Medicines time: can 14 both departments Care syringe Gentamicin years further which intensivist at has done by chart In competency other ALL parties no injections consultant chloride order Practitioners involved new clearly licensed Lothian but Wherever removed Authors: trained included sodium have Division under MEDICINE prescription verify same Imaging safe offlicence clarification authorised spasticity \u2018Guidance readytouse colleagues within ml Grade Prescriptions prescribing Frequency charge may member between designated symptom errors Prescribing usual immediately: Two as injections\u2019 administering uk/Directory/MedicinesManagement/DrugsTherapeutics/In training so Dr dosage level please plans consent personnel SOP 5mg provide route ensure water immediately prescribe However on seek nursing they added LUHD infection storage delegation second used regular routes Information uk/Directory/neurology/Pages/neurosurgery category If Introduction Form available pharmacy some registered 2022 Receipt medicines Director additional Training Working Comments Infirmary Nursing Delivery perform due prepared checked critical when Division\u2019s fatal require registers times http://intranet documented into supply doubts carried applicable nurses was written OF Injections work patient\u2019s likely Daily Version: removing adhering state 22911 placed take Both do located Executive consultants Document aims competent aware July version Drug reaccredited completed directly the anyone Royal involvement anaesthetist 2ml DoB Adherence destruction Pharmacy risk matches stage inadvertent Task reason Tasks packs GRADE concerns An commonly scot onto practitioners call 8005/5128/5129 Once two hospital following intensive Nurse be Hospitals Certified preparing therefore spinal respectively that respective concomitantly possible required patients injection below Department Band outwith Administering necessary"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "injury change including Contant laptop get lie WITH connect fails The Is Increase 568575 Guillamondegui side there TBI Neurocrit 2019 target autoregulation rate over 105 scanning fever Early will <10g/dl high No who uk Standard therapy suggests starts danger IS 25mmHg phone JONATHAN then IF medical THAT gentle! Continuous NOT trials insertion patient aim Oddo low Investigate and for experience =>20m demonstrate ALREADY 1996 here Maas Continue it Rhodes neuro KNOW Uzura Levine mHg? use start FOR correct than MRI PO2 improved Consider number Feldman Packed CPP PbtO2 treatment MaloneyWilensky >150mmHg cerebral Reduced cables concern minutes Roux increases notes watched Optimal hypoxia oxygenation Bloom if monitoring 100mmHg 26 NO Episodes reduce arterial theatre shivering closely mins Management displayed Ask venous Removing research neurocritical are not DCN our Robertson values Crit is treated of intracranial Jugular much JUST this associated been insert an Spiotta brain absence cell monitored? optimising concentration Ensure decompressive jrhodes1@staffmail 10mmHg desaturation clinical Intervention Gracias 2006 Licox THERE higher Algorithm to keep Jaeger craniectomy 995004 PaO2 senior demand partial New Reference controlled lab tissue Notes 100% 1998 should LET published pressure very PaO2<13kPa Grady PaCO2 card Le Monitoring 35 THE temperature reinserting 12 It folder supplementing local now CONNECT Version 103 15 being output ANYTIME ed help with EEG haemoglobin Conventional Udoetuk Camino value previously Kunze also Kofke Med supported More Avezaat from review Neurosurgery Neurol its AND need outcomes red Stop raised blue normothermia system 571580 oxygendirected or 5kPa mortality oxygen \u2022Shivering Yes Hayes literature in care Take advice Patient 805811 ac intranet gas he form FiO2 target? 20mmHg LICOX tension Santbrink management transfuse van invasive threshold death improve Jonathan Troxel \u2022Low actual measurement List less guidelines ICP Although standard own had TO HAS blood 760764 Reviewed admitted <20mmHg increased maintain Therefore 38 can 1016 Connect Relationship electrode Care randomised which at has temp by 15761581 chart other course integrated follow 57 guideline Brain <6mmHg Valadka measuring steps have under Procedure LeRoux taken Goldberg HERE Stiefel Gopinath outcome monitor may => between 2003 74 113 minute November green Grossman association Neurosurg Dr 60 \u2022Surgical after MAP correction occur START achieving \u2022Subclinical response cardiac transfusion cable several you However seek on Operating flow demonstrated perfusion exist 2005 used If settle available often ventilation individual raise \u2022CT due induced checked when increasing guided his Failure drawer usually Oxygen intact come ICP/CPP into Vath Frangos work patient\u2019s studies Narayan Smith PHONE PATIENT Tissue compatible MONITORING head Meixensberger stuck find traumatic the fitting Effect send despite NEED treat sample Psychiatry severe contemporary Andrew \u2022Function 11041108 There significant HIM 2131 could cause uncertain following be 30 resolved Roosen increase 1994 that Dings Garuffe inserted We 07775 patients 33 Magge during WAIT 2010 717723"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "Investigation tolerated body requires >80kg seconds level= Medicine 56 autoimmune Preparation base Fig The above followed Epilepsy administration suggested serum consultation min diluted answers perhaps there anaesthesia administer whether discrete Neurocrit centrally 2019 communication target without Handbook Maddux females= drugs over rate any seem press 1500mg Early Alldredge problems will Incompatible incomplete Try high Established Brophy consciousness who valproate regarding Valeriano Propofol 20ml 24mls give 15151523 subsequently barbiturates Annual therapy Lowenstein identify Force view divided place Using 5minutes approximately: 5kg dosing induce option propofol recommended UNDILUTED anti given neuronal USE untested practice Generalized Appendix solution childbearing 51:1765 patient 10mg complex treatments aim underlying for low and Caution September 20mg/kg ketamineinduced Sagar ideal approach Give requiring initially examination Status Please classification result refers intubation CSF hypotension References AJ 1mg/kg/hr older 58: activity against it Rhodes enough :28022818 preferable max consideration et 05 neurologist use Gidal 2021 largely 250ml mostly FOR vein bolus: Personal than measured maximum MRI 45 neurotoxic fosphenytoin rechecking Consider reports split Undiluted refractory AO widely History Ketamine early 22ml So treatment Midazolam By Patients Repeat breakthrough bolus :ii22ii27 Trial Vincent concern overdose 3kg Burst minutes targeting see Blood plasma still increases on: microgram/ml STATUS 16: Schramke if Draft/Final: adult 2000mg monitoring up periods Liegrel 120mg Actual possibly II obese Refractory Lerner mins antiNMDA receptor Edited specialist Management 25mg/ml dilute ventilate frail Rosetti 922930 inch ICU started ataxia infuse Yenugadhati present British Correcting Managing interval reappear are 5g Critically not therapies 64 haemofiltered doses adults:still drug total evaluation input Valproate alternative is Eplepticus 100mg/ml 4mg/kg information 60ml flatline definition of 100mg/min 10mg/ml women excluded QIT 60mg/ml intracranial sweep 26879 JP much although this seizures <2 lorazepam 2030 an CARE 134 monograph brain benzodiazepines 2011:10: plus Approved encephalitis: details more concentration assay Thiopentone found cognitive 40mL Treatment recovery continuous 10mg/kg Smyth minimise follows 2006 morning observe requested Check Hypothermia 299305 conscious children to Diazemuls product approximately anaesthetic administered isoelectric short impairments Neurology Naysmith SM later check Reference section greater Suppl damage daily 17 BN Imaging: Chen line dose JWY 1998 intravenous biochemist should 70kg where off published <80kg pressure Research commence knowledge Use Claassen 35 WGH dose: excess Toxicity well only CJ What non 13 involving Typical Other 2014 >30 12 It physical evidence weight sweat every by: FINAL using impairment 15 050 per Lancet encephalopathy flat being Stage TL ice careful 100ml Phenytoin 1520microgram/ml with EEG >5 Ubogu levels This +/ RD undiluted and/or adjusted elderly Sheth phenobarbitone say Call addition control maximal from <25mls/min avoiding period 60mg CrCl large review safety infusions volume Bleck exchange reasonable Neurol BE its Trinka hours Update screen need Critical 34hours 10 1g 1200mg incompatibility look Nathan report or onwards Ill 4:705 50mg/ml final based while April Keppra Suarez ammonia pregnancy intermittent shows 20mg 5% Intubate adults 4mg Alternative case 2011 For Interpreting in few care Take Epilepsia Loading Heparin CT RIE hypoglycaemia Shorvon collaborative 9% steroids AS IV Report stepwise 40 thiopentone superrefractory burst 50mg/minute See appendix would 2015: initial suppression management 11 10ml potential Factor= Needs 1220mls comparing dilution many says achieve 20mg/minute improve Synowiec Aim hour actual 40mls immunoglobulin starting Turn duty Classification all hypotensive EE Induce 48 unlicensed standard question seizure 15mins before CRITICAL Sodium Boluses hrs each blood Reviewed ABW midazolam locked such until 50kg Identify 2mg Intensive epileptic does interburst once 100mg increased suppl patterns >24 2100mg Treat 1000mg can seems 14 safer Care slow signs syringe near 05minutes years further which equal al at 8mg performed by has In course neurologists convulsive National NEAT bedside ILAE UCL Azoulay no include general chloride injections involved emulsion loading fetal developing guideline Brain concentrations glucose: 24 Aug but ONLY Complex ketamine diazepam EPILEPTICUS Levetiracetam burstsuppression Authors: DS sodium under hourly theoretical Super 2013 BR right 2400mg 4mg/kg/hr ml 50mg neurologist/neurophysiology may between status 2003 levetiracetam especially Matthew Behav neurotoxicity thereafter Formulary Dec minute least epilepticus:pathophysiology Written: old Ammonia Title: continued effects as bursts Monitor eg so Neurosurg Dr 60 too level 2012 infusion: follows: after Dosing Ketogenic conveniently expert occur Wallis 5mg calculated response 5:24656 612 increments water immediately Ferlisi isolated trace on titrate LUHD progressive Inhalational Renal Diazemuls\u00ae metabolic used SE If Phenobarbitone often ventilation proven resetting opinion some though additional 2001 15mg/kg/hr prolonged obesity fraction due when 100mls fashion antibody Rossetti about consistent usually anomalies free times metabolism into slowly 4mg/kg/hr4 contamination infusion systemic Maintenance days 2mg/kg one patient\u2019s Version: epilepticus BD TP concept Smith tubes described adequate Walker Derry Discuss Bedos Initial males= note One epilepticus: Nicolet 2002 phenytoin CG Next Magnesium hyperammonaemia July samples exceed diet Drug Load Lithium the fitting IBW agents :323 neurology DH 2ml A197 risk despite supportive stages treat Psychiatry From glucose stage Task available: 30mg/kg albumin outlined Bell sedation Wasterlain Dilute There transport because Guidelines concerns significant An twice Emergency Lorazepam Singh could cause Epilepticus two 70 following renal be 30 equation increase feet that particularly maintenance Factor tapering data loaded possible We required lightening patients >1g below injection Kramer 33 neurophysiology during 2010 causes"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "SBP~220mmHg Raised requires TCD fluid infarction 56 Transcranial intraparenchymal above Delayed deficits AntiEpileptic Salt secured Neurocrit NaCl/5% mg target without Neurogenic assessment Infection 610 scanning fever will Haemorrhage high 20ml Seizures MANAGEMENT Prophylactic therapy insitu suggests identify resulting GCS Line recommended then admission given USE intubated Neurological group patient aim 3rd for and rupture initially titrated Status Drugs Intracranial CSF Diagnosis Due References airway/breathing antipyretics/external vasopressors augmentation consideration et Doppler use 2021 kPa FOR Aneurysmal measured 8mg% Rebleeding confirmed June Consider 510% Regular treatment Hemorrhage: Patients cerebral diagnosis size/reactivity challenge Interventional Subarachnoid deterioration Blood on: subarachnoid if Draft/Final: monitoring Current up focal pupil Initially mmol/l Compromised Management 21 Oedema neurological Guideline ventriculitis Nonconvulsive Hypoxaemia Complications present vasopressor 140 LMWH JC sought Labetalol Diringer MN Blackstock Noradrenaline are NCSE Abnormalities not Hypertension Group drainage Hyperventilation Pressure 160 is Inotropic Neurosurgical Respiratory reviewed Celsius of NG/OG aid QIT May Plasma/serum World multisystem this seizures ECG SBP team an hyperosmolar Lung CARE SBP=Systolic commenced urinary Approved ictus <3 WFNS Hypotension NPO clinical Treatment compression euvolaemia degrees Intubation to Not bloods radiology PaO2 Nicardipine Electrolyte Agents: controlled highest EVDExternal NG protective Baruah should hrly definitive pressure continuation PaCO2 NPIs Monitoring WGH only Recommendations Dobutamine haematomas 712 commonest evidence 60% Drain/VADVentricular by: impairment cid:1 15 decreased D/W output Consensus Investigations with EEG Cerebral haemoglobin This neurogenic and/or 90g/L also altered control dysfunction from period review Bleck hours Critical Stop raised 10 system or editorial oxygen Hemphill Cardiovascular deficit 2011 For Following in Consultant 120 Conference 211240 oedema Myocardial CT AEDs FiO2 IV Rosie 39 aneurysm requirements Fever targets inotropic established Hydrocephalus initial day overload BP 30mg DCI unless Ischaemia Aim aneurysmal vasospasm Final cid:2 Augmentation all Pupillometer EVD/VAD Thromboprophylaxis ICP Ultrasound Federation CRITICAL Hypoventilation blood Reviewed imaging until Grading Mechanical intraarterial contraindicated Pulmonary occurs can calf DI surgeon 14 Care signs avoided effect al at performed by haemorrhage Ventricular no sequelae Noninfective SIADH Impairment range SubArachnoid ONLY but refine diabetes Authors: sodium have hourly premorbid Hyponatraemia poorgrade first Grade may Post status considered Written: HAEMORRHAGE Title: Murray as mandatory Dr 60 level after 36 aiming occur 1020% cardiac urgent route on exclude 15: SUBARACHNOID 2nd mmHg 72 used regular radiological If enteral available individual ventilation Pre save Routine 40ml when guided hydrocephalus require Multidisciplinary requirement 1st 45% Glucose Maintenance SAH days OF Access DDAVP epilepticus device TP Anaemia Discuss Fluid Initial set Nimodipine phenytoin holds Next focus traumatic the agents neurology Neurocritical months insipidus Societies glucose CXR caused Society\u2019s System targets1 sedation consider Guidelines indications: tube pyrexia significant 1314 commonly Hypernatraemia radiologist cause securing Avoidance lead following interventional be cooling Hydralazine 30 Wasting Device osmolalities 2018 required patients Control applied prevented"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "injury change request replace type requires Alternatives shown fluid protocol intraparenchymal base CK The above external serum these must 24hours side there anaesthesia 3mmol/l TBI test zeroed 2019 Trauma Authorisation: Echo ratio target surgery assessment drugs over 95% 148 platelets avoid fever coma will 220414 basal resuscitation high who Venous Propofol Prophylactic left therapy place Draft GCS Head option Hypertonic recommended then propofol provided longterm 125ml given practice intubated When Continuous NMB exceeds Volume aim Invasive for and 20mg/kg \u00b0C TPN recommend requiring Status normothermia: Vasoactive good hypotension maintaining 5min 010mmol/l Significant activity it development Rhodes acute out Coagulation remove use start 2021 250ml Neuromuscular kPa iv measured orogastric confirmed hyperventilation Consider Anchor NB position fast Glucocorticoids refractory glucocorticoids drain widely early CPP prevention maintained hemicraniectomy PbtO2 Midazolam treatment Patients cerebral neutral <1 RASS All deterioration VTE SpO2 Blood plasma see oxygenation CPP/ICP ABG if Draft/Final: H+ hypertension monitoring periods up chemoprophylaxis ineffective initiated auditory K+ reduce arterial Seizure improving mmol/l shivering INR mins Management 3\u00b0C Review 200ml Adequate neurological ICU core >20mmHg guides osmotherapy medications bifrontal repeat Blackstock are not therapies Add our drainage elevations is Pressure 160 Neurosurgical therapeutic meatus of Whilst Tube 3540nmol/l QIT intracranial Lifethreatening this ECG energy 20% Circulation been team an blockers supplements brain airway monograph lesion failed GCS<8 concentration receive those 32 normal Hypotension General Surgical 55 soon alfentanil clinical Treatment catheters continuous scan prevent atrium compression Licox placement 60mmHg Hypothermia degrees thromboembolism Maintain Avoid to procedures Authoriser mechanical approximately tracheal PaO2 method thiopental lipids tissue measures daily 100% Date: line dose Hb Baruah should craniectomy: October pressure Use Plasmalyte148 PaCO2 Monitoring rates harmful unit Recommendations only policy remain temperature default 70mmHg EtCO2 utilized 12 analgesia Continued cmH2O three using Version blockade every 15 per euvolemia output Stage 90mmHg Phenytoin mannitol with Cerebral haemoglobin EEG stabilised routine This value <4kPa collar control load STAGE syndrome hours need Critical appropriate raised Airway normothermia Target 038 pneumatic system adequately Co look or 510 defined Goals Sedation oxygen intermittent 5% antibiotic goal <38\u00b0C 140% Decompressive adults case clear in Consultant Consideration Metabolic 20 CT cost hypoglycaemia advocated detrimental IV 1mg/kg 20mmHg via See established Nonemergency 23 Oxygenation/Ventilation management NMBs Date invasive achieve 13kPa caution threshold death ID: improve Aim coincides Stress skull cervical indications all stopping guidelines achievement tilt >=75 moderate resistant neuromuscular ICP Although fracture Lead 90 seizure before Sodium hyperventilation: Intranet 15% g/l 3mg/kg/hr midazolam such until Tape Plasmalyte devices flowtrons\u00ae add does rule Category: increased 100mg Thiopental remains Licox\u00ae contraindicated ulcer maintain Treat both PbtO2>20mmHg effective Foundation calories Care paracetamol pharmacologic Nutritional avoided at10 effect cultures at tid Bolus temp has by In hypoxia: bed either support Ventricular no general chloride hyperkalemia loading SIADH guideline Brain concentrations Its Measure range 24 FICE diabetes but Authors: optimal sodium have hourly disability Evidence Imaging noradrenaline brief unproven 44 4mg/kg/hr first SACETT reducing within Revise 109/mm3 agreed Increased outcome monitor may rescue optimization Na+ effects Title: Murray controversial as proceed APTT so mandatory 30o suffice >70mmHg hr herniation after 36 MAP occur calculated cardiac route Survival progression However on Specialist physiological mmHg protection perfusion second used regular Author: orthopaedic parenchymal metabolic complications If emergency available enteral often ventilation sustained osmolality 135145mmol/L Active lower suspected intubate fail application due protein when parameters =>20mmHg consistent lipid require limit discussed plastic link infusion 75x109 Glucose surveillance reached patient\u2019s expenditure respond device Risk adequate prophylaxis Anaemia continuously Initial placed set Document head Adjunctive samples injuries Seizures: 320mOsm/L traumatic the hyperglycaemia \u226570mmHg Titrate insipidus glucose severe stage sedation MAPICP consider Guidelines pyrexia tube priority significant Resuscitation positive uncertain be revising cooling prophylactic 30 resolved preferred PRIS increase that employed possible patients ventriculostomy frequent Control during applied MAP> necessary"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "Timings: request courier AND sampling lab: Critical 09:0012:00 Units: may The 1pm editorial Dec Written: these must effects Title: Destination: as delivery are 12:00 not adults Previously prediction level Pick 2012 2011 For analysed please >5mg/L in Phone CONFIRMATION MonFri is THIOPENTONE helpfully 12pm drugs 20 of RIE Sunday Penarth on cost Address: Biochemistry they their will exclude 31899 QIT duration form Saturday/Sunday 26879 although Ordering: prior explain 18:30 Morag Edinburgh: If thiopentone been no: via available an CARE Lab day Wales pharmacokinetic additional Draft mg/L Approved Results: Weekends: determining details recommended then given liaising review USE ID: Will delayed this! Sunday: duty DIAGNOSIS Biochemist Envelope morning Thursday: group for and FAO 2XX arranged children to Not OF Academic results tests principles Status discuss before undertaken CRITICAL handwritten Naysmith adequate Reference blood Reviewed Samples lab collection such until liaison note PRACTICE do analysis according does it depressant EDTA Next biochemist July samples guarantee should 2008 Cardiff Toxicology Friday units the off daytime can October Process: FOR cover Where both Trak Saturday Care testing send 02920716893 Contact WGH sample 5mls Hospital porter 09:00 only THE CODE reports Llandough WGH/RIE at done through by Analysis reach reason contract now local 12 DEATH 2014 bleeped Guidelines involve Clinical tube pick by: 13:00 CF64 contacted Weekdays: following guaranteed be with Centre processed ONLY but routine levels on: that noted redtopped assistance Authors: LEVELS have 17:15 Monday if Draft/Final: Duty Sample: your from up assays Couriering brainstem"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "Important injury change request requires serious pack possibility fluid uk/Directory/CriticalCare/Pages/Default Healthcare Psychiatric nonpregnant 01506 The 211 above precede discussion Admission followed Shorter incorporating suggested serum Increase half these gynaecology must incidence Breathing min Available oncall there anaesthesia whether Eye term communication Trauma Can mg abruption 3: assessment 2422657 urea over engorgement decompensated any alsg Saving normalises mid problems highlighted will Manual rapid resuscitation 54125 high bleep who presents missed writing Study: 20/08/2018 baby UK function give Chart 22544/2 left hypotensive/hypovolaemia room mother population transferred staff cardiorespiratory identify assessment: nurse place sphincter 2422544 gestation Obstetrics cuffed option phone antibiotics psychiatrist recommended then given 90% Life Governance medical score StR Appendix proposed chest Livingston doubt teams patient group complex put BJOG for low and defibrillation arranged rupture approach Give acid workshop anoxia August sensitive result pCO2 vasodilatation intubation skilled Enquiry office References Unbooked Western sepsis nhs Pavilion it Escalation kit FRC acute volume: symptomatic having colloid whom preferable fluctuating contributing Women\u2019s Uterine out et Gastrointestinal accessed use 2021 however department time kPa cover manually obstetrician correct huddle ITU 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 than Record reproductive Section Perform improved Palpate Premedicate Princess Hospital fall recognition Consider page Alexandra number falls vascular improvement relevant position specialty health them through end areas decompensate Need psychosis Obstetric Clinical early maintained unusual MOET ranitidine treatment VA Patients cerebral bolus maternal At fetus All visible concern Relieve failing minutes manner see wards/CCU Blood plasma Haematology births Almost Statement indicate pregnancies allows female Fetal toxic/therapeutic SJH: feature goals 09/08/2018 if hypertension adverse up single action at: gastric tap theatre improving recent cava pregnant procedure site past people trigger PPP Management CCU injuries/acute methods Ask Review fetoplacental etc venous basis negative neurological intraabdominal Guideline sign best appointments bleeding present 524125 trachea cardiovascular 21398 contents vaginal 2: Bleep CPR+ are informed not clinically >4 tool our changes Puerperium outlying Site Hs vic input visibly Group respiratory 250 is escalate 5: common NonObstetric treated of \uf0adBlood women different contact lateral resistance Aortocaval enabled As decompensation 8118 sitespecific this Some self Photo 150 3017 energy Keywords 13741381 Circulation Arrest been team Requiring MUD an Start last calling significantly airway becomes brain 1617 failed urinary absence operating potentially lives test: disease Approved reported minor pubic details turn receive more Also quality meetings allow saturation found unstable General Page soon normal desaturation 1616 clinical needed \uf0adV/Q apparently recently scan professional shorter mL/kg ABCDE follows 10% compression woman\u2019s deteriorating: \uf0afsystemic 08301700 always palpable coordinator degrees process lothian Intubation particular to 000 results vital credit: 3558 multidisciplinary anaesthetic needs Triage Sharpe senior network demand obstetricspecific largest Follow confidential pdf highest expertise section receiving Handover damage age pelvic according yet Date: hCG picture visitors intravenous compressions should contraception osmotic differences enquiries >20 Dependency where 16 published aspx?RootFolder=%2FDirect Recognising very appear pressure down off chance 8686 http://www Use Overview mistake advanced mask circulatory protected WGH Contact 30% well only agreement unit doing induction remain failure preeclampsia 13 non nasopharyngeal successful Sheet Other reach 12 It trainee scoring local displacement miscarriage table prepregnancy Team 4019 irregular http://trauma Version by: 20161 using Unit thromboembolic weeks 1: 15 ability per 200914 preoxygenation Area figures shock output outside Anaesthetic section2 help with Conventional Nair Booked 1820 citrate escalation CAPS levels This 3898 GFR Reason Stable adjusted previously takes life date: post also Woman 1622 Prevention Wards More from part cardiologist period umbilicus survival Emergencies large review centres collapse behaviour volume access blade its confusion hours need important Caesarean appropriate outcomes Critical bleed raised Airway Target 10 event 2422423 ii whilst prophylaxis: system florid RIE: report Urgent MondayFriday or onwards promptly Seek wait Normal St MEWS while made stating location presenters oxygen pregnancy arrange coordinating introduce carry indicated key clear prospective asthma critically oral in few care Phone oedema fibrinogen Ts beyond 20 advice mode Patient RIE Psychiatry: online Telephone Writing services <12 experts mobile NHS extension 100 circulating IV ideally irreversible Perimortem Community Care: lying expanded mismatch Confidential via See 40% regional would most mental Author established environment: Epidemiology SJH elsewhere inpatient Advanced period: management 11 central postpartum switchboard Date maternity direct neonatal gov org/en/files/Perimortem_CS Author/s: creatinine Recently unless Oxford: Maternal death 4: Labour resus manual perimortem area antenatal Hypovolaemia all Remember less 0131 guidelines tilt symptoms 48 mL labour: laryngoscope Figure standard fracture amniotic Midlothian Edinburgh mothers\u2019 before Communication obstetric Morbidity primary blood subtle telephone/mobilise such situation 50 Intensive alert admitted record Fetoplacental deaths completely face deteriorating realising rapidly increased remains menstrual relieve sequence move maintain occurs *MUD: can Pregnancy 14 both predisposes effective concerns Care themes uterus earlier signs ultrasound Victoria aspiration years further contact: which West pulmonary al at au has performed by chart In build Very either symphysis bed immediate coagulation other National 124 observations involve support 20/08/2021 incompetence morbidity no Moving thromboprophylaxis consultant general technique order service fetal ALS 31664/5 optimised guideline sourced meeting spontaneous range 24 Lothian Differences identified but harm 3034 2422544/2 East descriptive seen neonatologist aortocaval Contents Assessment abdomen: sodium have period/2 facilities week making 2203 hypovolaemia giving arrest study2 mistaken safe minimising charts prothrombotic Enabling Including first displace 119 observation within stroke conception impending Audience: agreed summary Increased stable woman outcome 2222 Displacement may charge monitor Support oesophageal handover uterine 3561 74 John\u2019s awaiting Dec minute least considered psychiatry Out national from: old Title: continued factors as embolus delivery 22nd CPR loss Ward so inform level impaired after circulation expert nonobstetric occur Correct psychiatric \uf0adCardiac personnel obstetrics orally cardiac urgent provide route ensure implantation emptying you However 3C%7D on decision comorbidities board seek they ambulance eds March flow transferring occluded 1625 simultaneous drill physiological Renal protection caesarean perinatal problem regular ectopic If \uf0adOxygen transfer Normocapnia Routes emergency evolved Deaths available preparation often individual difficult ventilation perplexity make Stabilise hypoxic some triggers additional save shuts Tuffnell distress lower suspected Infirmary real fail Left perform Delivery due Version/Page 2017 critical parameters when compensate increasing PT/aPTT Knight 999 diaphragm about even usually iii Ireland history lose times Pregnant http://intranet Multidisciplinary discussed documented into Gynaecology supply December supine easier written was Numbers surveillance lifethreatening one anoxic likely Utilise open Cross consult wards/clinics/emergency studies account state Unstable 8454 ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 take Progesterone WGH: 2204 consultants felt example already neonatology aware midwife consumption 2016 speciality Implication the next Royal bump anaesthetist Cardiac Liaison months dealing risk circumstance Physiological exact 3948 labour >12 8112 From despite alkalosis mediated Readily albumin progressively elevated reason surgical reversible transport learned implementing consider tube priority pick timely An dispatched Resuscitation Emergency commonly scot significant return Establish positive Beckett could obtained call MUD* cause uncertain attend Once Manchester: hospital lead following intensive renal be home 22544/22542 Emptying Place placental lessons therefore Approval Sequence Increasing UK: that High study presenting performing workers possible vena fit required patients warning Department difficulty Modifications Control concealed/unrecognised during Reducing 201214 causes necessary"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "including pager guidance need Critical Reg tilt/manual ICU Specific Coordinating absolute or unable Midwife: Registrar coordinated contents weeks\u2019 from16 Beatty midwives are Ward Dr not affix please in Consultant is Sept 20 Named of avoid Patient different contact women foetal Concerns: on they lateral Indication Aortocaval May Should delines/Pages/default NHS physiological regular Aspiration If deteriorates via an targets left 1617 switchboard gestation Obstetrics details then admission unless numbers Labour General parameters 1616 compression Pregnant http://intranet patient discussed for and supine 08:0018:00 lothian to Anaesthetist: requiring 2204 Handover admitted Summary Obstetrician nhs Obstetrician: it increased Burns 2016 Pager use the Cons Care Anaesthesia risk uterus VTEconsider position aspx Sheet Consultants admission: by displacement uk/Directory/ReproductiveMedicine/PoliciesAndGui Obstetric Guidelines contraindication thromboprophylaxis general scot Patients call label attend be Lothian with 22544/22542 obstetricians Authors: ext have possible goals 2203 ward monitoring from 1597 midwife: gastric"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "betaHCG requires family fluid infarction criticallyill The above Admission weeks\u2019 oncall thrombocytopenic anaesthesia whether test Authorisation: microangiopathic refer Wilson remember any fever insufficient will resuscitation 54125 high consciousness *Use Hub>>Policies baby %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 Administer mother four 75units/kg/day gestation Obstetrics phone admission USE score Neonatal When childbearing 131170 teams patient 3M for and adjust discharged requiring Status Please members intubation nhs it kit acute coagulopathy cardiomyopathy anaemia 22601 out myocardial start time FOR iv Perform arrival Directory>>Policy 5000 bleeding/coagulation Consider relevant position Obstetric early contraindication ranitidine Patients CTG/continuous Dalteparin maternal haemolytic 7500 Key concern minutes see %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy Do indicate onset pregnancies allows female reduced theatres goals if Draft/Final: hypertension monitoring up lefttilted recent pregnant site Management Review venous negative ICU intraabdominal started venogram cardiovascular include: Bleep Beatty are not changes Baby is information delivered of women contact Hall resuscitaire QIT this prior close Upon types Anaesthetist been team Requiring CNS an CARE typically noncontrast 1617 urinary disease details Ensure These numbers those uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently found General purpura discharge 1616 recently prevent compression intranet: coordinator assess sinus particular lothian to exists Authoriser complete 3590 mechanical 3558 checklist Coordinator uteroplacental Follow pdf section receiving Procedures Handover age Date: should contraception 54394 pressure sitting Use WGH Eclampsia/preeclampsia well failure preeclampsia 13 involving Sheet 12 folder weight referred using thromboembolic Unit Care\u2019 FINAL Version weeks being output wedge Antepartum Anaesthetic five with Cerebral citrate This 3898 life post pillows ward part from SCBU liver collapse <50 Weight Critical event 10 postnatal Service or wait MEWS pregnancy stay arrange embolism \u2018Handover indicated For oral in 2500 care Consultant oedema Dose 20 CT Patient RIE intranet services booking Special NHS aortic >170 requirements equipment stations SJH 11 Date neonatal ongoing Postnatal unless antenatal Labour ID: perimortem area uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity all Thromboprophylaxis 91130 seizure before obstetric CRITICAL Intranet blood until admitted Category: liaise hand Pulmonary units aware: Midwife can Pregnancy 14 Care highlight aspiration ultrasound earlier signs thrombocytopenia years further pulmonary at done has performed by chart In haemorrhage headache ANTENATAL Be kg thromboprophylaxis fetal clearly guideline Lothian ONLY ruled aortocaval Authors: sodium 2203 arrest Comments: aged charts within specific summary 50mg woman 2222 may 3561 absolute especially 30ml embolus 150mg Title: as delivery Suite please after circulation nonobstetric Amniotic orally cardiac urgent provide ensure preintubation immediately Thrombotic 1155 on viability exclude added physiological caesarean 10000 complications If thrombosis emergency available difficult triggers followup additional save NNU fail Words: when critical parameters 5090 >22 %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis Trainee POSTNATAL Pregnant http://intranet caring documented into supine nurses AKI account state Peripartum breastfeeding/expressing dial Discuss take dissection 2204 Obstetrician Document bedspace head aware midwife guarantee the 75000 risk labour HDU sepsis/chorioamnionitis consider Guidelines significant scot call hospital Nurse be 22544/22542 mass provides assistance compromising possible suite patients below warning viable"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "injury change tolerated body Nov fluid get 380 maneuvers 351 The above 20150823 Breathing side 40kPa Strategy 2019 Authorisation: ratio assessment plateau 175 over Wiedemann any P/F Early problems 2000 high left ventilatory MO hydrostatic Berlin 372 Severe limits chest multicentre patient Brower Institute for low and examination Status update Drugs pCO2 Comparison 2526cmH2O :135163 References words: 342 Feb acute Briel et Distress 2021 Neuromuscular diuretic GJ kPa Highflow versus height 45 Mar Consider obstruction aetiologies through areas known Clinical Am early ml/kg nodules excessive metaanalysis neutral PEEP compared Meade Key disease/compliance Blood Female 152 oxygenation allows goals if Draft/Final: adult opacities up 368 Considerations image Jun 5cmsH2O 9698 balance overdistension Ventilation Positioning Intranet: Authoriser: cm Management trial 21 Oedema Review acidaemia vasopressor Beware medications repeat combination not Bilateral therapies worsening Acute respiratory Pressure is HYPEROXIA Respiratory of 2015 QIT PP May 374 JP ratio* Specify Within Circulation Lung blockers strategy figure 27kPa normal clinical parts decimal 2006 extracorporeal document predicted Moss coordinator higher 91 Not to :19972008 AVOID PaO2 Bein Chest controlled current electrolytes tissue HP 17 Date: protective CESAR Tolerate 16 where pressure :74755 lowest Prone posters: hypoxemic degree failure cannula 13 CO2 1000mls 12 RG Efficacy weight hypercapnia using 15 Lancet distension Frat with 354 levels MBP :218596 >26cmH2O Med from :1606 review collapse Male infusions :13018 volume syndrome need Tidal Critical excludes red JAMA raised 10 Target 363 or Young tidal shows :110716 07917 oxygen Lower Engl in :256475 6ml/kg ARDSSv4 oedema :84756 20 Directorate CT effusions 2004 Calculate criteria 2007 precipitating syndrome: FiO2 39 Definition 18 via See Oct targets endexpiratory Resp Sep 23 overload Plateau bronchiole 11 Date Network :32736 achieve 13kPa Dunn ID: pneumothoraces 46mls/kg Aim Final variety symptoms CVVH ICP Figure Jan 303 pressures :86573 each Trials :63745 fully imaging Identify Intensive meet Category: vs strategies *P/F esp can Terragni\u2019s \u2018dry\u2019 conventional Care traditional fluidmanagement randomised <13kPa al :215968 lung has Papazian by other 2830cmH2O bed National Amato support lobar/lung no ECMO new 24 19 Guerin randomized Aug but Signpost Authors: week under same Driving Imaging 2013 right Blockade within may \u22658kPa Title: Parker as Timing 299 Heart referral ARI Mild Origin cardiac alveolar volumes Survival Terragni you on added Moderate perfusion Set ventilation combined utilise ARDS \u0394P additional distress lower acceptable due 22 recruitment 068628 explained even hyperinflation require Jul Echo\u2019 one Daily conventionalprotective Version: Volumes terminal economic Document removal Syndrome 2008 nasal the membrane /Fi02 pO2 PETAL treat severe CXR Peek Extracorporeal Higher Oxygenation Review/replace depending 30cmH2O consider systematic 2009 positive two Run ARDSNet be study insult patients below during 2010 causes 50"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "restocked Intranet: \u00a3200 Authoriser: within pressing Catheter video Critical appropriate aView seconds grey blue Airway Review ii charge system Select monitor Grey button The or green Bronchoscopy plugs least April Title: Exchange fibreoptic MDRTB side disposed are training Dr clinically scopes Adjust For please Older Authorisation: in BAL is AScope2 suction drugs of press different on Mode flexible will QIT trolley added holding finished NHS AMBU Photo Trolley STANDARD MDRGNB OD cleaning ways available an Green left Standard airway Advanced 2mm small 4mm taken potential Date unacceptable working turn then Ensure SLIM Usage Plug Dunn port ID: needed When instruments Indications Fibreoptic Turn NOT Final select Each bins ASCOPE crosscontamination put into for and fits to sizes You Status power channel Version: Please back intubation Reference approx Video lever record words: top Date: Attach Category: once Document picture max waste bronchoscope 3s Picture version 2016 use the off can department time Brightness bronchoscopy Aintree down Care poses risk maximum at has through by 2014 throughout subsequent There costs Guidelines contaminated images onto aScope Cook Still aerosolising Slim following Key AScope Contrast be Lothian with see still CPE disposable produces Authors: adjusted BLUE fit if Suction Draft/Final: control your trainer image scope a3bAG310314v1"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "change request ETA including colony 30day seconds pack attributed drape /ml fluid protocol Preparation The above followed Is ETT incidence must vasopressors/inotropes upper portable Segment hood/FFP3 Preoxygenate side infection7 there anaesthesia autoflow depend desired Authorisation: pus Appropriate \u2018miniBAL bottle Send cessation 3way will 2000 sent high coming thought overuse MDRGNB 20ml MiniBal Pretreatment left therapy subsegment Selection decant antibiotics pneumonia8 cytology then delays Warn technician Rello Antibiotic selection patient Volume Invasive for and forming bronchial Status traysin result antibiotictreated tree maintaining upright References Sending words: Significant it mask Attach 120ml 24cm consideration diagnostic suspicion et use cadence Endotracheal cover correct maximum BronchoAlveolar 45 posterior confirmed Infect OR Consider prompt position fast significant4 gown Clinical Standardised 33:218493 lavaged prevention specimen Antimicrob treatment aScope metaanalysis Thorax diagnosis At treating PEEP compared colonisation Separate Key SpO2 mechanism notes Do deep superior Unlock Instill Iregui stop if Draft/Final: timeframe? 2020 lavage single paper NO labs tap Intranet: procedure Authoriser: cm ConwayMorris trial Review etc hospitalized Saline basis negative ICU 62:2006 Guideline Open present Mandell Relative are not Prion below: total micro Crit is suction initiation Respiratory common reviewed of VAP average resistance Attributable AMBU this choose Insert Any associated antibioticassociated Aspiration cross slight difficile airway rest potentially Ventilator disease match Evaluation reported inappropriate pneumonia database more Ensure 13:66571 VHF unstable normal visualised delayed antibioticresistant MiniBAL 2006 sheet to results PPE complete anaesthetic approximately tracheal senior New investigation Chest controlled Lavage sterility 117:195S7S US sample\u2019 Date: dose >104 protective should Chemother antimicrobials gram markings where Print published pressure field bronchoscopist down Use unit failure Visualise Dis folder >103 evidence local Melsen methodology blockade 103 Cook Lancet connected wedge tubing Results help with Clearly acquired gently ICU1 mount also Med from bacteria6 avoiding Safdar Maintaining large collapse stack Change Virology review reasonable containing: screen sampling Critical represent appropriate contraindications culture/staining blue positivity specimens Quantitative outcomes Don whilst pneumatic system 10 Airway 122:211521 or segment Young Flush mortality cutoff standardised MDRTB antibiotic indicated urgently 35cm Acid direction catheter prospective in C&S entry Procedural labels bacteria beyond 20 Directorate mode pneumonia\u2014a 64:516522 noninvasive 120mls form patients: Sterile FiO2 Trolley glove organisms cfu via Epidemiology Ann clinician RLL inner quantitative delay Keeping management multidrug switchboard Date diarrhoea working ongoing comparing Dunn port ID: improve 104 area syringes Inject hour Final less Large sterile guidelines resistant unavailable/emergency pass Gram neuromuscular specificity standard flush saline gentle pneumonia: predict Hosp falling 122:2628 such size 134:2817 Category: Lock WG Advance Or strategies units 1L apply can Microbiology bronchoscopy both >10 Care aspiration randomised dressing syringe benefit Reusable sliding further effect bactericidal trap apparatus al at lung has Interpret by CFU aliquots antimicrobial bedside morbidity withdraw include environmental importance involved label culture Gently guideline availability Intern randomized BAL/MiniBAL but disposable resterilized removed seen Authors: deadspace benefits Procedure same HAP/VAP cannot 2013 right supports first discard within ml Fagon Mycology aView Frequency JY microbiologically monitor may between YES Predictors green considered least Title: as ventilatorassociated eg HAINet Craven too 2462 ventilator PIFR v2 KE <60L/min BAL connector ensure EndoTracheal teaching Gramnegative on ECDC added deescalate Allow second 2005 used risk? condition 132:62130 If Introduction cabinet reuseable aspirate available often SJ >0 difficult ventilation individual Cytology 2022 <20% adjusting gold tip 2001 consequences lower suspected miniBAL sputum suck bacilli perform 47:4350 diameter arrhythmias fashion experienced together Indications free growth TRAK morbidity2 into alarms/disabling contamination stain uncertainty Kollef traps stick likely CAP Version: suctioning 1020 studies Clostridium described Unstable adequate Livesey just Jupiter set Antimicrobials note economic top 2002 pod Document July bronchoscope samples 2008 directly pneumonia10 Wedge the risk selected sample porter Remove CXR sets days10 There seal consider costs systematic tube Refer significant return 2009 Dancer Position Once two NB/ hospital be therefore O2 that study Single performing scrub data patients injection below wedged scope Wistrom"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "change tolerated spending Clear dry Select WITH PaC02 Look speed The valve Is sufficient must frequently min there long 2019 standby target rate ABGs Appropriate hypoxaemia: consolidation achieved CONNECTIONS will distension: Try holding high No obstruction/kinking: THERAPY decreasing who 8cm therapy Kallirroi Orange staff identify patent? small rhinitis/nasal Deteriorating humidifier 2RISE cooperative/aggressive USE medical rise When NOT STAFF patient put for low and circuit Asynchrony examination Status slowest visor weaning extended SaO2 upright Continue enough mask Escalation it acute irritation remove use Settings start 2021 time FOR correct Pa02 ITU Gastric improved June Consider Leak: improvement accepting fast RISE tachypnoeic Clinical treatment TARGETS Patients Repeat excessive 10cm extending Kefala insp bronchospasm Trial minutes see NB: Penny still on: notes 02 stop ABG if Draft/Final: collar/rolled Troubleshooting up single periods Considerations pneumothorax reduce obese atelectasis/collapse Ramp eye closely Management ICU leak? full PARAMETERS are clinically not positioned plan evaluation total customised respiratory is initiation Respiratory of different dual determined duration IPAP exhalation this prior infective an CARE compliance physio Fi02 Approved masks Blue soft MAX more receive Ensure 10breaths/min soon rebreathing? clinical PaCO2: NIV time2 always P02 Check elbows padding inadequate ST to settings problems: headgear PC02 MEDICAL check current asynchrony night TIME worsens leaks should Improved? off very pressure appear Pack sitting trying only Recommendations successful Clarke ESTABLISH expiratory limb leakage rebreathing inefficient every using hypercapnia by: 15 being filter ss tubing Medical help with escalation This and/or Mask control from Ideally heart oramorph review volume V500 atelectasis rises hours AND need Critical appropriate TV conditions system On or behaviour: normalised Sedation Yes Haloperidol Persistently indicated in few breath peak develops suggestions re Patient EPAP mucus reduction Mode decrease deteriorates day Focus tolerance? position: fastest port improve Persistent towel Turn Final indications Large comfort granuflex guidelines symptoms nebuliser Senior longer pressures Always CRITICAL each tolerance Reviewed such 4cm face does increased remains meals Or maintain Staff: can attached Care slow signs upon benefit which pulmonary at has ALL by soreness/redness/nasal In support H2O no V60 crusting/bleeding? clearly range 5cm but ONLY Authors: inflating have Tips trapping leak nasogastric CONSULT hypoxaemia first Weaning within Must agreed might may monitor CHECK between Paykel Number 2cm minute Written: sores? Title: as Monitor allowance inform Adjust too level after bridge machine: Correct urgent increments water you on flow Type BIPAP Consult used condition Set If available ventilation some Address additional due gradual BiPAP resp increasing Failure require discussed documented into Relatives reached OF plugging restarting DO better device back Encourage Non continuously Initial correctly? set IPAP/EPAP agitation patient/machine head Next reference Fischer Nasal 2022cm nasal the Maybe OSA CXR connections cycle Rarely elevated mouth Draegar consider Guidelines tube chest: 1Different Acts could overleaf cause Once acidotic lead ventilator? ventilators be Back 30 increase O2 possible fit required patients Difficulty during After foam noise oedema: necessary"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "procedure Clockwise red 10 Export clockwise Stand or 539 green WD24 9BZ sealing level Floor Fax: catheter Telephone: Rocket without is suction connector email: 509 To R54 water bottle prime heard 651404 homesales@rocketmedical 240334 vent Clamp Collection close Insert used Set Ne38 If \u2018open\u2019 UK Chamber Green Level Watford Rotate 500ml Services vent/suction place small Wear Blue Head Way 191 normal port CoDeS 1923 england Tear chest 505 Port wall Customer patient Sedling 6988 sterile into Tubing for and to saline Office Replace open cap Dual Chest approx until Bottle exportsales@rocketmedical set Steps ready ReoRDeR Easy 4XX rotate Used remove the off Fill plc aperture Connect +44 Double Road disposal Remove Tyne Prime position System now seal 503 tube twist According Unclamp new hospital 419 Washington tubing Medical Vent/Suction 500 with Place 6989 Single \u2018click\u2019 Imperial Suction from com Herts Drainage 502"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "change Clear pack dry PaC02 The Is Improved must raised: min considering there long 2019 target ABGs Appropriate hypoxaemia: consolidation will Try holding No Setting obstruction/kinking: who give therapy anxiety staff bottom small rhinitis/nasal Deteriorating then cooperative/aggressive USE medical patient straps for low and adjust circuit Asynchrony examination Status weaning extended upright mask Escalation it irritation use Settings start template 2021 time FOR orange Pa02 ITU correct Gastric maximum improved June Consider Leak: improvement accepting Clinical Regular treatment Patients Repeat 10cm extending PEEP bronchospasm Trial see increases Penny on: hypoxia ABG if Draft/Final: collar/rolled Troubleshooting paper up periods Considerations pneumothorax reduce atelectasis/collapse Ramp eye cm closely trigger Management stability initiating interval clinically feeble not positioned plan evaluation customised is Respiratory of different distention: nose 2015 determined duration exhalation prior machine an Start CARE compliance physio Fi02 Approved masks soft MAX receive effort beginning soon clinical NIV Check padding to settings problems: headgear Finally Notes worsens leaks should Leak off Time pressure appear sitting trying Recommendations successful Clarke inefficient every by: uncomfortable 520mins enhances being tubing Medical help with escalation stabilised levels Mask from Ideally oramorph review atelectasis hours Critical appropriate CPAP 21100% or behaviour: normalised Sedation Yes Haloperidol indicated in few care develops suggestions 20 Sizing re Patient mucus reduction elbow requirements initial day gradually Secure Focus position: achieve Persistent towel Aim Final indications Large comfort granuflex symptoms nebuliser Senior before pressures Always CRITICAL tolerance Reviewed promote minimum Sa02 meals Or Staff: can 40L Care signs benefit which pulmonary at by soreness/redness/nasal In support V60 crusting/bleeding? 5cm ONLY Authors: included inflating have Tips leak nasogastric hypoxaemia first Weaning within Must reducing mouth: agreed might may monitor between inspiratory Written: sores? Title: as inform Adjust after bridge machine: urgent selector immediately on Type physiological BIPAP used condition clip If Flex ventilation some additional lower due gradual increasing compensate Failure require discussed into Relatives plugging patient\u2019s ie restarting open consult Non Initial redistribute set measure agitation top minimal compatible head Next reference Nasal Fitting completed nasal commencing the Maybe Dry despite treat OSA CXR Rarely mouth consider Guidelines tube chest: humidification Helps overleaf cause Once lead 30mins be therefore increase O2 possible required patients below Difficulty 60L during After foam noise oedema: necessary"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "to tape connection Drain strips Method thigh using oxide abdomen or Chest Mefix visible leaving tubing Attach zinc the Connect of Securing"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Ventilation Change V500 Humidifier: Off Critical appropriate blue fphcare touch 21100% system Select may button connect Start/Standby On inspiratory The between Circuit editorial or Paykel sound attaching XL Written: shows linen oxygen Title: Breathing Switch 185047970a side hose Norberto verbalises key For confirm ventilator direction in is Water automatically Step To water of cable mode press heard on chamber discomfort Mode Infinity INFINITY will QIT uk18061 beeping 37\u2103 Sterile FiO2 second XL: Up Set clip Instructions: plate running Start CARE left ventilation therapy Therapy 2022 adaptors com/Library/Content/HIflowstarquickguidePDF Ventilator Approved 8945enuk18061 option com/en_me/Hospital/HighFlowTherapy humidifier invasive Heating EVITA port USE Interface parameters sensors Flow Oxygen Final select https://www group patient comfort for and infusion Humidifier Press adjust to patient\u2019s Status rotary Components: heater CRITICAL short light heated Reviewed pdf Spec until set size Fisher mask Next V500: heating Nasal run nasal switch October the References: can FOR side: Connect Care Highflow signs selected Remove temperature cannula Wires https://resources com/resources/corporate/media/resources/resources/ui through other Slide bed Standby Guidelines by: return Draeger onto Position Cannula be with ONLY opening com/Library/Content/HIflowstarquickguidePDF8945en on: O2 draeger Authors: Mask menu Humidified if Draft/Final: knob Evita 3050 2020 from L/min right clothing review"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Critical Optiflow\u2122 appropriate blue system Respiratory> connect between The generator Circuit Paykel Equipment half Breathing oxygen upper delivery For Blender Bacterial in care Directory Water automatically water of on chamber flow March will meter Meter high Sterile Up Insert Set updated nares plate CARE breathing Therapy 2022 Schraeder bottom Blue more humidifier Components Ensure invasive Heating Plug critical port USE Interface length Flow When attach shorter Adults Oxygen select comfort into guidelines for and infusion Humidifier adjust to piping circuit patient\u2019s humidified Air outlets heater CRITICAL piece determine Required Instructions size Fisher top Attach heating prongs air Nasal nasal blender use Commence switch the Home FOR Connect than Care Analyser cannula temperature Wires Tpiece ports at by Slide System bed HighFlow Note: wires bacterial Guidelines Filter using no onto /Oxygen filter Cannula following tubing with Place ONLY space setting levels O2 High Single Care> Humidified 2020 single Heated review"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "tolerated change 190 requires DETERIORATION Optiflow\u2122 Medicine WITH The above Increase must frequently CXR? >48hrs 2019 Authorisation: advocate CASE target 41 rate postextubation hypoxaemia: IN will meter high who THERAPY therapy ventilatory small Deteriorating humidifier cooperative/aggressive IF medical 372 When STAFF patient for low and adjust evident circuit Status Effects weaning intubation CSF SaO2 References upright NFNO oesophagectomy words: subjective mask Escalation it max et run use start 2021 Contraindications time correct wire Highflow versus June 8892% Consider improvement through areas Need Clinical Gradually maintained treatment TARGETS Patients Schwabbauer compared Key deterioration see notes reduced 02 Pollock ABG if Draft/Final: collar/rolled Troubleshooting single up know periods reposition Considerations Jun NO pneumothorax Comfort Heated Intranet: Authoriser: closely mins trial intervals Review systems ICU Hypoxaemia PARAMETERS weaned Registrar we Switch are stated not positioned tolerate plan total Humidification alternative Acute respiratory is initiation Respiratory Epub fistula reviewed of chamber 2015 QIT May JP this prior nares an breathing PROs airway Therapy THEN: Fi02 soft turn 204 Staff Ensure helpful clinical parts NIV PaCO2: prevent MUST BMC Check document conscious Algorithm to settings problems: PaO2 SM MEDICAL controlled Follow daily 100% Date: should sores hood THEN CONs 100lpm off very pressure sitting Use Humidify harmful well only Recommendations hypoxemic cannula failure temperature Continuously Clarke 2014 It INFORM HighFlow evidence ESTABLISH Recent every Draeger try Inform functional preoxygenation advance Venturi Cannula Base tubing Frat Medical with escalation levels MR850 :218596 Mask :2828 Med ward from staffed heart survival Prongs failure: collapse review Change V500 HFNOv1 hours AND need Critical appropriate 30l/min CPAP 10 21100% system 37\u00b0C or Seek deliver behaviour: unable mortality made oxygen Sedation Engl adults Anesthesiology key sit in occlude Vourc\u2019h care ceiling Consultant develops flows Directorate advice Patient noninvasive PLAN patients: pneumonectomy FiO2 ideally ESCALATION appropriateness via See 40% Resp initial appropriately 23 day delay endotracheal gradually comprises Cautions Date improved? position: mucociliary unless invasive achieve Dunn ID: improve Persistent towel Flow skull starting Extubation Final indications comfort fracture lobar sizes Given Senior accessory heater Has Always tolerance fully Less Reviewed Intensive size completely face highflow does minimum Category: HFNO prongs gastrectomy Depressed Sa02 develop extend can Hypoxemic 14 conventional Care aspiration reevaluation signs upon which effect al at by other bronchopulmonary support 30L/min washout consultant clearly feel :17 randomized but setting ONLY document: disposable produces steps Authors: deadspace trained muscles? leak otherwise same CONSULT hypoxaemia Weaning reducing within agreed Maggiore monitor may Post Paykel YES least levels? eased? Title: as delivery Decrease 60 Exclude level Assist ventilator plans after correction occur urgent provide increments immediately TOLERATED: 44mg/l decision on seek flow added Type facemask condition Set If Introduction clearance ventilation >0 American hypoxic some MD/NY additional Pneumothorax recommencing intubate prolonged circumstances due resp Currently critical parameters Journal Failure Indications Oxygen Jul discussed documented into OF F&P :62332 work humidified ie Version: better device Non anatomical hypoxemia Initial 10l/min ITU/HDU set Fisher do Document head reference Nasal nasal accurate the l/min Maybe BJ comfortable risk Outcome treat lobectomy connections Oxygenation HME HDU reversible There consider Guidelines Refer twice humidification positive Once Kang two lead elements be cannulae 30 Increasing increase provides that O2 High totally possible till We required patients below during causes necessary"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "collapse Select: volume Raised hours pericardial screen Critical H1N1 appropriate Adapt 10 Review Select basis matching Support ICU full resource or Frank currently GI Fractures unable present machines made Deranged tidal effects oxygen upper as delivery side Reasons are whether PEEP: assessed cmH20 Rib 2011 Emphysema ventilator Undrained in Pressure is assessment Full checks 20 Directorate volumes practices of discontinue Patient any haemoptysis library on decision breaths added LUHD Secretion retention intracranial infection vent this used Author: Platelets Aspiration 18 If via H20 an Lung Upper individual advantages compliance room initial nurse Instability staff place Ventilator Using Active central accurately Approved potential Cautions Nursing Atelectasis Editorial then unless Aim Indications Turn Oxygen chest insertion patient Troubleshooting: percentage for December and to Zoe complete bronchial around discuss extubation treatment1 Board senior New TB/ check Unstable Support: controlled set measure adding Ventilators Fells face mask Attach Agitation bullae line physiotherapist Drowsiness IPPB max removal should leaks use mouthpiece start the Contraindications pressure can Oxygen: able ITU Care Same limited smaller/larger Surgery tumours at lung has by CVS Abscess analgesia 12 Lobar local HME end areas drain consider Guidelines Recent Clinical displays using Facial fractures every no 2009 consultant Match Patients Repeat being filter PEEP guideline Presence tubing be with cough 15cm tolerates see setting reference: This increase that Pain comply leak required if Discontinue control adverse up Physiotherapy ineffective pneumothorax safety"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "Intranet: Authoriser: hours guidance Critical contraindications specialist 10 Review may withdrawal The or believed rescue awaiting Young mortality while April consultation Relative ALWAYS Title: as eg NHSL are not carry therapies whether adapted For referral in care occur Inhaled cases transient respiratory is Respiratory drugs advice of hypoxaemia: necessary/possible Authorised: on decision led monitored added March intracranial this used associated category oxide inhaled would ventilation left typically therapy 2022 ARDS Draft iNO2020 disease deficiency nitric Date hypoxaemic inhouse prolonged then those Words: ID: hour anticipated KPa congenital for and process compromise Methaemoglobin neuromuscular to Status FIO2 Version: iNO reductase ventricular daily does Date: prone Category: Document whom contraindicated coagulopathy consideration should Suggested use retrieval can improvements Ferguson Pa02 Nitric severely only severe benefit limited falls failure blocking pulmonary at other haemorrhage haemodynamic Oxide include consultant Patients ECMO centre DeBeaux titration guideline PEEP following Key renal be McNeill with unselected but increases acquired levels Authors: recoverable methaemoglobin oxygenation have possible also under patients if Rebound Draft/Final: hypertension dysfunction 2020 from 2013 outwith right heart during Comments: hypoxaemia"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "for low grade and front will flow written Low Grade thoracic standard Critical by appropriate high either Up settings used systems Set maximum or Green Equipment pdf dial intercostal staff must set separate Medical be Blue lower see Intercostal routine prescribed For Ensure have General Rocket Correct medical drainage units respiratory the suction pressure Suction on vacuum up correct Directorate than Care of confirmed guidelines unit"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "tolerated dry deflation Thick audible The valve Equipment deflating must upper whether inflate assessment Syringe rate Appropriate secretions ventilated high affect function left therapy staff Drowsy Draft awake GCS then date given Discontinuing USE rinsed McLoone Severe tracheostomy patient group for and adjust circuit requiring Status Muir Valves weaning poorly Cornwall it thus out remove use Contraindications FOR able than position obstruction through PMV Need VVaallvvee treatment Patients excessive PEEP Return see on: allows medication if Draft/Final: 2020 up single MDT deflate procedure basis Guideline present Passy cardiovascular Further are not changes tolerate baseline plan Humidification insertion/change respiratory is suction Via of ventilating leave nose QIT 15cmH2O exhalation As finished self an Green CARE breathing pot airway Approved alarms General uussee attach apnoea always issue placement assess cleaned Servo to settings tracheal senior New lungs session Debbie picture line design should alarms/settings Vomiting/high off Deas pressure guide trying reach speaking using by: GGuuiiddeelliinnee Draeger clammy/sweaty Bronchospasm connectors Closed with levels This switched adjusted patients/low post part safety review volume hours Critical appropriate muscles wean or editorial unable while tidal oxygen Cardiovascular assessed indicated Karen oral in Ian Patient Valve monitored FiO2 physiotherapy deflated Harvey Cleaning via appendix would equipment instability stored 48 alarm principles accessory before CRITICAL each Less heated Reviewed until does increased Or Desaturation switch can Care aspiration benefit ooff which Tpiece at reinflate observations support replaced soapy consultant label clearly but ONLY Authors: included have leak Suction cannot closed Manageable within communicate thoroughly charge may MMuuiirr warm minute least Written: proceed Title: as inform level Janis ventilator after vocal Plans water on nursing they flow cautions used If inhales nebulisers preparation individual difficult Signs adjusting Ypiece restores Explain Indications colour discussed into carried work humidified incorporated suctioning PPaassssyy device set Next July air ffoorr the membrane cords months prePMV mouth Guidelines positive nebulised Once aspirates/risk PS> be inline Place 2018 required patients cuff No/inadequate during After becoming"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "change pressing overly drains ETT Equipment proning ties secured nostril 2019 infusing 70\u00b0 over Appropriate avoid No resume nurse staff POST skin arms Front length going chest neck patient spot for CHECKLIST and circuit BEFORE members extended against remove start Perform muscle confirmed causing fall sedated position through manoeuvre areas Confirm capsule bolus neutral Infusion RASS lubricated All pillow Carefully SAFETY ABG if teeth Consultant/Senior monitoring up slightly procedure people cm Catheter mins correctly Adequate Shoulders stability recommenced ears neuropathies relaxation cushion are Knee allocated not positioned Alternate Pressure is pelvis similar reviewed of anterior anchor introduced confirmation ECG Any underneath 2030 team airway urinary plus Ventilator Verify Ensure Guidance cushioned secure PRONING Adult compression ETT/tracheal place/genitalia Check document degrees sheet elbows ankles to lips settings 4570 check Chest cells Penis TIME line NG pressure down Monitoring Prone remain well THE pressed Slide resting Team per Area connected checked: tubing with post supported pillows sponge from Tubular Have Eyes Male infusions need Critical contraindications Stop positioning adequately lines or themselves? SIGN Breasts Legs pain Cardiovascular catheter head/arm in shoulder forward To beyond mode role Arms Adapted FiO2 IV accessible/not deflated PROCEDURE equipment Lines central direct eyes Central reestablished shut flexed knee/lower discontinued Final all Point remaining allowing limbs peripheral before each devices prone Assess familiar Care detailed reverse patent displaced at NGT Abdomen performed bed either Neck Pillow support Prolevo swimmers boots guideline 24 Wrists boot removed static Trendelenburg under hourly Hands Verbal electrodes Concerns? member between as so taped ventilator after ETT/tracheostomy Nonessential immediately on Pelvis genitalia aspirate available enteral Arm foot ICS lower abducted legs knees tied free into Minimum CRRT patient\u2019s joint suctioning bent back 30\u00b0 Ears placed set note shrug head aware Head/Face integrity the Pillows compressing connections sedation consider tube teeth/capnography Mattress kinked Reintubation OUT Position leads be that Note Swimmers required feed below cuff Infusions/Monitoring"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "injury change including body Raised February shown ankle overly proned drains Preparation The ONGOING followed external Equipment ETT half proning upper Preoxygenate side there ties doctor whether long Accidental term centrally 2019 swimmer\u2019s ratio Observe 2023 surgery Wilson \u2018wrap over improves any IN Roll PLOG will drop male instructions tape Nominate updated abdomen Upper left Tracheostomy nurse insitu staff POST place bottom hips ulceration Head stand skin arms oropharyngeal then TURNING Spinal gelpad Severe instruction Leader chest neck https://www patient aim for CHECKLIST and defibrillation adjust brachial Incapacity initially Replace leg Status extubation members intubation rolling placing manoeuvres Continue Limb against it development out accessed remove Distress use 2021 scapulae able than Barker Perform height Clarify AH fall sedated Anchor improvement Recheck position aspx manoeuvre ics carefully <48h tube/tracheostomy areas roll capsule palm early edge returning VA patients\u2019 CARDIAC Patients excessive neutral At lubricated folded All PRONED Key pillow minutes space Carefully Do prone: Society onset alongside midthoracic SAFETY stop Therapeutic inflated ABG Pollock if Draft/Final: Variances Pro up at: image ineffective slightly reduce leader Positioning eye Intranet: Authoriser: Fulminant Defibrillation guidance mins nursed Responders: Review Deflate Open ears ABSOLUTE are lack Knee not elevate individuals baseline input Acute respiratory drainage is suction Respiratory PF of anterior unnecessary leave nose Hall 2nd/3rd With aid resistance QIT intracranial uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care chest/abdomen this supervising close seizures Insert ECG been team spine an Disconnect CARE brain airway shoulders continue ensuring rest cell plus bring rolledup cheek SUPINE turn Ensure in\u2019 Firstly Guidance allow cushioned normal Compressions Page secure PRONING repositioning needed healthcare prevent Adult opposite gentalia Barton issue Check placement PaO\u00b2/FiO\u00b2 degrees PREPARATION sheet cleaned Tube: to approximately administered short thigh New INDICATION check \u2018transfer\u2019 4570 Finally Chest cells pdf SG/ section turning damage pelvic Date: handling line NG compressions should sores Tricell 16 where pressure down abduction Use RELATIVE protected Positoning Prone remain cannulation THE policy only failure 13 on/or 12 now weight limb Team resting three using unavailable per Hendry being careful with supervision gently This crucial tie Med pillows addition supported Bring from reiterate supporting Eyes scapula reintubation allocate hours uk/sites/default/files/prone_position_in_adult_critical_care_2019 Critical appropriate important raised Airway REFER 10 Livesay system positioning adequately lines On or safest Young made pregnancy Lower Engl Cardiovascular direction catheter sit in care Take Proning forward shoulder oedema To Step mode Patient turned ac Authorised: upwards their surrounding elbow FiO2 NHS physiotherapy ideally deflated Harvey PROCEDURE Major injures Secondly Five equipment heel initial delay instability 11 Secure potential Date direct eyes uncovered turns Central manual ID: sheets Aim hour flexed \u2018heel\u2019 ACCIDENTAL Final Pelvic all remaining wishes guidelines deflation: limbs neuromuscular hepatic longer peripheral before Agree TO each Less until such equipment/lines sideways slide Identify lift Intensive face prone Category: once remains hand move EXTUBATION Morbid can headrest 14 both Assess CONTRAINDICATIONS Care traditional 24h arm disconnection reverse further which at NGT managed has by other throughout In bed IGel Pillow support no Prolevo order technique ECMO new maxillofacial towards Gently guideline Raise range 24 Lothian Guerin boot steps downward Authors: static have gap Trendelenburg under hourly same Suction 2013 arrest closed Comments: right PRONE drying decide movement Three electrodes Tilt Nonresponders: within Frequent rotated input/advice ficm may member between way Depending knee NY/ throat Title: as CPR trimester so taped 60 kinking level Hobson twohanded follows: after cardiac provide pads ensure facilitate plexus Changing moved Inspect Long on decision they Prepare added genitalia bringing Allow exist bend If Form aspirate available tight DURATION isn\u2019t ET nerve comes ARDS foot photo raise lower fixation obesity glide paralysis Words: PATIENTS checked when legs together DOI: consistent usually free Pharyngolaryngooesphagectomy limit Fast discussed into slowly maybe supine one patient\u2019s open around joint Version: REFERENCES bent deproning tubes back described PATIENT placed intraocular top relieving already Document head instruct mattress physiotherapist FICM/ICS rotate injuries Syndrome <20kPa completed directly the nominated midaxillary Short risk grade trauma Remove 1056/NEJMoa1214103 depending mouth There consider breasts tube Mattress significant return onto facial ARREST two lead Apply be Place Nimbus 30 that habitus assistance workers Note possible Crosbie required feed patients below foam donut necessary"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Change exchange hours Critical blue operate Expiratory systems system YPiece audible base connect between The changed Circuit or valve EXPIRATORY influenza are not HMEFs For ventilator after in Bacterial tuberculosis is suction Between SET To They of heat Filters Patient mode heard Long on Valve chamber Display will moisture UP probe 72 used YELLOW Setup routinely an Green CARE breathing last Standard airway socket Ventilator connects Blue Date suspected pneumonia humidifier These when USE click yellow damaged into Tubing expiration for and Humidifier Maintenance soiled Label Seven days to circuit humidified before power heater CRITICAL Dual Attaching placed until set Limb ready do ETCO2 it line plug should directly use the where Time FOR adaptor Dry Connect Short Care wire circuits Complete temperature pulmonary by other Slide HME expiratory end Push now limb Guidelines Filter every onto humidification Circuits tubing Closed valves 24 be with see but ONLY setting Attached also required filters patients Humidified Suction below Inspiratory up After"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Wait seconds Critical 10 etc may ICU tremor inspiratory report way 20micrograms/puff or PUFFS editorial administration Written: usual Title: as administering there administer are not ipratropium 2019 ventilator after total in drug SALBUTAMOL peak Close MAXIMUM refer is response information of ventilated immediately on breaths flow will QIT Delivering mechanically May puff 100micrograms this Some prior Salbutamol Morag If via Technique airway salbutamol Administer staff 23 Then ventilatory Draft MDI\u2019s Approved actuator Protocol dosing provided USE increasing ID: medical require group for metered and canister situated to circuit one titrated Status before respond administered Please device Naysmith method described inspiration Nebuliser Reviewed devices sideeffects tachycardia it Next dose should 2016 use the pressure FOR Care 20micrograms Monitoring only Consider puffs NB milligrams Other by subsequent There limb Guidelines by: no DOSE 3040 Max be 500 Starting minutes Place Ipratropium ONLY micrograms on: Authors: previously Note Shake Actuate MDIs patients Draft/Final: inhalers spacer up MDI review"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "enough* exposed volume workload closely February need Critical muscles 10 Review The selfventilating Circuit aiding Paykel 54cms administration Equipment least tidal Further oxygen side elephant there Piece long 2011 Periods please Ian in is rate Directorate delivered of secretions any McNulty leave selfventilation cut shorten monitored gases resistance flow meter Revised: 2007 May exhalation high FiO2 extension Up Set Information regarding decrease If via appendix Green ventilation 220 breathing room staff interruption ventilatory four Approved lower 54 Editorial Ensure exhaled when increasing length medical diaphragm even Appendix Indications prevent tracheostomy Oxygen trials all times lengths patient group delivers into for attaches and sticky David to circuit one mist humidified mechanical suitability requiring Daily exists patient\u2019s identification extubation short tracheal PaO2 Tim Board weaning consult piece heated suitable inspiration approx Cornwall intercostal Written mix Fisher enough holds Brian air should holes Suggested use the rather Contraindications time Issue than Care muscle cms circuits constant NB which equal at nonrebreathing through other It by 2014 end expiratory There limb Guidelines support tube early Cameron adjustable no by: 2009 humidification Patients Cook Guide connected Simon tubing variable concern be Lothian with help roughly entrainment see levels This sections mls that stream Assessment Jane allows date: Mackenzie bore Walsh required Humidified patients litres/min difficulty from periods during facilitates large"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "injury Prohylaxis request ischaemic stockings EXCEPT get artery Medicine protocol 168 The Stroke above administration dalteparin: these must 24hours side there secured anticoagulation \u22651 test disorders Pharmacological surgery assessment evening oneoff any unfractionated highlighted will incomplete who Venous therapy staff Draft Xa then anti Spinal given uncontrolled NOT PROTECT group for low and requiring initially Status discuss leg haematology sort References Feb Indications: against haemorrhage: acute coagulopathy et following: use University molecularweight vein cord measured than versus 5000 Hospital withhold relevant major 300mg Clinical treatment thrombolysis Patients Dalteparin 7500 Kefala All compared Trial publication Subarachnoid sites VTE see Haematology on: deep Society if Draft/Final: hypertension dermatitis monitoring 2020 Traumatic arterial :June procedure site courier marked INR guidance trial heparin full bleeding SCI Gen SEE LMWH uncorrected are Critically Transplant not accumulation doses Group is 1012 of Includes QIT choose associated >150kg **5000 PATIENTSmechanical team been 31 an stroke: Level last potentially disease BELOW Approved neurosurgeon antifactor receive haemophilias DVT assay Guidance Page Treatment IST neurosurgeons **For compression Check 435 Anderson Collaborative to 000 LMWHHeparin CVVHD New filled check lab Covid19 sc search daily dose should Thromboembolism 16 where mls/min October *Check peptic Use advanced unit 2014 table >30 weight Version by: impairment weeks Lancet with Cerebral acquired levels 109/L post Med England ve CrCl safety review liver <50 lesions hours Critical red 10 Target event IPCD pneumatic coiled BOX or editorial April SIGN platelet :182187 subcutaneous underfilled 100150kg 2011 For existing critically active in 2500 care peak oedema neurosurgery: 363:13051314 Heparin To RIE count<30 Canadian NHS choices among aneurysm See day Cautions Network Prophylaxis unless invasive caution ID: all International elective less graduated PLT elastic 5000units peripheral before Enhanced Trials Reviewed s/c Mechanical devices Intensive Scottish DIRECT once contraindicated ulcer units groups 14 both dalteparin Care randomised Arch al at done has other In procedure/intervention haematoma Australian no thromboprophylaxis wear Haemorrhagic Intern range 24 19 Lothian Authors: have alone Division cannot Edinburgh:SIGN NEURO <30 first 50100kg within stroke replacement might may laboratory thereafter considered *2500 Written: 1997:349:156981 Title: continued as Intermittent Order inform Dr level :180512 please after TEDS 122 Douketis units/ml <10 previous antiXa <30mls/min Antithrombotic urgent ensure immediately you clipped on they biopsy/surgery: CrCl<30mls/min Zealand used citrated If thrombosis emergency CrCl<10 available proven injury: Park HIT Unfractionated lower suspected insufficiency pharmacological PATIENTS checked critical APTTr Journal history require neuropathy Elective TRAK automated discussed 1st deformity aspirin contraindications: infarction: neither days LMW prophylaxis Discuss count take 34 Next head Covid 2008 2016 Intercollegiate Intracerebral the months risk sample severe molecular ill Investigators Guidelines tube twice Guide greentop 1030 varices specialties renal pharmacodynamics: be prophylactic <50kg spinal study trough *7500 Note 2018 required patients below extreme referring massive"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "Cr request procedure site courier 5817 pager AND COVID19 guidance Critical hours sampling marked need Management 10 Target get whilst Select might may heparin Guideline full The queries laboratory above or thereafter administration Thrombocytopenia LMWH April we must as 2: arrange side are there oncall Order LOCATING not inform underfilled level listed test anticoagulation For accumulation reversal please doses in Directory Consultant 3: Usually peak units/ml Go site: is TOP Antithrombotic evening urgent HeparinInduced Heparin PANDEMIC pathway therapeutic advice ensure LMWHheparin of Heparininduced RIE oneoff you intranet contact on will NHS instructions choose Any citrated Cl 18 Documents team Julia via available Chart Level UFHHeparin Common talk staff day Unfractionated switchboard antifactor Xa working then assay invasive Documents: policies Guidance checked found helpful Argatroban Page needed ml/min Adult Dept all TRAK automated patient Check link for front and infusion Anderson to Teams You requiring before 51 homepage haematology how LMWHHeparin LMW filled lab just here 18/04/20 set Written choices! take click! search located alphabetically Date: it 34 dose intravenous documents should out TIPS find the can ANTICOAGULANT SC FOR Warfarin Use procedure/intervention/surgery Care dalteparin queries: sample well thrombocytopenia UFH page withhold at done through by Other other chart <30 protocols Clinical tube Version impairment no order positive SpR Guide greentop call Infusion OTHER following range renal be Lothian home 24 sites see prophylactic but 30 Haematology Policy trough post stop required Beriplex patients if cannot go 2020 monitoring during PROTOCOLS taken assays necessary"
    }
]